CancerPPD ID,PMID,YEAR,SEQUENCE,NAME,LENGTH,LINEAR/CYCLIC,CHIRAL,CHEM-MOD,C-ter MOD,N-ter MOD,NATURE,ORIGIN,CELL LINE,CANCER TYPE,ASSAY,ACTIVITY,TESTING TIME,TISSUE EFFECTED,PATENTS,SMILES,DOI
No data available in table,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found
No data available in table,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found
No data available in table,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found
4644,8445676,1993,"2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N-
[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-
(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-
1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-
dimethylbutanamide",Dolastatin 10,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,Antineoplastic,Dolabella auricularia,DB,Lymphoma Cancer,Cell Viability assay,IC50=.0013-.013 nM,Not Available,Blood,None,NA,https://doi.org/10.1093/jnci/85.6.483
4645,8445676,1993,"2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N-
[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-
(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-
1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-
dimethylbutanamide",Dolastatin 10,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,Antineoplastic,Dolabella auricularia,HT,Lymphoma Cancer,Cell Viability assay,IC50=.0013-.013 nM,Not Available,Blood,None,NA,https://doi.org/10.1093/jnci/85.6.483
4646,8445676,1993,"2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N-
[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-
(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-
1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-
dimethylbutanamide",Dolastatin 10,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,Antineoplastic,Dolabella auricularia,RL,Lymphoma Cancer,Cell Viability assay,IC50=.00013-.0013 nM,Not Available,Blood,None,NA,https://doi.org/10.1093/jnci/85.6.483
4647,8445676,1993,"2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N-
[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-
(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-
1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-
dimethylbutanamide",Dolastatin 10,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,Antineoplastic,Dolabella auricularia,SR,Leukemia Cancer,Cell Viability assay,IC50=.0013-.013 nM,Not Available,Blood,None,NA,https://doi.org/10.1093/jnci/85.6.483
4211,"15875779, 1429232",2005,A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu,Laxaphycin B,13,Cyclic,L,"Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl",Free,Free,Antifungal,Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula,CEM-WT,Leukemia Cancer,Cell Viability assay,50% inhibition at 1 µM,96-h,Blood,None,NA,"['Not Found', 'https://doi.org/10.7164/antibiotics.45.1458']"
4212,"15875779, 1429232",2005,A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu,Laxaphycin B,13,Cyclic,L,"Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl",Free,Free,Antifungal,Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula,CEM-WT,Leukemia Cancer,Cell Viability assay,44% inhibition at 1 µM,96-h,Blood,None,NA,"['Not Found', 'https://doi.org/10.7164/antibiotics.45.1458']"
4213,"15875779, 1429232",2005,A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu,Laxaphycin B,13,Cyclic,L,"Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl",Free,Free,Antifungal,Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula,CEM-VM1,Leukemia Cancer,Cell Viability assay,44% inhibition at 1 µM,96-h,Blood,None,NA,"['Not Found', 'https://doi.org/10.7164/antibiotics.45.1458']"
4214,"15875779, 1429232",2005,A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu,Laxaphycin B,13,Cyclic,L,"Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl",Free,Free,Antifungal,Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula,CEM-VLB,Leukemia Cancer,Cell Viability assay,44% inhibition at 1 µM,96-h,Blood,None,NA,"['Not Found', 'https://doi.org/10.7164/antibiotics.45.1458']"
4215,"15875779, 1429232",2005,A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu,Laxaphycin B,13,Cyclic,L,"Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl",Free,Free,Antifungal,Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula,CEM-WT,Leukemia Cancer,Cell Viability assay,40% inhibition at 1 µM,96-h,Blood,None,NA,"['Not Found', 'https://doi.org/10.7164/antibiotics.45.1458']"
4216,"15875779, 1429232",2005,A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu,Laxaphycin B,13,Cyclic,L,"Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl",Free,Free,Antifungal,Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula,CEM-VM1,Leukemia Cancer,Cell Viability assay,40% inhibition at 1 µM,96-h,Blood,None,NA,"['Not Found', 'https://doi.org/10.7164/antibiotics.45.1458']"
4217,"15875779, 1429232",2005,A-Hleu-QN-MeIle-Hasn-TPLT-Ade-V-Hleu,Laxaphycin B,13,Cyclic,L,"Ade = 3-aminodecanoyl, Hleu =hydroxyleucyl, Hasn = hydoxyasparaginyl",Free,Free,Antifungal,Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula,CEM-VLB,Leukemia Cancer,Cell Viability assay,40% inhibition at 1 µM,96-h,Blood,None,NA,"['Not Found', 'https://doi.org/10.7164/antibiotics.45.1458']"
4484,22057278,2011,AAKKWAKAKWAKAKKWAKAA,Z10,21,Linear,L,None,Free,Free,Anticancer,Synthetic,Meth A,Skin Cancer,MTT/MTS assay,EC50 >211 µM,Not Available,Skin,None,N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4494,22057278,2011,AAKKWAKAKWAKAKKWAKAA,Z10,21,Linear,L,None,Free,Free,Anticancer,Synthetic,MT-1,Breast Cancer,MTT/MTS assay,EC50 >211 µM,Not Available,Breast,None,N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4504,22057278,2011,AAKKWAKAKWAKAKKWAKAA,Z10,21,Linear,L,None,Free,Free,Anticancer,Synthetic,HT-29,Colon Cancer,MTT/MTS assay,EC50 >211 µM,Not Available,Colon,None,N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4203,15867360,2005,AAVPIVNLKDELLFPSWEALFSGSE,hP4,25,Linear,L,None,Free,Free,Antiangiogenesis,Human endostatin peptides,BxPC-3,Pancreatic Cancer,Matrigel Assay,No inhibition at 7 mg/kg/d,672-h,Pancreatic,None,N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O,https://doi.org/10.1158/0008-5472.CAN-04-1833
4483,22057278,2011,AAWKWAWAKKWAKAKKWAKAA,Z9,21,Linear,L,None,Free,Free,Anticancer,Synthetic,Meth A,Skin Cancer,MTT/MTS assay,EC50 =9 µM,Not Available,Skin,None,N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4493,22057278,2011,AAWKWAWAKKWAKAKKWAKAA,Z9,21,Linear,L,None,Free,Free,Anticancer,Synthetic,MT-1,Breast Cancer,MTT/MTS assay,EC50 =16 µM,Not Available,Breast,None,N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4503,22057278,2011,AAWKWAWAKKWAKAKKWAKAA,Z9,21,Linear,L,None,Free,Free,Anticancer,Synthetic,HT-29,Colon Cancer,MTT/MTS assay,EC50 =13 µM,Not Available,Colon,None,N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
3837,20515045,2010,ACDCRGDCFCGGGGIVRRADRAAVP,AP,25,Linear,L,None,Free,Free,Antitumor,Endostatin derived synthetic peptide,BAE,Tumor,MTT/MTS assay,50% inhibition at 2.5µg/ml,NA,Not Available,None,N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)O,https://doi.org/10.1021/bc900292y
3838,20515045,2010,ACDCRGDCFCGGGGIVRRADRAAVP,AP,25,Linear,L,None,Free,Free,Antitumor,Endostatin derived synthetic peptide,BAE,Tumor,MTT/MTS assay,40% inhibition at 5µg/ml,NA,Not Available,None,N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)O,https://doi.org/10.1021/bc900292y
3839,20515045,2010,ACDCRGDCFCGGGGIVRRADRAAVP,AP,25,Linear,L,None,Free,Free,Antitumor,Endostatin derived synthetic peptide,BAE,Tumor,MTT/MTS assay,75% inhibition at 10µg/ml,NA,Not Available,None,N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)O,https://doi.org/10.1021/bc900292y
3840,20515045,2010,ACDCRGDCFCGGGGIVRRADRAAVP,AP(O),25,"Cyclic(C2-C10,C",L,None,Free,Free,Antitumor,Endostatin derived synthetic peptide,BAE,Tumor,MTT/MTS assay,40% inhibition at 2.5µg/ml,NA,Not Available,None,N[C@@H](C)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H]2NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CC(=O)O)CSSC2)CCCN=C)CC(=O)O)Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)O,https://doi.org/10.1021/bc900292y
3841,20515045,2010,ACDCRGDCFCGGGGIVRRADRAAVP,AP(O),25,"Cyclic(C2-C10,C",L,None,Free,Free,Antitumor,Endostatin derived synthetic peptide,BAE,Tumor,MTT/MTS assay,42% inhibition at 5µg/ml,NA,Not Available,None,N[C@@H](C)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H]2NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CC(=O)O)CSSC2)CCCN=C)CC(=O)O)Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)O,https://doi.org/10.1021/bc900292y
3842,20515045,2010,ACDCRGDCFCGGGGIVRRADRAAVP,AP(O),25,"Cyclic(C2-C10,C",L,None,Free,Free,Antitumor,Endostatin derived synthetic peptide,BAE,Tumor,MTT/MTS assay,52% inhibition at 10µg/ml,NA,Not Available,None,N[C@@H](C)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H]2NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CC(=O)O)CSSC2)CCCN=C)CC(=O)O)Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)O,https://doi.org/10.1021/bc900292y
4429,"15253156, 18957441",2004,ACSAG,EP5-1,5,Not Available,L,None,Free,Free,Anticancer,"redworms, brandling worms, ""tiger worms"" and red wiggler worms, Eisenia foetida",Not Available,Fibrosarcoma,Not Available,Not Available,Not Available,Fibrous connective tissue ,None,N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)O,"['https://doi.org/10.1093/abbs/36.4.297', 'https://doi.org/10.1093/nar/gkn823']"
4430,"4056036, 18957441",1985,ACYCRIPACIAGERRYGTCIYQGRLWAFCC,HNP-1,30,Not Available,L,None,Free,Free,Anticancer,Homo sapiens,Not Available,Fibrosarcoma,Not Available,Not Available,Not Available,Fibrous connective tissue ,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CS)CS)Cc2ccccc2)C)Cc2c[nH]c3c2cccc3)CC(C)C)CCCNC(=[NH2])N)CCC(=O)N)Cc2ccc(cc2)O)[C@H](CC)C)CS)[C@H](O)C)Cc2ccc(cc2)O)CCCNC(=[NH2])N)CCCNC(=[NH2])N)CCC(=O)O)C)[C@H](CC)C)CS)C)CCC1)[C@H](CC)C)CCCNC(=[NH2])N)CS)Cc1ccc(cc1)O)CS)C,"['https://doi.org/10.1172/JCI112121', 'https://doi.org/10.1093/nar/gkn823']"
3589,22100226,2012,AFGMALKLLKKVL,MAC1/2,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 16±3 µM,48-h,Cervix,None,N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3605,22100226,2012,AFGMALKLLKKVL,MAC1/2,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 16 µM,48-h,Colon,None,N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3621,22100226,2012,AFGMALKLLKKVL,MAC1/2,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 17 µM,48-h,Blood,None,N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
1041,"1319823, 2285300",1992,AIGKFLHSAKKFGKAFVGEIMNS,Magainin A,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,African clawed frog Xenopus laevis skin,NCI-H182,Lung Cancer,MTT/MTS assay,IC50=7.28 µM,24-h,Lung,None,NC[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['Not Found', 'https://doi.org/10.1128/AAC.34.9.1824']"
1042,"1319823, 2285300",1992,AIGKFLHSAKKFGKAFVGEIMNS,Magainin A,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,African clawed frog Xenopus laevis skin,NCI-H526,Lung Cancer,MTT/MTS assay,IC50=11.7 µM,24-h,Lung,None,NC[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['Not Found', 'https://doi.org/10.1128/AAC.34.9.1824']"
1043,"1319823, 2285300",1992,AIGKFLHSAKKFGKAFVGEIMNS,Magainin A,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,African clawed frog Xenopus laevis skin,NCI-H678,Lung Cancer,MTT/MTS assay,IC50=6.23 µM,24-h,Lung,None,NC[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['Not Found', 'https://doi.org/10.1128/AAC.34.9.1824']"
1044,"1319823, 2285300",1992,AIGKFLHSAKKFGKAFVGEIMNS,Magainin A,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,African clawed frog Xenopus laevis skin,NCI-H735,Lung Cancer,MTT/MTS assay,IC50=10.4 µM,24-h,Lung,None,NC[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['Not Found', 'https://doi.org/10.1128/AAC.34.9.1824']"
1045,"1319823, 2285300",1992,AIGKFLHSAKKFGKAFVGEIMNS,Magainin A,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,African clawed frog Xenopus laevis skin,NCI-H841,Lung Cancer,MTT/MTS assay,IC50=9.7 µM,24-h,Lung,None,NC[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['Not Found', 'https://doi.org/10.1128/AAC.34.9.1824']"
1046,"1319823, 2285300",1992,AIGKFLHSAKKFGKAFVGEIMNS,Magainin A,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,African clawed frog Xenopus laevis skin,NCI-H889,Lung Cancer,MTT/MTS assay,IC50=6.56 µM,24-h,Lung,None,NC[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['Not Found', 'https://doi.org/10.1128/AAC.34.9.1824']"
1356,"1708887, 2285300",1990,AIGKFLHSAKKFGKAFVGEIMNS,Magainin A,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,Xenopus laevis,U-937,Lymphoma Cancer,Trypan blue assay,IC50=16 µg/ml,72-h,Blood,None,NC[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1362,"1708887, 2285300",1990,AIGKFLHSAKKFGKAFVGEIMNS,Magainin A,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,Xenopus laevis,8402,Leukemia Cancer,Trypan blue assay,IC50=18 µg/ml,72-h,Blood,None,NC[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1368,"1708887, 2285300",1990,AIGKFLHSAKKFGKAFVGEIMNS,Magainin A,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,Xenopus laevis,SSKT-1,Hematopoietic Cancer,Trypan blue assay,IC50=23 µg/ml,72-h,Blood,None,NC[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1374,"1708887, 2285300",1990,AIGKFLHSAKKFGKAFVGEIMNS,Magainin A,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,Xenopus laevis,Daudi,Lung Cancer,Trypan blue assay,IC50=30 µg/ml,72-h,Blood,None,NC[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1380,"1708887, 2285300",1990,AIGKFLHSAKKFGKAFVGEIMNS,Magainin A,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,Xenopus laevis,MLA,Leukemia Cancer,Trypan blue assay,IC50=34 µg/ml,72-h,Blood,None,NC[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1386,"1708887, 2285300",1990,AIGKFLHSAKKFGKAFVGEIMNS,Magainin A,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,Xenopus laevis,Raji,Lymphoma Cancer,Trypan blue assay,IC50=20 µg/ml,72-h,Blood,None,NC[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1392,"1708887, 2285300",1990,AIGKFLHSAKKFGKAFVGEIMNS,Magainin A,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,Xenopus laevis,K-562,Leukemia Cancer,Trypan blue assay,IC50=40 µg/ml,72-h,Blood,None,NC[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1398,"1708887, 2285300",1990,AIGKFLHSAKKFGKAFVGEIMNS,Magainin A,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,Xenopus laevis,CHP-100,Ewing sarcoma,Trypan blue assay,IC50=45 µg/ml,72-h,Blood,None,NC[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1404,"1708887, 2285300",1990,AIGKFLHSAKKFGKAFVGEIMNS,Magainin A,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,Xenopus laevis,MCF-7,Breast Cancer,Trypan blue assay,IC50=49 µg/ml,72-h,Breast,None,NC[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1410,"1708887, 2285300",1990,AIGKFLHSAKKFGKAFVGEIMNS,Magainin A,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,Xenopus laevis,PC-3,Prostate Cancer,Trypan blue assay,IC50=53 µg/ml,72-h,Prostate,None,NC[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
4433,"12804591, 19923233",2003,AIGSILGALAKGLPTLISWIKNR,Prepromelittin-related peptide,23,Not Available,L,None,Free,Free,Antibacterial,Rana tagoi [Tago frog],Not Available,Fibrosarcoma,Not Available,Not Available,Not Available,Fibrous connective tissue ,None,N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)O,"['https://doi.org/10.1016/s0006-291x(03)00999-9', 'https://doi.org/10.1093/nar/gkp1021']"
4367,"22467870, 18957441",2012,AIPCGESCVWIPCISTVIGCSCSNKVCYR,Chassatide C8,29,Not Available,L,None,Free,Free,Antibacterial,Chassalia chartacea,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)O,"['https://doi.org/10.1074/jbc.M111.338970', 'https://doi.org/10.1093/nar/gkn823']"
1423,"16512752, 21403917",2006,AKRHHGYKRKFH,Demegen P-113,12,Linear,L,None,Amidation,Free,Antimicrobial,Amphibian skin peptide,U-937,Lymphoma Cancer,MTT/MTS assay,15% Cytotoxicity at 0.5 µg/ml,6-h,Blood,None,N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N,"['https://doi.org/10.1902/jop.2006.050049', 'Not Found']"
4594,21403917,2011,AKRHHGYKRKFH,Demegen P-113,12,Linear,L,None,Amidation,Free,Antimicrobial,Canaida albicans,U-939,Lymphoma Cancer,MTT/MTS assay,IC50 =85-90 µg/ml,Not Available,Blood,None,N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N,Not Found
1357,"1708887, 2285300",1990,ALSKALSKALSKALSKALSKALSK,Z44,24,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,U-937,Lymphoma Cancer,Trypan blue assay,IC50=97 µg/ml,72-h,Blood,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1358,"1708887, 2285300",1990,ALSKALSKALSKALSKALSKALSK,Z24,24,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,U-937,Lymphoma Cancer,Trypan blue assay,IC50=123 µg/ml,72-h,Blood,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1363,"1708887, 2285300",1990,ALSKALSKALSKALSKALSKALSK,Z44,24,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,8402,Leukemia Cancer,Trypan blue assay,IC50=60 µg/ml,72-h,Blood,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1364,"1708887, 2285300",1990,ALSKALSKALSKALSKALSKALSK,Z24,24,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,8402,Leukemia Cancer,Trypan blue assay,IC50=83 µg/ml,72-h,Blood,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1369,"1708887, 2285300",1990,ALSKALSKALSKALSKALSKALSK,Z44,24,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,SSKT-1,Hematopoietic Cancer,Trypan blue assay,IC50=107 µg/ml,72-h,Blood,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1370,"1708887, 2285300",1990,ALSKALSKALSKALSKALSKALSK,Z24,24,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,SSKT-1,Hematopoietic Cancer,Trypan blue assay,IC50=109 µg/ml,72-h,Blood,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1375,"1708887, 2285300",1990,ALSKALSKALSKALSKALSKALSK,Z44,24,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,Daudi,Brain Tumor,Trypan blue assay,IC50=115 µg/ml,72-h,Blood,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1376,"1708887, 2285300",1990,ALSKALSKALSKALSKALSKALSK,Z24,24,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,Daudi,Leukemia Cancer,Trypan blue assay,IC50=143 µg/ml,72-h,Blood,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1381,"1708887, 2285300",1990,ALSKALSKALSKALSKALSKALSK,Z44,24,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,MLA,Leukemia Cancer,Trypan blue assay,IC50=80 µg/ml,72-h,Blood,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1382,"1708887, 2285300",1990,ALSKALSKALSKALSKALSKALSK,Z24,24,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,MLA,Leukemia Cancer,Trypan blue assay,IC50=102 µg/ml,72-h,Blood,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1387,"1708887, 2285300",1990,ALSKALSKALSKALSKALSKALSK,Z44,24,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,Raji,Lymphoma Cancer,Trypan blue assay,IC50=64 µg/ml,72-h,Blood,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1388,"1708887, 2285300",1990,ALSKALSKALSKALSKALSKALSK,Z24,24,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,Raji,Lymphoma Cancer,Trypan blue assay,IC50=72 µg/ml,72-h,Blood,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1393,"1708887, 2285300",1990,ALSKALSKALSKALSKALSKALSK,Z44,24,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,K-562,Leukemia Cancer,Trypan blue assay,IC50=98 µg/ml,72-h,Blood,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1394,"1708887, 2285300",1990,ALSKALSKALSKALSKALSKALSK,Z24,24,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,K-562,Leukemia Cancer,Trypan blue assay,IC50=112 µg/ml,72-h,Blood,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1399,"1708887, 2285300",1990,ALSKALSKALSKALSKALSKALSK,Z44,24,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,CHP-100,Ewing sarcoma,Trypan blue assay,Not Available,72-h,Blood,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1400,"1708887, 2285300",1990,ALSKALSKALSKALSKALSKALSK,Z24,24,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,CHP-100,Ewing sarcoma,Trypan blue assay,Not Available,72-h,Blood,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1405,"1708887, 2285300",1990,ALSKALSKALSKALSKALSKALSK,Z44,24,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,MCF-7,Breast Cancer,Trypan blue assay,Not Available,72-h,Breast,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1406,"1708887, 2285300",1990,ALSKALSKALSKALSKALSKALSK,Z24,24,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,MCF-7,Breast Cancer,Trypan blue assay,Not Available,72-h,Breast,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1411,"1708887, 2285300",1990,ALSKALSKALSKALSKALSKALSK,Z44,24,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,PC-3,Prostate Cancer,Trypan blue assay,Not Available,72-h,Prostate,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1412,"1708887, 2285300",1990,ALSKALSKALSKALSKALSKALSK,Z24,24,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,PC-3,Prostate Cancer,Trypan blue assay,Not Available,72-h,Prostate,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1707,9614066,1998,ALWKDILKNVGKAAGKAVLNTVTDMVNQ,DRS B4,28,Linear,L,None,Amidation,Free,Antimicrobial,Dermaseptins B,MCF-7,Breast Cancer,Thymidine Incorporation assay,Cytotoxicity =15 µM,6-h,Breast,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N,https://doi.org/10.1074/jbc.273.24.14690
1706,9614066,1998,ALWKNMLKGIGKLAGQAALGAVKTLVGA,DRS B3,28,Linear,L,None,Free,Free,Antimicrobial,Dermaseptins B,MCF-7,Breast Cancer,Thymidine Incorporation assay,Cytotoxicity =12 µM,6-h,Breast,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.273.24.14690
1708,9614066,1998,ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ,DRS S1,35,Linear,L,None,Free,Free,Antimicrobial,Dermaseptins B,MCF-7,Breast Cancer,Thymidine Incorporation assay,Not Available,6-h,Breast,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O,https://doi.org/10.1074/jbc.273.24.14690
4208,"15875779, 1429232",2005,Aoc-Hse-E-Dhb-Hyp-Hse-FLIILG,Laxaphycin A,12,Cyclic,L,"Aoc = 3-aminooctanoic acid ,Hyp = 4- hydroxyproline, Dhb = didehydrobutyrine, Hse = Homoserine",Free,Free,Antifungal,Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula,CEM-WT,Leukemia Cancer,Cell Viability assay,No inhibition at 4 µM,96-h,Blood,None,NA,"['Not Found', 'https://doi.org/10.7164/antibiotics.45.1458']"
4209,"15875779, 1429232",2005,Aoc-Hse-E-Dhb-Hyp-Hse-FLIILG,Laxaphycin A,12,Cyclic,L,"Aoc = 3-aminooctanoic acid ,Hyp = 4- hydroxyproline, Dhb = didehydrobutyrine, Hse = Homoserine",Free,Free,Antifungal,Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula,CEM-VLB,Leukemia Cancer,Cell Viability assay,No inhibition at 4 µM,96-h,Blood,None,NA,"['Not Found', 'https://doi.org/10.7164/antibiotics.45.1458']"
4210,"15875779, 1429232",2005,Aoc-Hse-E-Dhb-Hyp-Hse-FLIILG,Laxaphycin A,12,Cyclic,L,"Aoc = 3-aminooctanoic acid ,Hyp = 4- hydroxyproline, Dhb = didehydrobutyrine, Hse = Homoserine",Free,Free,Antifungal,Terrestrial blue-green alga Anabaena laxa or the marine cyanobacterium Lyngbya Majuscula,CEM-VM1,Leukemia Cancer,Cell Viability assay,No inhibition at 4 µM,96-h,Blood,None,NA,"['Not Found', 'https://doi.org/10.7164/antibiotics.45.1458']"
4482,22057278,2011,AWKKWAKAWKWAKAKWWAKAA,Z8,21,Linear,L,None,Free,Free,Anticancer,Synthetic,Meth A,Skin Cancer,MTT/MTS assay,EC50 =19 µM,Not Available,Skin,None,N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4492,22057278,2011,AWKKWAKAWKWAKAKWWAKAA,Z8,21,Linear,L,None,Free,Free,Anticancer,Synthetic,MT-1,Breast Cancer,MTT/MTS assay,EC50 =14 µM,Not Available,Breast,None,N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4502,22057278,2011,AWKKWAKAWKWAKAKWWAKAA,Z8,21,Linear,L,None,Free,Free,Anticancer,Synthetic,HT-29,Colon Cancer,MTT/MTS assay,EC50 =23 µM,Not Available,Colon,None,N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4365,"21882228, 18957441",2012,AWKLFDDGV,Cr-ACP1,9,Not Available,L,None,Free,Free,Antibacterial,"Seeds,Cycas revoluta",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)O,"['https://doi.org/10.1002/jcb.23343', 'https://doi.org/10.1093/nar/gkn823']"
3143,23627474,2013,CAHNLTHAC,PTPRJ-pep19.2,9,Cyclic(C1-C9),L,None,Free,Free,Anticancer,PTPRJ agonist peptides,HeLa,Cervical Cancer,Trypan blue assay,16.5 ± 2.12% cell growth inhibition at 160 µM in 24 hours,24-h,Cervix,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)C)Cc1[nH]cnc1)CC(=O)N)CC(C)C)[C@@H](C)O)Cc1[nH]cnc1)C)C(=O)O,https://doi.org/10.1021/cb3007192
3144,23627474,2013,CAHNLTHAC,PTPRJ-pep19.2,9,Cyclic(C1-C9),L,None,Free,Free,Anticancer,PTPRJ agonist peptides,HeLa,Cervical Cancer,Trypan blue assay,30 ± 2.82% cell growth inhibition at 160 µM in 48 hours,48-h,Cervix,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)C)Cc1[nH]cnc1)CC(=O)N)CC(C)C)[C@@H](C)O)Cc1[nH]cnc1)C)C(=O)O,https://doi.org/10.1021/cb3007192
3145,23627474,2013,CAHNLTHAC,PTPRJ-pep19.2,9,Cyclic(C1-C9),L,None,Free,Free,Anticancer,PTPRJ agonist peptides,HeLa,Cervical Cancer,Trypan blue assay,32.0 ± 4.2% cell growth inhibition at 160 µM in 72 hours,72-h,Cervix,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)C)Cc1[nH]cnc1)CC(=O)N)CC(C)C)[C@@H](C)O)Cc1[nH]cnc1)C)C(=O)O,https://doi.org/10.1021/cb3007192
3146,23627474,2013,CHANLTHAC,PTPRJ-pep19.3,9,Cyclic(C1-C9),L,None,Free,Free,Anticancer,PTPRJ agonist peptides,HeLa,Cervical Cancer,Trypan blue assay,28 ± 5.5% cell growth inhibition at 160 µM in 24 hours,24-h,Cervix,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1[nH]cnc1)C)CC(=O)N)CC(C)C)[C@@H](C)O)Cc1[nH]cnc1)C)C(=O)O,https://doi.org/10.1021/cb3007192
3147,23627474,2013,CHANLTHAC,PTPRJ-pep19.3,9,Cyclic(C1-C9),L,None,Free,Free,Anticancer,PTPRJ agonist peptides,HeLa,Cervical Cancer,Trypan blue assay,46 ± 4.2% cell growth inhibition at 160 µM in 48 hours,48-h,Cervix,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1[nH]cnc1)C)CC(=O)N)CC(C)C)[C@@H](C)O)Cc1[nH]cnc1)C)C(=O)O,https://doi.org/10.1021/cb3007192
3148,23627474,2013,CHANLTHAC,PTPRJ-pep19.3,9,Cyclic(C1-C9),L,None,Free,Free,Anticancer,PTPRJ agonist peptides,HeLa,Cervical Cancer,Trypan blue assay,51 ± 1.4% cell growth inhibition at 160 µM in 72 hours,72-h,Cervix,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1[nH]cnc1)C)CC(=O)N)CC(C)C)[C@@H](C)O)Cc1[nH]cnc1)C)C(=O)O,https://doi.org/10.1021/cb3007192
3149,23627474,2013,CHHALTHAC,PTPRJ-pep19.4,9,Cyclic(C1-C9),L,None,Free,Free,Anticancer,PTPRJ agonist peptides,HeLa,Cervical Cancer,Trypan blue assay,48.0 ± 2.82% cell growth inhibition at 160 µM in 24 hours,24-h,Cervix,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1[nH]cnc1)Cc1[nH]cnc1)C)CC(C)C)[C@@H](C)O)Cc1[nH]cnc1)C)C(=O)O,https://doi.org/10.1021/cb3007192
3150,23627474,2013,CHHALTHAC,PTPRJ-pep19.4,9,Cyclic(C1-C9),L,None,Free,Free,Anticancer,PTPRJ agonist peptides,HeLa,Cervical Cancer,Trypan blue assay,62.5 ± 4.9% cell growth inhibition at 160 µM in 48 hours,48-h,Cervix,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1[nH]cnc1)Cc1[nH]cnc1)C)CC(C)C)[C@@H](C)O)Cc1[nH]cnc1)C)C(=O)O,https://doi.org/10.1021/cb3007192
3151,23627474,2013,CHHALTHAC,PTPRJ-pep19.4,9,Cyclic(C1-C9),L,None,Free,Free,Anticancer,PTPRJ agonist peptides,HeLa,Cervical Cancer,Trypan blue assay,66.5 ± 2.12% cell growth inhibition at 160 µM in 72 hours,72-h,Cervix,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1[nH]cnc1)Cc1[nH]cnc1)C)CC(C)C)[C@@H](C)O)Cc1[nH]cnc1)C)C(=O)O,https://doi.org/10.1021/cb3007192
3152,23627474,2013,CHHNATHAC,PTPRJ-pep19.5,9,Cyclic(C1-C9),L,None,Free,Free,Anticancer,PTPRJ agonist peptides,HeLa,Cervical Cancer,Trypan blue assay,2 ± 1.5% cell growth inhibition at 160 µM in 48 hours,48-h,Cervix,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1[nH]cnc1)Cc1[nH]cnc1)CC(=O)N)C)[C@@H](C)O)Cc1[nH]cnc1)C)C(=O)O,https://doi.org/10.1021/cb3007192
3153,23627474,2013,CHHNATHAC,PTPRJ-pep19.5,9,Cyclic(C1-C9),L,None,Free,Free,Anticancer,PTPRJ agonist peptides,HeLa,Cervical Cancer,Trypan blue assay,19 ± 4.2% cell growth inhibition at 160 µM in 72 hours,72-h,Cervix,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1[nH]cnc1)Cc1[nH]cnc1)CC(=O)N)C)[C@@H](C)O)Cc1[nH]cnc1)C)C(=O)O,https://doi.org/10.1021/cb3007192
3154,23627474,2013,CHHNLAHAC,PTPRJ-pep19.6,9,Cyclic(C1-C9),L,None,Free,Free,Anticancer,PTPRJ agonist peptides,HeLa,Cervical Cancer,Trypan blue assay,19 ± 4.2% cell growth inhibition at 160 µM in 72 hours,72-h,Cervix,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1[nH]cnc1)Cc1[nH]cnc1)CC(=O)N)CC(C)C)C)Cc1[nH]cnc1)C)C(=O)O,https://doi.org/10.1021/cb3007192
3155,23627474,2013,CHHNLTAAC,PTPRJ-pep19.7,9,Cyclic(C1-C9),L,None,Free,Free,Anticancer,PTPRJ agonist peptides,HeLa,Cervical Cancer,Trypan blue assay,4.5 ± 2.13% cell growth inhibition at 160 µM in 48 hours,48-h,Cervix,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1[nH]cnc1)Cc1[nH]cnc1)CC(=O)N)CC(C)C)[C@@H](C)O)C)C)C(=O)O,https://doi.org/10.1021/cb3007192
3156,23627474,2013,CHHNLTAAC,PTPRJ-pep19.7,9,Cyclic(C1-C9),L,None,Free,Free,Anticancer,PTPRJ agonist peptides,HeLa,Cervical Cancer,Trypan blue assay,20 ± 1.4% cell growth inhibition at 160 µM in 72 hours,72-h,Cervix,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1[nH]cnc1)Cc1[nH]cnc1)CC(=O)N)CC(C)C)[C@@H](C)O)C)C)C(=O)O,https://doi.org/10.1021/cb3007192
3140,23627474,2013,CHHNLTHAC,PTPRJ-pep19,9,Cyclic(C1-C9),L,None,Free,Free,Anticancer,PTPRJ agonist peptides,HeLa,Cervical Cancer,Trypan blue assay,4.5 ± 0.1.4% cell growth inhibition at 160 µM in 48 hours,48-h,Cervix,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1[nH]cnc1)Cc1[nH]cnc1)CC(=O)N)CC(C)C)[C@@H](C)O)Cc1[nH]cnc1)C)C(=O)O,https://doi.org/10.1021/cb3007192
3141,23627474,2013,CHHNLTHAC,PTPRJ-pep19,9,Cyclic(C1-C9),L,None,Free,Free,Anticancer,PTPRJ agonist peptides,HeLa,Cervical Cancer,Trypan blue assay,19 ± 2.82% cell growth inhibition at 160 µM in 72 hours,72-h,Cervix,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1[nH]cnc1)Cc1[nH]cnc1)CC(=O)N)CC(C)C)[C@@H](C)O)Cc1[nH]cnc1)C)C(=O)O,https://doi.org/10.1021/cb3007192
3142,23627474,2013,CHHNLTHAC,PTPRJ-pep19.0,9,Linear,L,None,Free,Free,Anticancer,PTPRJ agonist peptides,HeLa,Cervical Cancer,Trypan blue assay,4 ± 1.4% cell growth inhibition at 160 µM in 72 hours,72-h,Cervix,None,N[C@@H](CS)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O,https://doi.org/10.1021/cb3007192
4611,20802991,2010,CSSRTMHHC,Peptide-20,9,Cyclic(C1-C9),L,None,Free,Free,Antitumor,Synthetic Peptide,HL-60,Leukemia Cancer,MTT/MTS assay,at 100 µM 90% viablity,48-h,Blood,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CO)CO)CCCN=C)[C@@H](C)O)CCSC)Cc1[nH]cnc1)Cc1[nH]cnc1)C(=O)O,https://doi.org/10.1007/s00109-010-0671-9
4612,20802991,2010,CSSRTMHHC,Peptide-20,9,Cyclic(C1-C9),L,None,Free,Free,Antitumor,Synthetic Peptide,MDA-MB-231,Breast Cancer,MTT/MTS assay,at 100 µM 55% viablity,48-h,Breast,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CO)CO)CCCN=C)[C@@H](C)O)CCSC)Cc1[nH]cnc1)Cc1[nH]cnc1)C(=O)O,https://doi.org/10.1007/s00109-010-0671-9
4613,20802991,2010,CSSRTMHHC,Peptide-20,9,Cyclic(C1-C9),L,None,Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,at 100 µM 50% viablity,48-h,Cervix,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CO)CO)CCCN=C)[C@@H](C)O)CCSC)Cc1[nH]cnc1)Cc1[nH]cnc1)C(=O)O,https://doi.org/10.1007/s00109-010-0671-9
4614,20802991,2010,CSSRTMHHC,Peptide-20,9,Cyclic(C1-C9),L,None,Free,Free,Antitumor,Synthetic Peptide,B16F10-Nex 2,Skin Cancer,MTT/MTS assay,at 100 µM 50% viablity,48-h,Skin,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CO)CO)CCCN=C)[C@@H](C)O)CCSC)Cc1[nH]cnc1)Cc1[nH]cnc1)C(=O)O,https://doi.org/10.1007/s00109-010-0671-9
4615,20802991,2010,CSSRTMHHC,Peptide-20,9,Cyclic(C1-C9),L,None,Free,Free,Antitumor,Synthetic Peptide,A-2058,Skin Cancer,MTT/MTS assay,at 100 µM 30% viablity,48-h,Skin,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CO)CO)CCCN=C)[C@@H](C)O)CCSC)Cc1[nH]cnc1)Cc1[nH]cnc1)C(=O)O,https://doi.org/10.1007/s00109-010-0671-9
4616,20802991,2010,CSSRTMHHC,Peptide-20,9,Cyclic(C1-C9),L,None,Free,Free,Antitumor,Synthetic Peptide,Skmel-25,Skin Cancer,MTT/MTS assay,at 100 µM 55-60% viablity,48-h,Skin,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CO)CO)CCCN=C)[C@@H](C)O)CCSC)Cc1[nH]cnc1)Cc1[nH]cnc1)C(=O)O,https://doi.org/10.1007/s00109-010-0671-9
4617,20802991,2010,CSSRTMHHC,Peptide-20,9,Cyclic(C1-C9),L,None,Free,Free,Antitumor,Synthetic Peptide,Skmel-28,Skin Cancer,MTT/MTS assay,at 100 µM 35-40% viablity,48-h,Skin,None,N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CO)CO)CCCN=C)[C@@H](C)O)CCSC)Cc1[nH]cnc1)Cc1[nH]cnc1)C(=O)O,https://doi.org/10.1007/s00109-010-0671-9
4430,"4056036, 18957441",1985,ACYCRIPACIAGERRYGTCIYQGRLWAFCC,HNP-1,30,Not Available,L,None,Free,Free,Anticancer,Homo sapiens,Not Available,Fibrosarcoma,Not Available,Not Available,Not Available,Fibrous connective tissue ,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CS)CS)Cc2ccccc2)C)Cc2c[nH]c3c2cccc3)CC(C)C)CCCNC(=[NH2])N)CCC(=O)N)Cc2ccc(cc2)O)[C@H](CC)C)CS)[C@H](O)C)Cc2ccc(cc2)O)CCCNC(=[NH2])N)CCCNC(=[NH2])N)CCC(=O)O)C)[C@H](CC)C)CS)C)CCC1)[C@H](CC)C)CCCNC(=[NH2])N)CS)Cc1ccc(cc1)O)CS)C,"['https://doi.org/10.1172/JCI112121', 'https://doi.org/10.1093/nar/gkn823']"
4431,"4056036, 18957441",1985,CYCRIPACIAGERRYGTCIYQGRLWAFCC,HNP-2,29,Not Available,L,None,Free,Free,Anticancer,Homo sapiens,Not Available,Fibrosarcoma,Not Available,Not Available,Not Available,Fibrous connective tissue ,None,N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O,"['https://doi.org/10.1172/JCI112121', 'https://doi.org/10.1093/nar/gkn823']"
4432,"4056036, 18957441",1985,DCYCRIPACIAGERRYGTCIYQGRLWAFCC,HNP-3,30,Not Available,L,None,Free,Free,Anticancer,Homo sapiens,Not Available,Fibrosarcoma,Not Available,Not Available,Not Available,Fibrous connective tissue ,None,N[C@H](C(=O)N[C@@H]1C(=O)N[C@H](C(=O)N[C@@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@@H]4C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CSSC1)CSSC4)Cc1ccccc1)C)Cc1c[nH]c4c1cccc4)CC(C)C)CCCNC(=N)N)CCC(=O)N)Cc1ccc(cc1)O)[C@H](CC)C)CSSC2)[C@H](O)C)Cc1ccc(cc1)O)CCCNC(=N)N)C)CCC(=O)O)C)[C@H](CC)C)C)CCC3)[C@H](CC)C)CCCNC(=N)N)Cc1ccc(cc1)O)CC(=O)O,"['https://doi.org/10.1172/JCI112121', 'https://doi.org/10.1093/nar/gkn823']"
4432,"4056036, 18957441",1985,DCYCRIPACIAGERRYGTCIYQGRLWAFCC,HNP-3,30,Not Available,L,None,Free,Free,Anticancer,Homo sapiens,Not Available,Fibrosarcoma,Not Available,Not Available,Not Available,Fibrous connective tissue ,None,N[C@H](C(=O)N[C@@H]1C(=O)N[C@H](C(=O)N[C@@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@@H]4C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CSSC1)CSSC4)Cc1ccccc1)C)Cc1c[nH]c4c1cccc4)CC(C)C)CCCNC(=N)N)CCC(=O)N)Cc1ccc(cc1)O)[C@H](CC)C)CSSC2)[C@H](O)C)Cc1ccc(cc1)O)CCCNC(=N)N)C)CCC(=O)O)C)[C@H](CC)C)C)CCC3)[C@H](CC)C)CCCNC(=N)N)Cc1ccc(cc1)O)CC(=O)O,"['https://doi.org/10.1172/JCI112121', 'https://doi.org/10.1093/nar/gkn823']"
4278,None,2004,DDAlRRllRRllRRl,DDA-DL6R6-25,15,Linear,Mix,None,Free,Free,"Antimicrobial, Antifungal and Anticancer",Synthetic Peptide,22RV1,Prostate Cancer,MTT/MTS assay,LC50=3.125 µM,Not Available,Prostate,AU_2004_246909_A1,N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H](CC(C)C)C1OO1,Not Found
4279,None,2004,DDAlRRllRRllRRl,DDA-DL6R6-25,15,Linear,Mix,None,Free,Free,"Antimicrobial, Antifungal and Anticancer",Synthetic Peptide,CL-1,Tumor,MTT/MTS assay,LC50=3.125 µM,Not Available,Pancreatic,AU_2004_246909_A1,N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H](CC(C)C)C1OO1,Not Found
2872,23583573,2013,DEVD,caspase 3 inhibitor,4,Linear,L,None,Fluoromethyl ketone(fmk),Free,Anticancer,caspase 3 inhibitor,Bcap-37,Breast Cancer,MTT/MTS assay,65% Cell viability at 20 µM,1-h,Breast,None,NA,https://doi.org/10.1016/j.lfs.2013.03.016
2873,23583573,2013,DEVD,caspase 3 inhibitor,4,Linear,L,None,Fluoromethyl ketone(fmk),Free,Anticancer,caspase 3 inhibitor,Bcap-37,Breast Cancer,MTT/MTS assay,40% Cell viability at 30 µM,1-h,Breast,None,NA,https://doi.org/10.1016/j.lfs.2013.03.016
2874,23583573,2013,DEVD,caspase 3 inhibitor,4,Linear,L,None,Fluoromethyl ketone(fmk),Free,Anticancer,caspase 3 inhibitor,Bcap-37,Breast Cancer,MTT/MTS assay,35 % Cell viability at 40 µM,1-h,Breast,None,NA,https://doi.org/10.1016/j.lfs.2013.03.016
4434,"7628632, 18957441",1995,DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK,hBD-1,36,Not Available,L,None,Free,Free,Antibacterial,keratinocytes; skin; platelets;Homo sapiens,Not Available,Fibrosarcoma,Not Available,Not Available,Not Available,Fibrous connective tissue ,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]3C(=O)N4[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCC[NH3])CSSC3)CSSC1)CCCC[NH3])C)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccc(cc1)O)CSSC2)[C@H](O)C)CCC(=O)N)[C@H](CC)C)CCCC[NH3])[C@H](O)C)Cc1ccccc1)[C@H](CC)C)CCC4)C)CO)Cc1ccc(cc1)O)CC(C)C)CCC(=O)N)CO)CO)C(C)C)CC(=O)N)Cc1ccc(cc1)O)Cc1[nH]cnc1)CC(=O)O,"['https://doi.org/10.1016/0014-5793(95)00687-5', 'https://doi.org/10.1093/nar/gkn823']"
4435,"10942757, 18957441",2000,ECRRLCYKQRCVTYCRGR,Gomesin,18,Not Available,L,None,Free,Free,Antibacterial,"Hemocytes, Acanthoscurria gomesiana",Not Available,Breast Cancer,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)O,"['https://doi.org/10.1074/jbc.M001491200', 'https://doi.org/10.1093/nar/gkn823']"
2845,15634655,2004,ERRP,EGFR-related peptide,4,Linear,L,None,Free,Free,Anticancer,EGFR-related peptide,PC-3,Prostate Cancer,MTT/MTS assay,30% Cell viability at 5 µg/ml,48-h,Prostate,None,N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)O,Not Found
5060,24830845,2014,ESFSDWWKLLAE,mt_T18S/L22 W/P27A,12,Linear,L,None,Free,Free,Anticancer,MDM4,MCF-7,Breast Cancer,MTT/MTS assay,IC50=27 µM,Not Available,Breast,None,N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)O,https://doi.org/10.1007/s00726-014-1750-y
5061,24830845,2014,ETFADWWKLLAE,mt_S20A/L22 W/P27A,12,Linear,L,None,Free,Free,Anticancer,MDM5,MCF-7,Breast Cancer,MTT/MTS assay,IC50= 8.7 µM,Not Available,Breast,None,N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)O,https://doi.org/10.1007/s00726-014-1750-y
1350,18931881,2008,ETFSDLWKLL,PNC-28,10,Linear,L,None,Free,Free,Anticancer,Antennapedia,MiaPaCa.2,Pancreatic Cancer,MTT/MTS assay,Cytotoxicity=80% µMo/ml,48-h,Pancreatic,None,N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1245/s10434-008-0147-0
4581,21423613,2011,QETFSDLWKLLP,P5317-28,12,Linear,L,None,Free,Free,Antitumor,E3 ubiquitin-protein ligase,HCT-116-p53+/+,Colon Cancer,Immunoprecipitation assay,IC50 =4.7 µM,Not Available,Colon,None,N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C=O)CCC1)CC(C)C)CC(C)C)CC)Cc1c[nH]c2c1cccc2)CC(C)C)CC(=O)O)CO)Cc1ccccc1)[C@H](O)C)CCC(=O)O)CCC(=O)N,https://doi.org/10.1371/journal.pone.0017898
4591,21423613,2011,QETFSDLWKLLP,P5317-28,12,Linear,L,None,Free,Free,Antitumor,E3 ubiquitin-protein ligase,HCT-116-p53+/+,Colon Cancer,Immunoprecipitation assay,IC50 =30 µM,Not Available,Colon,None,N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C=O)CCC1)CC(C)C)CC(C)C)CC)Cc1c[nH]c2c1cccc2)CC(C)C)CC(=O)O)CO)Cc1ccccc1)[C@H](O)C)CCC(=O)O)CCC(=O)N,https://doi.org/10.1371/journal.pone.0017898
5058,24830845,2014,ETFSDWWKLLAE,mt_L22 W/P27A,12,Linear,L,None,Free,Free,Anticancer,MDM2,MCF-7,Breast Cancer,MTT/MTS assay,IC50=16.3 µM,Not Available,Breast,None,N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)O,https://doi.org/10.1007/s00726-014-1750-y
4206,15867360,2005,ETWRTEAPSATGQASSLLGGRLLGQ,hP7,25,Linear,L,None,Free,Free,Antiangiogenesis,Human endostatin peptides,BxPC-3,Pancreatic Cancer,Matrigel Assay,No inhibition at 7 mg/kg/d,672-h,Pancreatic,None,N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O,https://doi.org/10.1158/0008-5472.CAN-04-1833
3720,9815815,1997,fA*YwKA*T,Lan-7,7,Cyclic,Mix,A*=Lanthionine bridge between Alanine,Free,Free,Antitumor,Analogue of TT-232,Ovary tumor cellline,Ovarian Cancer,Sulforhodamine B assay,IC50=17.05±6.61 µM,24-h,Ovary,None,NA,Not Found
3721,9815815,1997,fA*YwKA*T,Lan-7,7,Cyclic,Mix,A*=Lanthionine bridge between Alanine,Free,Free,Antitumor,Analogue of TT-232,Ovary tumor cellline,Ovarian Cancer,Sulforhodamine B assay,IC50= 16.93±1.84 µM,48-h,Ovary,None,NA,Not Found
3722,9815815,1997,fA*YwKA*T,Lan-7,7,Cyclic,Mix,A*=Lanthionine bridge between Alanine,Free,Free,Antitumor,Analogue of TT-232,UMSCC10b,Head and Neck Cancer,Sulforhodamine B assay,IC50= 33.88±1.98 µM,24-h,Head and Neck,None,NA,Not Found
3723,9815815,1997,fA*YwKA*T,Lan-7,7,Cyclic,Mix,A*=Lanthionine bridge between Alanine,Free,Free,Antitumor,Analogue of TT-232,UMSCC10b,Head and Neck Cancer,Sulforhodamine B assay,IC50= 27.69±2.17 µM,48-h,Head and Neck,None,NA,Not Found
3724,9815815,1997,fA*YwKA*T,Lan-7,7,Cyclic,Mix,A*=Lanthionine bridge between Alanine,Free,Free,Antitumor,Analogue of TT-232,HCT-116,Colon Cancer,Sulforhodamine B assay,IC50= 29.97±1.19 µM,72-h,Colon,None,NA,Not Found
3725,9815815,1997,fA*YwKA*T,Lan-7,7,Cyclic,Mix,A*=Lanthionine bridge between Alanine,Free,Free,Antitumor,Analogue of TT-232,HEC-59,Endometrial cancer,Sulforhodamine B assay,IC50= 36.81±0.40 µM,72-h,Endometrial,None,NA,Not Found
1871,None,2005,FAFAKIIAKIAKKII,FLAK50 Z9,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
2023,None,2005,FAFAKIIAKIAKKII,FLAK50 Z9,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
2175,None,2005,FAFAKIIAKIAKKII,FLAK50 Z9,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
2327,None,2005,FAFAKIIAKIAKKII,FLAK50 Z9,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
2480,None,2005,FAFAKIIAKIAKKII,FLAK50 Z9,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
2623,None,2005,FAFAKIIAKIAKKII,FLAK50 Z9,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
2766,None,2005,FAFAKIIAKIAKKII,FLAK50 Z9,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =285 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
1869,None,2005,FAFGKGIGKIGKKGL,FLAK50 Z7,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2021,None,2005,FAFGKGIGKIGKKGL,FLAK50 Z7,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2173,None,2005,FAFGKGIGKIGKKGL,FLAK50 Z7,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2325,None,2005,FAFGKGIGKIGKKGL,FLAK50 Z7,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2478,None,2005,FAFGKGIGKIGKKGL,FLAK50 Z7,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2621,None,2005,FAFGKGIGKIGKKGL,FLAK50 Z7,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2764,None,2005,FAFGKGIGKIGKKGL,FLAK50 Z7,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1864,None,2005,FAFGKGIGKVGKKLL,FLAK50 Z2,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2016,None,2005,FAFGKGIGKVGKKLL,FLAK50 Z2,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2168,None,2005,FAFGKGIGKVGKKLL,FLAK50 Z2,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2320,None,2005,FAFGKGIGKVGKKLL,FLAK50 Z2,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2473,None,2005,FAFGKGIGKVGKKLL,FLAK50 Z2,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2616,None,2005,FAFGKGIGKVGKKLL,FLAK50 Z2,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2759,None,2005,FAFGKGIGKVGKKLL,FLAK50 Z2,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1003,14499271,2003,FAGLAANFLPTIICKISYKC,PTP2,20,Cyclic(C14-C20),L,None,Free,Free,Antibacterial,Gaegurin,A-549,Lung Cancer,MTT/MTS assay,IC50=>100 µg/ml,96-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)[C@@H](C)CC)CO)Cc1ccccc1)CCCCN)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1011,14499271,2003,FAGLAANFLPTIICKISYKC,PTP2,20,Cyclic(C14-C20),L,None,Free,Free,Antibacterial,Gaegurin,293,Renal Cancer,MTT/MTS assay,IC50=>100 µg/ml,96-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)[C@@H](C)CC)CO)Cc1ccccc1)CCCCN)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1019,14499271,2003,FAGLAANFLPTIICKISYKC,PTP2,20,Cyclic(C14-C20),L,None,Free,Free,Antibacterial,Gaegurin,293,Renal Cancer,MTT/MTS assay,IC50=>100 µg/ml,96-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)[C@@H](C)CC)CO)Cc1ccccc1)CCCCN)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1027,14499271,2003,FAGLAANFLPTIICKISYKC,PTP2,20,Cyclic(C14-C20),L,None,Free,Free,Antibacterial,Gaegurin,Hep3B,Liver Cancer,MTT/MTS assay,IC50=>100 µg/ml,96-h,Liver,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)[C@@H](C)CC)CO)Cc1ccccc1)CCCCN)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1035,14499271,2003,FAGLAANFLPTIICKISYKC,PTP2,20,Cyclic(C14-C20),L,None,Free,Free,Antibacterial,Gaegurin,MCF-7,Breast Cancer,MTT/MTS assay,IC50=>100 µg/ml,96-h,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)[C@@H](C)CC)CO)Cc1ccccc1)CCCCN)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1865,None,2005,FAKAIAKIAFGKGIGKVGKKLL,FLAK50 Z3,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2017,None,2005,FAKAIAKIAFGKGIGKVGKKLL,FLAK50 Z3,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =740 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2169,None,2005,FAKAIAKIAFGKGIGKVGKKLL,FLAK50 Z3,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2321,None,2005,FAKAIAKIAFGKGIGKVGKKLL,FLAK50 Z3,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2474,None,2005,FAKAIAKIAFGKGIGKVGKKLL,FLAK50 Z3,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2617,None,2005,FAKAIAKIAFGKGIGKVGKKLL,FLAK50 Z3,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2760,None,2005,FAKAIAKIAFGKGIGKVGKKLL,FLAK50 Z3,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1828,None,2005,FAKALAKLAKKLL,FLAK50B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =23 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1980,None,2005,FAKALAKLAKKLL,FLAK50B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =51 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2132,None,2005,FAKALAKLAKKLL,FLAK50B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =46 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2284,None,2005,FAKALAKLAKKLL,FLAK50B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =46 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2436,None,2005,FAKALAKLAKKLL,FLAK50B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =25 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2579,None,2005,FAKALAKLAKKLL,FLAK50B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =83 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2722,None,2005,FAKALAKLAKKLL,FLAK50B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =670 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1813,None,2005,FAKALKALLKALKAL,FLAK 17 C,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =80 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1965,None,2005,FAKALKALLKALKAL,FLAK 17 C,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 = µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2117,None,2005,FAKALKALLKALKAL,FLAK 17 C,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =35 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2269,None,2005,FAKALKALLKALKAL,FLAK 17 C,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =35 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2421,None,2005,FAKALKALLKALKAL,FLAK 17 C,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =30 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2564,None,2005,FAKALKALLKALKAL,FLAK 17 C,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =46 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2707,None,2005,FAKALKALLKALKAL,FLAK 17 C,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =30 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1844,None,2005,FAKFLAKFLKKAL,FLAK50 Q1,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =35 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1996,None,2005,FAKFLAKFLKKAL,FLAK50 Q1,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =27 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2148,None,2005,FAKFLAKFLKKAL,FLAK50 Q1,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =26 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2300,None,2005,FAKFLAKFLKKAL,FLAK50 Q1,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =26 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2453,None,2005,FAKFLAKFLKKAL,FLAK50 Q1,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =8 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2596,None,2005,FAKFLAKFLKKAL,FLAK50 Q1,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =11 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2739,None,2005,FAKFLAKFLKKAL,FLAK50 Q1,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =7 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1868,None,2005,FAKGVGKVGKKAL,FLAK50 Z6,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2020,None,2005,FAKGVGKVGKKAL,FLAK50 Z6,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2172,None,2005,FAKGVGKVGKKAL,FLAK50 Z6,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2324,None,2005,FAKGVGKVGKKAL,FLAK50 Z6,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2477,None,2005,FAKGVGKVGKKAL,FLAK50 Z6,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2620,None,2005,FAKGVGKVGKKAL,FLAK50 Z6,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2763,None,2005,FAKGVGKVGKKAL,FLAK50 Z6,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1870,None,2005,FAKIIAKIAKIAKKIL,FLAK50 Z8,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =625 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2022,None,2005,FAKIIAKIAKIAKKIL,FLAK50 Z8,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2174,None,2005,FAKIIAKIAKIAKKIL,FLAK50 Z8,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =525 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2326,None,2005,FAKIIAKIAKIAKKIL,FLAK50 Z8,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =525 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2479,None,2005,FAKIIAKIAKIAKKIL,FLAK50 Z8,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =850 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2622,None,2005,FAKIIAKIAKIAKKIL,FLAK50 Z8,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2765,None,2005,FAKIIAKIAKIAKKIL,FLAK50 Z8,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1871,None,2005,FAFAKIIAKIAKKII,FLAK50 Z9,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
1874,None,2005,FAKIIAKIAKKI,FLAK50 Z10,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
2023,None,2005,FAFAKIIAKIAKKII,FLAK50 Z9,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
2026,None,2005,FAKIIAKIAKKI,FLAK50 Z10,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
2175,None,2005,FAFAKIIAKIAKKII,FLAK50 Z9,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
2178,None,2005,FAKIIAKIAKKI,FLAK50 Z10,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
2327,None,2005,FAFAKIIAKIAKKII,FLAK50 Z9,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
2330,None,2005,FAKIIAKIAKKI,FLAK50 Z10,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
2480,None,2005,FAFAKIIAKIAKKII,FLAK50 Z9,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
2483,None,2005,FAKIIAKIAKKI,FLAK50 Z10,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
2623,None,2005,FAFAKIIAKIAKKII,FLAK50 Z9,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
2626,None,2005,FAKIIAKIAKKI,FLAK50 Z10,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
2766,None,2005,FAFAKIIAKIAKKII,FLAK50 Z9,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =285 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
2769,None,2005,FAKIIAKIAKKI,FLAK50 Z10,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,Not Found
1799,None,2005,FAKKALKALKKL,FLAK77,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =575 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1951,None,2005,FAKKALKALKKL,FLAK77,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2103,None,2005,FAKKALKALKKL,FLAK77,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =700 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2255,None,2005,FAKKALKALKKL,FLAK77,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =700 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2407,None,2005,FAKKALKALKKL,FLAK77,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2550,None,2005,FAKKALKALKKL,FLAK77,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2693,None,2005,FAKKALKALKKL,FLAK77,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1910,None,2005,FAKKFAKKFKKFAKKFAKFAFAF,D2A21,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =64 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2062,None,2005,FAKKFAKKFKKFAKKFAKFAFAF,D2A21,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =76 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2214,None,2005,FAKKFAKKFKKFAKKFAKFAFAF,D2A21,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2366,None,2005,FAKKFAKKFKKFAKKFAKFAFAF,D2A21,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2519,None,2005,FAKKFAKKFKKFAKKFAKFAFAF,D2A21,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =77 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2662,None,2005,FAKKFAKKFKKFAKKFAKFAFAF,D2A21,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =45 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2805,None,2005,FAKKFAKKFKKFAKKFAKFAFAF,D2A21,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =170 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
1808,None,2005,FAKKLAKALL,FLAK81,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1960,None,2005,FAKKLAKALL,FLAK81,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2112,None,2005,FAKKLAKALL,FLAK81,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2264,None,2005,FAKKLAKALL,FLAK81,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2416,None,2005,FAKKLAKALL,FLAK81,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2559,None,2005,FAKKLAKALL,FLAK81,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2702,None,2005,FAKKLAKALL,FLAK81,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1823,None,2005,FAKKLAKKAKLAKKL,FLAK 72,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1975,None,2005,FAKKLAKKAKLAKKL,FLAK 72,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2127,None,2005,FAKKLAKKAKLAKKL,FLAK 72,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =125 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2279,None,2005,FAKKLAKKAKLAKKL,FLAK 72,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =125 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2431,None,2005,FAKKLAKKAKLAKKL,FLAK 72,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2574,None,2005,FAKKLAKKAKLAKKL,FLAK 72,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2717,None,2005,FAKKLAKKAKLAKKL,FLAK 72,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1822,None,2005,FAKKLAKKLAKAAL,FLAK 58,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =970 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1974,None,2005,FAKKLAKKLAKAAL,FLAK 58,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =400 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2126,None,2005,FAKKLAKKLAKAAL,FLAK 58,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =750 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2278,None,2005,FAKKLAKKLAKAAL,FLAK 58,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =750 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2430,None,2005,FAKKLAKKLAKAAL,FLAK 58,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =860 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2573,None,2005,FAKKLAKKLAKAAL,FLAK 58,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =675 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2716,None,2005,FAKKLAKKLAKAAL,FLAK 58,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =380 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1820,None,2005,FAKKLAKKLAKAL,FLAK 54,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =465 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1972,None,2005,FAKKLAKKLAKAL,FLAK 54,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =340 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2124,None,2005,FAKKLAKKLAKAL,FLAK 54,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =460 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2276,None,2005,FAKKLAKKLAKAL,FLAK 54,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =460 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2428,None,2005,FAKKLAKKLAKAL,FLAK 54,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =670 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2571,None,2005,FAKKLAKKLAKAL,FLAK 54,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =660 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2714,None,2005,FAKKLAKKLAKAL,FLAK 54,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =260 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1797,None,2005,FAKKLAKKLAKLAL,FLAK57,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =260 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1949,None,2005,FAKKLAKKLAKLAL,FLAK57,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =180 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2101,None,2005,FAKKLAKKLAKLAL,FLAK57,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =160 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2253,None,2005,FAKKLAKKLAKLAL,FLAK57,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =160 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2405,None,2005,FAKKLAKKLAKLAL,FLAK57,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =330 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2548,None,2005,FAKKLAKKLAKLAL,FLAK57,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =170 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2691,None,2005,FAKKLAKKLAKLAL,FLAK57,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =160 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1821,None,2005,FAKKLAKKLAKLL,FLAK 56,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =42 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1973,None,2005,FAKKLAKKLAKLL,FLAK 56,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =17 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2125,None,2005,FAKKLAKKLAKLL,FLAK 56,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =24 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2277,None,2005,FAKKLAKKLAKLL,FLAK 56,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =24 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2429,None,2005,FAKKLAKKLAKLL,FLAK 56,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =80 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2572,None,2005,FAKKLAKKLAKLL,FLAK 56,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =54 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2715,None,2005,FAKKLAKKLAKLL,FLAK 56,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =74 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1777,None,2005,FAKKLAKKLKKLAKKLAKLALAL,SHIVA 10 AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1816,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA DERIV P69 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1817,None,2005,FAKKLAKKLKKLAKKLAK,Shiva 10(1-18 AC),18,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =190 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1818,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA 10 PEPTIDE 71 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =93 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1832,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =96 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1914,None,2005,FAKKLAKKLKKLAKKLAKLAKKL,Anubis-2,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =38 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1929,None,2005,FAKKLAKKLKKLAKKLAKLALAL,SHIVA 10 AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1968,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA DERIV P69 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =11 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1969,None,2005,FAKKLAKKLKKLAKKLAK,Shiva 10(1-18 AC),18,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =250 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1970,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA 10 PEPTIDE 71 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =82 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1984,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =125 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2066,None,2005,FAKKLAKKLKKLAKKLAKLAKKL,Anubis-2,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =73 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2081,None,2005,FAKKLAKKLKKLAKKLAKLALAL,SHIVA 10 AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2120,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA DERIV P69 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =94 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2121,None,2005,FAKKLAKKLKKLAKKLAK,Shiva 10(1-18 AC),18,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =445 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
2122,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA 10 PEPTIDE 71 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =290 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2136,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =94 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2218,None,2005,FAKKLAKKLKKLAKKLAKLAKKL,Anubis-2,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =83 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2233,None,2005,FAKKLAKKLKKLAKKLAKLALAL,SHIVA 10 AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2272,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA DERIV P69 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =94 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2273,None,2005,FAKKLAKKLKKLAKKLAK,Shiva 10(1-18 AC),18,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =445 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
2274,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA 10 PEPTIDE 71 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =290 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2288,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =94 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2370,None,2005,FAKKLAKKLKKLAKKLAKLAKKL,Anubis-2,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =83 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2385,None,2005,FAKKLAKKLKKLAKKLAKLALAL,SHIVA 10 AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2424,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA DERIV P69 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =63 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2425,None,2005,FAKKLAKKLKKLAKKLAK,Shiva 10(1-18 AC),18,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =320 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
2426,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA 10 PEPTIDE 71 + KWKL,22,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =160 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2441,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =53 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2523,None,2005,FAKKLAKKLKKLAKKLAKLAKKL,Anubis-2,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =160 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2528,None,2005,FAKKLAKKLKKLAKKLAKLALAL,SHIVA 10 AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =83 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2567,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA DERIV P69 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =82 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2568,None,2005,FAKKLAKKLKKLAKKLAK,Shiva 10(1-18 AC),18,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =270 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
2569,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA 10 PEPTIDE 71 + KWKL,22,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =63 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2584,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =52 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2666,None,2005,FAKKLAKKLKKLAKKLAKLAKKL,Anubis-2,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =66 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2671,None,2005,FAKKLAKKLKKLAKKLAKLALAL,SHIVA 10 AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2710,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA DERIV P69 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =28 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2711,None,2005,FAKKLAKKLKKLAKKLAK,Shiva 10(1-18 AC),18,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =570 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
2712,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA 10 PEPTIDE 71 + KWKL,22,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =240 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2727,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =175 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2809,None,2005,FAKKLAKKLKKLAKKLAKLAKKL,Anubis-2,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =100 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1816,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA DERIV P69 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1818,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA 10 PEPTIDE 71 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =93 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1968,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA DERIV P69 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =11 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1970,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA 10 PEPTIDE 71 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =82 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2120,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA DERIV P69 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =94 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2122,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA 10 PEPTIDE 71 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =290 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2272,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA DERIV P69 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =94 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2274,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA 10 PEPTIDE 71 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =290 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2424,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA DERIV P69 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =63 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2426,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA 10 PEPTIDE 71 + KWKL,22,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =160 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2567,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA DERIV P69 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =82 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2569,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA 10 PEPTIDE 71 + KWKL,22,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =63 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2710,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA DERIV P69 + KWKL,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =28 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2712,None,2005,FAKKLAKKLKKLAKKLAKKWKL,SHIVA 10 PEPTIDE 71 + KWKL,22,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =240 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1914,None,2005,FAKKLAKKLKKLAKKLAKLAKKL,Anubis-2,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =38 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2066,None,2005,FAKKLAKKLKKLAKKLAKLAKKL,Anubis-2,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =73 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2218,None,2005,FAKKLAKKLKKLAKKLAKLAKKL,Anubis-2,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =83 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2370,None,2005,FAKKLAKKLKKLAKKLAKLAKKL,Anubis-2,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =83 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2523,None,2005,FAKKLAKKLKKLAKKLAKLAKKL,Anubis-2,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =160 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2666,None,2005,FAKKLAKKLKKLAKKLAKLAKKL,Anubis-2,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =66 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2809,None,2005,FAKKLAKKLKKLAKKLAKLAKKL,Anubis-2,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =100 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1777,None,2005,FAKKLAKKLKKLAKKLAKLALAL,SHIVA 10 AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1832,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =96 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1929,None,2005,FAKKLAKKLKKLAKKLAKLALAL,SHIVA 10 AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1984,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =125 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2081,None,2005,FAKKLAKKLKKLAKKLAKLALAL,SHIVA 10 AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2136,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =94 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2233,None,2005,FAKKLAKKLKKLAKKLAKLALAL,SHIVA 10 AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2288,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =94 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2385,None,2005,FAKKLAKKLKKLAKKLAKLALAL,SHIVA 10 AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2441,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =53 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2528,None,2005,FAKKLAKKLKKLAKKLAKLALAL,SHIVA 10 AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =83 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2584,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =52 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2671,None,2005,FAKKLAKKLKKLAKKLAKLALAL,SHIVA 10 AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2727,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =175 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1832,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =96 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1984,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =125 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2136,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =94 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2288,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =94 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2441,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =53 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2584,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =52 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2727,None,2005,FAKKLAKKLKKLAKKLAKLALALKALALKAL,Shiva-11,31,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =175 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1833,None,2005,FAKKLAKKLKKLAKKLIGAVLKV,SHIVA 11[(1-16)ME(2-9]-COOH,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =95 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)O,Not Found
1985,None,2005,FAKKLAKKLKKLAKKLIGAVLKV,SHIVA 11[(1-16)ME(2-9]-COOH,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =120 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)O,Not Found
2137,None,2005,FAKKLAKKLKKLAKKLIGAVLKV,SHIVA 11[(1-16)ME(2-9]-COOH,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =94 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)O,Not Found
2289,None,2005,FAKKLAKKLKKLAKKLIGAVLKV,SHIVA 11[(1-16)ME(2-9]-COOH,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =94 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)O,Not Found
2442,None,2005,FAKKLAKKLKKLAKKLIGAVLKV,SHIVA 11[(1-16)ME(2-9]-COOH,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =54 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)O,Not Found
2585,None,2005,FAKKLAKKLKKLAKKLIGAVLKV,SHIVA 11[(1-16)ME(2-9]-COOH,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =28 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)O,Not Found
2728,None,2005,FAKKLAKKLKKLAKKLIGAVLKV,SHIVA 11[(1-16)ME(2-9]-COOH,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =180 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)O,Not Found
1793,None,2005,FAKKLAKKLKKLAKLALAK,FLAK 06R-AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =98 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
1945,None,2005,FAKKLAKKLKKLAKLALAK,FLAK 06R-AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =120 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2097,None,2005,FAKKLAKKLKKLAKLALAK,FLAK 06R-AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =290 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2249,None,2005,FAKKLAKKLKKLAKLALAK,FLAK 06R-AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =290 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2401,None,2005,FAKKLAKKLKKLAKLALAK,FLAK 06R-AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =245 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2544,None,2005,FAKKLAKKLKKLAKLALAK,FLAK 06R-AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2687,None,2005,FAKKLAKKLKKLAKLALAK,FLAK 06R-AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =185 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
1784,None,2005,FAKKLAKKLKKLAKLALAL,FLAK06 R-AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1936,None,2005,FAKKLAKKLKKLAKLALAL,FLAK06 R-AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =210 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2088,None,2005,FAKKLAKKLKKLAKLALAL,FLAK06 AM,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =300 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2240,None,2005,FAKKLAKKLKKLAKLALAL,FLAK06 R-AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =300 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2392,None,2005,FAKKLAKKLKKLAKLALAL,FLAK06 AM,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =170 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2535,None,2005,FAKKLAKKLKKLAKLALAL,FLAK06 R-AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =280 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2678,None,2005,FAKKLAKKLKKLAKLALAL,FLAK06 R-AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =260 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1809,None,2005,FAKKLAKKLL,FLAK82,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =31 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1961,None,2005,FAKKLAKKLL,FLAK82,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =42 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2113,None,2005,FAKKLAKKLL,FLAK82,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =155 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2265,None,2005,FAKKLAKKLL,FLAK82,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =155 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2417,None,2005,FAKKLAKKLL,FLAK82,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =180 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2560,None,2005,FAKKLAKKLL,FLAK82,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =81 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2703,None,2005,FAKKLAKKLL,FLAK82,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,Not Available,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1791,None,2005,FAKKLAKLAKKALAL,FLAK44 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =130 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1943,None,2005,FAKKLAKLAKKALAL,FLAK44 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =435 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2095,None,2005,FAKKLAKLAKKALAL,FLAK44 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =510 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2247,None,2005,FAKKLAKLAKKALAL,FLAK44 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =510 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2399,None,2005,FAKKLAKLAKKALAL,FLAK44 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =420 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2542,None,2005,FAKKLAKLAKKALAL,FLAK44 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =310 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2685,None,2005,FAKKLAKLAKKALAL,FLAK44 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =620 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1787,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =9 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1788,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =9 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1790,None,2005,FAKKLAKLAKKLLAL,FLAK43 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =17 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1811,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 Ac,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =105 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1839,None,2005,FAKKLAKLAKKL,FLAG26-D1,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =620 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1842,None,2005,FAKKLAKLAKKLAKAL,FLAK26-D2,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1915,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 17 CV,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =23 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1939,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =14 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1940,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =30 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1942,None,2005,FAKKLAKLAKKLLAL,FLAK43 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =13 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1963,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 Ac,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =100 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1991,None,2005,FAKKLAKLAKKL,FLAG26-D1,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =570 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1994,None,2005,FAKKLAKLAKKLAKAL,FLAK26-D2,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2067,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 17 CV,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2070,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM V,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2071,None,2005,FAKKLAKLAKKLLAL,FLAK43 AM V,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2091,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =7 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2092,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =56 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2094,None,2005,FAKKLAKLAKKLLAL,FLAK43 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =21 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2115,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 Ac,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2143,None,2005,FAKKLAKLAKKL,FLAG26-D1,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =690 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2146,None,2005,FAKKLAKLAKKLAKAL,FLAK26-D2,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2243,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =7 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2244,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =56 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2246,None,2005,FAKKLAKLAKKLLAL,FLAK43 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =21 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2267,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 Ac,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2295,None,2005,FAKKLAKLAKKL,FLAG26-D1,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =690 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2298,None,2005,FAKKLAKLAKKLAKAL,FLAK26-D2,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2395,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =16 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2396,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =57 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2398,None,2005,FAKKLAKLAKKLLAL,FLAK43 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =33 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2419,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 Ac,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =127 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2448,None,2005,FAKKLAKLAKKL,FLAG26-D1,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =920 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2451,None,2005,FAKKLAKLAKKLAKAL,FLAK26-D2,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2538,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =5 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2539,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =19 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2541,None,2005,FAKKLAKLAKKLLAL,FLAK43 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =10 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2562,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 Ac,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =66 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2591,None,2005,FAKKLAKLAKKL,FLAG26-D1,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2594,None,2005,FAKKLAKLAKKLAKAL,FLAK26-D2,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2681,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =27 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2682,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,Not Available,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2684,None,2005,FAKKLAKLAKKLLAL,FLAK43 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =35 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2705,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 Ac,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =170 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2734,None,2005,FAKKLAKLAKKL,FLAG26-D1,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =700 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2737,None,2005,FAKKLAKLAKKLAKAL,FLAK26-D2,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1842,None,2005,FAKKLAKLAKKLAKAL,FLAK26-D2,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1994,None,2005,FAKKLAKLAKKLAKAL,FLAK26-D2,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2146,None,2005,FAKKLAKLAKKLAKAL,FLAK26-D2,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2298,None,2005,FAKKLAKLAKKLAKAL,FLAK26-D2,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2451,None,2005,FAKKLAKLAKKLAKAL,FLAK26-D2,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2594,None,2005,FAKKLAKLAKKLAKAL,FLAK26-D2,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2737,None,2005,FAKKLAKLAKKLAKAL,FLAK26-D2,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1787,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =9 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1788,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =9 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1811,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 Ac,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =105 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1915,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 17 CV,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =23 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1939,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =14 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1940,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =30 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1963,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 Ac,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =100 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2067,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 17 CV,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2070,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM V,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2091,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =7 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2092,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =56 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2115,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 Ac,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2243,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =7 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2244,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =56 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2267,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 Ac,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2395,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =16 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2396,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =57 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2419,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 Ac,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =127 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2538,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =5 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2539,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =19 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2562,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 Ac,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =66 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2681,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =27 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2682,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,Not Available,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2705,None,2005,FAKKLAKLAKKLAKLAL,FLAK 26 Ac,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =170 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1788,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =9 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1915,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 17 CV,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =23 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1940,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =30 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2067,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 17 CV,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2070,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM V,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2092,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =56 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2244,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =56 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2396,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =57 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2539,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =19 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2682,None,2005,FAKKLAKLAKKLAKLALAL,FLAK 25 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,Not Available,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1790,None,2005,FAKKLAKLAKKLLAL,FLAK43 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =17 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1942,None,2005,FAKKLAKLAKKLLAL,FLAK43 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =13 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2071,None,2005,FAKKLAKLAKKLLAL,FLAK43 AM V,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2094,None,2005,FAKKLAKLAKKLLAL,FLAK43 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =21 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2246,None,2005,FAKKLAKLAKKLLAL,FLAK43 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =21 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2398,None,2005,FAKKLAKLAKKLLAL,FLAK43 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =33 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2541,None,2005,FAKKLAKLAKKLLAL,FLAK43 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =10 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2684,None,2005,FAKKLAKLAKKLLAL,FLAK43 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =35 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1796,None,2005,FAKKLAKLALKLAKL,FLAK51,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1948,None,2005,FAKKLAKLALKLAKL,FLAK51,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =32 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2100,None,2005,FAKKLAKLALKLAKL,FLAK51,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =47 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2252,None,2005,FAKKLAKLALKLAKL,FLAK51,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =47 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2404,None,2005,FAKKLAKLALKLAKL,FLAK51,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2547,None,2005,FAKKLAKLALKLAKL,FLAK51,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =45 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2690,None,2005,FAKKLAKLALKLAKL,FLAK51,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =22 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1824,None,2005,FAKKLKKLAKKL,FLAK 75,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =540 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1976,None,2005,FAKKLKKLAKKL,FLAK 75,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2128,None,2005,FAKKLKKLAKKL,FLAK 75,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =830 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2280,None,2005,FAKKLKKLAKKL,FLAK 75,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =830 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2432,None,2005,FAKKLKKLAKKL,FLAK 75,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2575,None,2005,FAKKLKKLAKKL,FLAK 75,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2718,None,2005,FAKKLKKLAKKL,FLAK 75,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1798,None,2005,FAKKLKKLAKLAKKL,FLAK71,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =300 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1950,None,2005,FAKKLKKLAKLAKKL,FLAK71,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =160 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2102,None,2005,FAKKLKKLAKLAKKL,FLAK71,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2254,None,2005,FAKKLKKLAKLAKKL,FLAK71,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2406,None,2005,FAKKLKKLAKLAKKL,FLAK71,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =290 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2549,None,2005,FAKKLKKLAKLAKKL,FLAK71,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =280 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2692,None,2005,FAKKLKKLAKLAKKL,FLAK71,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =280 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1843,None,2005,FAKKLLAKALKL,FLAG26-D3,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =180 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1995,None,2005,FAKKLLAKALKL,FLAG26-D3,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =325 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2147,None,2005,FAKKLLAKALKL,FLAG26-D3,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =400 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2299,None,2005,FAKKLLAKALKL,FLAG26-D3,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =400 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2452,None,2005,FAKKLLAKALKL,FLAG26-D3,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =95 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2595,None,2005,FAKKLLAKALKL,FLAG26-D3,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2738,None,2005,FAKKLLAKALKL,FLAG26-D3,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =540 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1810,None,2005,FAKLAKKLL,FLAK83M,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1852,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =400 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1859,None,2005,FAKLA,FLAK90,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =500 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,Not Found
1879,None,2005,FAKLAKKALAKLL,FLAK91B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =315 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1962,None,2005,FAKLAKKLL,FLAK83M,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2004,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =800 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2011,None,2005,FAKLA,FLAK90,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =530 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,Not Found
2031,None,2005,FAKLAKKALAKLL,FLAK91B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2114,None,2005,FAKLAKKLL,FLAK83M,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2156,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =670 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2163,None,2005,FAKLA,FLAK90,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =330 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,Not Found
2183,None,2005,FAKLAKKALAKLL,FLAK91B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =330 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2266,None,2005,FAKLAKKLL,FLAK83M,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2308,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =670 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2315,None,2005,FAKLA,FLAK90,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =330 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,Not Found
2335,None,2005,FAKLAKKALAKLL,FLAK91B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =330 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2418,None,2005,FAKLAKKLL,FLAK83M,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2461,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =460 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2468,None,2005,FAKLA,FLAK90,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,Not Found
2488,None,2005,FAKLAKKALAKLL,FLAK91B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =660 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2561,None,2005,FAKLAKKLL,FLAK83M,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2604,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2611,None,2005,FAKLA,FLAK90,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,Not Found
2631,None,2005,FAKLAKKALAKLL,FLAK91B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2704,None,2005,FAKLAKKLL,FLAK83M,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2747,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =830 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2754,None,2005,FAKLA,FLAK90,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =700 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,Not Found
2774,None,2005,FAKLAKKALAKLL,FLAK91B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1879,None,2005,FAKLAKKALAKLL,FLAK91B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =315 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2031,None,2005,FAKLAKKALAKLL,FLAK91B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2183,None,2005,FAKLAKKALAKLL,FLAK91B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =330 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2335,None,2005,FAKLAKKALAKLL,FLAK91B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =330 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2488,None,2005,FAKLAKKALAKLL,FLAK91B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =660 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2631,None,2005,FAKLAKKALAKLL,FLAK91B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2774,None,2005,FAKLAKKALAKLL,FLAK91B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1810,None,2005,FAKLAKKLL,FLAK83M,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1962,None,2005,FAKLAKKLL,FLAK83M,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2114,None,2005,FAKLAKKLL,FLAK83M,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2266,None,2005,FAKLAKKLL,FLAK83M,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2418,None,2005,FAKLAKKLL,FLAK83M,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2561,None,2005,FAKLAKKLL,FLAK83M,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2704,None,2005,FAKLAKKLL,FLAK83M,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1848,None,2005,FAKLFAKAFKKAL,FLAK50 Q5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1852,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =400 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1860,None,2005,FAKLF,FLAK91,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2000,None,2005,FAKLFAKAFKKAL,FLAK50 Q5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2004,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =800 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2012,None,2005,FAKLF,FLAK91,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =550 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2152,None,2005,FAKLFAKAFKKAL,FLAK50 Q5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2156,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =670 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2164,None,2005,FAKLF,FLAK91,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2304,None,2005,FAKLFAKAFKKAL,FLAK50 Q5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2308,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =670 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2316,None,2005,FAKLF,FLAK91,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2457,None,2005,FAKLFAKAFKKAL,FLAK50 Q5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2461,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =460 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2469,None,2005,FAKLF,FLAK91,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =790 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2600,None,2005,FAKLFAKAFKKAL,FLAK50 Q5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2604,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2612,None,2005,FAKLF,FLAK91,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2743,None,2005,FAKLFAKAFKKAL,FLAK50 Q5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2747,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =830 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2755,None,2005,FAKLF,FLAK91,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =550 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
1848,None,2005,FAKLFAKAFKKAL,FLAK50 Q5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2000,None,2005,FAKLFAKAFKKAL,FLAK50 Q5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2152,None,2005,FAKLFAKAFKKAL,FLAK50 Q5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2304,None,2005,FAKLFAKAFKKAL,FLAK50 Q5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2457,None,2005,FAKLFAKAFKKAL,FLAK50 Q5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2600,None,2005,FAKLFAKAFKKAL,FLAK50 Q5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2743,None,2005,FAKLFAKAFKKAL,FLAK50 Q5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1852,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =400 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2004,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =800 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2156,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =670 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2308,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =670 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2461,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =460 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2604,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2747,None,2005,FAKLFAKLAKKFAL,FLAK50 Q9,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =830 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1847,None,2005,FAKLLAKAFKKAL,FLAK50 Q4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =730 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1999,None,2005,FAKLLAKAFKKAL,FLAK50 Q4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2151,None,2005,FAKLLAKAFKKAL,FLAK50 Q4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2303,None,2005,FAKLLAKAFKKAL,FLAK50 Q4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2456,None,2005,FAKLLAKAFKKAL,FLAK50 Q4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2599,None,2005,FAKLLAKAFKKAL,FLAK50 Q4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2742,None,2005,FAKLLAKAFKKAL,FLAK50 Q4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1835,None,2005,FAKLLAKALKKAL,FLAK 50O,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =60 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1987,None,2005,FAKLLAKALKKAL,FLAK 50O,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =57 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2139,None,2005,FAKLLAKALKKAL,FLAK 50O,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =60 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2291,None,2005,FAKLLAKALKKAL,FLAK 50O,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =60 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2444,None,2005,FAKLLAKALKKAL,FLAK 50O,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =27 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2587,None,2005,FAKLLAKALKKAL,FLAK 50O,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =66 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2730,None,2005,FAKLLAKALKKAL,FLAK 50O,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =43 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1850,None,2005,FAKLLAKALKKFAL,FLAK50 Q7,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =54 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2002,None,2005,FAKLLAKALKKFAL,FLAK50 Q7,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =46 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2154,None,2005,FAKLLAKALKKFAL,FLAK50 Q7,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =36 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2306,None,2005,FAKLLAKALKKFAL,FLAK50 Q7,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =36 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2459,None,2005,FAKLLAKALKKFAL,FLAK50 Q7,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =33 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2602,None,2005,FAKLLAKALKKFAL,FLAK50 Q7,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2745,None,2005,FAKLLAKALKKFAL,FLAK50 Q7,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =30 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1849,None,2005,FAKLLAKALKKFL,FLAK50 Q6,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =70 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2001,None,2005,FAKLLAKALKKFL,FLAK50 Q6,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =115 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2153,None,2005,FAKLLAKALKKFL,FLAK50 Q6,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =135 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2305,None,2005,FAKLLAKALKKFL,FLAK50 Q6,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =135 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2458,None,2005,FAKLLAKALKKFL,FLAK50 Q6,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =74 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2601,None,2005,FAKLLAKALKKFL,FLAK50 Q6,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =330 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2744,None,2005,FAKLLAKALKKFL,FLAK50 Q6,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =87 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1805,None,2005,FAKLLAKALKKLL,FLAK50D,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =16 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1836,None,2005,FAKLLAKALKKL,FLAK 50P,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =46 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1957,None,2005,FAKLLAKALKKLL,FLAK50D,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =14 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1988,None,2005,FAKLLAKALKKL,FLAK 50P,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =90 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2109,None,2005,FAKLLAKALKKLL,FLAK50D,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =16 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2140,None,2005,FAKLLAKALKKL,FLAK 50P,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =75 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2261,None,2005,FAKLLAKALKKLL,FLAK50D,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =16 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2292,None,2005,FAKLLAKALKKL,FLAK 50P,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =75 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2413,None,2005,FAKLLAKALKKLL,FLAK50D,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =7 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2445,None,2005,FAKLLAKALKKL,FLAK 50P,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2556,None,2005,FAKLLAKALKKLL,FLAK50D,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =47 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2588,None,2005,FAKLLAKALKKL,FLAK 50P,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =330 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2699,None,2005,FAKLLAKALKKLL,FLAK50D,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =15 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2731,None,2005,FAKLLAKALKKL,FLAK 50P,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =70 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1805,None,2005,FAKLLAKALKKLL,FLAK50D,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =16 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1957,None,2005,FAKLLAKALKKLL,FLAK50D,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =14 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2109,None,2005,FAKLLAKALKKLL,FLAK50D,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =16 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2261,None,2005,FAKLLAKALKKLL,FLAK50D,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =16 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2413,None,2005,FAKLLAKALKKLL,FLAK50D,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =7 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2556,None,2005,FAKLLAKALKKLL,FLAK50D,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =47 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2699,None,2005,FAKLLAKALKKLL,FLAK50D,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =15 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1834,None,2005,FAKLLAKALKLKL,FLAK 50N,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =250 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1986,None,2005,FAKLLAKALKLKL,FLAK 50N,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =170 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2138,None,2005,FAKLLAKALKLKL,FLAK 50N,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =160 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2290,None,2005,FAKLLAKALKLKL,FLAK 50N,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =160 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2443,None,2005,FAKLLAKALKLKL,FLAK 50N,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =340 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2586,None,2005,FAKLLAKALKLKL,FLAK 50N,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =730 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2729,None,2005,FAKLLAKALKLKL,FLAK 50N,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =170 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1846,None,2005,FAKLLAKFLKKAL,FLAK50 Q3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1998,None,2005,FAKLLAKFLKKAL,FLAK50 Q3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =180 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2150,None,2005,FAKLLAKFLKKAL,FLAK50 Q3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =115 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2302,None,2005,FAKLLAKFLKKAL,FLAK50 Q3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =115 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2455,None,2005,FAKLLAKFLKKAL,FLAK50 Q3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =50 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2598,None,2005,FAKLLAKFLKKAL,FLAK50 Q3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =240 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2741,None,2005,FAKLLAKFLKKAL,FLAK50 Q3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =190 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1807,None,2005,FAKLLAKKLL,FLAK80,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1959,None,2005,FAKLLAKKLL,FLAK80,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =740 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2111,None,2005,FAKLLAKKLL,FLAK80,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =740 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2263,None,2005,FAKLLAKKLL,FLAK80,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =740 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2415,None,2005,FAKLLAKKLL,FLAK80,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2558,None,2005,FAKLLAKKLL,FLAK80,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2701,None,2005,FAKLLAKKLL,FLAK80,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =830 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1795,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =9 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1801,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =40 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1804,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =60 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1814,None,2005,FAKLLAKLAKAKL,FLAK 50H,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =475 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1815,None,2005,FAKLLAKLAKLKL,FLAK 50G,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =90 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1830,None,2005,FAKLLAKLAKAKA,FLAK50K,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
1831,None,2005,FAKLLAKLAKAKG,FLAK50L,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,Not Found
1851,None,2005,FAKLLAKLAKKFAL,FLAK50 Q8,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =730 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1854,None,2005,FAKLLAKLAK,FLAK50 T1,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =615 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
1855,None,2005,FAKLLAKLAKKVL,FLAK50 T2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =18 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1856,None,2005,FAKLLAKLAKKIL,FLAK50 T3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =90 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1857,None,2005,FAKLLAKLAKKEL,FLAK50 T4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1858,None,2005,FAKLLAKLAKKSL,FLAK50 T5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =440 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1882,None,2005,FAKLLAKLAKK,FLAK50T6,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
1883,None,2005,FAKLLAKLAKKGL,FLAK50T7,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =430 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1924,None,2005,FAKLLAKLAKKAA,FLAK50J,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,Not Available,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N,Not Found
1947,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =9 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1953,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =100 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1956,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1966,None,2005,FAKLLAKLAKAKL,FLAK 50H,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =345 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1967,None,2005,FAKLLAKLAKLKL,FLAK 50G,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =145 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1982,None,2005,FAKLLAKLAKAKA,FLAK50K,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
1983,None,2005,FAKLLAKLAKAKG,FLAK50L,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,Not Found
2003,None,2005,FAKLLAKLAKKFAL,FLAK50 Q8,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =630 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2006,None,2005,FAKLLAKLAK,FLAK50 T1,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2007,None,2005,FAKLLAKLAKKVL,FLAK50 T2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =9 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2008,None,2005,FAKLLAKLAKKIL,FLAK50 T3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =125 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2009,None,2005,FAKLLAKLAKKEL,FLAK50 T4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2010,None,2005,FAKLLAKLAKKSL,FLAK50 T5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =400 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2034,None,2005,FAKLLAKLAKK,FLAK50T6,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2035,None,2005,FAKLLAKLAKKGL,FLAK50T7,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =740 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2076,None,2005,FAKLLAKLAKKAA,FLAK50J,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N,Not Found
2099,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =7 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2105,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =115 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2108,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =90 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2118,None,2005,FAKLLAKLAKAKL,FLAK 50H,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =250 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2119,None,2005,FAKLLAKLAKLKL,FLAK 50G,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =200 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2134,None,2005,FAKLLAKLAKAKA,FLAK50K,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =820 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2135,None,2005,FAKLLAKLAKAKG,FLAK50L,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,Not Found
2155,None,2005,FAKLLAKLAKKFAL,FLAK50 Q8,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =660 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2158,None,2005,FAKLLAKLAK,FLAK50 T1,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =635 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2159,None,2005,FAKLLAKLAKKVL,FLAK50 T2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =10 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2160,None,2005,FAKLLAKLAKKIL,FLAK50 T3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =220 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2161,None,2005,FAKLLAKLAKKEL,FLAK50 T4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2162,None,2005,FAKLLAKLAKKSL,FLAK50 T5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =535 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2186,None,2005,FAKLLAKLAKK,FLAK50T6,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2187,None,2005,FAKLLAKLAKKGL,FLAK50T7,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2228,None,2005,FAKLLAKLAKKAA,FLAK50J,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N,Not Found
2251,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =7 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2257,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =115 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2260,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =90 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2270,None,2005,FAKLLAKLAKAKL,FLAK 50H,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =250 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2271,None,2005,FAKLLAKLAKLKL,FLAK 50G,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =200 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2286,None,2005,FAKLLAKLAKAKA,FLAK50K,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =820 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2287,None,2005,FAKLLAKLAKAKG,FLAK50L,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,Not Found
2307,None,2005,FAKLLAKLAKKFAL,FLAK50 Q8,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =660 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2310,None,2005,FAKLLAKLAK,FLAK50 T1,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =635 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2311,None,2005,FAKLLAKLAKKVL,FLAK50 T2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =10 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2312,None,2005,FAKLLAKLAKKIL,FLAK50 T3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =220 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2313,None,2005,FAKLLAKLAKKEL,FLAK50 T4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2314,None,2005,FAKLLAKLAKKSL,FLAK50 T5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =535 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2338,None,2005,FAKLLAKLAKK,FLAK50T6,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2339,None,2005,FAKLLAKLAKKGL,FLAK50T7,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2380,None,2005,FAKLLAKLAKKAA,FLAK50J,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N,Not Found
2403,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =6 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2409,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2412,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =80 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2422,None,2005,FAKLLAKLAKAKL,FLAK 50H,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =450 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2423,None,2005,FAKLLAKLAKLKL,FLAK 50G,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =130 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2437,None,2005,FAKLLAKLAKKAA,FLAK50J,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =320 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N,Not Found
2439,None,2005,FAKLLAKLAKAKA,FLAK50K,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2440,None,2005,FAKLLAKLAKAKG,FLAK50L,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,Not Found
2460,None,2005,FAKLLAKLAKKFAL,FLAK50 Q8,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =620 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2463,None,2005,FAKLLAKLAK,FLAK50 T1,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2464,None,2005,FAKLLAKLAKKVL,FLAK50 T2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =30 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2465,None,2005,FAKLLAKLAKKIL,FLAK50 T3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =76 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2466,None,2005,FAKLLAKLAKKEL,FLAK50 T4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2467,None,2005,FAKLLAKLAKKSL,FLAK50 T5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =770 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2491,None,2005,FAKLLAKLAKK,FLAK50T6,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2492,None,2005,FAKLLAKLAKKGL,FLAK50T7,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =410 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2546,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =12 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2552,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =77 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2555,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =90 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2565,None,2005,FAKLLAKLAKAKL,FLAK 50H,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =470 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2566,None,2005,FAKLLAKLAKLKL,FLAK 50G,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =170 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2580,None,2005,FAKLLAKLAKKAA,FLAK50J,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =690 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N,Not Found
2582,None,2005,FAKLLAKLAKAKA,FLAK50K,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2583,None,2005,FAKLLAKLAKAKG,FLAK50L,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,Not Found
2603,None,2005,FAKLLAKLAKKFAL,FLAK50 Q8,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2606,None,2005,FAKLLAKLAK,FLAK50 T1,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2607,None,2005,FAKLLAKLAKKVL,FLAK50 T2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =10 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2608,None,2005,FAKLLAKLAKKIL,FLAK50 T3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =145 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2609,None,2005,FAKLLAKLAKKEL,FLAK50 T4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2610,None,2005,FAKLLAKLAKKSL,FLAK50 T5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2634,None,2005,FAKLLAKLAKK,FLAK50T6,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2635,None,2005,FAKLLAKLAKKGL,FLAK50T7,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2689,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =15 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2695,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,Not Available,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2698,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =190 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2708,None,2005,FAKLLAKLAKAKL,FLAK 50H,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =210 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1830,None,2005,FAKLLAKLAKAKA,FLAK50K,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
1982,None,2005,FAKLLAKLAKAKA,FLAK50K,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2134,None,2005,FAKLLAKLAKAKA,FLAK50K,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =820 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2286,None,2005,FAKLLAKLAKAKA,FLAK50K,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =820 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2439,None,2005,FAKLLAKLAKAKA,FLAK50K,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2582,None,2005,FAKLLAKLAKAKA,FLAK50K,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2725,None,2005,FAKLLAKLAKAKA,FLAK50K,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
1831,None,2005,FAKLLAKLAKAKG,FLAK50L,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,Not Found
1983,None,2005,FAKLLAKLAKAKG,FLAK50L,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,Not Found
2135,None,2005,FAKLLAKLAKAKG,FLAK50L,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,Not Found
2287,None,2005,FAKLLAKLAKAKG,FLAK50L,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,Not Found
2440,None,2005,FAKLLAKLAKAKG,FLAK50L,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,Not Found
2583,None,2005,FAKLLAKLAKAKG,FLAK50L,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,Not Found
2726,None,2005,FAKLLAKLAKAKG,FLAK50L,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,Not Found
1814,None,2005,FAKLLAKLAKAKL,FLAK 50H,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =475 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1966,None,2005,FAKLLAKLAKAKL,FLAK 50H,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =345 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2118,None,2005,FAKLLAKLAKAKL,FLAK 50H,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =250 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2270,None,2005,FAKLLAKLAKAKL,FLAK 50H,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =250 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2422,None,2005,FAKLLAKLAKAKL,FLAK 50H,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =450 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2565,None,2005,FAKLLAKLAKAKL,FLAK 50H,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =470 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2708,None,2005,FAKLLAKLAKAKL,FLAK 50H,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =210 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1795,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =9 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1801,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =40 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1804,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =60 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1851,None,2005,FAKLLAKLAKKFAL,FLAK50 Q8,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =730 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1855,None,2005,FAKLLAKLAKKVL,FLAK50 T2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =18 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1856,None,2005,FAKLLAKLAKKIL,FLAK50 T3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =90 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1857,None,2005,FAKLLAKLAKKEL,FLAK50 T4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1858,None,2005,FAKLLAKLAKKSL,FLAK50 T5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =440 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1882,None,2005,FAKLLAKLAKK,FLAK50T6,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
1883,None,2005,FAKLLAKLAKKGL,FLAK50T7,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =430 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1924,None,2005,FAKLLAKLAKKAA,FLAK50J,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,Not Available,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N,Not Found
1947,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =9 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1953,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =100 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1956,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2003,None,2005,FAKLLAKLAKKFAL,FLAK50 Q8,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =630 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2007,None,2005,FAKLLAKLAKKVL,FLAK50 T2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =9 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2008,None,2005,FAKLLAKLAKKIL,FLAK50 T3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =125 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2009,None,2005,FAKLLAKLAKKEL,FLAK50 T4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2010,None,2005,FAKLLAKLAKKSL,FLAK50 T5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =400 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2034,None,2005,FAKLLAKLAKK,FLAK50T6,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2035,None,2005,FAKLLAKLAKKGL,FLAK50T7,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =740 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2076,None,2005,FAKLLAKLAKKAA,FLAK50J,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N,Not Found
2099,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =7 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2105,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =115 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2108,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =90 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2155,None,2005,FAKLLAKLAKKFAL,FLAK50 Q8,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =660 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2159,None,2005,FAKLLAKLAKKVL,FLAK50 T2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =10 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2160,None,2005,FAKLLAKLAKKIL,FLAK50 T3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =220 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2161,None,2005,FAKLLAKLAKKEL,FLAK50 T4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2162,None,2005,FAKLLAKLAKKSL,FLAK50 T5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =535 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2186,None,2005,FAKLLAKLAKK,FLAK50T6,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2187,None,2005,FAKLLAKLAKKGL,FLAK50T7,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2228,None,2005,FAKLLAKLAKKAA,FLAK50J,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N,Not Found
2251,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =7 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2257,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =115 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2260,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =90 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2307,None,2005,FAKLLAKLAKKFAL,FLAK50 Q8,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =660 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2311,None,2005,FAKLLAKLAKKVL,FLAK50 T2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =10 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2312,None,2005,FAKLLAKLAKKIL,FLAK50 T3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =220 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2313,None,2005,FAKLLAKLAKKEL,FLAK50 T4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2314,None,2005,FAKLLAKLAKKSL,FLAK50 T5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =535 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2338,None,2005,FAKLLAKLAKK,FLAK50T6,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2339,None,2005,FAKLLAKLAKKGL,FLAK50T7,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2380,None,2005,FAKLLAKLAKKAA,FLAK50J,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N,Not Found
2403,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =6 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2409,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2412,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =80 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2437,None,2005,FAKLLAKLAKKAA,FLAK50J,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =320 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N,Not Found
2460,None,2005,FAKLLAKLAKKFAL,FLAK50 Q8,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =620 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2464,None,2005,FAKLLAKLAKKVL,FLAK50 T2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =30 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2465,None,2005,FAKLLAKLAKKIL,FLAK50 T3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =76 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2466,None,2005,FAKLLAKLAKKEL,FLAK50 T4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2467,None,2005,FAKLLAKLAKKSL,FLAK50 T5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =770 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2491,None,2005,FAKLLAKLAKK,FLAK50T6,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2492,None,2005,FAKLLAKLAKKGL,FLAK50T7,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =410 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2546,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =12 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2552,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =77 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2555,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =90 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2580,None,2005,FAKLLAKLAKKAA,FLAK50J,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =690 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N,Not Found
2603,None,2005,FAKLLAKLAKKFAL,FLAK50 Q8,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2607,None,2005,FAKLLAKLAKKVL,FLAK50 T2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =10 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2608,None,2005,FAKLLAKLAKKIL,FLAK50 T3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =145 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2609,None,2005,FAKLLAKLAKKEL,FLAK50 T4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2610,None,2005,FAKLLAKLAKKSL,FLAK50 T5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2634,None,2005,FAKLLAKLAKK,FLAK50T6,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2635,None,2005,FAKLLAKLAKKGL,FLAK50T7,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2689,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =15 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2695,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,Not Available,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2698,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =190 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2723,None,2005,FAKLLAKLAKKAA,FLAK50J,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N,Not Found
2746,None,2005,FAKLLAKLAKKFAL,FLAK50 Q8,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =810 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2750,None,2005,FAKLLAKLAKKVL,FLAK50 T2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =14 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2751,None,2005,FAKLLAKLAKKIL,FLAK50 T3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =220 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2752,None,2005,FAKLLAKLAKKEL,FLAK50 T4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2753,None,2005,FAKLLAKLAKKSL,FLAK50 T5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =610 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2777,None,2005,FAKLLAKLAKK,FLAK50T6,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2778,None,2005,FAKLLAKLAKKGL,FLAK50T7,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1924,None,2005,FAKLLAKLAKKAA,FLAK50J,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,Not Available,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N,Not Found
2076,None,2005,FAKLLAKLAKKAA,FLAK50J,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N,Not Found
2228,None,2005,FAKLLAKLAKKAA,FLAK50J,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N,Not Found
2380,None,2005,FAKLLAKLAKKAA,FLAK50J,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N,Not Found
2437,None,2005,FAKLLAKLAKKAA,FLAK50J,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =320 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N,Not Found
2580,None,2005,FAKLLAKLAKKAA,FLAK50J,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =690 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N,Not Found
2723,None,2005,FAKLLAKLAKKAA,FLAK50J,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N,Not Found
1804,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =60 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1956,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2108,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =90 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2260,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =90 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2412,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =80 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2555,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =90 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2698,None,2005,FAKLLAKLAKKAL,FLAK50C,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =190 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1857,None,2005,FAKLLAKLAKKEL,FLAK50 T4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2009,None,2005,FAKLLAKLAKKEL,FLAK50 T4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2161,None,2005,FAKLLAKLAKKEL,FLAK50 T4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2313,None,2005,FAKLLAKLAKKEL,FLAK50 T4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2466,None,2005,FAKLLAKLAKKEL,FLAK50 T4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2609,None,2005,FAKLLAKLAKKEL,FLAK50 T4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2752,None,2005,FAKLLAKLAKKEL,FLAK50 T4,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1851,None,2005,FAKLLAKLAKKFAL,FLAK50 Q8,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =730 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2003,None,2005,FAKLLAKLAKKFAL,FLAK50 Q8,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =630 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2155,None,2005,FAKLLAKLAKKFAL,FLAK50 Q8,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =660 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2307,None,2005,FAKLLAKLAKKFAL,FLAK50 Q8,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =660 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2460,None,2005,FAKLLAKLAKKFAL,FLAK50 Q8,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =620 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2603,None,2005,FAKLLAKLAKKFAL,FLAK50 Q8,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2746,None,2005,FAKLLAKLAKKFAL,FLAK50 Q8,14,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =810 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1883,None,2005,FAKLLAKLAKKGL,FLAK50T7,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =430 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2035,None,2005,FAKLLAKLAKKGL,FLAK50T7,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =740 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2187,None,2005,FAKLLAKLAKKGL,FLAK50T7,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2339,None,2005,FAKLLAKLAKKGL,FLAK50T7,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2492,None,2005,FAKLLAKLAKKGL,FLAK50T7,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =410 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2635,None,2005,FAKLLAKLAKKGL,FLAK50T7,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2778,None,2005,FAKLLAKLAKKGL,FLAK50T7,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1856,None,2005,FAKLLAKLAKKIL,FLAK50 T3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =90 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2008,None,2005,FAKLLAKLAKKIL,FLAK50 T3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =125 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2160,None,2005,FAKLLAKLAKKIL,FLAK50 T3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =220 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2312,None,2005,FAKLLAKLAKKIL,FLAK50 T3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =220 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2465,None,2005,FAKLLAKLAKKIL,FLAK50 T3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =76 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2608,None,2005,FAKLLAKLAKKIL,FLAK50 T3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =145 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2751,None,2005,FAKLLAKLAKKIL,FLAK50 T3,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =220 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1795,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =9 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1801,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =40 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1947,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =9 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1953,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =100 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2099,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =7 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2105,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =115 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2251,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =7 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2257,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =115 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2403,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =6 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2409,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2546,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =12 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2552,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =77 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2689,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =15 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2695,None,2005,FAKLLAKLAKKL,FLAK50F,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,Not Available,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1795,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =9 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1947,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =9 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2099,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =7 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2251,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =7 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2403,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =6 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2546,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =12 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2689,None,2005,FAKLLAKLAKKLL,FLAK50,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =15 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1858,None,2005,FAKLLAKLAKKSL,FLAK50 T5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =440 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2010,None,2005,FAKLLAKLAKKSL,FLAK50 T5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =400 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2162,None,2005,FAKLLAKLAKKSL,FLAK50 T5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =535 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2314,None,2005,FAKLLAKLAKKSL,FLAK50 T5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =535 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2467,None,2005,FAKLLAKLAKKSL,FLAK50 T5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =770 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2610,None,2005,FAKLLAKLAKKSL,FLAK50 T5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2753,None,2005,FAKLLAKLAKKSL,FLAK50 T5,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =610 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1855,None,2005,FAKLLAKLAKKVL,FLAK50 T2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =18 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2007,None,2005,FAKLLAKLAKKVL,FLAK50 T2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =9 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2159,None,2005,FAKLLAKLAKKVL,FLAK50 T2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =10 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2311,None,2005,FAKLLAKLAKKVL,FLAK50 T2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =10 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2464,None,2005,FAKLLAKLAKKVL,FLAK50 T2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =30 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2607,None,2005,FAKLLAKLAKKVL,FLAK50 T2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =10 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2750,None,2005,FAKLLAKLAKKVL,FLAK50 T2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =14 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1815,None,2005,FAKLLAKLAKLKL,FLAK 50G,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =90 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1967,None,2005,FAKLLAKLAKLKL,FLAK 50G,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =145 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2119,None,2005,FAKLLAKLAKLKL,FLAK 50G,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =200 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2271,None,2005,FAKLLAKLAKLKL,FLAK 50G,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =200 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2423,None,2005,FAKLLAKLAKLKL,FLAK 50G,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =130 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2566,None,2005,FAKLLAKLAKLKL,FLAK 50G,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =170 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2709,None,2005,FAKLLAKLAKLKL,FLAK 50G,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1829,None,2005,FAKLLALALKLKL,FLAK50I,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =65 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1981,None,2005,FAKLLALALKLKL,FLAK50I,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2133,None,2005,FAKLLALALKLKL,FLAK50I,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =11 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2285,None,2005,FAKLLALALKLKL,FLAK50I,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =11 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2438,None,2005,FAKLLALALKLKL,FLAK50I,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,Not Available,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2581,None,2005,FAKLLALALKLKL,FLAK50I,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,Not Available,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2724,None,2005,FAKLLALALKLKL,FLAK50I,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1845,None,2005,FAKLLFKALKKAL,FLAK50 Q2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =500 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1997,None,2005,FAKLLFKALKKAL,FLAK50 Q2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =800 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2149,None,2005,FAKLLFKALKKAL,FLAK50 Q2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =445 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2301,None,2005,FAKLLFKALKKAL,FLAK50 Q2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =445 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2454,None,2005,FAKLLFKALKKAL,FLAK50 Q2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =470 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2597,None,2005,FAKLLFKALKKAL,FLAK50 Q2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =640 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2740,None,2005,FAKLLFKALKKAL,FLAK50 Q2,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =660 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1806,None,2005,FAKLLKLAAKKLL,FLAK 50E,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =500 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1958,None,2005,FAKLLKLAAKKLL,FLAK 50E,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =215 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2110,None,2005,FAKLLKLAAKKLL,FLAK 50E,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =205 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2262,None,2005,FAKLLKLAAKKLL,FLAK 50E,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =205 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2414,None,2005,FAKLLKLAAKKLL,FLAK 50E,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =370 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2557,None,2005,FAKLLKLAAKKLL,FLAK 50E,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =435 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2700,None,2005,FAKLLKLAAKKLL,FLAK 50E,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =300 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1866,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =54 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2018,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =80 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2170,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =155 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2322,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =155 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2475,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =115 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2618,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =310 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2761,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =215 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1867,None,2005,FAKLWAKLAKKL,FLAK50 Z5,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =500 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2019,None,2005,FAKLWAKLAKKL,FLAK50 Z5,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =600 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2171,None,2005,FAKLWAKLAKKL,FLAK50 Z5,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =530 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2323,None,2005,FAKLWAKLAKKL,FLAK50 Z5,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =530 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2476,None,2005,FAKLWAKLAKKL,FLAK50 Z5,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =450 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2619,None,2005,FAKLWAKLAKKL,FLAK50 Z5,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =900 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2762,None,2005,FAKLWAKLAKKL,FLAK50 Z5,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =400 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1773,None,2005,FALALKALKKALKKLKKALKKAL,Hecate Ac,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =54 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1774,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =23 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1778,None,2005,FALAAKALKKLAKKLKKLAKKAL,FLAK01 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =62 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1779,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =26 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1780,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =10 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1781,None,2005,FALAKLAKKAKAKLKKALKAL,FLAK05 AM,21,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =74 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1782,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =14 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1783,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =65 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1786,None,2005,FALALKKALKALKKAL,FLAK 17 AM,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =21 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1789,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =14 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1792,None,2005,FALAKKALKKAKKAL,FLAK62 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =760 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1872,None,2005,FALALKA,FLAK94,7,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =430 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
1875,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1891,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =360 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1892,None,2005,FALAKALKKAL,FLAK121,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1893,None,2005,FALALKLAKKAL,FLAK96B,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =230 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1895,None,2005,FALALKALKK,FLAK96F,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =510 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
1900,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
1902,None,2005,FALALKLAKKL,Flak 96J,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =770 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1905,None,2005,FALALKLKKL,FLAK-120D,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =550 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1906,None,2005,FALALKAKKL,FLAK-120C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1907,None,2005,FALA,FLAK-120B,4,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,Not Found
1925,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =6 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1926,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =46 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1930,None,2005,FALAAKALKKLAKKLKKLAKKAL,FLAK01 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =5 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1931,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =38 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1932,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =12 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1933,None,2005,FALAKLAKKAKAKLKKALKAL,FLAK05 AM,21,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =8 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1934,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =26 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1935,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =59 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1938,None,2005,FALALKKALKALKKAL,FLAK 17 AM,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =35 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1941,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =57 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1944,None,2005,FALAKKALKKAKKAL,FLAK62 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2024,None,2005,FALALKA,FLAK94,7,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =560 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2027,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =285 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2044,None,2005,FALAKALKKAL,FLAK121,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2045,None,2005,FALALKLAKKAL,FLAK96B,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =360 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2047,None,2005,FALALKALKK,FLAK96F,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2052,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2054,None,2005,FALALKLAKKL,Flak 96J,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2057,None,2005,FALALKLKKL,FLAK-120D,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =870 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2058,None,2005,FALALKAKKL,FLAK-120C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2059,None,2005,FALA,FLAK-120B,4,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,Not Found
2075,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2077,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2078,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =128 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2082,None,2005,FALAAKALKKLAKKLKKLAKKAL,FLAK01 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =27 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2083,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =85 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2084,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =36 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2085,None,2005,FALAKLAKKAKAKLKKALKAL,FLAK05 AM,21,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =94 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2086,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2087,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =93 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2090,None,2005,FALALKKALKALKKAL,FLAK 17 AM,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =53 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2093,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2096,None,2005,FALAKKALKKAKKAL,FLAK62 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2176,None,2005,FALALKA,FLAK94,7,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =465 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2179,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =250 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2195,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =240 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2196,None,2005,FALAKALKKAL,FLAK121,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2197,None,2005,FALALKLAKKAL,FLAK96B,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =240 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2199,None,2005,FALALKALKK,FLAK96F,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =530 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2204,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2206,None,2005,FALALKLAKKL,Flak 96J,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =640 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2209,None,2005,FALALKLKKL,FLAK-120D,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =830 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2210,None,2005,FALALKAKKL,FLAK-120C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2211,None,2005,FALA,FLAK-120B,4,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,Not Found
2227,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2229,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2230,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =128 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2234,None,2005,FALAAKALKKLAKKLKKLAKKAL,FLAK01 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =27 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2235,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =85 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2236,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =36 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2237,None,2005,FALAKLAKKAKAKLKKALKAL,FLAK05 AM,21,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =94 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2238,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2239,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =93 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2242,None,2005,FALALKKALKALKKAL,FLAK 17 AM,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =53 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2245,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2248,None,2005,FALAKKALKKAKKAL,FLAK62 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2328,None,2005,FALALKA,FLAK94,7,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =465 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2331,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =250 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2347,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =240 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2348,None,2005,FALAKALKKAL,FLAK121,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2349,None,2005,FALALKLAKKAL,FLAK96B,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =240 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2351,None,2005,FALALKALKK,FLAK96F,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =530 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2356,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2358,None,2005,FALALKLAKKL,Flak 96J,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =640 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2361,None,2005,FALALKLKKL,FLAK-120D,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =830 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2362,None,2005,FALALKAKKL,FLAK-120C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2363,None,2005,FALA,FLAK-120B,4,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,Not Found
2381,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2382,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2386,None,2005,FALAAKALKKLAKKLKKLAKKAL,FLAK01 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =64 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2387,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2388,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =37 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2389,None,2005,FALAKLAKKAKAKLKKALKAL,FLAK05 AM,21,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =84 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2390,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =16 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2391,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =54 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2394,None,2005,FALALKKALKALKKAL,FLAK 17 AM,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =24 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2397,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2400,None,2005,FALAKKALKKAKKAL,FLAK62 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1778,None,2005,FALAAKALKKLAKKLKKLAKKAL,FLAK01 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =62 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1930,None,2005,FALAAKALKKLAKKLKKLAKKAL,FLAK01 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =5 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2082,None,2005,FALAAKALKKLAKKLKKLAKKAL,FLAK01 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =27 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2234,None,2005,FALAAKALKKLAKKLKKLAKKAL,FLAK01 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =27 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2386,None,2005,FALAAKALKKLAKKLKKLAKKAL,FLAK01 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =64 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2529,None,2005,FALAAKALKKLAKKLKKLAKKAL,FLAK01 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =41 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2672,None,2005,FALAAKALKKLAKKLKKLAKKAL,FLAK01 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =82 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1892,None,2005,FALAKALKKAL,FLAK121,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2044,None,2005,FALAKALKKAL,FLAK121,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2196,None,2005,FALAKALKKAL,FLAK121,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2348,None,2005,FALAKALKKAL,FLAK121,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2501,None,2005,FALAKALKKAL,FLAK121,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2644,None,2005,FALAKALKKAL,FLAK121,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2787,None,2005,FALAKALKKAL,FLAK121,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1792,None,2005,FALAKKALKKAKKAL,FLAK62 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =760 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1944,None,2005,FALAKKALKKAKKAL,FLAK62 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2096,None,2005,FALAKKALKKAKKAL,FLAK62 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2248,None,2005,FALAKKALKKAKKAL,FLAK62 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2400,None,2005,FALAKKALKKAKKAL,FLAK62 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2543,None,2005,FALAKKALKKAKKAL,FLAK62 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =435 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2686,None,2005,FALAKKALKKAKKAL,FLAK62 AM,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1781,None,2005,FALAKLAKKAKAKLKKALKAL,FLAK05 AM,21,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =74 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1933,None,2005,FALAKLAKKAKAKLKKALKAL,FLAK05 AM,21,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =8 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2085,None,2005,FALAKLAKKAKAKLKKALKAL,FLAK05 AM,21,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =94 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2237,None,2005,FALAKLAKKAKAKLKKALKAL,FLAK05 AM,21,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =94 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2389,None,2005,FALAKLAKKAKAKLKKALKAL,FLAK05 AM,21,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =84 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2532,None,2005,FALAKLAKKAKAKLKKALKAL,FLAK05 AM,21,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =125 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2675,None,2005,FALAKLAKKAKAKLKKALKAL,FLAK05 AM,21,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1773,None,2005,FALALKALKKALKKLKKALKKAL,Hecate Ac,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =54 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1774,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =23 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1779,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =26 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1780,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =10 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1782,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =14 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1783,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =65 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1789,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =14 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1872,None,2005,FALALKA,FLAK94,7,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =430 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
1875,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1891,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =360 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1895,None,2005,FALALKALKK,FLAK96F,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =510 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
1900,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
1906,None,2005,FALALKAKKL,FLAK-120C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1925,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =6 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1926,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =46 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1931,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =38 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1932,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =12 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1934,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =26 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1935,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =59 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1941,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =57 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2024,None,2005,FALALKA,FLAK94,7,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =560 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2027,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =285 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2047,None,2005,FALALKALKK,FLAK96F,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2052,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2058,None,2005,FALALKAKKL,FLAK-120C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2075,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2077,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2078,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =128 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2083,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =85 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2084,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =36 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2086,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2087,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =93 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2093,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2176,None,2005,FALALKA,FLAK94,7,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =465 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2179,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =250 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2195,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =240 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2199,None,2005,FALALKALKK,FLAK96F,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =530 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2204,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2210,None,2005,FALALKAKKL,FLAK-120C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2227,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2229,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2230,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =128 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2235,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =85 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2236,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =36 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2238,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2239,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =93 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2245,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2328,None,2005,FALALKA,FLAK94,7,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =465 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2331,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =250 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2347,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =240 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2351,None,2005,FALALKALKK,FLAK96F,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =530 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2356,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2362,None,2005,FALALKAKKL,FLAK-120C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2381,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2382,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2387,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2388,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =37 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2390,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =16 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2391,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =54 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2397,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2481,None,2005,FALALKA,FLAK94,7,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2484,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =225 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2500,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =56 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2504,None,2005,FALALKALKK,FLAK96F,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =640 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2509,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2515,None,2005,FALALKAKKL,FLAK-120C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2524,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =61 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2525,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2530,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =38 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2531,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =12 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2533,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =8 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2534,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =16 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2540,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =64 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2624,None,2005,FALALKA,FLAK94,7,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,Not Available,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2627,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =350 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2643,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =340 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2647,None,2005,FALALKALKK,FLAK96F,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2652,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2658,None,2005,FALALKAKKL,FLAK-120C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2667,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =95 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2668,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =50 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2673,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =145 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2674,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =20 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2676,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =25 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2677,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =80 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2683,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,Not Available,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2767,None,2005,FALALKA,FLAK94,7,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2770,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =275 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2786,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =400 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2790,None,2005,FALALKALKK,FLAK96F,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2795,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2801,None,2005,FALALKAKKL,FLAK-120C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1906,None,2005,FALALKAKKL,FLAK-120C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2058,None,2005,FALALKAKKL,FLAK-120C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2210,None,2005,FALALKAKKL,FLAK-120C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2362,None,2005,FALALKAKKL,FLAK-120C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2515,None,2005,FALALKAKKL,FLAK-120C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2658,None,2005,FALALKAKKL,FLAK-120C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2801,None,2005,FALALKAKKL,FLAK-120C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1773,None,2005,FALALKALKKALKKLKKALKKAL,Hecate Ac,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =54 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1774,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =23 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1779,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =26 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1780,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =10 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1782,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =14 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1783,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =65 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1789,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =14 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1875,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1891,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =360 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1895,None,2005,FALALKALKK,FLAK96F,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =510 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
1900,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
1925,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =6 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1926,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =46 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1931,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =38 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1932,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =12 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1934,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =26 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1935,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =59 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1941,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =57 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2027,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =285 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2047,None,2005,FALALKALKK,FLAK96F,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2052,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2075,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2077,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2078,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =128 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2083,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =85 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2084,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =36 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2086,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2087,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =93 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2093,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2179,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =250 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2195,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =240 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2199,None,2005,FALALKALKK,FLAK96F,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =530 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2204,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2227,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2229,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2230,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =128 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2235,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =85 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2236,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =36 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2238,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2239,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =93 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2245,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2331,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =250 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2347,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =240 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2351,None,2005,FALALKALKK,FLAK96F,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =530 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2356,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2381,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2382,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2387,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2388,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =37 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2390,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =16 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2391,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =54 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2397,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2484,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =225 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2500,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =56 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2504,None,2005,FALALKALKK,FLAK96F,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =640 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2509,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2524,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =61 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2525,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2530,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =38 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2531,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =12 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2533,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =8 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2534,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =16 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2540,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =64 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2627,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =350 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2643,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =340 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2647,None,2005,FALALKALKK,FLAK96F,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2652,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2667,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =95 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2668,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =50 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2673,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =145 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2674,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =20 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2676,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =25 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2677,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =80 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2683,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,Not Available,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2770,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =275 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2786,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =400 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2790,None,2005,FALALKALKK,FLAK96F,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2795,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
1773,None,2005,FALALKALKKALKKLKKALKKAL,Hecate Ac,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =54 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1774,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =23 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1789,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =14 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1875,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1900,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
1925,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =6 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1926,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =46 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1941,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =57 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2027,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =285 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2052,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2077,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2078,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =128 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2093,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2179,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =250 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2204,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2229,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2230,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =128 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2245,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2331,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =250 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2356,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2381,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2382,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2397,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2484,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =225 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2509,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2524,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =61 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2525,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2540,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =64 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2627,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =350 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2652,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
2667,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =95 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2668,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =50 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2683,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,Not Available,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2770,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =275 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2795,None,2005,FALALKALKKA,Flak 96H,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N,Not Found
1773,None,2005,FALALKALKKALKKLKKALKKAL,Hecate Ac,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =54 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1774,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =23 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1789,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =14 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1875,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1925,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =6 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1926,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =46 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1941,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =57 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2027,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =285 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2077,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2078,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =128 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2093,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2179,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =250 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2229,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2230,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =128 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2245,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2331,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =250 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2381,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2382,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2397,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2484,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =225 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2524,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =61 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2525,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2540,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =64 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2627,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =350 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2667,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =95 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2668,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =50 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2683,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,Not Available,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2770,None,2005,FALALKALKKAL,FLAK96,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =275 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1773,None,2005,FALALKALKKALKKLKKALKKAL,Hecate Ac,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =54 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1774,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =23 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1789,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =14 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1925,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =6 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1926,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =46 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1941,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =57 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2077,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2078,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =128 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2093,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2229,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2230,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =128 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2245,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2381,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2382,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2397,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2524,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =61 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2525,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2540,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =64 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2667,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =95 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2668,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =50 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2683,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,Not Available,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1773,None,2005,FALALKALKKALKKLKKALKKAL,Hecate Ac,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =54 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1774,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =23 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1789,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =14 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1925,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =6 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1926,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =46 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1941,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =57 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2077,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2078,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =128 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2093,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2229,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2230,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =128 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2245,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2381,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2382,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2397,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2524,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =61 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2525,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2540,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =64 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2667,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AC,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =95 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2668,None,2005,FALALKALKKALKKLKKALKKAL,Hecate AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =50 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2683,None,2005,FALALKALKKALkkLKKALKKAL,HECATE 2DAc,23,Linear,Mix,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,Not Available,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1779,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =26 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1780,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =10 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1782,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =14 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1783,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =65 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1891,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =360 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1931,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =38 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1932,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =12 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1934,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =26 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1935,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =59 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2075,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2083,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =85 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2084,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =36 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2086,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2087,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =93 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2195,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =240 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2227,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2235,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =85 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2236,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =36 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2238,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2239,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =93 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2347,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =240 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2387,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2388,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =37 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2390,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =16 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2391,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =54 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2500,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =56 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2530,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =38 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2531,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =12 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2533,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =8 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2534,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =16 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2643,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =340 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2673,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =145 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2674,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =20 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2676,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =25 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2677,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =80 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2786,None,2005,FALALKALKKL,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =400 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1780,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =10 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1932,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =12 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2075,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2084,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =36 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2227,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2236,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =36 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2388,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =37 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2531,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =12 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2674,None,2005,FALALKALKKLAKKLKKLAKKAL,FLAK04 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =20 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1782,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =14 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1783,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =65 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1934,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =26 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1935,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =59 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2086,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2087,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =93 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2238,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2239,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =93 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2390,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =16 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2391,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =54 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2533,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =8 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2534,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =16 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2676,None,2005,FALALKALKKLKKALKKAL,FLAK06 AM,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =25 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2677,None,2005,FALALKALKKLKKALKKAL,FLAK06 AC,19,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =80 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1779,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =26 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1931,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =38 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2083,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =85 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2235,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =85 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2387,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2530,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =38 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2673,None,2005,FALALKALKKLLKKLKKLAKKAL,FLAK03 AM,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =145 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1786,None,2005,FALALKKALKALKKAL,FLAK 17 AM,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =21 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1938,None,2005,FALALKKALKALKKAL,FLAK 17 AM,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =35 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2090,None,2005,FALALKKALKALKKAL,FLAK 17 AM,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =53 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2242,None,2005,FALALKKALKALKKAL,FLAK 17 AM,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =53 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2394,None,2005,FALALKKALKALKKAL,FLAK 17 AM,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =24 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2537,None,2005,FALALKKALKALKKAL,FLAK 17 AM,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =9 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2680,None,2005,FALALKKALKALKKAL,FLAK 17 AM,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =62 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1893,None,2005,FALALKLAKKAL,FLAK96B,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =230 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2045,None,2005,FALALKLAKKAL,FLAK96B,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =360 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2197,None,2005,FALALKLAKKAL,FLAK96B,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =240 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2349,None,2005,FALALKLAKKAL,FLAK96B,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =240 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2502,None,2005,FALALKLAKKAL,FLAK96B,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =300 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2645,None,2005,FALALKLAKKAL,FLAK96B,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =320 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2788,None,2005,FALALKLAKKAL,FLAK96B,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =325 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1902,None,2005,FALALKLAKKL,Flak 96J,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =770 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2054,None,2005,FALALKLAKKL,Flak 96J,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2206,None,2005,FALALKLAKKL,Flak 96J,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =640 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2358,None,2005,FALALKLAKKL,Flak 96J,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =640 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2511,None,2005,FALALKLAKKL,Flak 96J,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2654,None,2005,FALALKLAKKL,Flak 96J,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2797,None,2005,FALALKLAKKL,Flak 96J,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1905,None,2005,FALALKLKKL,FLAK-120D,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =550 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2057,None,2005,FALALKLKKL,FLAK-120D,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =870 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2209,None,2005,FALALKLKKL,FLAK-120D,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =830 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2361,None,2005,FALALKLKKL,FLAK-120D,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =830 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2514,None,2005,FALALKLKKL,FLAK-120D,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2657,None,2005,FALALKLKKL,FLAK-120D,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2800,None,2005,FALALKLKKL,FLAK-120D,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1876,None,2005,FALKALKK,FLAK97,8,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
1884,None,2005,FALKALKKLKKALKKAL,FLAK95,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =64 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1896,None,2005,FALKALKKAL,FLAK96C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =940 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2028,None,2005,FALKALKK,FLAK97,8,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2036,None,2005,FALKALKKLKKALKKAL,FLAK95,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =61 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2048,None,2005,FALKALKKAL,FLAK96C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2180,None,2005,FALKALKK,FLAK97,8,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2188,None,2005,FALKALKKLKKALKKAL,FLAK95,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =165 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2200,None,2005,FALKALKKAL,FLAK96C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2332,None,2005,FALKALKK,FLAK97,8,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2340,None,2005,FALKALKKLKKALKKAL,FLAK95,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =165 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2352,None,2005,FALKALKKAL,FLAK96C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2485,None,2005,FALKALKK,FLAK97,8,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2493,None,2005,FALKALKKLKKALKKAL,FLAK95,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =50 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2505,None,2005,FALKALKKAL,FLAK96C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2628,None,2005,FALKALKK,FLAK97,8,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2636,None,2005,FALKALKKLKKALKKAL,FLAK95,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =97 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2648,None,2005,FALKALKKAL,FLAK96C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2771,None,2005,FALKALKK,FLAK97,8,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =240 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2779,None,2005,FALKALKKLKKALKKAL,FLAK95,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2791,None,2005,FALKALKKAL,FLAK96C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1896,None,2005,FALKALKKAL,FLAK96C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =940 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2048,None,2005,FALKALKKAL,FLAK96C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2200,None,2005,FALKALKKAL,FLAK96C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2352,None,2005,FALKALKKAL,FLAK96C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2505,None,2005,FALKALKKAL,FLAK96C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2648,None,2005,FALKALKKAL,FLAK96C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2791,None,2005,FALKALKKAL,FLAK96C,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1884,None,2005,FALKALKKLKKALKKAL,FLAK95,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =64 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2036,None,2005,FALKALKKLKKALKKAL,FLAK95,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =61 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2188,None,2005,FALKALKKLKKALKKAL,FLAK95,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =165 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2340,None,2005,FALKALKKLKKALKKAL,FLAK95,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =165 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2493,None,2005,FALKALKKLKKALKKAL,FLAK95,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =50 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2636,None,2005,FALKALKKLKKALKKAL,FLAK95,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =97 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2779,None,2005,FALKALKKLKKALKKAL,FLAK95,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1897,None,2005,FALLKALKKAL,FLAK96D,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =305 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2049,None,2005,FALLKALKKAL,FLAK96D,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =770 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2201,None,2005,FALLKALKKAL,FLAK96D,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =600 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2353,None,2005,FALLKALKKAL,FLAK96D,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =600 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2506,None,2005,FALLKALKKAL,FLAK96D,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =540 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2649,None,2005,FALLKALKKAL,FLAK96D,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =600 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2792,None,2005,FALLKALKKAL,FLAK96D,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =820 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1901,None,2005,FALLKALLKKAL,Flak 96I,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =190 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2053,None,2005,FALLKALLKKAL,Flak 96I,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =310 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2205,None,2005,FALLKALLKKAL,Flak 96I,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =310 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2357,None,2005,FALLKALLKKAL,Flak 96I,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =310 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2510,None,2005,FALLKALLKKAL,Flak 96I,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =240 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2653,None,2005,FALLKALLKKAL,Flak 96I,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =120 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2796,None,2005,FALLKALLKKAL,Flak 96I,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =380 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1894,None,2005,FALLKL,FLAK96G,6,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =630 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2046,None,2005,FALLKL,FLAK96G,6,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2198,None,2005,FALLKL,FLAK96G,6,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =590 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2350,None,2005,FALLKL,FLAK96G,6,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =590 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2503,None,2005,FALLKL,FLAK96G,6,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2646,None,2005,FALLKL,FLAK96G,6,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2789,None,2005,FALLKL,FLAK96G,6,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1888,None,2005,FAVGLRAIKRALKKLRRGVRKVAKDL,FAGVL,26,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =240 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2040,None,2005,FAVGLRAIKRALKKLRRGVRKVAKDL,FAGVL,26,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =530 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2192,None,2005,FAVGLRAIKRALKKLRRGVRKVAKDL,FAGVL,26,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =600 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2344,None,2005,FAVGLRAIKRALKKLRRGVRKVAKDL,FAGVL,26,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =600 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2497,None,2005,FAVGLRAIKRALKKLRRGVRKVAKDL,FAGVL,26,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =315 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2640,None,2005,FAVGLRAIKRALKKLRRGVRKVAKDL,FAGVL,26,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =375 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2783,None,2005,FAVGLRAIKRALKKLRRGVRKVAKDL,FAGVL,26,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
3165,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",KB,Oral Cancer,MTT/MTS assay,10.6 % inhibition of cell proliferation at 1 nM,24-h,Oral mucosa,None,NA,https://doi.org/10.1002/psc.867
3166,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",KB,Oral Cancer,MTT/MTS assay,18.2 % inhibition of cell proliferation at 10 nM,24-h,Oral mucosa,None,NA,https://doi.org/10.1002/psc.867
3167,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",KB,Oral Cancer,MTT/MTS assay,30.7 % inhibition of cell proliferation at 100 nM,72-h,Oral mucosa,None,NA,https://doi.org/10.1002/psc.867
3168,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",KB,Oral Cancer,MTT/MTS assay,43.1 % inhibition of cell proliferation at 1 µM,24-h,Oral mucosa,None,NA,https://doi.org/10.1002/psc.867
3169,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",KB,Oral Cancer,MTT/MTS assay,98.3 % inhibition of cell proliferation at 10 µM,24-h,Oral mucosa,None,NA,https://doi.org/10.1002/psc.867
3170,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",MiaPaCa.2,Pancreatic Cancer,MTT/MTS assay,24.2 % inhibition of cell proliferation at 1 nM,24-h,Pancreatic,None,NA,https://doi.org/10.1002/psc.867
3171,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",MiaPaCa.2,Pancreatic Cancer,MTT/MTS assay,37.8 % inhibition of cell proliferation at 10 nM,24-h,Pancreatic,None,NA,https://doi.org/10.1002/psc.867
3172,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",MiaPaCa.2,Pancreatic Cancer,MTT/MTS assay,48.2 % inhibition of cell proliferation at 100 nM,72-h,Pancreatic,None,NA,https://doi.org/10.1002/psc.867
3173,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",MiaPaCa.2,Pancreatic Cancer,MTT/MTS assay,59.6 % inhibition of cell proliferation at 1 µM,24-h,Pancreatic,None,NA,https://doi.org/10.1002/psc.867
3174,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",MiaPaCa.2,Pancreatic Cancer,MTT/MTS assay,84.5 % inhibition of cell proliferation at 10 µM,24-h,Pancreatic,None,NA,https://doi.org/10.1002/psc.867
3175,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",PTC,Colon Cancer,MTT/MTS assay,16.5 % inhibition of cell proliferation at 1 nM,24-h,Colon,None,NA,https://doi.org/10.1002/psc.867
3176,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",PTC,Colon Cancer,MTT/MTS assay,14.2 % inhibition of cell proliferation at 10 nM,24-h,Colon,None,NA,https://doi.org/10.1002/psc.867
3177,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",PTC,Colon Cancer,MTT/MTS assay,16.8 % inhibition of cell proliferation at 100 nM,72-h,Colon,None,NA,https://doi.org/10.1002/psc.867
3178,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",PTC,Colon Cancer,MTT/MTS assay,21.7 % inhibition of cell proliferation at 1 µM,24-h,Colon,None,NA,https://doi.org/10.1002/psc.867
3179,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",PTC,Colon Cancer,MTT/MTS assay,27.9 % inhibition of cell proliferation at 10 µM,24-h,Colon,None,NA,https://doi.org/10.1002/psc.867
3180,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",MOLT-4,Leukemia Cancer,MTT/MTS assay,10.4 % inhibition of cell proliferation at 1 nM,24-h,Blood,None,NA,https://doi.org/10.1002/psc.867
3181,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",MOLT-4,Leukemia Cancer,MTT/MTS assay,18.7 % inhibition of cell proliferation at 10 nM,24-h,Blood,None,NA,https://doi.org/10.1002/psc.867
3182,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",MOLT-4,Leukemia Cancer,MTT/MTS assay,34.7 % inhibition of cell proliferation at 100 nM,72-h,Blood,None,NA,https://doi.org/10.1002/psc.867
3183,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",MOLT-4,Leukemia Cancer,MTT/MTS assay,54.3 % inhibition of cell proliferation at 1 µM,24-h,Blood,None,NA,https://doi.org/10.1002/psc.867
3184,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",MOLT-4,Leukemia Cancer,MTT/MTS assay,94.5 % inhibition of cell proliferation at 10 µM,24-h,Blood,None,NA,https://doi.org/10.1002/psc.867
3185,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",KB,Oral Cancer,MTT/MTS assay,ED50 =2.1 µM,24-h,Oral mucosa,None,NA,https://doi.org/10.1002/psc.867
3186,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",MiaPaCa.2,Pancreatic Cancer,MTT/MTS assay,ED50 =0.210 µM,24-h,Pancreatic,None,NA,https://doi.org/10.1002/psc.867
3187,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",PTC,Colon Cancer,MTT/MTS assay,ED50 >10 µM,24-h,Colon,None,NA,https://doi.org/10.1002/psc.867
3188,17559067,2007,fCYwO-CyLeu-Pen-TKKrPKPfQwFwL-CyLeu-KKLMYPTYLKKfQWAV-Aib-HL,Peptide 5,40,Linear,Mix,"Aib = = 1-amino-isobutyric acid, O= Ornithine, Pen=penicillamine, CyLeu=cycloleucine or 1-aminocyclopentane-1-carboxylic acid and disulfide bond between Cys and Pen",Amidation,Free,Anticancer,"Synthetic peptide of four designed analogs of vasoactive intestinal peptide, bombesin, substance P a",MOLT-4,Leukemia Cancer,MTT/MTS assay,ED50 =0.29 µM,24-h,Blood,None,NA,https://doi.org/10.1002/psc.867
4436,"12581207, 18957441",2003,FFGWLIKGAIHAGKAIHGLIHRRRH,Chrysophsin-1,25,Not Available,L,None,Free,Free,Antibacterial,"Red sea bream,Chrysophrys majororPagrus major",Not Available,Breast Cancer,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)O,"['https://doi.org/10.1046/j.1432-1033.2003.03419.x', 'https://doi.org/10.1093/nar/gkn823']"
4437,"11713517, 18957441",2001,FFHHIFRGIVHVGKTIHRLVTG,Piscidin 1,22,Not Available,L,None,Free,Free,Antibacterial,Hybrid striped bass (Morone saxatilis x M. chrysops),Not Available,Breast Cancer,Not Available,Not Available,Not Available,Not Available,None,N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC=O)[C@H](O)C)C(C)C)CC(C)C)CCCNC(=[NH2])N)Cc1[nH]cnc1)[C@H](CC)C)[C@H](O)C)CCCCN)C(C)C)Cc1[nH]cnc1)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)Cc1ccccc1)[C@H](CC)C)Cc1[nH]cnc1)Cc1[nH]cnc1)Cc1ccccc1)Cc1ccccc1,"['https://doi.org/10.1038/35104690', 'https://doi.org/10.1093/nar/gkn823']"
1863,None,2005,FGKGIGKVGKKLL,FLAK50 Z1,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1864,None,2005,FAFGKGIGKVGKKLL,FLAK50 Z2,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1865,None,2005,FAKAIAKIAFGKGIGKVGKKLL,FLAK50 Z3,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1866,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =54 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2015,None,2005,FGKGIGKVGKKLL,FLAK50 Z1,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2016,None,2005,FAFGKGIGKVGKKLL,FLAK50 Z2,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2017,None,2005,FAKAIAKIAFGKGIGKVGKKLL,FLAK50 Z3,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =740 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2018,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =80 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2167,None,2005,FGKGIGKVGKKLL,FLAK50 Z1,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2168,None,2005,FAFGKGIGKVGKKLL,FLAK50 Z2,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2169,None,2005,FAKAIAKIAFGKGIGKVGKKLL,FLAK50 Z3,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2170,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =155 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2319,None,2005,FGKGIGKVGKKLL,FLAK50 Z1,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2320,None,2005,FAFGKGIGKVGKKLL,FLAK50 Z2,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2321,None,2005,FAKAIAKIAFGKGIGKVGKKLL,FLAK50 Z3,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2322,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =155 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2472,None,2005,FGKGIGKVGKKLL,FLAK50 Z1,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2473,None,2005,FAFGKGIGKVGKKLL,FLAK50 Z2,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2474,None,2005,FAKAIAKIAFGKGIGKVGKKLL,FLAK50 Z3,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2475,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =115 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2615,None,2005,FGKGIGKVGKKLL,FLAK50 Z1,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2616,None,2005,FAFGKGIGKVGKKLL,FLAK50 Z2,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2617,None,2005,FAKAIAKIAFGKGIGKVGKKLL,FLAK50 Z3,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2618,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =310 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2758,None,2005,FGKGIGKVGKKLL,FLAK50 Z1,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2759,None,2005,FAFGKGIGKVGKKLL,FLAK50 Z2,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2760,None,2005,FAKAIAKIAFGKGIGKVGKKLL,FLAK50 Z3,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2761,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =215 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2925,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,45% Cytotoxicity at 50 mg/L,3-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2926,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,38% Cytotoxicity at 25 mg/L,3-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2927,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,75% Cytotoxicity at 50 mg/L,6-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2928,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,65% Cytotoxicity at 25 mg/L,6-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2929,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,75 % Cytotoxicity at 50 mg/L,12-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2930,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,65% Cytotoxicity at 25 mg/L,12-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2931,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,83% Cytotoxicity at 50 mg/L,24-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2932,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,77 % Cytotoxicity at 25 mg/L,24-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2933,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,82 % Cytotoxicity at 50 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2934,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,85 % Cytotoxicity at 25 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2935,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,42 % Cytotoxicity at 12.5 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2936,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,41 % Cytotoxicity at 6.25 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2937,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,39 % Cytotoxicity at 3.125 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2938,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,41 % Cytotoxicity at 6.25 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2939,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,41 % Cytotoxicity at 6.25 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2940,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,41 % Cytotoxicity at 6.25 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2941,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,90 % Cytotoxicity at 50 mg/L,6-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2942,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,95 % Cytotoxicity at 25 mg/L,6-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2943,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,45 % Cytotoxicity at 12.5 mg/L,6-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2944,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,25 % Cytotoxicity at 6.25 mg/L,6-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2945,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,25 % Cytotoxicity at 3.125 mg/L,6-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2946,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,95 % Cytotoxicity at 50 mg/L,12-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2947,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,96 % Cytotoxicity at 25 mg/L,12-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2948,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,46 % Cytotoxicity at 12.5 mg/L,12-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2949,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,30 % Cytotoxicity at 6.25 mg/L,12-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2950,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,28 % Cytotoxicity at 3.125 mg/L,12-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2951,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,84 % Cytotoxicity at 50 mg/L,24-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2952,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,85 % Cytotoxicity at 25 mg/L,24-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2953,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,38 % Cytotoxicity at 12.5 mg/L,24-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2954,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,30 % Cytotoxicity at 6.25 mg/L,24-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2955,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,28 % Cytotoxicity at 3.125 mg/L,24-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2956,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,60 % Cytotoxicity at 50 mg/L,3-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2957,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,50 % Cytotoxicity at 25 mg/L,3-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2958,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,8 % Cytotoxicity at 12.5 mg/L,3-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2959,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,10 % Cytotoxicity at 6.25 mg/L,3-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2960,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,5 % Cytotoxicity at 3.125 mg/L,3-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2961,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,75 % Cytotoxicity at 50 mg/L,6-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2962,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,70 % Cytotoxicity at 25 mg/L,6-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2963,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,5 % Cytotoxicity at 12.5 mg/L,6-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2964,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,7 % Cytotoxicity at 6.25 mg/L,6-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2965,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,10 % Cytotoxicity at 3.125 mg/L,6-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2966,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,76 % Cytotoxicity at 50 mg/L,12-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2967,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,70 % Cytotoxicity at 25 mg/L,12-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2968,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,12 % Cytotoxicity at 12.5 mg/L,12-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2969,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,4 % Cytotoxicity at 6.25 mg/L,12-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2970,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,4 % Cytotoxicity at 3.125 mg/L,12-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2971,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,90 % Cytotoxicity at 50 mg/L,24-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2972,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,75 % Cytotoxicity at 25 mg/L,24-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2973,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,8 % Cytotoxicity at 12.5 mg/L,24-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2974,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,3 % Cytotoxicity at 6.25 mg/L,24-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2975,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,3 % Cytotoxicity at 3.125 mg/L,24-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2976,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,60 % Cytotoxicity at 50 mg/L,3-h,Fibrous connective tissue ,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2977,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,50 % Cytotoxicity at 25 mg/L,3-h,Fibrous connective tissue ,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2978,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,8 % Cytotoxicity at 12.5 mg/L,3-h,Fibrous connective tissue ,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2979,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,10 % Cytotoxicity at 6.25 mg/L,3-h,Fibrous connective tissue ,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2980,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,5 % Cytotoxicity at 3.125 mg/L,3-h,Fibrous connective tissue ,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2981,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,75 % Cytotoxicity at 50 mg/L,6-h,Fibrous connective tissue ,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2982,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,70 % Cytotoxicity at 25 mg/L,6-h,Fibrous connective tissue ,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2983,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,5 %Cytotoxicity at 12.5 mg/L,6-h,Fibrous connective tissue ,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2984,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,7 % Cytotoxicity at 6.25 mg/L,6-h,Fibrous connective tissue ,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2985,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,10 % Cytotoxicity at 3.125 mg/L,6-h,Fibrous connective tissue ,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2986,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,76 % Cytotoxicity at 50 mg/L,12-h,Fibrous connective tissue ,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2987,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,70 % Cytotoxicity at 25 mg/L,12-h,Fibrous connective tissue ,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2988,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,12 % Cytotoxicity at 12.5 mg/L,12-h,Fibrous connective tissue ,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2989,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,4 % Cytotoxicity at 6.25 mg/L,12-h,Fibrous connective tissue ,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2990,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,4 % Cytotoxicity at 3.125 mg/L,12-h,Fibrous connective tissue ,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2991,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,90 % Cytotoxicity at 50 mg/L,24-h,Fibrous connective tissue ,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2992,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,75 % Cytotoxicity at 25 mg/L,24-h,Fibrous connective tissue ,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2993,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,8 % Cytotoxicity at 12.5 mg/L,24-h,Fibrous connective tissue ,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2994,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,3 % Cytotoxicity at 6.25 mg/L,24-h,Fibrous connective tissue ,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2995,23598079,2013,FIFHIIKGLFHAGKMI,Epinecidin-8,16,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,3 % Cytotoxicity at 3.125 mg/L,24-h,Fibrous connective tissue ,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
1111,16572423,2008,FKCRRWQWRMKKLGA,Lactoferricin B,15,Linear,L,None,Amidation,Free,Antibacterial,Temporins family,Kelly,Brain Tumor,MTT/MTS assay,IC50=15.5 µM,48-h,Brain,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1002/ijc.21886
1112,16572423,2008,FKCRRWQWRMKKLGA,Lactoferricin B,15,Linear,L,None,Amidation,Free,Antimicrobial,Temporins family,IMR-32,Brain Tumor,MTT/MTS assay,IC50=29 µM,48-h,Brain,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1002/ijc.21886
1113,16572423,2008,FKCRRWQWRMKKLGA,Lactoferricin B,15,Linear,L,None,Amidation,Free,Antimicrobial,Temporins family,SK-N-DZ,Brain Tumor,MTT/MTS assay,IC50=37 µM,48-h,Brain,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1002/ijc.21886
1114,16572423,2008,FKCRRWQWRMKKLGA,Lactoferricin B,15,Linear,L,None,Amidation,Free,Antimicrobial,Temporins family,SHEP-12,Brain Tumor,MTT/MTS assay,IC50=45 µM,48-h,Brain,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1002/ijc.21886
1115,16572423,2008,FKCRRWQWRMKKLGA,Lactoferricin B,15,Linear,L,None,Amidation,Free,Antimicrobial,Temporins family,SH-SY-5Y2,Brain Tumor,MTT/MTS assay,IC50=60 µM,48-h,Brain,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1002/ijc.21886
1352,18425992,2008,FKCRRWQWRMKKLGAPSITCVR,pep1,22,Linear,L,None,Free,Free,Antimicrobial,Bovine lactoferrin (Lf-B),HL-60,Prostate Cancer,MTT/MTS assay,IC50=77 µM,24-h,Blood,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1002/psc.1039
1604,12366526,2002,PEWFKCRRWQWRMKKLGA,L1,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,Meth A,Skin Cancer,MTT/MTS assay,IC50=>404 µM,4-h,Skin,None,N12CCC[C@@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1619,12366526,2002,PEWFKCRRWQWRMKKLGA,L1,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,MT-1,Breast Cancer,MTT/MTS assay,IC50=>404 µM,4-h,Breast,None,N12CCC[C@@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1634,12366526,2002,PEWFKCRRWQWRMKKLGA,L1,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,HT-29,Colon Cancer,MTT/MTS assay,IC50=>404 µM,4-h,Colon,None,N12CCC[C@@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
3280,"19527490, 23533710",2009,FKCRRWQWRMKK,LfcinB,12,Linear,L,None,Free,Free,Anticancer,Bovine lactoferrin (Lf-B),FEMX,Skin Cancer,MTT/MTS assay,IC50 =40±7 µM,NA,Skin,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1186/1471-2407-9-183', 'https://doi.org/10.1155/2013/939804']"
3281,"19527490, 23533710",2009,FKCRRWQWRMKK,LfcinB,12,Linear,L,None,Free,Free,Anticancer,Bovine lactoferrin (Lf-B),HT-29,Colon Cancer,MTT/MTS assay,IC50 =148±8 µM,NA,Colon,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1186/1471-2407-9-183', 'https://doi.org/10.1155/2013/939804']"
3282,"19527490, 23533710",2009,FKCRRWQWRMKK,LfcinB,12,Linear,L,None,Free,Free,Anticancer,Bovine lactoferrin (Lf-B),KMS-5,Skin Cancer,MTT/MTS assay,IC50 = 38 µM,NA,Skin,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1186/1471-2407-9-183', 'https://doi.org/10.1155/2013/939804']"
3283,"19527490, 23533710",2009,FKCRRWQWRMKK,LfcinB,12,Linear,L,None,Free,Free,Anticancer,Bovine lactoferrin (Lf-B),U-266,Lymphoma Cancer,MTT/MTS assay,IC50 = 55 µM,NA,Blood,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1186/1471-2407-9-183', 'https://doi.org/10.1155/2013/939804']"
3284,"19527490, 23533710",2009,FKCRRWQWRMKK,LfcinB,12,Linear,L,None,Free,Free,Anticancer,Bovine lactoferrin (Lf-B),KMM-1,Skin Cancer,MTT/MTS assay,IC50 = 57 µM,NA,Skin,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1186/1471-2407-9-183', 'https://doi.org/10.1155/2013/939804']"
3285,"19527490, 23533710",2009,FKCRRWQWRMKK,LfcinB,12,Linear,L,None,Free,Free,Anticancer,Bovine lactoferrin (Lf-B),Sudhl-4,Skin Cancer,MTT/MTS assay,IC50 = 16 µM,NA,Skin,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1186/1471-2407-9-183', 'https://doi.org/10.1155/2013/939804']"
3286,"19527490, 23533710",2009,FKCRRWQWRMKK,LfcinB,12,Linear,L,None,Free,Free,Anticancer,Bovine lactoferrin (Lf-B),Raji,Lymphoma Cancer,MTT/MTS assay,IC50 = 13 µM,NA,Blood,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1186/1471-2407-9-183', 'https://doi.org/10.1155/2013/939804']"
3287,"19527490, 23533710",2009,FKCRRWQWRMKK,LfcinB,12,Linear,L,None,Free,Free,Anticancer,Bovine lactoferrin (Lf-B),Ramos,Lymphoma Cancer,MTT/MTS assay,IC50 = 10 µM,NA,Blood,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1186/1471-2407-9-183', 'https://doi.org/10.1155/2013/939804']"
3314,"21453492, 23533710",2011,FKCRRWQWRMKK,LfcinB,12,Linear,L,None,Free,Free,Antimicrobial and Anticancer,Bovine lactoferrin (Lf-B),HT-29,Colon Cancer,MTT/MTS assay,IC50 > 160 µM,30-Min,Colon,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1186/1471-2407-11-116', 'https://doi.org/10.1155/2013/939804']"
3315,"21453492, 23533710",2011,FKCRRWQWRMKK,LfcinB,12,Linear,L,None,Free,Free,Antimicrobial and Anticancer,Bovine lactoferrin (Lf-B),MT-1,Breast Cancer,MTT/MTS assay,IC50 > 160 µM,30-Min,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1186/1471-2407-11-116', 'https://doi.org/10.1155/2013/939804']"
3316,"21453492, 23533710",2011,FKCRRWQWRMKK,LfcinB,12,Linear,L,None,Free,Free,Antimicrobial and Anticancer,Bovine lactoferrin (Lf-B),Kelly,Brain Tumor,MTT/MTS assay,IC50 =141 ± 3 µM,30-Min,Brain,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1186/1471-2407-11-116', 'https://doi.org/10.1155/2013/939804']"
3341,23533710,2013,FKCRRWQWRMKK,LfcinB,12,Linear,L,None,Amidation,Free,Antihypertensive and Antimicrobial and Antiviral and Antioxidant,Bovine milk,AZ-97,Colon Cancer,MTT/MTS assay,Inhibition at 0.1g/l,NA,Colon,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1155/2013/939804
1111,16572423,2008,FKCRRWQWRMKKLGA,Lactoferricin B,15,Linear,L,None,Amidation,Free,Antibacterial,Temporins family,Kelly,Brain Tumor,MTT/MTS assay,IC50=15.5 µM,48-h,Brain,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1002/ijc.21886
1112,16572423,2008,FKCRRWQWRMKKLGA,Lactoferricin B,15,Linear,L,None,Amidation,Free,Antimicrobial,Temporins family,IMR-32,Brain Tumor,MTT/MTS assay,IC50=29 µM,48-h,Brain,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1002/ijc.21886
1113,16572423,2008,FKCRRWQWRMKKLGA,Lactoferricin B,15,Linear,L,None,Amidation,Free,Antimicrobial,Temporins family,SK-N-DZ,Brain Tumor,MTT/MTS assay,IC50=37 µM,48-h,Brain,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1002/ijc.21886
1114,16572423,2008,FKCRRWQWRMKKLGA,Lactoferricin B,15,Linear,L,None,Amidation,Free,Antimicrobial,Temporins family,SHEP-12,Brain Tumor,MTT/MTS assay,IC50=45 µM,48-h,Brain,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1002/ijc.21886
1115,16572423,2008,FKCRRWQWRMKKLGA,Lactoferricin B,15,Linear,L,None,Amidation,Free,Antimicrobial,Temporins family,SH-SY-5Y2,Brain Tumor,MTT/MTS assay,IC50=60 µM,48-h,Brain,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1002/ijc.21886
1352,18425992,2008,FKCRRWQWRMKKLGAPSITCVR,pep1,22,Linear,L,None,Free,Free,Antimicrobial,Bovine lactoferrin (Lf-B),HL-60,Prostate Cancer,MTT/MTS assay,IC50=77 µM,24-h,Blood,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1002/psc.1039
1604,12366526,2002,PEWFKCRRWQWRMKKLGA,L1,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,Meth A,Skin Cancer,MTT/MTS assay,IC50=>404 µM,4-h,Skin,None,N12CCC[C@@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1619,12366526,2002,PEWFKCRRWQWRMKKLGA,L1,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,MT-1,Breast Cancer,MTT/MTS assay,IC50=>404 µM,4-h,Breast,None,N12CCC[C@@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1634,12366526,2002,PEWFKCRRWQWRMKKLGA,L1,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,HT-29,Colon Cancer,MTT/MTS assay,IC50=>404 µM,4-h,Colon,None,N12CCC[C@@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1352,18425992,2008,FKCRRWQWRMKKLGAPSITCVR,pep1,22,Linear,L,None,Free,Free,Antimicrobial,Bovine lactoferrin (Lf-B),HL-60,Prostate Cancer,MTT/MTS assay,IC50=77 µM,24-h,Blood,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1002/psc.1039
1853,None,2005,FKLAFKLAKKAFL,FLAK50 Q10,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =360 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2005,None,2005,FKLAFKLAKKAFL,FLAK50 Q10,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =570 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2157,None,2005,FKLAFKLAKKAFL,FLAK50 Q10,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =700 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2309,None,2005,FKLAFKLAKKAFL,FLAK50 Q10,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =700 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2462,None,2005,FKLAFKLAKKAFL,FLAK50 Q10,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =830 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2605,None,2005,FKLAFKLAKKAFL,FLAK50 Q10,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =800 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2748,None,2005,FKLAFKLAKKAFL,FLAK50 Q10,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =780 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1124,12005420,2001,FKLFKKIPKFLHLAKKF,N-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=11 µM,48-h,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1146,12005420,2001,FKLFKKIPKFLHLAKKF,N-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=11 µM,48-h,Blood,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1168,12005420,2001,FKLFKKIPKFLHLAKKF,N-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=7 µM,48-h,Blood,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1526,16637646,2006,IGKEFKRIVQRIKDFLRNLVPRTES,LL-37(13-37),25,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KBv,Tumor,MTT/MTS assay,LC50=39 µM,24-h,Not Available,None,N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1021/ja0584875
1527,16637646,2006,FKRIVQRIKDFLRNLV,LL-37(17-32)b,16,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KBv,Tumor,MTT/MTS assay,LC50=30 µM,24-h,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1021/ja0584875
1528,16637646,2006,FKRIVQRIKDFLR,LL-37(17-29),13,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KBv,Tumor,MTT/MTS assay,LC50=60 µM,24-h,Not Available,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1,https://doi.org/10.1021/ja0584875
1530,16637646,2006,FKRiVQRiKDFlRNLV,dLL-37(17-32)c,16,Linear,Mix,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KBv,Tumor,MTT/MTS assay,Not Available,24-h,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1021/ja0584875
1532,16637646,2006,IGKEFKRIVQRIKDFLRNLVPRTES,LL-37(13-37),25,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KB,Oral Cancer,MTT/MTS assay,LC50=40 µM,24-h,Not Available,None,N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1021/ja0584875
1533,16637646,2006,FKRIVQRIKDFLRNLV,LL-37(17-32)b,16,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KB,Oral Cancer,MTT/MTS assay,LC50=30 µM,24-h,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1021/ja0584875
1534,16637646,2006,FKRIVQRIKDFLR,LL-37(17-29),13,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KB,Oral Cancer,MTT/MTS assay,LC50=57 µM,24-h,Not Available,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1,https://doi.org/10.1021/ja0584875
1536,16637646,2006,FKRIVQRIKDFLRNLV,dLL-37(17-32)c,16,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KB,Oral Cancer,MTT/MTS assay,Not Available,24-h,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1021/ja0584875
1538,16637646,2006,IGKEFKRIVQRIKDFLRNLVPRTES,LL-37(13-37),25,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",HBMEC,Prostate Cancer,MTT/MTS assay,LC50=38 µM,24-h,Not Available,None,N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1021/ja0584875
1539,16637646,2006,FKRIVQRIKDFLRNLV,LL-37(17-32)b,16,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",HBMEC,Prostate Cancer,MTT/MTS assay,LC50=25 µM,24-h,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1021/ja0584875
1540,16637646,2006,FKRIVQRIKDFLR,LL-37(17-29),13,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",HBMEC,Prostate Cancer,MTT/MTS assay,LC50=55 µM,24-h,Not Available,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1,https://doi.org/10.1021/ja0584875
1542,16637646,2006,FKRIVQRIKDFLRNLV,dLL-37(17-32)c,16,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",HBMEC,Prostate Cancer,MTT/MTS assay,Not Available,24-h,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1021/ja0584875
4674,15279899,2004,FRKSKEKIGKEFKRIVQRIKDFLRNLV,HCAP18(109-135),27,Linear,L,None,Free,Free,Antimicrobial,hCAP18 synthetic peptide,SAS-H1,Oral Cancer,Not Available,Not Available,Not Available,Oral mucosa,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O.CCCCCN.C.C.C.C.C,https://doi.org/10.1016/j.canlet.2004.04.006
5002,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,MCF-7,Breast Cancer,MTT/MTS assay,LC50= 21 at 100 µM,72-h,Breast,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
5004,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,LNCaP,Prostate cancer,MTT/MTS assay,LC50= 27 at 100 µM,72-h,Prostate,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
5006,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,OVRCAR-3,Ovarian Cancer,MTT/MTS assay,LC50= 24 at 100 µM,72-h,Ovary,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
1526,16637646,2006,IGKEFKRIVQRIKDFLRNLVPRTES,LL-37(13-37),25,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KBv,Tumor,MTT/MTS assay,LC50=39 µM,24-h,Not Available,None,N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1021/ja0584875
1527,16637646,2006,FKRIVQRIKDFLRNLV,LL-37(17-32)b,16,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KBv,Tumor,MTT/MTS assay,LC50=30 µM,24-h,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1021/ja0584875
1530,16637646,2006,FKRiVQRiKDFlRNLV,dLL-37(17-32)c,16,Linear,Mix,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KBv,Tumor,MTT/MTS assay,Not Available,24-h,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1021/ja0584875
1532,16637646,2006,IGKEFKRIVQRIKDFLRNLVPRTES,LL-37(13-37),25,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KB,Oral Cancer,MTT/MTS assay,LC50=40 µM,24-h,Not Available,None,N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1021/ja0584875
1533,16637646,2006,FKRIVQRIKDFLRNLV,LL-37(17-32)b,16,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KB,Oral Cancer,MTT/MTS assay,LC50=30 µM,24-h,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1021/ja0584875
1536,16637646,2006,FKRIVQRIKDFLRNLV,dLL-37(17-32)c,16,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KB,Oral Cancer,MTT/MTS assay,Not Available,24-h,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1021/ja0584875
1538,16637646,2006,IGKEFKRIVQRIKDFLRNLVPRTES,LL-37(13-37),25,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",HBMEC,Prostate Cancer,MTT/MTS assay,LC50=38 µM,24-h,Not Available,None,N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1021/ja0584875
1539,16637646,2006,FKRIVQRIKDFLRNLV,LL-37(17-32)b,16,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",HBMEC,Prostate Cancer,MTT/MTS assay,LC50=25 µM,24-h,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1021/ja0584875
1542,16637646,2006,FKRIVQRIKDFLRNLV,dLL-37(17-32)c,16,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",HBMEC,Prostate Cancer,MTT/MTS assay,Not Available,24-h,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1021/ja0584875
4674,15279899,2004,FRKSKEKIGKEFKRIVQRIKDFLRNLV,HCAP18(109-135),27,Linear,L,None,Free,Free,Antimicrobial,hCAP18 synthetic peptide,SAS-H1,Oral Cancer,Not Available,Not Available,Not Available,Oral mucosa,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O.CCCCCN.C.C.C.C.C,https://doi.org/10.1016/j.canlet.2004.04.006
5002,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,MCF-7,Breast Cancer,MTT/MTS assay,LC50= 21 at 100 µM,72-h,Breast,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
5004,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,LNCaP,Prostate cancer,MTT/MTS assay,LC50= 27 at 100 µM,72-h,Prostate,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
5006,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,OVRCAR-3,Ovarian Cancer,MTT/MTS assay,LC50= 24 at 100 µM,72-h,Ovary,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
1526,16637646,2006,IGKEFKRIVQRIKDFLRNLVPRTES,LL-37(13-37),25,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KBv,Tumor,MTT/MTS assay,LC50=39 µM,24-h,Not Available,None,N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1021/ja0584875
1527,16637646,2006,FKRIVQRIKDFLRNLV,LL-37(17-32)b,16,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KBv,Tumor,MTT/MTS assay,LC50=30 µM,24-h,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1021/ja0584875
1530,16637646,2006,FKRiVQRiKDFlRNLV,dLL-37(17-32)c,16,Linear,Mix,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KBv,Tumor,MTT/MTS assay,Not Available,24-h,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1021/ja0584875
1532,16637646,2006,IGKEFKRIVQRIKDFLRNLVPRTES,LL-37(13-37),25,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KB,Oral Cancer,MTT/MTS assay,LC50=40 µM,24-h,Not Available,None,N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1021/ja0584875
1533,16637646,2006,FKRIVQRIKDFLRNLV,LL-37(17-32)b,16,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KB,Oral Cancer,MTT/MTS assay,LC50=30 µM,24-h,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1021/ja0584875
1536,16637646,2006,FKRIVQRIKDFLRNLV,dLL-37(17-32)c,16,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KB,Oral Cancer,MTT/MTS assay,Not Available,24-h,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1021/ja0584875
1538,16637646,2006,IGKEFKRIVQRIKDFLRNLVPRTES,LL-37(13-37),25,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",HBMEC,Prostate Cancer,MTT/MTS assay,LC50=38 µM,24-h,Not Available,None,N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1021/ja0584875
1539,16637646,2006,FKRIVQRIKDFLRNLV,LL-37(17-32)b,16,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",HBMEC,Prostate Cancer,MTT/MTS assay,LC50=25 µM,24-h,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1021/ja0584875
1542,16637646,2006,FKRIVQRIKDFLRNLV,dLL-37(17-32)c,16,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",HBMEC,Prostate Cancer,MTT/MTS assay,Not Available,24-h,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1021/ja0584875
4674,15279899,2004,FRKSKEKIGKEFKRIVQRIKDFLRNLV,HCAP18(109-135),27,Linear,L,None,Free,Free,Antimicrobial,hCAP18 synthetic peptide,SAS-H1,Oral Cancer,Not Available,Not Available,Not Available,Oral mucosa,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O.CCCCCN.C.C.C.C.C,https://doi.org/10.1016/j.canlet.2004.04.006
5002,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,MCF-7,Breast Cancer,MTT/MTS assay,LC50= 21 at 100 µM,72-h,Breast,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
5004,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,LNCaP,Prostate cancer,MTT/MTS assay,LC50= 27 at 100 µM,72-h,Prostate,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
5006,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,OVRCAR-3,Ovarian Cancer,MTT/MTS assay,LC50= 24 at 100 µM,72-h,Ovary,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
1878,None,2005,FKRLAKIKVLRLAKIKR,FKRLA,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =106 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N,Not Found
2030,None,2005,FKRLAKIKVLRLAKIKR,FKRLA,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =185 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N,Not Found
2182,None,2005,FKRLAKIKVLRLAKIKR,FKRLA,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =110 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N,Not Found
2334,None,2005,FKRLAKIKVLRLAKIKR,FKRLA,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =110 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N,Not Found
2487,None,2005,FKRLAKIKVLRLAKIKR,FKRLA,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =93 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N,Not Found
2630,None,2005,FKRLAKIKVLRLAKIKR,FKRLA,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =340 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N,Not Found
2773,None,2005,FKRLAKIKVLRLAKIKR,FKRLA,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N,Not Found
1912,None,2005,FKVKFKVKVK,KSL-7,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =315 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2064,None,2005,FKVKFKVKVK,KSL-7,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =530 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2216,None,2005,FKVKFKVKVK,KSL-7,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =330 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2368,None,2005,FKVKFKVKVK,KSL-7,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =330 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2521,None,2005,FKVKFKVKVK,KSL-7,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =345 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2664,None,2005,FKVKFKVKVK,KSL-7,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =530 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2807,None,2005,FKVKFKVKVK,KSL-7,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
3266,22934601,2012,FLGALFHALSKLL,PTP-7a,13,Linear,L,None,Free,Free,Anticancer,Synthetic peptide,A-549,Lung Cancer,MTT/MTS assay,IC50 =28 µM,NA,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1021/bm301106p
3267,22934601,2012,FLGALFKALSHLL,PTP-7b,13,Linear,L,None,Free,Free,Anticancer,Synthetic peptide,A-549,Lung Cancer,MTT/MTS assay,IC50 =32 µM,NA,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1021/bm301106p
1007,14499271,2003,FLGALFKALSKLL,PTP7,13,Linear,L,None,Free,Free,Antibacterial,Gaegurin,A-549,Lung Cancer,MTT/MTS assay,IC50=8.01 µg/ml,96-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1015,14499271,2003,FLGALFKALSKLL,PTP7,13,Linear,L,None,Free,Free,Antibacterial,Gaegurin,293,Renal Cancer,MTT/MTS assay,IC50=6.71 µg/ml,96-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1023,14499271,2003,FLGALFKALSKLL,PTP7,13,Linear,L,None,Free,Free,Antibacterial,Gaegurin,PC-3,Prostate Cancer,MTT/MTS assay,IC50=5.01 µg/ml,96-h,Prostate,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1031,14499271,2003,FLGALFKALSKLL,PTP7,13,Linear,L,None,Free,Free,Antibacterial,Gaegurin,Hep3B,Liver Cancer,MTT/MTS assay,IC50=5.4 µg/ml,96-h,Liver,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1039,14499271,2003,FLGALFKALSKLL,PTP7,13,Linear,L,None,Free,Free,Antibacterial,Gaegurin,MCF-7,Breast Cancer,MTT/MTS assay,IC50=5.25 µg/ml,96-h,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
3125,23770440,2013,FLGMIPGLIGGLISAFK,TsAP-2,17,Linear,L,None,Amidation,Free,Antimicrobial,"Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus",HI-57,Lung Cancer,MTT/MTS assay,IC50 = 4.1 µM,24-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.biochi.2013.06.003
3126,23770440,2013,FLGMIPGLIGGLISAFK,TsAP-2,17,Linear,L,None,Amidation,Free,Antimicrobial,"Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus",H-838,Lung Cancer,MTT/MTS assay,IC50 = 11.0 µM,24-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.biochi.2013.06.003
3127,23770440,2013,FLGMIPGLIGGLISAFK,TsAP-2,17,Linear,L,None,Amidation,Free,Antimicrobial,"Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus",MCF-7,Breast Cancer,MTT/MTS assay,IC50 = 6.4 µM,24-h,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.biochi.2013.06.003
3128,23770440,2013,FLGMIPGLIGGLISAFK,TsAP-2,17,Linear,L,None,Amidation,Free,Antimicrobial,"Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus",PC-3,Prostate Cancer,MTT/MTS assay,IC50 = 13.3 µM,24-h,Prostate,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.biochi.2013.06.003
3129,23770440,2013,FLGMIPGLIGGLISAFK,TsAP-2,17,Linear,L,None,Amidation,Free,Antimicrobial,"Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus",U251-MG,Brain Tumor,MTT/MTS assay,IC50 = 15.4 µM,24-h,Brain,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.biochi.2013.06.003
3135,23770440,2013,FLGMIPKLIKKLIKAFK,TsAP-S2,17,Linear,L,None,Amidation,Free,Antimicrobial,"Derivative of TsAP-1, Brazilian yellow scorpion venom peptide",HI-57,Lung Cancer,MTT/MTS assay,IC50 = 0.83 µM,24-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.biochi.2013.06.003
3136,23770440,2013,FLGMIPKLIKKLIKAFK,TsAP-S2,17,Linear,L,None,Amidation,Free,Antimicrobial,"Derivative of TsAP-1, Brazilian yellow scorpion venom peptide",H-838,Lung Cancer,MTT/MTS assay,IC50 = 1.6 µM,24-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.biochi.2013.06.003
3137,23770440,2013,FLGMIPKLIKKLIKAFK,TsAP-S2,17,Linear,L,None,Amidation,Free,Antimicrobial,"Derivative of TsAP-1, Brazilian yellow scorpion venom peptide",MCF-7,Breast Cancer,MTT/MTS assay,IC50 = 1.8 µM,24-h,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.biochi.2013.06.003
3138,23770440,2013,FLGMIPKLIKKLIKAFK,TsAP-S2,17,Linear,L,None,Amidation,Free,Antimicrobial,"Derivative of TsAP-1, Brazilian yellow scorpion venom peptide",PC-3,Prostate Cancer,MTT/MTS assay,IC50 = 1.6 µM,24-h,Prostate,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.biochi.2013.06.003
3139,23770440,2013,FLGMIPKLIKKLIKAFK,TsAP-S2,17,Linear,L,None,Amidation,Free,Antimicrobial,"Derivative of TsAP-1, Brazilian yellow scorpion venom peptide",U251-MG,Brain Tumor,MTT/MTS assay,IC50 = 2.0 µM,24-h,Brain,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.biochi.2013.06.003
1710,None,2011,FLGWLFKWAKK,Gaegurin peptides SEQID NO: 1,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50 = 27.39 mM,24-h,Skin,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1711,None,2011,FLGWLFKWAKK,Gaegurin peptides SEQID NO: 1,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,A-549,Lung Cancer,MTT/MTS assay,IC50 = 25.2 mM,24-h,Lung,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1712,None,2011,FLGWLFKWAKK,Gaegurin peptides SEQID NO: 1,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50 = 24.76 mM,24-h,Ovary,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1713,None,2011,FLGWLFKWAKK,Gaegurin peptides SEQID NO: 1,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,MKN-45,Gastric Cancer,MTT/MTS assay,IC50 = 26.7 mM,24-h,Stomach,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1714,None,2011,FLGWLFKWAKK,Gaegurin peptides SEQID NO: 1,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,PC-3,Prostate Cancer,MTT/MTS assay,IC50 = 47.69 mM,24-h,Prostate,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1715,None,2011,FLGWLFKWAKK,Gaegurin peptides SEQID NO: 1,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,A-498,Renal Cancer,MTT/MTS assay,IC50 = 41.21 mM,24-h,Renal,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1734,None,2011,FLGWLFKWAKK,Gaegurin peptides SEQID NO: 1,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,HCTl-16,Colon Cancer,MTT/MTS assay,IC50 = 27 mM,24-h,Colon,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1738,None,2011,FLGWLFKWAKK,Gaegurin peptides SEQID NO: 1,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,NCI-H630,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1742,None,2011,FLGWLFKWAKK,Gaegurin peptides SEQID NO: 1,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,A-498,Renal Cancer,MTT/MTS assay,IC50 = 41.21 mM,24-h,Renal,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1743,None,2011,FLGWLFKWAKK,Gaegurin peptides SEQID NO: 1,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,A-549,Lung Cancer,MTT/MTS assay,IC50 = 25.2 mM,24-h,Lung,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1744,None,2011,FLGWLFKWAKK,Gaegurin peptides SEQID NO: 1,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,MKN-45,Gastric Cancer,MTT/MTS assay,IC50 = 26.7 mM,24-h,Stomach,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1745,None,2011,FLGWLFKWAKK,Gaegurin peptides SEQID NO: 1,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,NCI-H630,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1746,None,2011,FLGWLFKWAKK,Gaegurin peptides SEQID NO: 1,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,PC-3,Prostate Cancer,MTT/MTS assay,IC50 = 47.69 mM,24-h,Prostate,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1747,None,2011,FLGWLFKWAKK,Gaegurin peptides SEQID NO: 1,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50 = 27.39 mM,24-h,Skin,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1748,None,2011,FLGWLFKWAKK,Gaegurin peptides SEQID NO: 1,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50 = 24.76 mM,24-h,Ovary,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
3240,22644847,2012,FLGWLFKWAKK,GA-K3,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,A-498,Renal Cancer,MTT/MTS assay,IC50 =41.21 µM,72-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3241,22644847,2012,FLGWLFKWAKK,GA-K3,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,A-549,Lung Cancer,MTT/MTS assay,IC50 =25.20 µM,72-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3242,22644847,2012,FLGWLFKWAKK,GA-K3,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,HCT-116,Colon Cancer,MTT/MTS assay,IC50 =27.00 µM,72-h,Colon,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3243,22644847,2012,FLGWLFKWAKK,GA-K3,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,MKN-45,Gastric Cancer,MTT/MTS assay,IC50 =26.70 µM,72-h,Stomach,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3244,22644847,2012,FLGWLFKWAKK,GA-K3,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,PC-3,Prostate Cancer,MTT/MTS assay,IC50 =47.69 µM,72-h,Prostate,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3245,22644847,2012,FLGWLFKWAKK,GA-K3,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50 =27.39 µM,72-h,Skin,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3246,22644847,2012,FLGWLFKWAKK,GA-K3,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50,72-h,Ovary,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3741,22644847,2012,FLGWLFKWAKK,GA-K3,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,A-498,Renal Cancer,MTT/MTS assay,IC50= 41.21 µM,72-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3742,22644847,2012,FLGWLFKWAKK,GA-K3,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,A-549,Lung Cancer,MTT/MTS assay,IC50= 25.20 µM,72-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3743,22644847,2012,FLGWLFKWAKK,GA-K3,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,HCT-116,Colon Cancer,MTT/MTS assay,IC50= 27.00 µM,72-h,Colon,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3744,22644847,2012,FLGWLFKWAKK,GA-K3,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,MKN-45,Gastric Cancer,MTT/MTS assay,IC50= 26.70 µM,72-h,Stomach,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3745,22644847,2012,FLGWLFKWAKK,GA-K3,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,PC-3,Prostate Cancer,MTT/MTS assay,IC50= 47.69 µM,72-h,Prostate,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3746,22644847,2012,FLGWLFKWAKK,GA-K3,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50= 27.39 µM,72-h,Skin,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
1722,None,2011,FLGWLFKWAWK,Gaegurin peptides SEQID NO: 3,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50 = 13.97 mM,24-h,Skin,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1723,None,2011,FLGWLFKWAWK,Gaegurin peptides SEQID NO: 3,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,A-549,Lung Cancer,MTT/MTS assay,IC50 = 20.36 mM,24-h,Lung,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1724,None,2011,FLGWLFKWAWK,Gaegurin peptides SEQID NO: 3,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50 = 22.06 mM,24-h,Ovary,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1725,None,2011,FLGWLFKWAWK,Gaegurin peptides SEQID NO: 3,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,MKN-45,Gastric Cancer,MTT/MTS assay,IC50 = 24.31 mM,24-h,Stomach,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1726,None,2011,FLGWLFKWAWK,Gaegurin peptides SEQID NO: 3,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,PC-3,Prostate Cancer,MTT/MTS assay,IC50 = 46.51 mM,24-h,Prostate,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1727,None,2011,FLGWLFKWAWK,Gaegurin peptides SEQID NO: 3,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,A-498,Renal Cancer,MTT/MTS assay,Not Available,24-h,Renal,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1736,None,2011,FLGWLFKWAWK,Gaegurin peptides SEQID NO: 3,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,HCTl-16,Colon Cancer,MTT/MTS assay,IC50 = 24.63 mM,24-h,Colon,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1740,None,2011,FLGWLFKWAWK,Gaegurin peptides SEQID NO: 3,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,NCI-H630,Colon Cancer,MTT/MTS assay,IC50 = 48 mM,24-h,Colon,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1757,None,2011,FLGWLFKWAWK,Gaegurin peptides SEQID NO: 3,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,A-498,Renal Cancer,MTT/MTS assay,Not Available,24-h,Renal,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1758,None,2011,FLGWLFKWAWK,Gaegurin peptides SEQID NO: 3,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,A-549,Lung Cancer,MTT/MTS assay,IC50 = 20.36 mM,24-h,Lung,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1759,None,2011,FLGWLFKWAWK,Gaegurin peptides SEQID NO: 3,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,HCTl-16,Colon Cancer,MTT/MTS assay,IC50 = 24.63 mM,24-h,Colon,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1760,None,2011,FLGWLFKWAWK,Gaegurin peptides SEQID NO: 3,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,MKN-45,Gastric Cancer,MTT/MTS assay,IC50 = 22.31 mM,24-h,Stomach,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1761,None,2011,FLGWLFKWAWK,Gaegurin peptides SEQID NO: 3,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,NCI-H630,Colon Cancer,MTT/MTS assay,IC50 = 48 mM,24-h,Colon,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1762,None,2011,FLGWLFKWAWK,Gaegurin peptides SEQID NO: 3,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,PC-3,Prostate Cancer,MTT/MTS assay,IC50 = 46.51 mM,24-h,Prostate,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1763,None,2011,FLGWLFKWAWK,Gaegurin peptides SEQID NO: 3,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50 = 13.97 mM,24-h,Skin,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1764,None,2011,FLGWLFKWAWK,Gaegurin peptides SEQID NO: 3,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50 = 22.06 mM,24-h,Ovary,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
3226,22644847,2012,FLGWLFKWAWK,GA-W3,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,A-498,Renal Cancer,MTT/MTS assay,IC50 =22.88 µM,72-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3227,22644847,2012,FLGWLFKWAWK,GA-W3,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,A-549,Lung Cancer,MTT/MTS assay,IC50 =20.36 µM,72-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3228,22644847,2012,FLGWLFKWAWK,GA-W3,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,HCT-116,Colon Cancer,MTT/MTS assay,IC50 =24.63 µM,72-h,Colon,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3229,22644847,2012,FLGWLFKWAWK,GA-W3,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,MKN-45,Gastric Cancer,MTT/MTS assay,IC50 =24.31 µM,72-h,Stomach,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3230,22644847,2012,FLGWLFKWAWK,GA-W3,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,PC-3,Prostate Cancer,MTT/MTS assay,IC50 =46.51 µM,72-h,Prostate,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3231,22644847,2012,FLGWLFKWAWK,GA-W3,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50 =13.97 µM,72-h,Skin,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3232,22644847,2012,FLGWLFKWAWK,GA-W3,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50 =22.06 µM,72-h,Ovary,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3727,22644847,2012,FLGWLFKWAWK,GA-W3,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,A-498,Renal Cancer,MTT/MTS assay,IC50= 22.88 µM,72-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3728,22644847,2012,FLGWLFKWAWK,GA-W3,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,A-549,Lung Cancer,MTT/MTS assay,IC50= 20.36 µM,72-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3729,22644847,2012,FLGWLFKWAWK,GA-W3,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,HCT-116,Colon Cancer,MTT/MTS assay,IC50= 24.63 µM,72-h,Colon,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3730,22644847,2012,FLGWLFKWAWK,GA-W3,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,MKN-45,Gastric Cancer,MTT/MTS assay,IC50= 24.31 µM,72-h,Stomach,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3731,22644847,2012,FLGWLFKWAWK,GA-W3,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,PC-3,Prostate Cancer,MTT/MTS assay,IC50= 46.51 µM,72-h,Prostate,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3732,22644847,2012,FLGWLFKWAWK,GA-W3,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50= 13.97 µM,72-h,Skin,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3733,22644847,2012,FLGWLFKWAWK,GA-W3,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50= 22.06 µM,72-h,Ovary,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
4355,"17698251, 18957441",2007,FLIGMTQGLICLITRKC,Dybowskin-2,17,Not Available,L,None,Free,Free,Antibacterial,"Rana dybowskii, Rana chensinensis, Asia",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O,"['https://doi.org/10.1016/j.peptides.2007.07.002', 'https://doi.org/10.1093/nar/gkn823']"
1008,14499271,2003,FLKLLAGLLKNFA,PTP8,13,Linear,L,None,Free,Free,Antibacterial,Gaegurin,A-549,Lung Cancer,MTT/MTS assay,IC50=24.58 µg/ml,96-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1016,14499271,2003,FLKLLAGLLKNFA,PTP8,13,Linear,L,None,Free,Free,Antibacterial,Gaegurin,293,Renal Cancer,MTT/MTS assay,IC50=26.8 µg/ml,96-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1024,14499271,2003,FLKLLAGLLKNFA,PTP8,13,Linear,L,None,Free,Free,Antibacterial,Gaegurin,PC-3,Prostate Cancer,MTT/MTS assay,IC50=28.9 µg/ml,96-h,Prostate,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1032,14499271,2003,FLKLLAGLLKNFA,PTP8,13,Linear,L,None,Free,Free,Antibacterial,Gaegurin,Hep3B,Liver Cancer,MTT/MTS assay,IC50=30.79 µg/ml,96-h,Liver,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1040,14499271,2003,FLKLLAGLLKNFA,PTP8,13,Linear,L,None,Free,Free,Antibacterial,Gaegurin,MCF-7,Breast Cancer,MTT/MTS assay,IC50=32.23 µg/ml,96-h,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1004,14499271,2003,FLKLLKKLAAKFLPTIICKISYKC,PTP4,24,Linear,L,None,Free,Free,Antibacterial,Gaegurin,A-549,Lung Cancer,MTT/MTS assay,IC50=13.71 µg/ml,96-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1012,14499271,2003,FLKLLKKLAAKFLPTIICKISYKC,PTP4,24,Linear,L,None,Free,Free,Antibacterial,Gaegurin,293,Renal Cancer,MTT/MTS assay,IC50=26.15 µg/ml,96-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1020,14499271,2003,FLKLLKKLAAKFLPTIICKISYKC,PTP4,24,Linear,L,None,Free,Free,Antibacterial,Gaegurin,PC-3,Prostate Cancer,MTT/MTS assay,IC50=18.63 µg/ml,96-h,Prostate,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1028,14499271,2003,FLKLLKKLAAKFLPTIICKISYKC,PTP4,24,Linear,L,None,Free,Free,Antibacterial,Gaegurin,Hep3B,Liver Cancer,MTT/MTS assay,IC50=18.18 µg/ml,96-h,Liver,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1036,14499271,2003,FLKLLKKLAAKFLPTIICKISYKC,PTP4,24,Linear,L,None,Free,Free,Antibacterial,Gaegurin,MCF-7,Breast Cancer,MTT/MTS assay,IC50=18.1 µg/ml,96-h,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1005,14499271,2003,FLKLLKKLAAKLF,PTP5,13,Linear,L,None,Free,Free,Antibacterial,Gaegurin,A-549,Lung Cancer,MTT/MTS assay,IC50=9.09 µg/ml,96-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1006,14499271,2003,FLKLLKKLAAKLF,PTP6,13,Linear,L,None,Free,Free,Antibacterial,Gaegurin,A-549,Lung Cancer,MTT/MTS assay,IC50=13.94 µg/ml,96-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1013,14499271,2003,FLKLLKKLAAKLF,PTP5,13,Linear,L,None,Free,Free,Antibacterial,Gaegurin,293,Renal Cancer,MTT/MTS assay,IC50=15.11 µg/ml,96-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1014,14499271,2003,FLKLLKKLAAKLF,PTP6,13,Linear,L,None,Free,Free,Antibacterial,Gaegurin,293,Renal Cancer,MTT/MTS assay,IC50=14 µg/ml,96-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1021,14499271,2003,FLKLLKKLAAKLF,PTP5,13,Linear,L,None,Free,Free,Antibacterial,Gaegurin,PC-3,Prostate Cancer,MTT/MTS assay,Not Available,96-h,Prostate,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1022,14499271,2003,FLKLLKKLAAKLF,PTP6,13,Linear,L,None,Free,Free,Antibacterial,Gaegurin,PC-3,Prostate Cancer,MTT/MTS assay,IC50=13.27 µg/ml,96-h,Prostate,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1029,14499271,2003,FLKLLKKLAAKLF,PTP5,13,Linear,L,None,Free,Free,Antibacterial,Gaegurin,Hep3B,Liver Cancer,MTT/MTS assay,Not Available,96-h,Liver,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1030,14499271,2003,FLKLLKKLAAKLF,PTP6,13,Linear,L,None,Free,Free,Antibacterial,Gaegurin,Hep3B,Liver Cancer,MTT/MTS assay,IC50=15.07 µg/ml,96-h,Liver,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1037,14499271,2003,FLKLLKKLAAKLF,PTP5,13,Linear,L,None,Free,Free,Antibacterial,Gaegurin,MCF-7,Breast Cancer,MTT/MTS assay,IC50=5.43 µg/ml,96-h,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1038,14499271,2003,FLKLLKKLAAKLF,PTP6,13,Linear,L,None,Free,Free,Antibacterial,Gaegurin,MCF-7,Breast Cancer,MTT/MTS assay,IC50=17.56 µg/ml,96-h,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1716,None,2011,FLKWLFKWAKK,Gaegurin peptides SEQID NO: 2,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50 = 22.25 mM,24-h,Skin,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1717,None,2011,FLKWLFKWAKK,Gaegurin peptides SEQID NO: 2,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,A-549,Lung Cancer,MTT/MTS assay,IC50 = 14.53 mM,24-h,Lung,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1718,None,2011,FLKWLFKWAKK,Gaegurin peptides SEQID NO: 2,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50 = 12.55 mM,24-h,Ovary,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1719,None,2011,FLKWLFKWAKK,Gaegurin peptides SEQID NO: 2,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,MKN-45,Gastric Cancer,MTT/MTS assay,IC50 = 22.51 mM,24-h,Stomach,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1720,None,2011,FLKWLFKWAKK,Gaegurin peptides SEQID NO: 2,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,PC-3,Prostate Cancer,MTT/MTS assay,IC50 = 29.1 mM,24-h,Prostate,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1721,None,2011,FLKWLFKWAKK,Gaegurin peptides SEQID NO: 2,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,A-498,Renal Cancer,MTT/MTS assay,IC50 = 21.48 mM,24-h,Renal,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1735,None,2011,FLKWLFKWAKK,Gaegurin peptides SEQID NO: 2,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,HCTl-16,Colon Cancer,MTT/MTS assay,IC50 = 14.8 mM,24-h,Colon,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1739,None,2011,FLKWLFKWAKK,Gaegurin peptides SEQID NO: 2,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,NCI-H630,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1749,None,2011,FLKWLFKWAKK,Gaegurin peptides SEQID NO: 2,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,A-498,Renal Cancer,MTT/MTS assay,IC50 = 21.48 mM,24-h,Renal,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1750,None,2011,FLKWLFKWAKK,Gaegurin peptides SEQID NO: 2,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,A-549,Lung Cancer,MTT/MTS assay,IC50 = 14.53 mM,24-h,Lung,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1751,None,2011,FLKWLFKWAKK,Gaegurin peptides SEQID NO: 2,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,HCTl-16,Colon Cancer,MTT/MTS assay,IC50 = 14.8 mM,24-h,Colon,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1752,None,2011,FLKWLFKWAKK,Gaegurin peptides SEQID NO: 2,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,MKN-45,Gastric Cancer,MTT/MTS assay,IC50 = 22.51 mM,24-h,Stomach,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1753,None,2011,FLKWLFKWAKK,Gaegurin peptides SEQID NO: 2,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,NCI-H630,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1754,None,2011,FLKWLFKWAKK,Gaegurin peptides SEQID NO: 2,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,PC-3,Prostate Cancer,MTT/MTS assay,IC50 = 29.1 mM,24-h,Prostate,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1755,None,2011,FLKWLFKWAKK,Gaegurin peptides SEQID NO: 2,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50 = 22.25 mM,24-h,Skin,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1756,None,2011,FLKWLFKWAKK,Gaegurin peptides SEQID NO: 2,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50 = 12.55 mM,24-h,Ovary,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
3247,22644847,2012,FLKWLFKWAKK,GA-K4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,A-498,Renal Cancer,MTT/MTS assay,IC50 =21.48 µM,72-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3248,22644847,2012,FLKWLFKWAKK,GA-K4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,A-549,Lung Cancer,MTT/MTS assay,IC50 =14.53 µM,72-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3249,22644847,2012,FLKWLFKWAKK,GA-K4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,HCT-116,Colon Cancer,MTT/MTS assay,IC50 =14.80 µM,72-h,Colon,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3250,22644847,2012,FLKWLFKWAKK,GA-K4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,MKN-45,Gastric Cancer,MTT/MTS assay,IC50 =22.51 µM,72-h,Stomach,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3251,22644847,2012,FLKWLFKWAKK,GA-K4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,PC-3,Prostate Cancer,MTT/MTS assay,IC50 =29.10 µM,72-h,Prostate,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3252,22644847,2012,FLKWLFKWAKK,GA-K4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50 =22.25 µM,72-h,Skin,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3253,22644847,2012,FLKWLFKWAKK,GA-K4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50 =12.55 µM,72-h,Ovary,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3747,22644847,2012,FLKWLFKWAKK,GA-K3,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50= 24.76 µM,72-h,Ovary,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3748,22644847,2012,FLKWLFKWAKK,GA-K4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,A-498,Renal Cancer,MTT/MTS assay,IC50= 21.48 µM,72-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3749,22644847,2012,FLKWLFKWAKK,GA-K4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,A-549,Lung Cancer,MTT/MTS assay,IC50= 14.53 µM,72-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3750,22644847,2012,FLKWLFKWAKK,GA-K4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,HCT-116,Colon Cancer,MTT/MTS assay,IC50= 14.8 µM,72-h,Colon,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3751,22644847,2012,FLKWLFKWAKK,GA-K4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,MKN-45,Gastric Cancer,MTT/MTS assay,IC50= 22.51 µM,72-h,Stomach,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3752,22644847,2012,FLKWLFKWAKK,GA-K4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,PC-3,Prostate Cancer,MTT/MTS assay,IC50= 29.10 µM,72-h,Prostate,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3753,22644847,2012,FLKWLFKWAKK,GA-K4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50= 22.25 µM,72-h,Skin,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3754,22644847,2012,FLKWLFKWAKK,GA-K4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50= 12.55 µM,72-h,Ovary,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
4356,"19254736, 18957441",2009,FLPAIVGAAAKFLPKIFCAISKKC,Brevinin-1BLa,24,Not Available,L,None,Free,Free,Antibacterial,"North America, leopard frog, Lithobates blairi",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O,"['https://doi.org/10.1016/j.toxicon.2009.02.018', 'https://doi.org/10.1093/nar/gkn823']"
4357,"19254736, 18957441",2009,FLPIIAGAAAKVVEKIFCAISKKC,Brevinin-1BLa,24,Not Available,L,None,Free,Free,Antibacterial,"North America, leopard frog, Lithobates blairi",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O,"['https://doi.org/10.1016/j.toxicon.2009.02.018', 'https://doi.org/10.1093/nar/gkn823']"
4358,"19254736, 18957441",2009,FLPIIAGAAAKVVQKIFCAISKKC,Brevinin-1BLa,24,Not Available,L,None,Free,Free,Antibacterial,"North America, leopard frog, Lithobates blairi",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O,"['https://doi.org/10.1016/j.toxicon.2009.02.018', 'https://doi.org/10.1093/nar/gkn823']"
4359,"19254736, 18957441",2009,FLPIIAGIAAKFLPKIFCTISKKC,Brevinin-1BLa,24,Not Available,L,None,Free,Free,Antibacterial,"North America, leopard frog, Lithobates blairi",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O,"['https://doi.org/10.1016/j.toxicon.2009.02.018', 'https://doi.org/10.1093/nar/gkn823']"
4360,"19254736, 18957441",2009,FLPIIAGVAAKVLPKIFCAISKKC,Brevinin-1BLa,24,Not Available,L,None,Free,Free,Antibacterial,"North America, leopard frog, Lithobates blairi",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O,"['https://doi.org/10.1016/j.toxicon.2009.02.018', 'https://doi.org/10.1093/nar/gkn823']"
4364,"16713189, 18957441",2006,FLPILASLAAKFGPKLFCLVTKKC,Brevinin-1BYa,24,Not Available,L,None,Free,Free,Antibacterial,"Rana boylii, North America",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O,"['https://doi.org/10.1016/j.ijantimicag.2006.01.010', 'https://doi.org/10.1093/nar/gkn823']"
1427,9022710,1996,FLPLIGRVLSGIL,Temporin A,13,Linear,L,None,Amidation,Free,Antimicrobial,Frog Rana temporaria,U-937,Lymphoma Cancer,MTT/MTS assay,15% Cytotoxicity at 0.5 µg/ml,6-h,Blood,None,N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C=O)CC(C)C)[C@H](CC)C)CO)CC(C)C)C(C)C)CCCNC(=[NH2])N)[C@H](CC)C)CC(C)C)CCC1)CC(C)C)Cc1ccccc1,https://doi.org/10.1111/j.1432-1033.1996.0788r.x
4598,21403917,2011,FLPLIGRVLSGIL,Temporin A,13,Linear,L,None,Amidation,Free,Antimicrobial,Frog Rana temporaria,U-943,Lymphoma Cancer,MTT/MTS assay,IC50 =80-90 µg/ml,Not Available,Blood,None,N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C=O)CC(C)C)[C@H](CC)C)CO)CC(C)C)C(C)C)CCCNC(=[NH2])N)[C@H](CC)C)CC(C)C)CCC1)CC(C)C)Cc1ccccc1,Not Found
1001,14499271,2003,FLPLLAGLAANFLPTIICKISYKC,GGN6,24,Cyclic(C18-C24),L,None,Free,Free,Antibacterial,Gaegurin,A-549,Lung Cancer,MTT/MTS assay,IC50=6.49 µg/ml,96-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)[C@@H](C)CC)CO)Cc1ccccc1)CCCCN)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1009,14499271,2003,FLPLLAGLAANFLPTIICKISYKC,GGN6,24,Cyclic(C18-C24),L,None,Free,Free,Antibacterial,Gaegurin,293,Renal Cancer,MTT/MTS assay,IC50=5.62 µg/ml,96-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)[C@@H](C)CC)CO)Cc1ccccc1)CCCCN)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1017,14499271,2003,FLPLLAGLAANFLPTIICKISYKC,GGN6,24,Cyclic(C18-C24),L,None,Free,Free,Antibacterial,Gaegurin,293,Renal Cancer,MTT/MTS assay,IC50=5.75 µg/ml,96-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)[C@@H](C)CC)CO)Cc1ccccc1)CCCCN)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1025,14499271,2003,FLPLLAGLAANFLPTIICKISYKC,GGN6,24,Cyclic(C18-C24),L,None,Free,Free,Antibacterial,Gaegurin,Hep3B,Liver Cancer,MTT/MTS assay,IC50=4.91 µg/ml,96-h,Liver,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)[C@@H](C)CC)CO)Cc1ccccc1)CCCCN)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1033,14499271,2003,FLPLLAGLAANFLPTIICKISYKC,GGN6,24,Cyclic(C18-C24),L,None,Free,Free,Antibacterial,Gaegurin,MCF-7,Breast Cancer,MTT/MTS assay,IC50=4.88 µg/ml,96-h,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)[C@@H](C)CC)CO)Cc1ccccc1)CCCCN)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
4361,"19254736, 18957441",2009,FLPVIAGVAANFLPKLFCAISKKC,Brevinin-1BLa,24,Not Available,L,None,Free,Free,Antibacterial,"North America, leopard frog, Lithobates blairi",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)O,"['https://doi.org/10.1016/j.toxicon.2009.02.018', 'https://doi.org/10.1093/nar/gkn823']"
3130,23770440,2013,FLSLIPKLVKKIIKAFK,TsAP-S1,17,Linear,L,None,Amidation,Free,Antimicrobial,"Derivative of TsAP-1, Brazilian yellow scorpion venom peptide",HI-57,Lung Cancer,MTT/MTS assay,IC50 = 1.5 µM,24-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.biochi.2013.06.003
3131,23770440,2013,FLSLIPKLVKKIIKAFK,TsAP-S1,17,Linear,L,None,Amidation,Free,Antimicrobial,"Derivative of TsAP-1, Brazilian yellow scorpion venom peptide",H-838,Lung Cancer,MTT/MTS assay,IC50 = 1.6 µM,24-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.biochi.2013.06.003
3132,23770440,2013,FLSLIPKLVKKIIKAFK,TsAP-S1,17,Linear,L,None,Amidation,Free,Antimicrobial,"Derivative of TsAP-1, Brazilian yellow scorpion venom peptide",MCF-7,Breast Cancer,MTT/MTS assay,IC50 = 1.8 µM,24-h,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.biochi.2013.06.003
3133,23770440,2013,FLSLIPKLVKKIIKAFK,TsAP-S1,17,Linear,L,None,Amidation,Free,Antimicrobial,"Derivative of TsAP-1, Brazilian yellow scorpion venom peptide",PC-3,Prostate Cancer,MTT/MTS assay,IC50 = 2.1 µM,24-h,Prostate,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.biochi.2013.06.003
3134,23770440,2013,FLSLIPKLVKKIIKAFK,TsAP-S1,17,Linear,L,None,Amidation,Free,Antimicrobial,"Derivative of TsAP-1, Brazilian yellow scorpion venom peptide",U251-MG,Brain Tumor,MTT/MTS assay,IC50 = 2.9 µM,24-h,Brain,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.biochi.2013.06.003
3123,23770440,2013,FLSLIPSLVGGSISAFK,TsAP-1,17,Linear,L,None,Amidation,Free,Antimicrobial,"Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus",HI-57,Lung Cancer,MTT/MTS assay,IC50 =55.9 µM,24-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.biochi.2013.06.003
3124,23770440,2013,FLSLIPSLVGGSISAFK,TsAP-1,17,Linear,L,None,Amidation,Free,Antimicrobial,"Venom-derived cDNot Available library of the Brazilian yellow scorpion, Tityus serrulatus",H-838,Lung Cancer,MTT/MTS assay,IC50 =52.5 µM,24-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.biochi.2013.06.003
1728,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50 = 13.16 mM,24-h,Skin,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1729,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,A-549,Lung Cancer,MTT/MTS assay,IC50 = 14.8 mM,24-h,Lung,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1730,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50 = 14.58 mM,24-h,Ovary,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1731,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,MKN-45,Gastric Cancer,MTT/MTS assay,IC50 = 13.77 mM,24-h,Stomach,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1732,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,PC-3,Prostate Cancer,MTT/MTS assay,IC50 = 24.32 mM,24-h,Prostate,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1733,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,A-498,Renal Cancer,MTT/MTS assay,Not Available,24-h,Renal,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1737,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,HCTl-16,Colon Cancer,MTT/MTS assay,IC50 = 14.8 mM,24-h,Colon,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1741,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,NCI-H630,Colon Cancer,MTT/MTS assay,IC50 = 57 mM,24-h,Colon,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1765,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,A-498,Renal Cancer,MTT/MTS assay,Not Available,24-h,Renal,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1766,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,A-549,Lung Cancer,MTT/MTS assay,IC50 = 15.88 mM,24-h,Lung,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1767,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,HCTl-16,Colon Cancer,MTT/MTS assay,IC50 = 14.8 mM,24-h,Colon,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1768,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,MKN-45,Gastric Cancer,MTT/MTS assay,IC50 = 13.77 mM,24-h,Stomach,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1769,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,NCI-H630,Colon Cancer,MTT/MTS assay,IC50 = 57 mM,24-h,Colon,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1770,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,PC-3,Prostate Cancer,MTT/MTS assay,IC50 = 24.32 mM,24-h,Prostate,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1771,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50 = 13.16 mM,24-h,Skin,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1772,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50 = 14.58 mM,24-h,Ovary,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
3233,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,A-498,Renal Cancer,MTT/MTS assay,IC50 =22.59 µM,72-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3234,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,A-549,Lung Cancer,MTT/MTS assay,IC50 =15.88 µM,72-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3235,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,HCT-116,Colon Cancer,MTT/MTS assay,IC50 =14.80 µM,72-h,Colon,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3236,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,MKN-45,Gastric Cancer,MTT/MTS assay,IC50 =13.77 µM,72-h,Stomach,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3237,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,PC-3,Prostate Cancer,MTT/MTS assay,IC50 =24.32 µM,72-h,Prostate,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3238,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50 =13.16 µM,72-h,Skin,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3239,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50 =14.58 µM,72-h,Ovary,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3734,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,A-498,Renal Cancer,MTT/MTS assay,IC50= 22.59 µM,72-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3735,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,A-549,Lung Cancer,MTT/MTS assay,IC50= 15.88 µM,72-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3736,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,HCT-116,Colon Cancer,MTT/MTS assay,IC50= 14.80 µM,72-h,Colon,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3737,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,MKN-45,Gastric Cancer,MTT/MTS assay,IC50= 13.77 µM,72-h,Stomach,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3738,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,PC-3,Prostate Cancer,MTT/MTS assay,IC50= 24.32 µM,72-h,Prostate,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3739,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50= 13.16 µM,72-h,Skin,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3740,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50= 14.58 µM,72-h,Ovary,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
4674,15279899,2004,FRKSKEKIGKEFKRIVQRIKDFLRNLV,HCAP18(109-135),27,Linear,L,None,Free,Free,Antimicrobial,hCAP18 synthetic peptide,SAS-H1,Oral Cancer,Not Available,Not Available,Not Available,Oral mucosa,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O.CCCCCN.C.C.C.C.C,https://doi.org/10.1016/j.canlet.2004.04.006
5002,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,MCF-7,Breast Cancer,MTT/MTS assay,LC50= 21 at 100 µM,72-h,Breast,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
5004,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,LNCaP,Prostate cancer,MTT/MTS assay,LC50= 27 at 100 µM,72-h,Prostate,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
5006,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,OVRCAR-3,Ovarian Cancer,MTT/MTS assay,LC50= 24 at 100 µM,72-h,Ovary,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
2851,"23577112, 21871946",2012,FVDLKKIANIINSIF,Tempoprin-1CEa,15,Linear,L,None,Amidation,Free,Antimicrobial,Chinese brown frog Rana chensinensis.,MDA-MB-231,Breast Cancer,MTT/MTS assay,22% Cell viability at 40 µM,1-h,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,"['https://doi.org/10.1371/journal.pone.0060462', 'https://doi.org/10.1016/j.biochi.2011.08.011']"
2852,"23577112, 21871946",2012,FVDLKKIANIINSIF,Tempoprin-1CEa,15,Linear,L,None,Amidation,Free,Antimicrobial,Chinese brown frog Rana chensinensis.,MDA-MB-231,Breast Cancer,LDH leakage assay,61% Cytotoxicity at 40 µM,1-h,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,"['https://doi.org/10.1371/journal.pone.0060462', 'https://doi.org/10.1016/j.biochi.2011.08.011']"
2853,"23577112, 21871946",2012,FVDLKKIANIINSIF,Tempoprin-1CEa,15,Linear,L,None,Amidation,Free,Antimicrobial,Chinese brown frog Rana chensinensis.,MCF-7,Breast Cancer,MTT/MTS assay,61% Cell viability at 40 µM,1-h,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,"['https://doi.org/10.1371/journal.pone.0060462', 'https://doi.org/10.1016/j.biochi.2011.08.011']"
2854,"23577112, 21871946",2012,FVDLKKIANIINSIF,Tempoprin-1CEa,15,Linear,L,None,Amidation,Free,Antimicrobial,Chinese brown frog Rana chensinensis.,MCF-7,Breast Cancer,LDH leakage assay,32% Cytotoxicity at 40 µM,1-h,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,"['https://doi.org/10.1371/journal.pone.0060462', 'https://doi.org/10.1016/j.biochi.2011.08.011']"
2875,23583573,2013,FVDLKKIANIINSIF,Tempoprin-1CEa,15,Linear,L,None,Amidation,Free,Antimicrobial,Chinese brown frog Rana chensinensis.,Bcap-37,Breast Cancer,MTT/MTS assay,70% Cell viability at 20 µM,1-h,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1016/j.lfs.2013.03.016
2876,23583573,2013,FVDLKKIANIINSIF,Tempoprin-1CEa,15,Linear,L,None,Amidation,Free,Antimicrobial,Chinese brown frog Rana chensinensis.,Bcap-37,Breast Cancer,MTT/MTS assay,45% Cell viability at 30 µM,1-h,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1016/j.lfs.2013.03.016
2877,23583573,2013,FVDLKKIANIINSIF,Tempoprin-1CEa,15,Linear,L,None,Amidation,Free,Antimicrobial,Chinese brown frog Rana chensinensis.,Bcap-37,Breast Cancer,MTT/MTS assay,30 % Cell viability at 40 µM,1-h,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1016/j.lfs.2013.03.016
4363,"9022710, 18957441",1996,FVQWFSKFLGRIL,Temporin L,13,Not Available,L,None,Free,Free,Antibacterial,"European common frog,Rana temporaria",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O,"['https://doi.org/10.1111/j.1432-1033.1996.0788r.x', 'https://doi.org/10.1093/nar/gkn823']"
4369,"22467870, 18957441",2012,GASCGETCFTGICFTAGCSCNPWPTCTRN,Chassatide C4,29,Not Available,L,None,Free,Free,Antibacterial,Chassalia chartacea,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1074/jbc.M111.338970', 'https://doi.org/10.1093/nar/gkn823']"
4370,"22467870, 18957441",2012,GDACGETCFTGICFTAGCSCNPWPTCTRN,Chassatide C4,29,Not Available,L,None,Free,Free,Antibacterial,Chassalia chartacea,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1074/jbc.M111.338970', 'https://doi.org/10.1093/nar/gkn823']"
4384,"21596752, 18957441",2011,GEFLKCGESCVQGECYTPGCSCDWPICKKN,Cliotide T2,30,Not Available,L,None,Free,Free,Antibacterial,Clitoria ternatea,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1074/jbc.M111.229922', 'https://doi.org/10.1093/nar/gkn823']"
4385,"6385903, 18957441",1984,"GETDPNTQLLNDLGNNMAWGAALGAPGGLGSAALGAAGGALQTVGQ
GLIDHGPVNVFIPVLIGPSWNGSGSGYNSATSSSGSGS",Microcin E492,84,Not Available,L,None,Free,Free,Antibacterial,Klebsiella pneumoniaeRYC492,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(=O)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@H](CC)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1ccc(cc1)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)O,"['https://doi.org/10.1007/BF00692715', 'https://doi.org/10.1093/nar/gkn823']"
4371,"22467870, 18957441",2012,GEYCGESCYLIPCFTPGCYCVSRQCVNKN,Chassatide C10,29,Not Available,L,None,Free,Free,Antibacterial,Chassalia chartacea,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1074/jbc.M111.338970', 'https://doi.org/10.1093/nar/gkn823']"
1543,22073006,2011,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin,33,Linear,L,None,Free,Free,Antibacterial,Red Sea Mosessole,HT-1080,Fibrosarcoma,MTT/MTS assay,IC50=15.74 µg/ml,3-h,Not Available,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.3390/md9101995
1544,22073006,2011,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin,33,Linear,L,None,Free,Free,Antibacterial,Red Sea Mosessole,HT-1080,Fibrosarcoma,MTT/MTS assay,IC50=15.40 µg/ml,6-h,Not Available,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.3390/md9101995
1545,22073006,2011,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin,33,Linear,L,None,Free,Free,Antibacterial,Red Sea Mosessole,HT-1080,Fibrosarcoma,MTT/MTS assay,IC50=14.51 µg/ml,12-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.3390/md9101995
1546,22073006,2011,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin,33,Linear,L,None,Free,Free,Antibacterial,Red Sea Mosessole,HT-1080,Fibrosarcoma,MTT/MTS assay,IC50=14.52 µg/ml,24-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.3390/md9101995
2996,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,62 % Cytotoxicity at 50 mg/L,3-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
2997,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,44 % Cytotoxicity at 25 mg/L,3-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
2998,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,4 % Cytotoxicity at 12.5 mg/L,3-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
2999,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,75 % Cytotoxicity at 50 mg/L,6-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3000,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,70 % Cytotoxicity at 25 mg/L,6-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3001,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,4 % Cytotoxicity at 3.125 mg/L,6-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3002,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,78 % Cytotoxicity at 50 mg/L,12-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3003,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,68 % Cytotoxicity at 25 mg/L,12-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3004,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,4 % Cytotoxicity at 12.5 mg/L,12-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3005,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,5 % Cytotoxicity at 6.25 mg/L,12-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3006,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,10 % Cytotoxicity at 3.125 mg/L,12-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3007,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,90 % Cytotoxicity at 50 mg/L,24-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3008,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,80 % Cytotoxicity at 25 mg/L,24-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3009,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,15 % Cytotoxicity at 12.5 mg/L,24-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3010,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,12 % Cytotoxicity at 6.25 mg/L,24-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3011,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,5 % Cytotoxicity at 3.125 mg/L,24-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3012,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,88 % Cytotoxicity at 50 mg/L,3-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3013,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,82 % Cytotoxicity at 25 mg/L,3-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3014,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,40 % Cytotoxicity at 12.5 mg/L,3-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3015,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,35 % Cytotoxicity at 6.25 mg/L,3-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3016,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,35 % Cytotoxicity at 3.125 mg/L,3-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3017,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,90 % Cytotoxicity at 50 mg/L,6-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3018,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,90 % Cytotoxicity at 25 mg/L,6-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3019,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,30 % Cytotoxicity at 12.5 mg/L,6-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3020,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,30 % Cytotoxicity at 6.25 mg/L,6-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3021,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,30 % Cytotoxicity at 3.125 mg/L,6-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3022,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,97 % Cytotoxicity at 50 mg/L,12-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3023,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,95 % Cytotoxicity at 25 mg/L,12-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3024,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,39 % Cytotoxicity at 12.5 mg/L,12-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3025,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,28 % Cytotoxicity at 6.25 mg/L,12-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3026,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,38 % Cytotoxicity at 3.125 mg/L,12-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3027,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,90 % Cytotoxicity at 50 mg/L,24-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3028,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,90 % Cytotoxicity at 25 mg/L,24-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3029,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,15 % Cytotoxicity at 12.5 mg/L,24-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3030,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,5 % Cytotoxicity at 6.25 mg/L,24-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3031,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,10 % Cytotoxicity at 3.125 mg/L,24-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3032,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,70 % Cytotoxicity at 50 mg/L,3-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3033,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,60 % Cytotoxicity at 25 mg/L,3-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3034,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,4 % Cytotoxicity at 12.5 mg/L,3-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3035,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,5 % Cytotoxicity at 6.25 mg/L,3-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3036,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,1 % Cytotoxicity at 3.125 mg/L,3-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3037,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,78 % Cytotoxicity at 50 mg/L,6-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3038,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,70 % Cytotoxicity at 25 mg/L,6-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3039,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,10 % Cytotoxicity at 12.5 mg/L,6-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3040,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,10 % Cytotoxicity at 6.25 mg/L,6-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3041,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,5 % Cytotoxicity at 3.125 mg/L,6-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3042,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,82 % Cytotoxicity at 50 mg/L,12-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3043,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,70 % Cytotoxicity at 25 mg/L,12-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3044,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,18 % Cytotoxicity at 12.5 mg/L,12-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3045,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,4 % Cytotoxicity at 6.25 mg/L,12-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3046,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,10 % Cytotoxicity at 3.125 mg/L,12-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3047,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,90 % Cytotoxicity at 50 mg/L,24-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3048,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,82 % Cytotoxicity at 25 mg/L,24-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3049,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,18 % Cytotoxicity at 12.5 mg/L,24-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3050,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,18 % Cytotoxicity at 6.25 mg/L,24-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3051,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,18 % Cytotoxicity at 3.125 mg/L,24-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3052,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,80 % Cytotoxicity at 50 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3053,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,85 % Cytotoxicity at 25 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3054,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,45 % Cytotoxicity at 12.5 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3055,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,30 % Cytotoxicity at 6.25 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3056,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,25 % Cytotoxicity at 3.125 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3057,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,84 % Cytotoxicity at 50 mg/L,6-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3058,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,84% Cytotoxicity at 25 mg/L,6-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3059,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,48 % Cytotoxicity at 12.5 mg/L,6-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3060,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,30 % Cytotoxicity at 6.25 mg/L,6-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3061,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,35 % Cytotoxicity at 3.125 mg/L,6-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3062,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,90 % Cytotoxicity at 50 mg/L,12-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3063,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,85 % Cytotoxicity at 25 mg/L,12-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3064,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,30 % Cytotoxicity at 12.5 mg/L,12-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3065,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,35 % Cytotoxicity at 6.25 mg/L,12-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3066,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,15 % Cytotoxicity at 3.125 mg/L,12-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3067,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,90 % Cytotoxicity at 50 mg/L,24-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3068,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,90 % Cytotoxicity at 25 mg/L,24-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3069,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,20 % Cytotoxicity at 12.5 mg/L,24-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3070,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,1 % Cytotoxicity at 6.25 mg/L,24-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
3071,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALS,Pardaxin-6,27,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,10 % Cytotoxicity at 3.125 mg/L,24-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
1543,22073006,2011,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin,33,Linear,L,None,Free,Free,Antibacterial,Red Sea Mosessole,HT-1080,Fibrosarcoma,MTT/MTS assay,IC50=15.74 µg/ml,3-h,Not Available,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.3390/md9101995
1544,22073006,2011,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin,33,Linear,L,None,Free,Free,Antibacterial,Red Sea Mosessole,HT-1080,Fibrosarcoma,MTT/MTS assay,IC50=15.40 µg/ml,6-h,Not Available,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.3390/md9101995
1545,22073006,2011,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin,33,Linear,L,None,Free,Free,Antibacterial,Red Sea Mosessole,HT-1080,Fibrosarcoma,MTT/MTS assay,IC50=14.51 µg/ml,12-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.3390/md9101995
1546,22073006,2011,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin,33,Linear,L,None,Free,Free,Antibacterial,Red Sea Mosessole,HT-1080,Fibrosarcoma,MTT/MTS assay,IC50=14.52 µg/ml,24-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.3390/md9101995
2996,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,62 % Cytotoxicity at 50 mg/L,3-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
2997,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,44 % Cytotoxicity at 25 mg/L,3-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
2998,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,4 % Cytotoxicity at 12.5 mg/L,3-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
2999,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,75 % Cytotoxicity at 50 mg/L,6-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3000,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,70 % Cytotoxicity at 25 mg/L,6-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3001,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,4 % Cytotoxicity at 3.125 mg/L,6-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3002,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,78 % Cytotoxicity at 50 mg/L,12-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3003,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,68 % Cytotoxicity at 25 mg/L,12-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3004,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,4 % Cytotoxicity at 12.5 mg/L,12-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3005,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,5 % Cytotoxicity at 6.25 mg/L,12-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3006,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,10 % Cytotoxicity at 3.125 mg/L,12-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3007,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,90 % Cytotoxicity at 50 mg/L,24-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3008,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,80 % Cytotoxicity at 25 mg/L,24-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3009,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,15 % Cytotoxicity at 12.5 mg/L,24-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3010,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,12 % Cytotoxicity at 6.25 mg/L,24-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3011,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,5 % Cytotoxicity at 3.125 mg/L,24-h,Cervix,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3012,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,88 % Cytotoxicity at 50 mg/L,3-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3013,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,82 % Cytotoxicity at 25 mg/L,3-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3014,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,40 % Cytotoxicity at 12.5 mg/L,3-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3015,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,35 % Cytotoxicity at 6.25 mg/L,3-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3016,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,35 % Cytotoxicity at 3.125 mg/L,3-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3017,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,90 % Cytotoxicity at 50 mg/L,6-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3018,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,90 % Cytotoxicity at 25 mg/L,6-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3019,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,30 % Cytotoxicity at 12.5 mg/L,6-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3020,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,30 % Cytotoxicity at 6.25 mg/L,6-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3021,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,30 % Cytotoxicity at 3.125 mg/L,6-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3022,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,97 % Cytotoxicity at 50 mg/L,12-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3023,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,95 % Cytotoxicity at 25 mg/L,12-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3024,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,39 % Cytotoxicity at 12.5 mg/L,12-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3025,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,28 % Cytotoxicity at 6.25 mg/L,12-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3026,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,38 % Cytotoxicity at 3.125 mg/L,12-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3027,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,90 % Cytotoxicity at 50 mg/L,24-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3028,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,90 % Cytotoxicity at 25 mg/L,24-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3029,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,15 % Cytotoxicity at 12.5 mg/L,24-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3030,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,5 % Cytotoxicity at 6.25 mg/L,24-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3031,23598079,2013,GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE,Pardaxin-1,33,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,10 % Cytotoxicity at 3.125 mg/L,24-h,Fibrous connective tissue ,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)CCC(=O)N)CO)CO)CO)CC(C)C)C)CO)C(C)C)C)CO)CC(C)C)CC(C)C)[C@H](O)C)CCCC[NH3])Cc3ccccc3)CC(C)C)CCC2)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCC1)[C@H](CC)C)CC(C)C)C)Cc1ccccc1)Cc1ccccc1,https://doi.org/10.1016/j.peptides.2013.04.004
3601,22100226,2012,GFGMA-(AC6C)-KLLKKVL,MAC1/26,13,Linear,L,AC6C = cyclohexyl-1-carboxylic acid,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 8±2 µM,48-h,Cervix,None,NA,https://doi.org/10.1016/j.peptides.2011.11.002
3617,22100226,2012,GFGMA-(AC6C)-KLLKKVL,MAC1/26,13,Linear,L,AC6C = cyclohexyl-1-carboxylic acid,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 18±1 µM,48-h,Colon,None,NA,https://doi.org/10.1016/j.peptides.2011.11.002
3633,22100226,2012,GFGMA-(AC6C)-KLLKKVL,MAC1/26,13,Linear,L,AC6C = cyclohexyl-1-carboxylic acid,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 9±2 µM,48-h,Blood,None,NA,https://doi.org/10.1016/j.peptides.2011.11.002
3600,22100226,2012,GFGMALK-(AC6C)-LKKVL,MAC1/25,13,Linear,L,AC6C = cyclohexyl-1-carboxylic acid,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 7±1 µM,48-h,Cervix,None,NA,https://doi.org/10.1016/j.peptides.2011.11.002
3616,22100226,2012,GFGMALK-(AC6C)-LKKVL,MAC1/25,13,Linear,L,AC6C = cyclohexyl-1-carboxylic acid,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 14±1 µM,48-h,Colon,None,NA,https://doi.org/10.1016/j.peptides.2011.11.002
3632,22100226,2012,GFGMALK-(AC6C)-LKKVL,MAC1/25,13,Linear,L,AC6C = cyclohexyl-1-carboxylic acid,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 12±2 µM,48-h,Blood,None,NA,https://doi.org/10.1016/j.peptides.2011.11.002
3599,22100226,2012,GFGMALKL-(AC6C)-KKVL,MAC1/24,13,Linear,L,AC6C = cyclohexyl-1-carboxylic acid,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 8±2 µM,48-h,Cervix,None,NA,https://doi.org/10.1016/j.peptides.2011.11.002
3615,22100226,2012,GFGMALKL-(AC6C)-KKVL,MAC1/24,13,Linear,L,AC6C = cyclohexyl-1-carboxylic acid,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 16±1 µM,48-h,Colon,None,NA,https://doi.org/10.1016/j.peptides.2011.11.002
3631,22100226,2012,GFGMALKL-(AC6C)-KKVL,MAC1/24,13,Linear,L,AC6C = cyclohexyl-1-carboxylic acid,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 11 µM,48-h,Blood,None,NA,https://doi.org/10.1016/j.peptides.2011.11.002
3586,22100226,2012,GFGMALKLLKKVL,MAC1,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 10±4 µM,48-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3588,22100226,2012,gfgmalkllkkvl,MAC1/1,13,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 12±4 µM,48-h,Cervix,None,NCC(=O)N[C@H](Cc1ccccc1)C(=O)NCC(=O)N[C@H](CCSC)C(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3591,22100226,2012,GFGMALKLLKKVL,MAC1/4,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 15±5 µM,48-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3592,22100226,2012,GFGMALKLLKKVL,MAC1/6,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 8±2 µM,48-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3595,22100226,2012,GFGMALKLLKKVL,MAC1/16,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 32±2 µM,48-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3596,22100226,2012,GFGMALKLLKKVL,MAC1/19,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 21±4 µM,48-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3602,22100226,2012,GFGMALKLLKKVL,MAC1,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 23±4 µM,48-h,Colon,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3604,22100226,2012,gfgmalkllkkvl,MAC1/1,13,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 19±2 µM,48-h,Colon,None,NCC(=O)N[C@H](Cc1ccccc1)C(=O)NCC(=O)N[C@H](CCSC)C(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3607,22100226,2012,GFGMALKLLKKVL,MAC1/4,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 49±9 µM,48-h,Colon,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3608,22100226,2012,GFGMALKLLKKVL,MAC1/6,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 29±3 µM,48-h,Colon,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3611,22100226,2012,GFGMALKLLKKVL,MAC1/16,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 100 µM,48-h,Colon,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3612,22100226,2012,GFGMALKLLKKVL,MAC1/19,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 68±2 µM,48-h,Colon,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3618,22100226,2012,GFGMALKLLKKVL,MAC1,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 12±6 µM,48-h,Blood,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3620,22100226,2012,gfgmalkllkkvl,MAC1/1,13,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 11 µM,48-h,Blood,None,NCC(=O)N[C@H](Cc1ccccc1)C(=O)NCC(=O)N[C@H](CCSC)C(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3623,22100226,2012,GFGMALKLLKKVL,MAC1/4,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 29 µM,48-h,Blood,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3624,22100226,2012,GFGMALKLLKKVL,MAC1/6,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 15 µM,48-h,Blood,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3627,22100226,2012,GFGMALKLLKKVL,MAC1/16,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 70 µM,48-h,Blood,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3628,22100226,2012,GFGMALKLLKKVL,MAC1/19,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 43±11 µM,48-h,Blood,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
4387,"22100226, 18957441",2012,GFGMALKLLKKVL,Macropin 1,13,Not Available,L,None,Free,Free,Antibacterial,"Venom, the solitary beeMacropis fulvipes",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,"['https://doi.org/10.1016/j.peptides.2011.11.002', 'https://doi.org/10.1093/nar/gkn823']"
3586,22100226,2012,GFGMALKLLKKVL,MAC1,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 10±4 µM,48-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3588,22100226,2012,gfgmalkllkkvl,MAC1/1,13,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 12±4 µM,48-h,Cervix,None,NCC(=O)N[C@H](Cc1ccccc1)C(=O)NCC(=O)N[C@H](CCSC)C(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3591,22100226,2012,GFGMALKLLKKVL,MAC1/4,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 15±5 µM,48-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3592,22100226,2012,GFGMALKLLKKVL,MAC1/6,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 8±2 µM,48-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3595,22100226,2012,GFGMALKLLKKVL,MAC1/16,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 32±2 µM,48-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3596,22100226,2012,GFGMALKLLKKVL,MAC1/19,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 21±4 µM,48-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3602,22100226,2012,GFGMALKLLKKVL,MAC1,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 23±4 µM,48-h,Colon,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3604,22100226,2012,gfgmalkllkkvl,MAC1/1,13,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 19±2 µM,48-h,Colon,None,NCC(=O)N[C@H](Cc1ccccc1)C(=O)NCC(=O)N[C@H](CCSC)C(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3607,22100226,2012,GFGMALKLLKKVL,MAC1/4,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 49±9 µM,48-h,Colon,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3608,22100226,2012,GFGMALKLLKKVL,MAC1/6,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 29±3 µM,48-h,Colon,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3611,22100226,2012,GFGMALKLLKKVL,MAC1/16,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 100 µM,48-h,Colon,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3612,22100226,2012,GFGMALKLLKKVL,MAC1/19,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 68±2 µM,48-h,Colon,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3618,22100226,2012,GFGMALKLLKKVL,MAC1,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 12±6 µM,48-h,Blood,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3620,22100226,2012,gfgmalkllkkvl,MAC1/1,13,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 11 µM,48-h,Blood,None,NCC(=O)N[C@H](Cc1ccccc1)C(=O)NCC(=O)N[C@H](CCSC)C(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3623,22100226,2012,GFGMALKLLKKVL,MAC1/4,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 29 µM,48-h,Blood,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3624,22100226,2012,GFGMALKLLKKVL,MAC1/6,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 15 µM,48-h,Blood,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3627,22100226,2012,GFGMALKLLKKVL,MAC1/16,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 70 µM,48-h,Blood,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3628,22100226,2012,GFGMALKLLKKVL,MAC1/19,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 43±11 µM,48-h,Blood,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
4387,"22100226, 18957441",2012,GFGMALKLLKKVL,Macropin 1,13,Not Available,L,None,Free,Free,Antibacterial,"Venom, the solitary beeMacropis fulvipes",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,"['https://doi.org/10.1016/j.peptides.2011.11.002', 'https://doi.org/10.1093/nar/gkn823']"
3597,22100226,2012,GFGMALOLLOOVL,MAC1/20,13,Linear,L,O = Ornithine,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 10±1 µM,48-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3613,22100226,2012,GFGMALOLLOOVL,MAC1/20,13,Linear,L,O = Ornithine,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 35±4 µM,48-h,Colon,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3629,22100226,2012,GFGMALOLLOOVL,MAC1/20,13,Linear,L,O = Ornithine,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 25±3 µM,48-h,Blood,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3598,22100226,2012,GFGMALRLLRRVL,MAC1/21,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 9±3 µM,48-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3614,22100226,2012,GFGMALRLLRRVL,MAC1/21,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 17±2 µM,48-h,Colon,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3630,22100226,2012,GFGMALRLLRRVL,MAC1/21,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 22±4 µM,48-h,Blood,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
2925,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,45% Cytotoxicity at 50 mg/L,3-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2926,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,38% Cytotoxicity at 25 mg/L,3-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2927,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,75% Cytotoxicity at 50 mg/L,6-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2928,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,65% Cytotoxicity at 25 mg/L,6-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2929,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,75 % Cytotoxicity at 50 mg/L,12-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2930,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,65% Cytotoxicity at 25 mg/L,12-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2931,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,83% Cytotoxicity at 50 mg/L,24-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2932,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HeLa,Cervical Cancer,MTT/MTS assay,77 % Cytotoxicity at 25 mg/L,24-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2933,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,82 % Cytotoxicity at 50 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2934,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,85 % Cytotoxicity at 25 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2935,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,42 % Cytotoxicity at 12.5 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2936,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,41 % Cytotoxicity at 6.25 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2937,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,39 % Cytotoxicity at 3.125 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2938,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,41 % Cytotoxicity at 6.25 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2939,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,41 % Cytotoxicity at 6.25 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2940,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,41 % Cytotoxicity at 6.25 mg/L,3-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2941,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,90 % Cytotoxicity at 50 mg/L,6-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2942,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,95 % Cytotoxicity at 25 mg/L,6-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2943,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,45 % Cytotoxicity at 12.5 mg/L,6-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2944,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,25 % Cytotoxicity at 6.25 mg/L,6-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2945,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,25 % Cytotoxicity at 3.125 mg/L,6-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2946,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,95 % Cytotoxicity at 50 mg/L,12-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2947,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,96 % Cytotoxicity at 25 mg/L,12-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2948,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,46 % Cytotoxicity at 12.5 mg/L,12-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2949,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,30 % Cytotoxicity at 6.25 mg/L,12-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2950,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,28 % Cytotoxicity at 3.125 mg/L,12-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2951,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,84 % Cytotoxicity at 50 mg/L,24-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2952,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,85 % Cytotoxicity at 25 mg/L,24-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2953,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,38 % Cytotoxicity at 12.5 mg/L,24-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2954,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,30 % Cytotoxicity at 6.25 mg/L,24-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
2955,23598079,2013,GFIFHIIKGLFHAGKMIHGLV,Epinecidin-1,21,Linear,L,None,Free,Free,Antimicrobial,Epinephelus nebulosus,HT-1080,Fibrosarcoma,MTT/MTS assay,28 % Cytotoxicity at 3.125 mg/L,24-h,Fibrous connective tissue ,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1016/j.peptides.2013.04.004
4388,"15207717, 18957441",2004,GFKDLLKGAAKALVKTVLF,Ascaphin-8,19,Not Available,L,None,Free,Free,Antibacterial,"Coastal Tailed Frog,Ascaphus truei, Pacific Northwest, USA, North America",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,"['https://doi.org/10.1016/j.bbrc.2004.05.141', 'https://doi.org/10.1093/nar/gkn823']"
3593,22100226,2012,GFKMALKLLKKVL,MAC1/9,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 8±1 µM,48-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3594,22100226,2012,GFKMALKLLKKVL,MAC1/10,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 15±6 µM,48-h,Cervix,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3609,22100226,2012,GFKMALKLLKKVL,MAC1/9,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 13±3 µM,48-h,Colon,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3610,22100226,2012,GFKMALKLLKKVL,MAC1/10,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,Not tested,48-h,Colon,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3625,22100226,2012,GFKMALKLLKKVL,MAC1/9,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 14±4 µM,48-h,Blood,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3626,22100226,2012,GFKMALKLLKKVL,MAC1/10,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 16 µM,48-h,Blood,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
4389,"9620615, 18957441",1998,GFVDFLKKVAGTIANVVT,Maculatin 2.1,18,Not Available,L,None,Free,Free,Antibacterial,"Litoria genimaculate, Litoria eucnemis, Australia",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O,"['https://doi.org/10.1002/(sici)1099-1387(199804)4:2<111::aid-psc134>3.0.co;2-8', 'https://doi.org/10.1093/nar/gkn823']"
4394,"8910461, 18957441",1996,GGLRSLGRKILRAWKKYGPIIVPIIRIG,BMAP-28,28,Not Available,L,None,Free,Free,Antibacterial,CowBos taurus,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)O,"['https://doi.org/10.1074/jbc.271.45.28375', 'https://doi.org/10.1093/nar/gkn823']"
4397,"20575512, 18957441",2010,GIACGESCVFLGCFIPGCSCKSKVCYFN,Psyle A,28,Not Available,L,None,Free,Free,Antibacterial,Psychotria leptothyrsa,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1021/np9007365', 'https://doi.org/10.1093/nar/gkn823']"
1841,None,2005,GIGAVLKVLTTGLPALISWIKRKRQQ,MELITTIIN,26,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =9 µg/ml,24-h,Breast,US_06875744_B2,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CCC(=O)N)CCCNC(=[NH2])N)CCCC[NH3])CCCNC(=[NH2])N)CCCC[NH3])[C@H](CC)C)Cc2c[nH]c3c2cccc3)CO)[C@H](CC)C)CC(C)C)C)CCC1)CC(C)C)[C@H](O)C)[C@H](O)C)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C,Not Found
1993,None,2005,GIGAVLKVLTTGLPALISWIKRKRQQ,MELITTIIN,26,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =23 µg/ml,24-h,Colon,US_06875744_B2,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CCC(=O)N)CCCNC(=[NH2])N)CCCC[NH3])CCCNC(=[NH2])N)CCCC[NH3])[C@H](CC)C)Cc2c[nH]c3c2cccc3)CO)[C@H](CC)C)CC(C)C)C)CCC1)CC(C)C)[C@H](O)C)[C@H](O)C)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C,Not Found
2145,None,2005,GIGAVLKVLTTGLPALISWIKRKRQQ,MELITTIIN,26,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =18 µg/ml,24-h,Skin,US_06875744_B2,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CCC(=O)N)CCCNC(=[NH2])N)CCCC[NH3])CCCNC(=[NH2])N)CCCC[NH3])[C@H](CC)C)Cc2c[nH]c3c2cccc3)CO)[C@H](CC)C)CC(C)C)C)CCC1)CC(C)C)[C@H](O)C)[C@H](O)C)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C,Not Found
2297,None,2005,GIGAVLKVLTTGLPALISWIKRKRQQ,MELITTIIN,26,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =18 µg/ml,24-h,Skin,US_06875744_B2,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CCC(=O)N)CCCNC(=[NH2])N)CCCC[NH3])CCCNC(=[NH2])N)CCCC[NH3])[C@H](CC)C)Cc2c[nH]c3c2cccc3)CO)[C@H](CC)C)CC(C)C)C)CCC1)CC(C)C)[C@H](O)C)[C@H](O)C)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C,Not Found
2450,None,2005,GIGAVLKVLTTGLPALISWIKRKRQQ,MELITTIIN,26,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =25 µg/ml,24-h,Lung,US_06875744_B2,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CCC(=O)N)CCCNC(=[NH2])N)CCCC[NH3])CCCNC(=[NH2])N)CCCC[NH3])[C@H](CC)C)Cc2c[nH]c3c2cccc3)CO)[C@H](CC)C)CC(C)C)C)CCC1)CC(C)C)[C@H](O)C)[C@H](O)C)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C,Not Found
2593,None,2005,GIGAVLKVLTTGLPALISWIKRKRQQ,MELITTIIN,26,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =13 µg/ml,24-h,Prostate,US_06875744_B2,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CCC(=O)N)CCCNC(=[NH2])N)CCCC[NH3])CCCNC(=[NH2])N)CCCC[NH3])[C@H](CC)C)Cc2c[nH]c3c2cccc3)CO)[C@H](CC)C)CC(C)C)C)CCC1)CC(C)C)[C@H](O)C)[C@H](O)C)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C,Not Found
2736,None,2005,GIGAVLKVLTTGLPALISWIKRKRQQ,MELITTIIN,26,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =35 µg/ml,24-h,Cervix,US_06875744_B2,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CCC(=O)N)CCCNC(=[NH2])N)CCCC[NH3])CCCNC(=[NH2])N)CCCC[NH3])[C@H](CC)C)Cc2c[nH]c3c2cccc3)CO)[C@H](CC)C)CC(C)C)C)CCC1)CC(C)C)[C@H](O)C)[C@H](O)C)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C,Not Found
3337,23893605,2013,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,26,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 =3.2 ± 0.1 µM,30-Min,Skin,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CCC(=O)N)CCCNC(=[NH2])N)CCCC[NH3])CCCNC(=[NH2])N)CCCC[NH3])[C@H](CC)C)Cc2c[nH]c3c2cccc3)CO)[C@H](CC)C)CC(C)C)C)CCC1)CC(C)C)[C@H](O)C)[C@H](O)C)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C,https://doi.org/10.1002/psc.2540
3338,23893605,2013,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,26,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 =2.1 ± 0.1 µM,2-h,Skin,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CCC(=O)N)CCCNC(=[NH2])N)CCCC[NH3])CCCNC(=[NH2])N)CCCC[NH3])[C@H](CC)C)Cc2c[nH]c3c2cccc3)CO)[C@H](CC)C)CC(C)C)C)CCC1)CC(C)C)[C@H](O)C)[C@H](O)C)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C,https://doi.org/10.1002/psc.2540
3339,23893605,2013,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,26,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 =1.8 ± 0.1 µM,4-h,Skin,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CCC(=O)N)CCCNC(=[NH2])N)CCCC[NH3])CCCNC(=[NH2])N)CCCC[NH3])[C@H](CC)C)Cc2c[nH]c3c2cccc3)CO)[C@H](CC)C)CC(C)C)C)CCC1)CC(C)C)[C@H](O)C)[C@H](O)C)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C,https://doi.org/10.1002/psc.2540
3340,23893605,2013,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,26,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 =1.4 ± 0.1 µM,24-h,Skin,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CCC(=O)N)CCCNC(=[NH2])N)CCCC[NH3])CCCNC(=[NH2])N)CCCC[NH3])[C@H](CC)C)Cc2c[nH]c3c2cccc3)CO)[C@H](CC)C)CC(C)C)C)CCC1)CC(C)C)[C@H](O)C)[C@H](O)C)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C,https://doi.org/10.1002/psc.2540
3791,23893605,2013,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,26,Linear,L,None,Amidation,Free,Anticancer,Natural component of bee venom,E42/02,Skin Cancer,MTT/MTS assay,IC50= 1.4±0.1 µM,4-h,Skin,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CCC(=O)N)CCCNC(=[NH2])N)CCCC[NH3])CCCNC(=[NH2])N)CCCC[NH3])[C@H](CC)C)Cc2c[nH]c3c2cccc3)CO)[C@H](CC)C)CC(C)C)C)CCC1)CC(C)C)[C@H](O)C)[C@H](O)C)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C,https://doi.org/10.1002/psc.2540
3797,23893605,2013,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,26,Linear,L,None,Amidation,Free,Anticancer,Natural component of bee venom,E42/02,Skin Cancer,MTT/MTS assay,IC50= 3.2±0.1 µM,30-Min,Skin,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CCC(=O)N)CCCNC(=[NH2])N)CCCC[NH3])CCCNC(=[NH2])N)CCCC[NH3])[C@H](CC)C)Cc2c[nH]c3c2cccc3)CO)[C@H](CC)C)CC(C)C)C)CCC1)CC(C)C)[C@H](O)C)[C@H](O)C)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C,https://doi.org/10.1002/psc.2540
3803,23893605,2013,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,26,Linear,L,None,Amidation,Free,Anticancer,Natural component of bee venom,E42/02,Skin Cancer,MTT/MTS assay,IC50= 2.1±0.1 µM,2-h,Skin,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CCC(=O)N)CCCNC(=[NH2])N)CCCC[NH3])CCCNC(=[NH2])N)CCCC[NH3])[C@H](CC)C)Cc2c[nH]c3c2cccc3)CO)[C@H](CC)C)CC(C)C)C)CCC1)CC(C)C)[C@H](O)C)[C@H](O)C)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C,https://doi.org/10.1002/psc.2540
3809,23893605,2013,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,26,Linear,L,None,Amidation,Free,Anticancer,Natural component of bee venom,E42/02,Skin Cancer,MTT/MTS assay,IC50= 1.8±0.1 µM,4-h,Skin,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CCC(=O)N)CCCNC(=[NH2])N)CCCC[NH3])CCCNC(=[NH2])N)CCCC[NH3])[C@H](CC)C)Cc2c[nH]c3c2cccc3)CO)[C@H](CC)C)CC(C)C)C)CCC1)CC(C)C)[C@H](O)C)[C@H](O)C)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C,https://doi.org/10.1002/psc.2540
3815,23893605,2013,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,26,Linear,L,None,Amidation,Free,Anticancer,Natural component of bee venom,E42/02,Skin Cancer,MTT/MTS assay,IC50= 1.4±0.1 µM,24-h,Skin,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CCC(=O)N)CCCNC(=[NH2])N)CCCC[NH3])CCCNC(=[NH2])N)CCCC[NH3])[C@H](CC)C)Cc2c[nH]c3c2cccc3)CO)[C@H](CC)C)CC(C)C)C)CCC1)CC(C)C)[C@H](O)C)[C@H](O)C)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C,https://doi.org/10.1002/psc.2540
5011,24661024,2014,GIGAVLKVLTTGLPALISWIKRKRQQ,Melittin,26,Linear,L,None,Free,Free,Antimicrobial,Main component of honey bee venom,SCC25,Skin Cancer,Cell Viability assay,102.9 ± 4.1% cell growth inhibition at 1 µM,24-h,Skin,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CCC(=O)N)CCCNC(=[NH2])N)CCCC[NH3])CCCNC(=[NH2])N)CCCC[NH3])[C@H](CC)C)Cc2c[nH]c3c2cccc3)CO)[C@H](CC)C)CC(C)C)C)CCC1)CC(C)C)[C@H](O)C)[C@H](O)C)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C,https://doi.org/10.1111/exd.12384
1650,11835991,2001,GIGGKILSGLKTALKGAAKELASTYLH,maximin3,27,Linear,L,None,Free,Free,Antimicrobial,Bombina maxima,C8166,Leukemia Cancer,MTT/MTS assay,IC50=11.4 µg/ml,48-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)O,https://doi.org/10.1016/s0196-9781(01)00641-6
1654,11835991,2001,GIGGKILSGLKTALKGAAKELASTYLH,maximin3,27,Linear,L,None,Free,Free,Antimicrobial,Bombina maxima,MOLT-4,Leukemia Cancer,MTT/MTS assay,IC50 =25.2 µg/ml,48-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)O,https://doi.org/10.1016/s0196-9781(01)00641-6
1658,11835991,2001,GIGGKILSGLKTALKGAAKELASTYLH,maximin3,27,Linear,L,None,Free,Free,Antimicrobial,Bombina maxima,BIU-87,Bladder Cancer,MTT/MTS assay,IC50=28 µg/ml,48-h,Bladder,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)O,https://doi.org/10.1016/s0196-9781(01)00641-6
1662,11835991,2001,GIGGKILSGLKTALKGAAKELASTYLH,maximin3,27,Linear,L,None,Free,Free,Antimicrobial,Bombina maxima,T-24,Bladder Cancer,MTT/MTS assay,IC50 =18 µg/ml,48-h,Bladder,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)O,https://doi.org/10.1016/s0196-9781(01)00641-6
4399,"11835991, 18957441",2002,GIGGKILSGLKTALKGAAKELASTYLH,Maximin 3,27,Not Available,L,None,Free,Free,Antibacterial,Bombina maxima,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)O,"['https://doi.org/10.1016/s0196-9781(01)00641-6', 'https://doi.org/10.1093/nar/gkn823']"
4400,"11835991, 18957441",2002,GIGGVLLSAGKAALKGLAKVLAEKYAN,Maximin 4,27,Not Available,L,None,Free,Free,Anticancer,Bombina maxima,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(=O)N)C)Cc1ccc(cc1)O)CCCC[NH3])CCC(=O)O)C)CC(C)C)C(C)C)CCCC[NH3])C)CC(C)C)CCCC[NH3])CC(C)C)C)C)CCCC[NH3])C)CO)CC(C)C)CC(C)C)C(C)C)[C@H](CC)C,"['https://doi.org/10.1016/s0196-9781(01)00641-6', 'https://doi.org/10.1093/nar/gkn823']"
1354,"1708887, 2285300",1990,GIGKFLHAAKKFAKAFVAEIMNS,Magainin B,23,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,U-937,Lymphoma Cancer,Trypan blue assay,IC50=17 µg/ml,72-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1360,"1708887, 2285300",1990,GIGKFLHAAKKFAKAFVAEIMNS,Magainin B,23,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,8402,Leukemia Cancer,Trypan blue assay,IC50=12 µg/ml,72-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1366,"1708887, 2285300",1990,GIGKFLHAAKKFAKAFVAEIMNS,Magainin B,23,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,SSKT-1,Hematopoietic Cancer,Trypan blue assay,IC50=27 µg/ml,72-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1372,"1708887, 2285300",1990,GIGKFLHAAKKFAKAFVAEIMNS,Magainin B,23,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,Daudi,Ovarian Cancer,Trypan blue assay,IC50=28 µg/ml,72-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1378,"1708887, 2285300",1990,GIGKFLHAAKKFAKAFVAEIMNS,Magainin B,23,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,MLA,Leukemia Cancer,Trypan blue assay,IC50=30 µg/ml,72-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1384,"1708887, 2285300",1990,GIGKFLHAAKKFAKAFVAEIMNS,Magainin B,23,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,Raji,Lymphoma Cancer,Trypan blue assay,IC50=23 µg/ml,72-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1390,"1708887, 2285300",1990,GIGKFLHAAKKFAKAFVAEIMNS,Magainin B,23,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,K-562,Leukemia Cancer,Trypan blue assay,IC50=32 µg/ml,72-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1396,"1708887, 2285300",1990,GIGKFLHAAKKFAKAFVAEIMNS,Magainin B,23,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,CHP-100,Ewing sarcoma,Trypan blue assay,IC50=32 µg/ml,72-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1402,"1708887, 2285300",1990,GIGKFLHAAKKFAKAFVAEIMNS,Magainin B,23,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,MCF-7,Breast Cancer,Trypan blue assay,IC50=37 µg/ml,72-h,Breast,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1408,"1708887, 2285300",1990,GIGKFLHAAKKFAKAFVAEIMNS,Magainin B,23,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,PC-3,Prostate Cancer,Trypan blue assay,IC50=41 µg/ml,72-h,Prostate,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1909,None,2005,GIGKFLHAAKKFAKAFVAEIMNS,Magainin2wisc,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =22 µg/ml,24-h,Breast,US_06875744_B2,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,Not Found
2061,None,2005,GIGKFLHAAKKFAKAFVAEIMNS,Magainin2wisc,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =60 µg/ml,24-h,Colon,US_06875744_B2,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,Not Found
2213,None,2005,GIGKFLHAAKKFAKAFVAEIMNS,Magainin2wisc,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =130 µg/ml,24-h,Skin,US_06875744_B2,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,Not Found
2365,None,2005,GIGKFLHAAKKFAKAFVAEIMNS,Magainin2wisc,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =130 µg/ml,24-h,Skin,US_06875744_B2,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,Not Found
2518,None,2005,GIGKFLHAAKKFAKAFVAEIMNS,Magainin2wisc,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =60 µg/ml,24-h,Lung,US_06875744_B2,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,Not Found
2661,None,2005,GIGKFLHAAKKFAKAFVAEIMNS,Magainin2wisc,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =45 µg/ml,24-h,Prostate,US_06875744_B2,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,Not Found
2804,None,2005,GIGKFLHAAKKFAKAFVAEIMNS,Magainin2wisc,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =125 µg/ml,24-h,Cervix,US_06875744_B2,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,Not Found
1047,"1319823, 2285300",1992,GIGKFLHSAKKFAKAFVAEIMNS,Magainin G,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,African clawed frog Xenopus laevis skin,NCI-H182,Lung Cancer,MTT/MTS assay,IC50=12.5 µM,24-h,Lung,None,NC[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['Not Found', 'https://doi.org/10.1128/AAC.34.9.1824']"
1048,"1319823, 2285300",1992,GIGKFLHSAKKFAKAFVAEIMNS,Magainin G,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,African clawed frog Xenopus laevis skin,NCI-H526,Lung Cancer,MTT/MTS assay,IC50=10.5 µM,24-h,Lung,None,NC[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['Not Found', 'https://doi.org/10.1128/AAC.34.9.1824']"
1049,"1319823, 2285300",1992,GIGKFLHSAKKFAKAFVAEIMNS,Magainin G,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,African clawed frog Xenopus laevis skin,NCI-H678,Lung Cancer,MTT/MTS assay,IC50=4.44 µM,24-h,Lung,None,NC[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['Not Found', 'https://doi.org/10.1128/AAC.34.9.1824']"
1050,"1319823, 2285300",1992,GIGKFLHSAKKFAKAFVAEIMNS,Magainin G,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,African clawed frog Xenopus laevis skin,NCI-H735,Lung Cancer,MTT/MTS assay,IC50=7.23 µM,24-h,Lung,None,NC[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['Not Found', 'https://doi.org/10.1128/AAC.34.9.1824']"
1051,"1319823, 2285300",1992,GIGKFLHSAKKFAKAFVAEIMNS,Magainin G,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,African clawed frog Xenopus laevis skin,NCI-H841,Lung Cancer,MTT/MTS assay,IC50=11.7 µM,24-h,Lung,None,NC[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['Not Found', 'https://doi.org/10.1128/AAC.34.9.1824']"
1052,"1319823, 2285300",1992,GIGKFLHSAKKFAKAFVAEIMNS,Magainin G,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,African clawed frog Xenopus laevis skin,NCI-H889,Lung Cancer,MTT/MTS assay,IC50=6.57 µM,24-h,Lung,None,NC[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['Not Found', 'https://doi.org/10.1128/AAC.34.9.1824']"
1355,"1708887, 2285300",1990,GIGKFLHSAKKFAKAFVAEIMNS,Magainin G,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,Xenopus laevis,U-937,Lymphoma Cancer,Trypan blue assay,IC50=19 µg/ml,72-h,Blood,None,NC[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1361,"1708887, 2285300",1990,GIGKFLHSAKKFAKAFVAEIMNS,Magainin G,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,Xenopus laevis,8402,Leukemia Cancer,Trypan blue assay,IC50=16 µg/ml,72-h,Blood,None,NC[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1367,"1708887, 2285300",1990,GIGKFLHSAKKFAKAFVAEIMNS,Magainin G,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,Xenopus laevis,SSKT-1,Hematopoietic Cancer,Trypan blue assay,IC50=29 µg/ml,72-h,Blood,None,NC[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1373,"1708887, 2285300",1990,GIGKFLHSAKKFAKAFVAEIMNS,Magainin G,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,Xenopus laevis,Daudi,Renal Cancer,Trypan blue assay,IC50=38 µg/ml,72-h,Blood,None,NC[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1379,"1708887, 2285300",1990,GIGKFLHSAKKFAKAFVAEIMNS,Magainin G,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,Xenopus laevis,MLA,Leukemia Cancer,Trypan blue assay,IC50=33 µg/ml,72-h,Blood,None,NC[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1385,"1708887, 2285300",1990,GIGKFLHSAKKFAKAFVAEIMNS,Magainin G,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,Xenopus laevis,Raji,Lymphoma Cancer,Trypan blue assay,IC50=25 µg/ml,72-h,Blood,None,NC[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1391,"1708887, 2285300",1990,GIGKFLHSAKKFAKAFVAEIMNS,Magainin G,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,Xenopus laevis,K-562,Leukemia Cancer,Trypan blue assay,IC50=37 µg/ml,72-h,Blood,None,NC[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1397,"1708887, 2285300",1990,GIGKFLHSAKKFAKAFVAEIMNS,Magainin G,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,Xenopus laevis,CHP-100,Ewing sarcoma,Trypan blue assay,IC50=39 µg/ml,72-h,Blood,None,NC[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1403,"1708887, 2285300",1990,GIGKFLHSAKKFAKAFVAEIMNS,Magainin G,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,Xenopus laevis,MCF-7,Breast Cancer,Trypan blue assay,IC50=42 µg/ml,72-h,Breast,None,NC[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1409,"1708887, 2285300",1990,GIGKFLHSAKKFAKAFVAEIMNS,Magainin G,23,Linear,L,None,Amidation,Beta-alanine,Antibacterial,Xenopus laevis,PC-3,Prostate Cancer,Trypan blue assay,IC50=47 µg/ml,72-h,Prostate,None,NC[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1116,8319212,1993,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Amidation,Free,Antibacterial,African clawed frog Xenopus laevis skin,A-549,Lung Cancer,MTT/MTS assay,IC50=110 µM,48-h,Lung,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,Not Found
1306,16476519,2006,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Amidation,Free,Antimicrobial,African clawed frog Xenopus laevis skin,RT4(G1),Bladder Cancer,LDH leakage assay,IC50=32.3 µM,48-h,Bladder,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,https://doi.org/10.1016/j.eururo.2005.12.043
1307,16476519,2006,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Amidation,Free,Antimicrobial,African clawed frog Xenopus laevis skin,647V(G2),Bladder Cancer,LDH leakage assay,IC50=54.1 µM,48-h,Bladder,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,https://doi.org/10.1016/j.eururo.2005.12.043
1308,16476519,2006,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Amidation,Free,Antimicrobial,African clawed frog Xenopus laevis skin,486P(G4),Bladder Cancer,LDH leakage assay,IC50=28.6 µM,48-h,Bladder,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,https://doi.org/10.1016/j.eururo.2005.12.043
1309,16476519,2006,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Amidation,Free,Antimicrobial,African clawed frog Xenopus laevis skin,RT4(G1),Bladder Cancer,WST-1 assay,IC50=484 µM,48-h,Bladder,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,https://doi.org/10.1016/j.eururo.2005.12.043
1310,16476519,2006,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Amidation,Free,Antimicrobial,African clawed frog Xenopus laevis skin,647V(G2),Bladder Cancer,WST-1 assay,IC50=52.4 µM,48-h,Bladder,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,https://doi.org/10.1016/j.eururo.2005.12.043
1311,16476519,2006,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Amidation,Free,Antimicrobial,African clawed frog Xenopus laevis skin,486P(G4),Bladder Cancer,WST-1 assay,IC50=57.8 µM,48-h,Bladder,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,https://doi.org/10.1016/j.eururo.2005.12.043
1312,16476519,2006,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Amidation,Free,Antimicrobial,African clawed frog Xenopus laevis skin,RT4(G1),Bladder Cancer,Cell Viability assay,IC50=135.3 µM,48-h,Bladder,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,https://doi.org/10.1016/j.eururo.2005.12.043
1313,16476519,2006,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Amidation,Free,Antimicrobial,African clawed frog Xenopus laevis skin,647V(G2),Bladder Cancer,Cell Viability assay,IC50=31 µM,48-h,Bladder,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,https://doi.org/10.1016/j.eururo.2005.12.043
1314,16476519,2006,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Amidation,Free,Antimicrobial,African clawed frog Xenopus laevis skin,486P(G4),Bladder Cancer,Cell Viability assay,IC50=59.4 µM,48-h,Bladder,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,https://doi.org/10.1016/j.eururo.2005.12.043
1359,"1708887, 2285300",1990,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,U-937,Lymphoma Cancer,Trypan blue assay,IC50 >150 µg/ml,72-h,Blood,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1365,"1708887, 2285300",1990,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,8402,Leukemia Cancer,Trypan blue assay,IC50 >150 µg/ml,72-h,Blood,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1371,"1708887, 2285300",1990,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,SSKT-1,Hematopoietic Cancer,Trypan blue assay,IC50 >150 µg/ml,72-h,Blood,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1377,"1708887, 2285300",1990,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,Daudi,Colon Cancer,Trypan blue assay,IC50 >150 µg/ml,72-h,Blood,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1383,"1708887, 2285300",1990,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,MLA,Leukemia Cancer,Trypan blue assay,IC50 >150 µg/ml,72-h,Blood,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1389,"1708887, 2285300",1990,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,Raji,Lymphoma Cancer,Trypan blue assay,IC50 >150 µg/ml,72-h,Blood,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1395,"1708887, 2285300",1990,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,K-562,Leukemia Cancer,Trypan blue assay,IC50 >150 µg/ml,72-h,Blood,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1401,"1708887, 2285300",1990,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,CHP-100,Ewing sarcoma,Trypan blue assay,IC50 >200 µg/ml,72-h,Blood,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1407,"1708887, 2285300",1990,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,MCF-7,Breast Cancer,Trypan blue assay,IC50 >200 µg/ml,72-h,Breast,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1413,"1708887, 2285300",1990,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Amidation,Free,Antibacterial,Xenopus laevis,PC-3,Prostate Cancer,Trypan blue assay,IC50 >200 µg/ml,72-h,Prostate,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,"['https://doi.org/10.1073/pnas.88.9.3792', 'https://doi.org/10.1128/AAC.34.9.1824']"
1435,21955251,2011,GIGKFLHSAKKFGKAFVGEIMNS,Magainin 2,23,Linear,L,None,Free,Free,Antimicrobial,Xenopus laevis,HeLa,Pancreatic Cancer,WST-1 assay,IC50 = >60 µM,Not Available,Pancreatic,None,[NH3]CC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCSC)[C@H](CC)C)CCC(=O)O)C(C)C)Cc1ccccc1)C)CCCC[NH3])Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)CC1=CNCN1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C,https://doi.org/10.1021/bm201098j
4602,12417587,2003,GIGKFLHSAKKWGKAFVGQIMNC,MG2d,23,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic,HeLa,Cervical Cancer,MTT/MTS assay,at 1 µM 90-100% viablity,6-h,Cervix,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)N,https://doi.org/10.1074/jbc.M208762200
1117,8319212,1993,GIGKFLKKAKKFAKAFVKIINN,MSI-136,22,Linear,L,None,Amidation,Free,Antibacterial,African clawed frog Xenopus laevis skin,A-549,Lung Cancer,MTT/MTS assay,IC50=10 µM,48-h,Lung,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N,Not Found
1118,8319212,1993,gigkflkkakkfakafvkiinn,MSI-238,22,Linear,D,None,Amidation,Free,Antibacterial,African clawed frog Xenopus laevis skin,A-549,Lung Cancer,MTT/MTS assay,IC50=6 µM,48-h,Lung,None,NCC(=O)N[C@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CC(=O)N)C(=O)N[C@H](CC(=O)N)C(=O)N,Not Found
1117,8319212,1993,GIGKFLKKAKKFAKAFVKIINN,MSI-136,22,Linear,L,None,Amidation,Free,Antibacterial,African clawed frog Xenopus laevis skin,A-549,Lung Cancer,MTT/MTS assay,IC50=10 µM,48-h,Lung,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N,Not Found
1118,8319212,1993,gigkflkkakkfakafvkiinn,MSI-238,22,Linear,D,None,Amidation,Free,Antibacterial,African clawed frog Xenopus laevis skin,A-549,Lung Cancer,MTT/MTS assay,IC50=6 µM,48-h,Lung,None,NCC(=O)N[C@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CC(=O)N)C(=O)N[C@H](CC(=O)N)C(=O)N,Not Found
1425,"7768152, 21403917",1994,GIGKFLKKAKKFGKAFVKILKK,PexigaNAn MSI-78,22,Linear,L,None,Amidation,Free,Antimicrobial,Helical peptide with a predominance of one or more amino acids tryptophane-rich,U-937,Lymphoma Cancer,MTT/MTS assay,75% Cytotoxicity at 0.5 µg/ml,6-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1002/9780470514658.ch12', 'Not Found']"
1794,None,2005,GIGKFLKKAKKFGKAFVKILKK,MSI-78 AM,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =31 µg/ml,24-h,Breast,US_06875744_B2,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
1946,None,2005,GIGKFLKKAKKFGKAFVKILKK,MSI-78 AM,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =34 µg/ml,24-h,Colon,US_06875744_B2,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2098,None,2005,GIGKFLKKAKKFGKAFVKILKK,MSI-78 AM,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Skin,US_06875744_B2,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2250,None,2005,GIGKFLKKAKKFGKAFVKILKK,MSI-78 AM,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Skin,US_06875744_B2,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2402,None,2005,GIGKFLKKAKKFGKAFVKILKK,MSI-78 AM,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Lung,US_06875744_B2,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2545,None,2005,GIGKFLKKAKKFGKAFVKILKK,MSI-78 AM,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =66 µg/ml,24-h,Prostate,US_06875744_B2,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2688,None,2005,GIGKFLKKAKKFGKAFVKILKK,MSI-78 AM,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,Not Available,24-h,Cervix,US_06875744_B2,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
4596,21403917,2011,GIGKFLKKAKKFGKAFVKILKK,Pexiganan MSI-78,18,Linear,L,None,Amidation,Free,Antimicrobial,Analog of Magainin,U-941,Lymphoma Cancer,MTT/MTS assay,IC50 =20-30 µg/ml,Not Available,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
5001,24587350,2014,GIGKFLKKAKKFGKAFVKILKK,Pexiganan,22,Linear,L,None,Amidation,Free,Antimicrobial,Analog of magainin 2,MCF-7,Breast Cancer,MTT/MTS assay,LC50= 8 at 100 µM,72-h,Breast,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1371/journal.pone.0090397
5003,24587350,2014,GIGKFLKKAKKFGKAFVKILKK,Pexiganan,22,Linear,L,None,Amidation,Free,Antimicrobial,Analog of magainin 2,LNCaP,Prostate cancer,MTT/MTS assay,LC50= 6 at 100 µM,72-h,Prostate,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1371/journal.pone.0090397
5005,24587350,2014,GIGKFLKKAKKFGKAFVKILKK,Pexiganan,22,Linear,L,None,Amidation,Free,Antimicrobial,Analog of magainin 2,OVRCAR-3,Ovarian Cancer,MTT/MTS assay,LC50= 13 at 100 µM,72-h,Ovary,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1371/journal.pone.0090397
1649,11835991,2001,GIGTKILGGVKTALKGALKELASTYAN,maximin1,27,Linear,L,None,Amidation,Free,Antimicrobial,Bombina maxima,C8166,Leukemia Cancer,MTT/MTS assay,IC50=15.3 µg/ml,48-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N,https://doi.org/10.1016/s0196-9781(01)00641-6
1653,11835991,2001,GIGTKILGGVKTALKGALKELASTYAN,maximin1,27,Linear,L,None,Amidation,Free,Antimicrobial,Bombina maxima,MOLT-4,Leukemia Cancer,MTT/MTS assay,IC50=24.3 µg/ml,48-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N,https://doi.org/10.1016/s0196-9781(01)00641-6
1657,11835991,2001,GIGTKILGGVKTALKGALKELASTYAN,maximin1,27,Linear,L,None,Amidation,Free,Antimicrobial,Bombina maxima,BIU-87,Bladder Cancer,MTT/MTS assay,IC50=20.5 µg/ml,48-h,Bladder,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N,https://doi.org/10.1016/s0196-9781(01)00641-6
1661,11835991,2001,GIGTKILGGVKTALKGALKELASTYAN,maximin1,27,Linear,L,None,Amidation,Free,Antimicrobial,Bombina maxima,T-24,Bladder Cancer,MTT/MTS assay,IC50 =35.4 µg/ml,48-h,Bladder,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N,https://doi.org/10.1016/s0196-9781(01)00641-6
4401,"11835991, 18957441",2002,GIGTKILGGVKTALKGALKELASTYAN,Maximin 1,27,Not Available,L,None,Free,Free,Anticancer,Bombina maxima,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1016/s0196-9781(01)00641-6', 'https://doi.org/10.1093/nar/gkn823']"
1651,11835991,2001,GIGVLLSAGKAALKGLAKVLAEKYAN,maximin4,26,Linear,L,None,Amidation,Free,Antimicrobial,Bombina maxima,C8166,Leukemia Cancer,MTT/MTS assay,IC50=24.2 µg/ml,48-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N,https://doi.org/10.1016/s0196-9781(01)00641-6
1655,11835991,2001,GIGVLLSAGKAALKGLAKVLAEKYAN,maximin4,26,Linear,L,None,Amidation,Free,Antimicrobial,Bombina maxima,MOLT-4,Leukemia Cancer,MTT/MTS assay,IC50 =53.4 µg/ml,48-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N,https://doi.org/10.1016/s0196-9781(01)00641-6
1659,11835991,2001,GIGVLLSAGKAALKGLAKVLAEKYAN,maximin4,26,Linear,L,None,Amidation,Free,Antimicrobial,Bombina maxima,BIU-87,Bladder Cancer,MTT/MTS assay,IC50 =>50 µg/ml,48-h,Bladder,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N,https://doi.org/10.1016/s0196-9781(01)00641-6
1663,11835991,2001,GIGVLLSAGKAALKGLAKVLAEKYAN,maximin4,26,Linear,L,None,Amidation,Free,Antimicrobial,Bombina maxima,T-24,Bladder Cancer,MTT/MTS assay,IC50=>50 µg/ml,48-h,Bladder,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N,https://doi.org/10.1016/s0196-9781(01)00641-6
1432,21955251,2011,GIIKKIIIKKI,Cationic Amphiphilic,11,Cyclic,L,None,Free,Free,Antimicrobial,AMP,HeLa,Cervical Cancer,WST-1 assay,IC50 = 160 µM,Not Available,Cervix,None,N1CC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C21OO2,https://doi.org/10.1021/bm201098j
1433,21955251,2011,GIIKKIIIKKIIIKKI,Cationic Amphiphilic,16,Cyclic,L,None,Free,Free,Antimicrobial,AMP,HeLa,Cervical Cancer,WST-1 assay,IC50 = 15 µM,Not Available,Cervix,None,N1CC(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C21OO2,https://doi.org/10.1021/bm201098j
1434,21955251,2011,GIIKKIIIKKIIIKKIIIKKI,Cationic Amphiphilic,21,Cyclic,L,None,Free,Free,Antimicrobial,AMP,HeLa,Pancreatic Cancer,WST-1 assay,IC50 = 4 µM,Not Available,Pancreatic,None,N1CC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C21OO2,https://doi.org/10.1021/bm201098j
1436,21955251,2011,GIIKKIIIKKI,Cationic Amphiphilic,11,Cyclic,L,None,Free,Free,Antimicrobial,AMP,HL-60,Pancreatic Cancer,WST-1 assay,IC50 = >500 µM,Not Available,Pancreatic,None,N1CC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C21OO2,https://doi.org/10.1021/bm201098j
1437,21955251,2011,GIIKKIIIKKIIIKKI,Cationic Amphiphilic,16,Cyclic,L,None,Free,Free,Antimicrobial,AMP,HL-60,Pancreatic Cancer,WST-1 assay,IC50 = 25 µM,Not Available,Pancreatic,None,N1CC(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C21OO2,https://doi.org/10.1021/bm201098j
1438,21955251,2011,GIIKKIIIKKIIIKKIIIKKI,Cationic Amphiphilic,21,Cyclic,L,None,Free,Free,Antimicrobial,AMP,HL-60,Pancreatic Cancer,WST-1 assay,IC50 = 10 µM,Not Available,Pancreatic,None,N1CC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C21OO2,https://doi.org/10.1021/bm201098j
1433,21955251,2011,GIIKKIIIKKIIIKKI,Cationic Amphiphilic,16,Cyclic,L,None,Free,Free,Antimicrobial,AMP,HeLa,Cervical Cancer,WST-1 assay,IC50 = 15 µM,Not Available,Cervix,None,N1CC(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C21OO2,https://doi.org/10.1021/bm201098j
1434,21955251,2011,GIIKKIIIKKIIIKKIIIKKI,Cationic Amphiphilic,21,Cyclic,L,None,Free,Free,Antimicrobial,AMP,HeLa,Pancreatic Cancer,WST-1 assay,IC50 = 4 µM,Not Available,Pancreatic,None,N1CC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C21OO2,https://doi.org/10.1021/bm201098j
1437,21955251,2011,GIIKKIIIKKIIIKKI,Cationic Amphiphilic,16,Cyclic,L,None,Free,Free,Antimicrobial,AMP,HL-60,Pancreatic Cancer,WST-1 assay,IC50 = 25 µM,Not Available,Pancreatic,None,N1CC(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C21OO2,https://doi.org/10.1021/bm201098j
1438,21955251,2011,GIIKKIIIKKIIIKKIIIKKI,Cationic Amphiphilic,21,Cyclic,L,None,Free,Free,Antimicrobial,AMP,HL-60,Pancreatic Cancer,WST-1 assay,IC50 = 10 µM,Not Available,Pancreatic,None,N1CC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C21OO2,https://doi.org/10.1021/bm201098j
1434,21955251,2011,GIIKKIIIKKIIIKKIIIKKI,Cationic Amphiphilic,21,Cyclic,L,None,Free,Free,Antimicrobial,AMP,HeLa,Pancreatic Cancer,WST-1 assay,IC50 = 4 µM,Not Available,Pancreatic,None,N1CC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C21OO2,https://doi.org/10.1021/bm201098j
1438,21955251,2011,GIIKKIIIKKIIIKKIIIKKI,Cationic Amphiphilic,21,Cyclic,L,None,Free,Free,Antimicrobial,AMP,HL-60,Pancreatic Cancer,WST-1 assay,IC50 = 10 µM,Not Available,Pancreatic,None,N1CC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C21OO2,https://doi.org/10.1021/bm201098j
2839,24246647,2014,GIIKKIIKKI,Short α-helical peptides,10,Linear,L,None,Amidation,Free,Antimicrobial,Alpha-helical proteins,HeLa,Cervical Cancer,MTT/MTS assay,99% Cytotoxicity at 4 µM Approx,24-h,Cervix,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1016/j.biomaterials.2013.10.082
2840,24246647,2014,GIIKKIIKKIIKKI,Short α-helical peptides,14,Linear,L,None,Amidation,Free,Antimicrobial,Alpha-helical proteins,HeLa,Cervical Cancer,MTT/MTS assay,95% Cytotoxicity at 4 µM Approx,24-h,Cervix,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1016/j.biomaterials.2013.10.082
2841,24246647,2014,GIIKKIIKKIIKKIIKKI,Short α-helical peptides,18,Linear,L,None,Amidation,Free,Antimicrobial,Alpha-helical proteins,HeLa,Cervical Cancer,MTT/MTS assay,80% Cytotoxicity at 4 µM Approx,24-h,Cervix,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1016/j.biomaterials.2013.10.082
2842,24246647,2014,GIIKKIIKKI,Short α-helical peptides,10,Linear,L,None,Amidation,Free,Antimicrobial,Alpha-helical proteins,HL-60,Leukemia Cancer,MTT/MTS assay,100% Cytotoxicity at 5 µM Approx,24-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1016/j.biomaterials.2013.10.082
2843,24246647,2014,GIIKKIIKKIIKKI,Short α-helical peptides,14,Linear,L,None,Amidation,Free,Antimicrobial,Alpha-helical proteins,HL-60,Leukemia Cancer,MTT/MTS assay,90% Cytotoxicity at 5 µM Approx,24-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1016/j.biomaterials.2013.10.082
2844,24246647,2014,GIIKKIIKKIIKKIIKKI,Short α-helical peptides,18,Linear,L,None,Amidation,Free,Antimicrobial,Alpha-helical proteins,HL-60,Leukemia Cancer,MTT/MTS assay,70% Cytotoxicity at 5 µM Approx,24-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1016/j.biomaterials.2013.10.082
2840,24246647,2014,GIIKKIIKKIIKKI,Short α-helical peptides,14,Linear,L,None,Amidation,Free,Antimicrobial,Alpha-helical proteins,HeLa,Cervical Cancer,MTT/MTS assay,95% Cytotoxicity at 4 µM Approx,24-h,Cervix,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1016/j.biomaterials.2013.10.082
2841,24246647,2014,GIIKKIIKKIIKKIIKKI,Short α-helical peptides,18,Linear,L,None,Amidation,Free,Antimicrobial,Alpha-helical proteins,HeLa,Cervical Cancer,MTT/MTS assay,80% Cytotoxicity at 4 µM Approx,24-h,Cervix,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1016/j.biomaterials.2013.10.082
2843,24246647,2014,GIIKKIIKKIIKKI,Short α-helical peptides,14,Linear,L,None,Amidation,Free,Antimicrobial,Alpha-helical proteins,HL-60,Leukemia Cancer,MTT/MTS assay,90% Cytotoxicity at 5 µM Approx,24-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1016/j.biomaterials.2013.10.082
2844,24246647,2014,GIIKKIIKKIIKKIIKKI,Short α-helical peptides,18,Linear,L,None,Amidation,Free,Antimicrobial,Alpha-helical proteins,HL-60,Leukemia Cancer,MTT/MTS assay,70% Cytotoxicity at 5 µM Approx,24-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1016/j.biomaterials.2013.10.082
2841,24246647,2014,GIIKKIIKKIIKKIIKKI,Short α-helical peptides,18,Linear,L,None,Amidation,Free,Antimicrobial,Alpha-helical proteins,HeLa,Cervical Cancer,MTT/MTS assay,80% Cytotoxicity at 4 µM Approx,24-h,Cervix,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1016/j.biomaterials.2013.10.082
2844,24246647,2014,GIIKKIIKKIIKKIIKKI,Short α-helical peptides,18,Linear,L,None,Amidation,Free,Antimicrobial,Alpha-helical proteins,HL-60,Leukemia Cancer,MTT/MTS assay,70% Cytotoxicity at 5 µM Approx,24-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1016/j.biomaterials.2013.10.082
4454,"17067680, 18957441",2007,GIKCRFCCGCCTPGICGVCCRF,hepcidin TH1-5,22,Not Available,L,None,Free,Free,Anticancer,"Tilapia, Oreochromis mossambicus",Not Available,Colorectal Cancer,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,"['https://doi.org/10.1016/j.molimm.2006.09.031', 'https://doi.org/10.1093/nar/gkn823']"
4422,"18191970, 18957441",2008,GIPCAESCVWIPCTVTALIGCGCSNKVCYN,Vibi E,30,Not Available,L,None,Free,Free,Anticancer,Alpine violetViola biflora,Not Available,Leukemia Cancer,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1016/j.phytochem.2007.10.023', 'https://doi.org/10.1093/nar/gkn823']"
4372,"22467870, 18957441",2012,GIPCAESCVWIPPCTITALMGCSCKNNVCYNN,Chassatide C2,32,Not Available,L,None,Free,Free,Antibacterial,Chassalia chartacea,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1074/jbc.M111.338970', 'https://doi.org/10.1093/nar/gkn823']"
4383,"21596752, 18957441",2011,GIPCGESCVFIPCITAAIGCSCKSKVCYRN,Cliotide T4,30,Not Available,L,None,Free,Free,Antibacterial,Clitoria ternatea,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1074/jbc.M111.229922', 'https://doi.org/10.1093/nar/gkn823']"
4382,"21596752, 18957441",2011,GIPCGESCVFIPCITGAIGCSCKSKVCYRN,Cliotide T1,30,Not Available,L,None,Free,Free,Antibacterial,Clitoria ternatea,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1074/jbc.M111.229922', 'https://doi.org/10.1093/nar/gkn823']"
4376,"21723349, 18957441",2011,GIPCGESCVFIPCLTSAIDCSCKSKVCYRN,Mram 8,30,Not Available,L,None,Free,Free,Antibacterial,Viola philippica,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1016/j.peptides.2011.06.016', 'https://doi.org/10.1093/nar/gkn823']"
4380,"10600388, 18957441",1999,GIPCGESCVWIPCISSAIGCSCKSKVCYRN,Cycloviolacin O2,30,Not Available,L,None,Free,Free,Antibacterial,Viola odorata,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,N1CC(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@@H]3C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]4C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N5[C@H](C(=O)N[C@@H]6C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C1=O)CC(=O)N)CCCNC(=[NH2])N)Cc1ccc(cc1)O)CSSC6)C(C)C)CCCC[NH3])CO)CCCC[NH3])CSSC4)CO)CSSC3)[C@H](CC)C)C)CO)CO)[C@H](CC)C)CCC5)[C@H](CC)C)Cc1c[nH]c3c1cccc3)C(C)C)CO)CCC(=O)O)CCC2)[C@H](CC)C,"['https://doi.org/10.1006/jmbi.1999.3383', 'https://doi.org/10.1093/nar/gkn823']"
3658,22100226,2012,GKFMSLLKHILK,HAL-2/24,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 34 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3686,22100226,2012,GKFMSLLKHILK,HAL-2/24,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3714,22100226,2012,GKFMSLLKHILK,HAL-2/24,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3645,22100226,2012,GKWKKILGHLIR,HAL-1/19,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 > 100 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3673,22100226,2012,GKWKKILGHLIR,HAL-1/19,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 100 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3701,22100226,2012,GKWKKILGHLIR,HAL-1/19,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3646,22100226,2012,GKWKKILGKLIR,HAL-1/21,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 30±3 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3674,22100226,2012,GKWKKILGKLIR,HAL-1/21,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 100 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3702,22100226,2012,GKWKKILGKLIR,HAL-1/21,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3653,22100226,2012,GKWKSLLKHILK,HAL-2/1,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 14±2 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3681,22100226,2012,GKWKSLLKHILK,HAL-2/1,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 100 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3709,22100226,2012,GKWKSLLKHILK,HAL-2/1,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Blood,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3661,22100226,2012,GKWLSLLKHILK,HAL-2/11,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 14±3 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3689,22100226,2012,GKWLSLLKHILK,HAL-2/11,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 40 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3717,22100226,2012,GKWLSLLKHILK,HAL-2/11,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3652,22100226,2012,GKWMKLLKHILK,HAL-2/2,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 6±1 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3680,22100226,2012,GKWMKLLKHILK,HAL-2/2,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 35±5 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3708,22100226,2012,GKWMKLLKHILK,HAL-2/2,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Blood,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3659,22100226,2012,GKWMSFLKHILK,HAL-2/6,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 23±3 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3687,22100226,2012,GKWMSFLKHILK,HAL-2/6,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3715,22100226,2012,GKWMSFLKHILK,HAL-2/6,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3649,22100226,2012,GKWMSLLKHILK,HAL-2,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 12±1 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3650,22100226,2012,gkwmsllkhilk,HAL-2/22,12,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 12 µM,48-h,Cervix,None,NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CCSC)C(=O)N[C@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3654,22100226,2012,GKWMSLLKHILK,HAL-2/8,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 15±3 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3677,22100226,2012,GKWMSLLKHILK,HAL-2,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 35±3 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3678,22100226,2012,gkwmsllkhilk,HAL-2/22,12,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 100 µM,48-h,Colon,None,NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CCSC)C(=O)N[C@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3682,22100226,2012,GKWMSLLKHILK,HAL-2/8,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3705,22100226,2012,GKWMSLLKHILK,HAL-2,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 34 µM,48-h,Blood,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3706,22100226,2012,gkwmsllkhilk,HAL-2/22,12,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CCSC)C(=O)N[C@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3710,22100226,2012,GKWMSLLKHILK,HAL-2/8,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
4403,"20198492, 18957441",2010,GKWMSLLKHILK,Halictine 2,12,Not Available,L,None,Free,Free,Anticancer,"Venom, the eusocial bee, Halictus sexcinctus",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1007/s00726-010-0519-1', 'https://doi.org/10.1093/nar/gkn823']"
3649,22100226,2012,GKWMSLLKHILK,HAL-2,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 12±1 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3650,22100226,2012,gkwmsllkhilk,HAL-2/22,12,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 12 µM,48-h,Cervix,None,NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CCSC)C(=O)N[C@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3654,22100226,2012,GKWMSLLKHILK,HAL-2/8,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 15±3 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3677,22100226,2012,GKWMSLLKHILK,HAL-2,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 35±3 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3678,22100226,2012,gkwmsllkhilk,HAL-2/22,12,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 100 µM,48-h,Colon,None,NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CCSC)C(=O)N[C@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3682,22100226,2012,GKWMSLLKHILK,HAL-2/8,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3705,22100226,2012,GKWMSLLKHILK,HAL-2,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 34 µM,48-h,Blood,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3706,22100226,2012,gkwmsllkhilk,HAL-2/22,12,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CCSC)C(=O)N[C@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3710,22100226,2012,GKWMSLLKHILK,HAL-2/8,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
4403,"20198492, 18957441",2010,GKWMSLLKHILK,Halictine 2,12,Not Available,L,None,Free,Free,Anticancer,"Venom, the eusocial bee, Halictus sexcinctus",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1007/s00726-010-0519-1', 'https://doi.org/10.1093/nar/gkn823']"
3655,22100226,2012,GKWMSLLKHIWK,HAL-2/18,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 14±2 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3683,22100226,2012,GKWMSLLKHIWK,HAL-2/18,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3711,22100226,2012,GKWMSLLKHIWK,HAL-2/18,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3656,22100226,2012,GKWMSLLKHWLK,HAL-2/19,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 16±4 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3684,22100226,2012,GKWMSLLKHWLK,HAL-2/19,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3712,22100226,2012,GKWMSLLKHWLK,HAL-2/19,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3651,22100226,2012,GKWMSLLKKILK,HAL-2/4,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3679,22100226,2012,GKWMSLLKKILK,HAL-2/4,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 38±6 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3707,22100226,2012,GKWMSLLKKILK,HAL-2/4,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3657,22100226,2012,GKWMSLWKHILK,HAL-2/20,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 30±5 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3685,22100226,2012,GKWMSLWKHILK,HAL-2/20,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3713,22100226,2012,GKWMSLWKHILK,HAL-2/20,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3660,22100226,2012,GKWMTLLKHILK,HAL-2/13,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 13±3 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3688,22100226,2012,GKWMTLLKHILK,HAL-2/13,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 60 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3716,22100226,2012,GKWMTLLKHILK,HAL-2/13,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3641,22100226,2012,GKWSKILGHLIR,HAL-1/12,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 43±14 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3669,22100226,2012,GKWSKILGHLIR,HAL-1/12,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 100 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3697,22100226,2012,GKWSKILGHLIR,HAL-1/12,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Blood,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3644,22100226,2012,GKWSKILGKLIR,HAL-1/20,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 22±3 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3672,22100226,2012,GKWSKILGKLIR,HAL-1/20,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3700,22100226,2012,GKWSKILGKLIR,HAL-1/20,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Blood,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
4120,"12631273, 9266696",2003,GLFAVIKKVAAVIKKL,17,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Leukemia tumor cellline,Leukemia Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4121,"12631273, 9266696",2003,GLFAVIKKVAAVIKKL,17,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Lung tumor cellline,Lung Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Lung,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4122,"12631273, 9266696",2003,GLFAVIKKVAAVIKKL,17,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Colon tumor cellline,Colon Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Colon,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4123,"12631273, 9266696",2003,GLFAVIKKVAAVIKKL,17,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Brain tumor cellline,Brain Tumor,Sulforhodamine B assay,IC50= 5 M,Not Available,Brain,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4124,"12631273, 9266696",2003,GLFAVIKKVAAVIKKL,17,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Skin tumor cellline,Skin Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Skin,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4125,"12631273, 9266696",2003,GLFAVIKKVAAVIKKL,17,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Ovary tumor cellline,Ovarian Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Ovary,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4126,"12631273, 9266696",2003,GLFAVIKKVAAVIKKL,17,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Liver tumor celline,Liver Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Liver,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4127,"12631273, 9266696",2003,GLFAVIKKVAAVIKKL,17,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Prostate tumor cellline,Prostate Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4128,"12631273, 9266696",2003,GLFAVIKKVAAVIKKL,17,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Breast tumor cellline,Breast Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4129,"12631273, 9266696",2003,GLFAVIKKVAAVIRRL,18,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Leukemia tumor cellline,Leukemia Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4130,"12631273, 9266696",2003,GLFAVIKKVAAVIRRL,18,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Lung tumor cellline,Lung Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Lung,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4131,"12631273, 9266696",2003,GLFAVIKKVAAVIRRL,18,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Colon tumor cellline,Colon Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Colon,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4132,"12631273, 9266696",2003,GLFAVIKKVAAVIRRL,18,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Brain tumor cellline,Brain Tumor,Sulforhodamine B assay,IC50= 5 M,Not Available,Brain,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4133,"12631273, 9266696",2003,GLFAVIKKVAAVIRRL,18,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Skin tumor cellline,Skin Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Skin,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4134,"12631273, 9266696",2003,GLFAVIKKVAAVIRRL,18,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Ovary tumor cellline,Ovarian Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Ovary,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4135,"12631273, 9266696",2003,GLFAVIKKVAAVIRRL,18,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Liver tumor celline,Liver Cancer,Sulforhodamine B assay,IC50= >10 µM,Not Available,Liver,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4136,"12631273, 9266696",2003,GLFAVIKKVAAVIRRL,18,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Prostate tumor cellline,Prostate Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4137,"12631273, 9266696",2003,GLFAVIKKVAAVIRRL,18,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Breast tumor cellline,Breast Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4138,"12631273, 9266696",2003,GLFAVIKKVAKVIKKL,19,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Leukemia tumor cellline,Leukemia Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4139,"12631273, 9266696",2003,GLFAVIKKVAKVIKKL,19,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Lung tumor cellline,Lung Cancer,Sulforhodamine B assay,IC50= 6 M,Not Available,Lung,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4140,"12631273, 9266696",2003,GLFAVIKKVAKVIKKL,19,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Colon tumor cellline,Colon Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Colon,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4141,"12631273, 9266696",2003,GLFAVIKKVAKVIKKL,19,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Brain tumor cellline,Brain Tumor,Sulforhodamine B assay,IC50= 5 M,Not Available,Brain,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4142,"12631273, 9266696",2003,GLFAVIKKVAKVIKKL,19,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Skin tumor cellline,Skin Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Skin,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4143,"12631273, 9266696",2003,GLFAVIKKVAKVIKKL,19,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Ovary tumor cellline,Ovarian Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Ovary,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4144,"12631273, 9266696",2003,GLFAVIKKVAKVIKKL,19,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Liver tumor celline,Liver Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Liver,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4145,"12631273, 9266696",2003,GLFAVIKKVAKVIKKL,19,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Prostate tumor cellline,Prostate Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4146,"12631273, 9266696",2003,GLFAVIKKVAKVIKKL,19,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Breast tumor cellline,Breast Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4048,"12631273, 9266696",2003,GLFAVIKKVASVIGGL,3,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Leukemia tumor cellline,Leukemia Cancer,Sulforhodamine B assay,IC50= 6 M,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4049,"12631273, 9266696",2003,GLFAVIKKVASVIGGL,3,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Lung tumor cellline,Lung Cancer,Sulforhodamine B assay,IC50= 6 M,Not Available,Lung,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4050,"12631273, 9266696",2003,GLFAVIKKVASVIGGL,3,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Colon tumor cellline,Colon Cancer,Sulforhodamine B assay,IC50= 6 M,Not Available,Colon,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4051,"12631273, 9266696",2003,GLFAVIKKVASVIGGL,3,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Brain tumor cellline,Brain Tumor,Sulforhodamine B assay,IC50= 6 M,Not Available,Brain,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4052,"12631273, 9266696",2003,GLFAVIKKVASVIGGL,3,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Skin tumor cellline,Skin Cancer,Sulforhodamine B assay,IC50= 6 M,Not Available,Skin,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4053,"12631273, 9266696",2003,GLFAVIKKVASVIGGL,3,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Ovary tumor cellline,Ovarian Cancer,Sulforhodamine B assay,IC50= 6 M,Not Available,Ovary,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4054,"12631273, 9266696",2003,GLFAVIKKVASVIGGL,3,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Liver tumor celline,Liver Cancer,Sulforhodamine B assay,IC50= > 1 µM,Not Available,Liver,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4055,"12631273, 9266696",2003,GLFAVIKKVASVIGGL,3,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Prostate tumor cellline,Prostate Cancer,Sulforhodamine B assay,IC50= 6 M,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4056,"12631273, 9266696",2003,GLFAVIKKVASVIGGL,3,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Breast tumor cellline,Breast Cancer,Sulforhodamine B assay,IC50= 6 M,Not Available,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4102,"12631273, 9266696",2003,GLFAVIKKVASVIKGL,15,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Leukemia tumor cellline,Leukemia Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4103,"12631273, 9266696",2003,GLFAVIKKVASVIKGL,15,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Lung tumor cellline,Lung Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Lung,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4104,"12631273, 9266696",2003,GLFAVIKKVASVIKGL,15,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Colon tumor cellline,Colon Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Colon,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4105,"12631273, 9266696",2003,GLFAVIKKVASVIKGL,15,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Brain tumor cellline,Brain Tumor,Sulforhodamine B assay,IC50= 5 M,Not Available,Brain,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4106,"12631273, 9266696",2003,GLFAVIKKVASVIKGL,15,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Skin tumor cellline,Skin Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Skin,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4107,"12631273, 9266696",2003,GLFAVIKKVASVIKGL,15,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Ovary tumor cellline,Ovarian Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Ovary,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4108,"12631273, 9266696",2003,GLFAVIKKVASVIKGL,15,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Liver tumor celline,Liver Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Liver,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4109,"12631273, 9266696",2003,GLFAVIKKVASVIKGL,15,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Prostate tumor cellline,Prostate Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4110,"12631273, 9266696",2003,GLFAVIKKVASVIKGL,15,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Breast tumor cellline,Breast Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4111,"12631273, 9266696",2003,GLFAVIKKVASVIKKL,16,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Leukemia tumor cellline,Leukemia Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4112,"12631273, 9266696",2003,GLFAVIKKVASVIKKL,16,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Lung tumor cellline,Lung Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Lung,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4113,"12631273, 9266696",2003,GLFAVIKKVASVIKKL,16,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Colon tumor cellline,Colon Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Colon,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4114,"12631273, 9266696",2003,GLFAVIKKVASVIKKL,16,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Brain tumor cellline,Brain Tumor,Sulforhodamine B assay,IC50= 5 M,Not Available,Brain,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4115,"12631273, 9266696",2003,GLFAVIKKVASVIKKL,16,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Skin tumor cellline,Skin Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Skin,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4116,"12631273, 9266696",2003,GLFAVIKKVASVIKKL,16,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Ovary tumor cellline,Ovarian Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Ovary,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4117,"12631273, 9266696",2003,GLFAVIKKVASVIKKL,16,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Liver tumor celline,Liver Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Liver,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4118,"12631273, 9266696",2003,GLFAVIKKVASVIKKL,16,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Prostate tumor cellline,Prostate Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4119,"12631273, 9266696",2003,GLFAVIKKVASVIKKL,16,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Breast tumor cellline,Breast Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
1270,10951191,2000,GLFDIAKKVIGVIGSL,Aurein2.6,16,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Breast tumor cellline,Breast Cancer,Not Available,LC50 = 10 µM,Not Available,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1271,10951191,2000,GLFDIAKKVIGVIGSL,Aurein2.6,16,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Leukemia tumor cellline,Leukemia Cancer,Not Available,LC50=10-100 µM,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1272,10951191,2000,GLFDIAKKVIGVIGSL,Aurein2.6,16,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Lung tumor cellline,Lung Cancer,Not Available,LC50 = 10 µM,Not Available,Lung,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1273,10951191,2000,GLFDIAKKVIGVIGSL,Aurein2.6,16,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Colon tumor cellline,Colon Cancer,Not Available,LC50=10-100 µM,Not Available,Colon,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1274,10951191,2000,GLFDIAKKVIGVIGSL,Aurein2.6,16,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Brain tumor cellline,Brain Tumor,Not Available,LC50 = 10 µM,Not Available,Brain,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1275,10951191,2000,GLFDIAKKVIGVIGSL,Aurein2.6,16,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Skin tumor cellline,Skin Cancer,Not Available,LC50 = 10 µM,Not Available,Skin,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1276,10951191,2000,GLFDIAKKVIGVIGSL,Aurein2.6,16,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Ovary tumor cellline,Ovarian Cancer,Not Available,LC50 = 10 µM,Not Available,Ovary,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1277,10951191,2000,GLFDIAKKVIGVIGSL,Aurein2.6,16,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Renal tumor cellline,Renal Cancer,Not Available,LC50 = 10 µM,Not Available,Renal,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1278,10951191,2000,GLFDIAKKVIGVIGSL,Aurein2.6,16,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Prostate tumor cellline,Prostate Cancer,Not Available,LC50 = 10 µM,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1252,10951191,2000,GLFDIIKKIAESF,Aurein1.2,13,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Breast tumor cellline,Breast Cancer,Not Available,LC50 = 10 µM,Not Available,Breast,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CO)CCC(=O)O)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CC(=O)O)Cc1ccccc1)CC(C)C,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1253,10951191,2000,GLFDIIKKIAESF,Aurein1.2,13,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Leukemia tumor cellline,Leukemia Cancer,Not Available,LC50=10-100 µM,Not Available,Blood,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CO)CCC(=O)O)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CC(=O)O)Cc1ccccc1)CC(C)C,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1254,10951191,2000,GLFDIIKKIAESF,Aurein1.2,13,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Lung tumor cellline,Lung Cancer,Not Available,LC50 = 10 µM,Not Available,Lung,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CO)CCC(=O)O)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CC(=O)O)Cc1ccccc1)CC(C)C,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1255,10951191,2000,GLFDIIKKIAESF,Aurein1.2,13,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Colon tumor cellline,Colon Cancer,Not Available,LC50 = 10 µM,Not Available,Colon,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CO)CCC(=O)O)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CC(=O)O)Cc1ccccc1)CC(C)C,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1256,10951191,2000,GLFDIIKKIAESF,Aurein1.2,13,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Brain tumor cellline,Brain Tumor,Not Available,LC50 = 10 µM,Not Available,Brain,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CO)CCC(=O)O)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CC(=O)O)Cc1ccccc1)CC(C)C,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1257,10951191,2000,GLFDIIKKIAESF,Aurein1.2,13,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Skin tumor cellline,Skin Cancer,Not Available,LC50 = 10 µM,Not Available,Skin,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CO)CCC(=O)O)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CC(=O)O)Cc1ccccc1)CC(C)C,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1258,10951191,2000,GLFDIIKKIAESF,Aurein1.2,13,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Ovary tumor cellline,Ovarian Cancer,Not Available,LC50 = 10 µM,Not Available,Ovary,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CO)CCC(=O)O)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CC(=O)O)Cc1ccccc1)CC(C)C,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1259,10951191,2000,GLFDIIKKIAESF,Aurein1.2,13,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Renal tumor cellline,Renal Cancer,Not Available,LC50 = 10 µM,Not Available,Renal,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CO)CCC(=O)O)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CC(=O)O)Cc1ccccc1)CC(C)C,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1260,10951191,2000,GLFDIIKKIAESF,Aurein1.2,13,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Prostate tumor cellline,Prostate Cancer,Not Available,LC50 = 10 µM,Not Available,Prostate,None,[NH3]CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CO)CCC(=O)O)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CC(=O)O)Cc1ccccc1)CC(C)C,https://doi.org/10.1046/j.1432-1327.2000.01536.x
4404,"10951191, 18957441",2000,GLFDIIKKIAESI,Aurein 1.1,13,Not Available,L,None,Free,Free,Anticancer,"Litoria aureaandLitoria raniformis, Australia",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O,"['https://doi.org/10.1046/j.1432-1327.2000.01536.x', 'https://doi.org/10.1093/nar/gkn823']"
4405,"10504394, 18957441",1999,GLFDIIKKVASVIGGL,Citropin 1.3,16,Not Available,L,None,Free,Free,Anticancer,"Australian blue mountains tree frog, Litoria citropa",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O,"['https://doi.org/10.1046/j.1432-1327.1999.00750.x', 'https://doi.org/10.1093/nar/gkn823']"
4406,"10504394, 18957441",1999,GLFDIIKKVASVVGGL,Citropin 1.2,16,Not Available,L,None,Free,Free,Anticancer,"Australian blue mountains tree frog, Litoria citropa",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O,"['https://doi.org/10.1046/j.1432-1327.1999.00750.x', 'https://doi.org/10.1093/nar/gkn823']"
1279,10951191,2000,GLFDIVKKIAGHIAGSI,Aurein 3.1,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Breast tumor cellline,Breast Cancer,Not Available,LC50=10-100 µM,Not Available,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1280,10951191,2000,GLFDIVKKIAGHIAGSI,Aurein 3.1,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Leukemia tumor cellline,Leukemia Cancer,Not Available,LC50 = 10 µM,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1281,10951191,2000,GLFDIVKKIAGHIAGSI,Aurein 3.1,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Lung tumor cellline,Lung Cancer,Not Available,LC50 = 10 µM,Not Available,Lung,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1282,10951191,2000,GLFDIVKKIAGHIAGSI,Aurein 3.1,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Colon tumor cellline,Colon Cancer,Not Available,LC50 = 10 µM,Not Available,Colon,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1283,10951191,2000,GLFDIVKKIAGHIAGSI,Aurein 3.1,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Brain tumor cellline,Brain Tumor,Not Available,LC50=10-100 µM,Not Available,Brain,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1284,10951191,2000,GLFDIVKKIAGHIAGSI,Aurein 3.1,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Skin tumor cellline,Skin Cancer,Not Available,LC50=10-100 µM,Not Available,Skin,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1285,10951191,2000,GLFDIVKKIAGHIAGSI,Aurein 3.1,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Ovary tumor cellline,Ovarian Cancer,Not Available,LC50=10-100 µM,Not Available,Ovary,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1286,10951191,2000,GLFDIVKKIAGHIAGSI,Aurein 3.1,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Renal tumor cellline,Renal Cancer,Not Available,LC50=10-100 µM,Not Available,Renal,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1287,10951191,2000,GLFDIVKKIAGHIAGSI,Aurein 3.1,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Prostate tumor cellline,Prostate Cancer,Not Available,LC50 = 10 µM,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1288,10951191,2000,GLFDIVKKIAGHIASSI,Aurein 3.2,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Breast tumor cellline,Breast Cancer,Not Available,LC50 = 10 µM,Not Available,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1289,10951191,2000,GLFDIVKKIAGHIASSI,Aurein 3.2,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Leukemia tumor cellline,Leukemia Cancer,Not Available,LC50 = 10 µM,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1290,10951191,2000,GLFDIVKKIAGHIASSI,Aurein 3.2,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Lung tumor cellline,Lung Cancer,Not Available,LC50 = 10 µM,Not Available,Lung,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1291,10951191,2000,GLFDIVKKIAGHIASSI,Aurein 3.2,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Colon tumor cellline,Colon Cancer,Not Available,LC50=10-100 µM,Not Available,Colon,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1292,10951191,2000,GLFDIVKKIAGHIASSI,Aurein 3.2,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Brain tumor cellline,Brain Tumor,Not Available,LC50 = 10 µM,Not Available,Brain,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1293,10951191,2000,GLFDIVKKIAGHIASSI,Aurein 3.2,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Skin tumor cellline,Skin Cancer,Not Available,LC50 = 10 µM,Not Available,Skin,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1294,10951191,2000,GLFDIVKKIAGHIASSI,Aurein 3.2,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Ovary tumor cellline,Ovarian Cancer,Not Available,LC50 = 10 µM,Not Available,Ovary,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1295,10951191,2000,GLFDIVKKIAGHIASSI,Aurein 3.2,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Renal tumor cellline,Renal Cancer,Not Available,LC50 = 10 µM,Not Available,Renal,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1296,10951191,2000,GLFDIVKKIAGHIASSI,Aurein 3.2,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Prostate tumor cellline,Prostate Cancer,Not Available,LC50 = 10 µM,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1297,10951191,2000,GLFDIVKKIAGHIVSSI,Aurein 3.3,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Breast tumor cellline,Breast Cancer,Not Available,LC50 = 10 µM,Not Available,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1298,10951191,2000,GLFDIVKKIAGHIVSSI,Aurein 3.3,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Leukemia tumor cellline,Leukemia Cancer,Not Available,LC50=10-100 µM,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1299,10951191,2000,GLFDIVKKIAGHIVSSI,Aurein 3.3,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Lung tumor cellline,Lung Cancer,Not Available,LC50 = 10 µM,Not Available,Lung,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1300,10951191,2000,GLFDIVKKIAGHIVSSI,Aurein 3.3,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Colon tumor cellline,Colon Cancer,Not Available,LC50 = 10 µM,Not Available,Colon,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1301,10951191,2000,GLFDIVKKIAGHIVSSI,Aurein 3.3,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Brain tumor cellline,Brain Tumor,Not Available,LC50 = 10 µM,Not Available,Brain,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1302,10951191,2000,GLFDIVKKIAGHIVSSI,Aurein 3.3,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Skin tumor cellline,Skin Cancer,Not Available,LC50 = 10 µM,Not Available,Skin,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1303,10951191,2000,GLFDIVKKIAGHIVSSI,Aurein 3.3,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Ovary tumor cellline,Ovarian Cancer,Not Available,LC50 = 10 µM,Not Available,Ovary,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1304,10951191,2000,GLFDIVKKIAGHIVSSI,Aurein 3.3,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Renal tumor cellline,Renal Cancer,Not Available,LC50 = 10 µM,Not Available,Renal,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1305,10951191,2000,GLFDIVKKIAGHIVSSI,Aurein 3.3,17,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Prostate tumor cellline,Prostate Cancer,Not Available,LC50 = 10 µM,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1261,10951191,2000,GLFDIVKKVVGAFGSL,Aurein2.5,16,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Breast tumor cellline,Breast Cancer,Not Available,LC50 = 10 µM,Not Available,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1262,10951191,2000,GLFDIVKKVVGAFGSL,Aurein2.5,16,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Leukemia tumor cellline,Leukemia Cancer,Not Available,LC50=10-100 µM,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1263,10951191,2000,GLFDIVKKVVGAFGSL,Aurein2.5,16,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Lung tumor cellline,Lung Cancer,Not Available,LC50 = 10 µM,Not Available,Lung,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1264,10951191,2000,GLFDIVKKVVGAFGSL,Aurein2.5,16,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Colon tumor cellline,Colon Cancer,Not Available,LC50=10-100 µM,Not Available,Colon,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1265,10951191,2000,GLFDIVKKVVGAFGSL,Aurein2.5,16,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Brain tumor cellline,Brain Tumor,Not Available,LC50 = 10 µM,Not Available,Brain,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1266,10951191,2000,GLFDIVKKVVGAFGSL,Aurein2.5,16,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Skin tumor cellline,Skin Cancer,Not Available,LC50 = 10 µM,Not Available,Skin,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1267,10951191,2000,GLFDIVKKVVGAFGSL,Aurein2.5,16,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Ovary tumor cellline,Ovarian Cancer,Not Available,LC50 = 10 µM,Not Available,Ovary,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1268,10951191,2000,GLFDIVKKVVGAFGSL,Aurein2.5,16,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Renal tumor cellline,Renal Cancer,Not Available,LC50 = 10 µM,Not Available,Renal,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
1269,10951191,2000,GLFDIVKKVVGAFGSL,Aurein2.5,16,Linear,L,None,Amidation,Free,Antimicrobial,Southern bell frog,Prostate tumor cellline,Prostate Cancer,Not Available,LC50 = 10 µM,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1046/j.1432-1327.2000.01536.x
4407,"10951191, 18957441",2000,GLFDIVKKVVGAIGSL,Aurein 2.3,16,Not Available,L,None,Free,Free,Anticancer,"Litoria aureaandLitoria raniformis, Australia",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O,"['https://doi.org/10.1046/j.1432-1327.2000.01536.x', 'https://doi.org/10.1093/nar/gkn823']"
4408,"10951191, 18957441",2000,GLFDIVKKVVGALGSL,Aurein 2.2,16,Not Available,L,None,Free,Free,Anticancer,"Litoria aureaandLitoria raniformis, Australia",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O,"['https://doi.org/10.1046/j.1432-1327.2000.01536.x', 'https://doi.org/10.1093/nar/gkn823']"
4409,"10951191, 18957441",2000,GLFDIVKKVVGTLAGL,Aurein 2.4,16,Not Available,L,None,Free,Free,Anticancer,"Litoria aureaandLitoria raniformis, Australia",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O,"['https://doi.org/10.1046/j.1432-1327.2000.01536.x', 'https://doi.org/10.1093/nar/gkn823']"
4093,"12631273, 9266696",2003,GLFDVIAKVASVIKKL,14,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Leukemia tumor cellline,Leukemia Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4094,"12631273, 9266696",2003,GLFDVIAKVASVIKKL,14,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Lung tumor cellline,Lung Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Lung,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4095,"12631273, 9266696",2003,GLFDVIAKVASVIKKL,14,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Colon tumor cellline,Colon Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Colon,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4096,"12631273, 9266696",2003,GLFDVIAKVASVIKKL,14,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Brain tumor cellline,Brain Tumor,Sulforhodamine B assay,IC50= 5 M,Not Available,Brain,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4097,"12631273, 9266696",2003,GLFDVIAKVASVIKKL,14,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Skin tumor cellline,Skin Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Skin,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4098,"12631273, 9266696",2003,GLFDVIAKVASVIKKL,14,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Ovary tumor cellline,Ovarian Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Ovary,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4099,"12631273, 9266696",2003,GLFDVIAKVASVIKKL,14,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Liver tumor celline,Liver Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Liver,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4100,"12631273, 9266696",2003,GLFDVIAKVASVIKKL,14,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Prostate tumor cellline,Prostate Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4101,"12631273, 9266696",2003,GLFDVIAKVASVIKKL,14,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Breast tumor cellline,Breast Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4057,"12631273, 9266696",2003,GLFDVIKAVASVIGGL,5,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Leukemia tumor cellline,Leukemia Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4058,"12631273, 9266696",2003,GLFDVIKAVASVIGGL,5,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Lung tumor cellline,Lung Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Lung,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4059,"12631273, 9266696",2003,GLFDVIKAVASVIGGL,5,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Colon tumor cellline,Colon Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Colon,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4060,"12631273, 9266696",2003,GLFDVIKAVASVIGGL,5,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Brain tumor cellline,Brain Tumor,Sulforhodamine B assay,IC50= 5 M,Not Available,Brain,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4061,"12631273, 9266696",2003,GLFDVIKAVASVIGGL,5,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Skin tumor cellline,Skin Cancer,Sulforhodamine B assay,IC50= >100 µM,Not Available,Skin,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4062,"12631273, 9266696",2003,GLFDVIKAVASVIGGL,5,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Ovary tumor cellline,Ovarian Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Ovary,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4063,"12631273, 9266696",2003,GLFDVIKAVASVIGGL,5,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Liver tumor celline,Liver Cancer,Sulforhodamine B assay,IC50= >100 µM,Not Available,Liver,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4064,"12631273, 9266696",2003,GLFDVIKAVASVIGGL,5,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Prostate tumor cellline,Prostate Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4065,"12631273, 9266696",2003,GLFDVIKAVASVIGGL,5,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Breast tumor cellline,Breast Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4066,"12631273, 9266696",2003,GLFDVIKKVAAVIGGL,7,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Leukemia tumor cellline,Leukemia Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4067,"12631273, 9266696",2003,GLFDVIKKVAAVIGGL,7,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Lung tumor cellline,Lung Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Lung,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4068,"12631273, 9266696",2003,GLFDVIKKVAAVIGGL,7,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Colon tumor cellline,Colon Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Colon,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4069,"12631273, 9266696",2003,GLFDVIKKVAAVIGGL,7,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Brain tumor cellline,Brain Tumor,Sulforhodamine B assay,IC50= 5 M,Not Available,Brain,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4070,"12631273, 9266696",2003,GLFDVIKKVAAVIGGL,7,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Skin tumor cellline,Skin Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Skin,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4071,"12631273, 9266696",2003,GLFDVIKKVAAVIGGL,7,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Ovary tumor cellline,Ovarian Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Ovary,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4072,"12631273, 9266696",2003,GLFDVIKKVAAVIGGL,7,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Liver tumor celline,Liver Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Liver,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4073,"12631273, 9266696",2003,GLFDVIKKVAAVIGGL,7,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Prostate tumor cellline,Prostate Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4074,"12631273, 9266696",2003,GLFDVIKKVAAVIGGL,7,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Breast tumor cellline,Breast Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
1421,"10455241, 21403917",2009,GLFDVIKKVASVIGGL,Citropin1.1,16,Linear,L,None,Amidation,Free,Antibacterial,"Australian blue mountains tree frog, Litoria citropa",U-937,Lymphoma Cancer,MTT/MTS assay,60% Cytotoxicity at 0.5 µg/ml,6-h,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1002/(SICI)1097-0231(19990915)13:17<1724::AID-RCM706>3.0.CO;2-T', 'Not Found']"
1422,"10504394, 21403917",2009,GLFDVIKKVASVIGGL,Citropin1.1,16,Linear,L,None,Amidation,Free,Antibacterial,"Australian blue mountains tree frog, Litoria citropa",U-937,Lymphoma Cancer,MTT/MTS assay,60% Cytotoxicity at 0.5 µg/ml,6-h,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1327.1999.00750.x', 'Not Found']"
4030,"12631273, 9266696",2003,GLFDVIKKVASVIGGL,Citropin 1.1,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Leukemia tumor cellline,Leukemia Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4031,"12631273, 9266696",2003,GLFDVIKKVASVIGGL,Citropin 1.1,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Lung tumor cellline,Lung Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Lung,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4032,"12631273, 9266696",2003,GLFDVIKKVASVIGGL,Citropin 1.1,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Colon tumor cellline,Colon Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Colon,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4033,"12631273, 9266696",2003,GLFDVIKKVASVIGGL,Citropin 1.1,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Brain tumor cellline,Brain Tumor,Sulforhodamine B assay,IC50= 5 M,Not Available,Brain,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4034,"12631273, 9266696",2003,GLFDVIKKVASVIGGL,Citropin 1.1,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Skin tumor cellline,Skin Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Skin,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4035,"12631273, 9266696",2003,GLFDVIKKVASVIGGL,Citropin 1.1,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Ovary tumor cellline,Ovarian Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Ovary,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4036,"12631273, 9266696",2003,GLFDVIKKVASVIGGL,Citropin 1.1,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Liver tumor celline,Liver Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Liver,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4037,"12631273, 9266696",2003,GLFDVIKKVASVIGGL,Citropin 1.1,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Prostate tumor cellline,Prostate Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4038,"12631273, 9266696",2003,GLFDVIKKVASVIGGL,Citropin 1.1,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Breast tumor cellline,Breast Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4039,"12631273, 9266696",2003,glfdvikkvasviggl,Citropin 1.1D,16,Linear,D,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Leukemia tumor cellline,Leukemia Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Blood,None,NCC(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4040,"12631273, 9266696",2003,glfdvikkvasviggl,Citropin 1.1D,16,Linear,D,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Lung tumor cellline,Lung Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Lung,None,NCC(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4041,"12631273, 9266696",2003,glfdvikkvasviggl,Citropin 1.1D,16,Linear,D,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Colon tumor cellline,Colon Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Colon,None,NCC(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4042,"12631273, 9266696",2003,glfdvikkvasviggl,Citropin 1.1D,16,Linear,D,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Brain tumor cellline,Brain Tumor,Sulforhodamine B assay,IC50= 5 M,Not Available,Brain,None,NCC(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4043,"12631273, 9266696",2003,glfdvikkvasviggl,Citropin 1.1D,16,Linear,D,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Skin tumor cellline,Skin Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Skin,None,NCC(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4044,"12631273, 9266696",2003,glfdvikkvasviggl,Citropin 1.1D,16,Linear,D,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Ovary tumor cellline,Ovarian Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Ovary,None,NCC(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4045,"12631273, 9266696",2003,glfdvikkvasviggl,Citropin 1.1D,16,Linear,D,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Liver tumor celline,Liver Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Liver,None,NCC(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4046,"12631273, 9266696",2003,glfdvikkvasviggl,Citropin 1.1D,16,Linear,D,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Prostate tumor cellline,Prostate Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Prostate,None,NCC(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4047,"12631273, 9266696",2003,glfdvikkvasviggl,Citropin 1.1D,16,Linear,D,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Breast tumor cellline,Breast Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Breast,None,NCC(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4593,21403917,2011,GLFDVIKKVASVIGGL,Citropin 1.1,16,Linear,L,None,Amidation,Free,Antimicrobial,"Australian blue mountains tree frog, Litoria citropa",U-938,Lymphoma Cancer,MTT/MTS assay,IC50 =40 µg/ml,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1421,"10455241, 21403917",2009,GLFDVIKKVASVIGGL,Citropin1.1,16,Linear,L,None,Amidation,Free,Antibacterial,"Australian blue mountains tree frog, Litoria citropa",U-937,Lymphoma Cancer,MTT/MTS assay,60% Cytotoxicity at 0.5 µg/ml,6-h,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1002/(SICI)1097-0231(19990915)13:17<1724::AID-RCM706>3.0.CO;2-T', 'Not Found']"
1422,"10504394, 21403917",2009,GLFDVIKKVASVIGGL,Citropin1.1,16,Linear,L,None,Amidation,Free,Antibacterial,"Australian blue mountains tree frog, Litoria citropa",U-937,Lymphoma Cancer,MTT/MTS assay,60% Cytotoxicity at 0.5 µg/ml,6-h,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1327.1999.00750.x', 'Not Found']"
4030,"12631273, 9266696",2003,GLFDVIKKVASVIGGL,Citropin 1.1,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Leukemia tumor cellline,Leukemia Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4031,"12631273, 9266696",2003,GLFDVIKKVASVIGGL,Citropin 1.1,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Lung tumor cellline,Lung Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Lung,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4032,"12631273, 9266696",2003,GLFDVIKKVASVIGGL,Citropin 1.1,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Colon tumor cellline,Colon Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Colon,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4033,"12631273, 9266696",2003,GLFDVIKKVASVIGGL,Citropin 1.1,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Brain tumor cellline,Brain Tumor,Sulforhodamine B assay,IC50= 5 M,Not Available,Brain,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4034,"12631273, 9266696",2003,GLFDVIKKVASVIGGL,Citropin 1.1,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Skin tumor cellline,Skin Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Skin,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4035,"12631273, 9266696",2003,GLFDVIKKVASVIGGL,Citropin 1.1,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Ovary tumor cellline,Ovarian Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Ovary,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4036,"12631273, 9266696",2003,GLFDVIKKVASVIGGL,Citropin 1.1,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Liver tumor celline,Liver Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Liver,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4037,"12631273, 9266696",2003,GLFDVIKKVASVIGGL,Citropin 1.1,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Prostate tumor cellline,Prostate Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4038,"12631273, 9266696",2003,GLFDVIKKVASVIGGL,Citropin 1.1,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Breast tumor cellline,Breast Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4039,"12631273, 9266696",2003,glfdvikkvasviggl,Citropin 1.1D,16,Linear,D,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Leukemia tumor cellline,Leukemia Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Blood,None,NCC(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4040,"12631273, 9266696",2003,glfdvikkvasviggl,Citropin 1.1D,16,Linear,D,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Lung tumor cellline,Lung Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Lung,None,NCC(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4041,"12631273, 9266696",2003,glfdvikkvasviggl,Citropin 1.1D,16,Linear,D,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Colon tumor cellline,Colon Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Colon,None,NCC(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4042,"12631273, 9266696",2003,glfdvikkvasviggl,Citropin 1.1D,16,Linear,D,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Brain tumor cellline,Brain Tumor,Sulforhodamine B assay,IC50= 5 M,Not Available,Brain,None,NCC(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4043,"12631273, 9266696",2003,glfdvikkvasviggl,Citropin 1.1D,16,Linear,D,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Skin tumor cellline,Skin Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Skin,None,NCC(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4044,"12631273, 9266696",2003,glfdvikkvasviggl,Citropin 1.1D,16,Linear,D,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Ovary tumor cellline,Ovarian Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Ovary,None,NCC(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4045,"12631273, 9266696",2003,glfdvikkvasviggl,Citropin 1.1D,16,Linear,D,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Liver tumor celline,Liver Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Liver,None,NCC(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4046,"12631273, 9266696",2003,glfdvikkvasviggl,Citropin 1.1D,16,Linear,D,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Prostate tumor cellline,Prostate Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Prostate,None,NCC(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4047,"12631273, 9266696",2003,glfdvikkvasviggl,Citropin 1.1D,16,Linear,D,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Breast tumor cellline,Breast Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Breast,None,NCC(=O)N[C@H](CC(C)C)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C)C(=O)N[C@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4593,21403917,2011,GLFDVIKKVASVIGGL,Citropin 1.1,16,Linear,L,None,Amidation,Free,Antimicrobial,"Australian blue mountains tree frog, Litoria citropa",U-938,Lymphoma Cancer,MTT/MTS assay,IC50 =40 µg/ml,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
4075,"12631273, 9266696",2003,GLFDVIKKVASVIKGL,11,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Leukemia tumor cellline,Leukemia Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4076,"12631273, 9266696",2003,GLFDVIKKVASVIKGL,11,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Lung tumor cellline,Lung Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Lung,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4077,"12631273, 9266696",2003,GLFDVIKKVASVIKGL,11,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Colon tumor cellline,Colon Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Colon,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4078,"12631273, 9266696",2003,GLFDVIKKVASVIKGL,11,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Brain tumor cellline,Brain Tumor,Sulforhodamine B assay,IC50= 5 M,Not Available,Brain,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4079,"12631273, 9266696",2003,GLFDVIKKVASVIKGL,11,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Skin tumor cellline,Skin Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Skin,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4080,"12631273, 9266696",2003,GLFDVIKKVASVIKGL,11,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Ovary tumor cellline,Ovarian Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Ovary,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4081,"12631273, 9266696",2003,GLFDVIKKVASVIKGL,11,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Liver tumor celline,Liver Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Liver,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4082,"12631273, 9266696",2003,GLFDVIKKVASVIKGL,11,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Prostate tumor cellline,Prostate Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4083,"12631273, 9266696",2003,GLFDVIKKVASVIKGL,11,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Breast tumor cellline,Breast Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4084,"12631273, 9266696",2003,GLFDVIKKVASVIKKL,13,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Leukemia tumor cellline,Leukemia Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4085,"12631273, 9266696",2003,GLFDVIKKVASVIKKL,13,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Lung tumor cellline,Lung Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Lung,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4086,"12631273, 9266696",2003,GLFDVIKKVASVIKKL,13,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Colon tumor cellline,Colon Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Colon,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4087,"12631273, 9266696",2003,GLFDVIKKVASVIKKL,13,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Brain tumor cellline,Brain Tumor,Sulforhodamine B assay,IC50= 5 M,Not Available,Brain,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4088,"12631273, 9266696",2003,GLFDVIKKVASVIKKL,13,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Skin tumor cellline,Skin Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Skin,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4089,"12631273, 9266696",2003,GLFDVIKKVASVIKKL,13,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Ovary tumor cellline,Ovarian Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Ovary,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4090,"12631273, 9266696",2003,GLFDVIKKVASVIKKL,13,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Liver tumor celline,Liver Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Liver,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4091,"12631273, 9266696",2003,GLFDVIKKVASVIKKL,13,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Prostate tumor cellline,Prostate Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4092,"12631273, 9266696",2003,GLFDVIKKVASVIKKL,13,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Breast tumor cellline,Breast Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4673,22885172,2012,GLFGKLIKKFARKAISYAVKKARGKH,ltc2aG11A,26,Linear,L,None,Free,Free,Antimicrobial,"Central Asian spider, Lachesana tarabaevi",Prostate tumor cellline,Prostate Cancer,LDH leakage assay,graph fig 8 A,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)O,https://doi.org/10.1016/j.bbamem.2012.07.030
4672,22885172,2012,GLFGKLIKKFGRKAISYAVKKARGKH,Latarcin 2a,26,Linear,L,None,Free,Free,Antimicrobial,"Central Asian spider, Lachesana tarabaevi",Breast tumor cellline,Breast Cancer,LDH leakage assay,graph fig 8 A,Not Available,Breast,None,NCC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC1=CNCN1)CCCC[NH3])CCCNC(=[NH2])N)C)CCCC[NH3])CCCC[NH3])C(C)C)C)Cc1ccc(cc1)O)CO)[C@H](CC)C)C)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])[C@H](CC)C)CC(C)C)CCCC[NH3])Cc1ccccc1)CC(C)C,https://doi.org/10.1016/j.bbamem.2012.07.030
4410,"9516047, 18957441",1998,GLFGVLGSIAKHVLPHVVPVIAEK,Caerin 1.9,24,Not Available,L,None,Free,Free,Anticancer,"Litoria chloris, Australia",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1111/j.1399-3011.1998.tb00629.x', 'https://doi.org/10.1093/nar/gkn823']"
4156,"12631273, 9266696",2003,GLFKVIKKVAKVIKKL,23,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Leukemia tumor cellline,Leukemia Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4157,"12631273, 9266696",2003,GLFKVIKKVAKVIKKL,23,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Lung tumor cellline,Lung Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Lung,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4158,"12631273, 9266696",2003,GLFKVIKKVAKVIKKL,23,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Colon tumor cellline,Colon Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Colon,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4159,"12631273, 9266696",2003,GLFKVIKKVAKVIKKL,23,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Brain tumor cellline,Brain Tumor,Sulforhodamine B assay,IC50= 5 M,Not Available,Brain,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4160,"12631273, 9266696",2003,GLFKVIKKVAKVIKKL,23,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Skin tumor cellline,Skin Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Skin,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4161,"12631273, 9266696",2003,GLFKVIKKVAKVIKKL,23,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Ovary tumor cellline,Ovarian Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Ovary,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4162,"12631273, 9266696",2003,GLFKVIKKVAKVIKKL,23,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Liver tumor celline,Liver Cancer,Sulforhodamine B assay,IC50= >10 µM,Not Available,Liver,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4163,"12631273, 9266696",2003,GLFKVIKKVAKVIKKL,23,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Prostate tumor cellline,Prostate Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4164,"12631273, 9266696",2003,GLFKVIKKVAKVIKKL,23,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Breast tumor cellline,Breast Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4147,"12631273, 9266696",2003,GLFKVIKKVASVIGGL,22,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Leukemia tumor cellline,Leukemia Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4148,"12631273, 9266696",2003,GLFKVIKKVASVIGGL,22,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Lung tumor cellline,Lung Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Lung,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4149,"12631273, 9266696",2003,GLFKVIKKVASVIGGL,22,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Colon tumor cellline,Colon Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Colon,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4150,"12631273, 9266696",2003,GLFKVIKKVASVIGGL,22,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Brain tumor cellline,Brain Tumor,Sulforhodamine B assay,IC50= 5 M,Not Available,Brain,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4151,"12631273, 9266696",2003,GLFKVIKKVASVIGGL,22,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Skin tumor cellline,Skin Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Skin,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4152,"12631273, 9266696",2003,GLFKVIKKVASVIGGL,22,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Ovary tumor cellline,Ovarian Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Ovary,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4153,"12631273, 9266696",2003,GLFKVIKKVASVIGGL,22,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Liver tumor celline,Liver Cancer,Sulforhodamine B assay,IC50= >10 µM,Not Available,Liver,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4154,"12631273, 9266696",2003,GLFKVIKKVASVIGGL,22,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Prostate tumor cellline,Prostate Cancer,Sulforhodamine B assay,IC50= >10 µM,Not Available,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4155,"12631273, 9266696",2003,GLFKVIKKVASVIGGL,22,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Breast tumor cellline,Breast Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4411,"9230483, 18957441",1997,GLFKVLGSVAKHLLPHVAPVIAEK,Caerin 1.7,24,Not Available,L,None,Free,Free,Anticancer,"Orange-thighed frog,Litoria xanthomera, Australia",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1002/(sici)1099-1387(199705)3:3<181::aid-psc97>3.0.co;2-k', 'https://doi.org/10.1093/nar/gkn823']"
4412,"9230483, 18957441",1997,GLFKVLGSVAKHLLPHVVPVIAEK,Caerin 1.8,24,Not Available,L,None,Free,Free,Anticancer,"Blue-thighed frog,Litoria chloris, Australia",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1002/(sici)1099-1387(199705)3:3<181::aid-psc97>3.0.co;2-k', 'https://doi.org/10.1093/nar/gkn823']"
4413,"9230483, 18957441",1997,GLFSVLGAVAKHVLPHVVPVIAEK,Caerin 1.6,24,Not Available,L,None,Free,Free,Anticancer,"Blue-thighed frog,Litoria chloris, Australia",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1002/(sici)1099-1387(199705)3:3<181::aid-psc97>3.0.co;2-k', 'https://doi.org/10.1093/nar/gkn823']"
4390,"9620615, 18957441",1998,GLFVGLAKVAAHNNPAIAEHFQA,Maculatin 1.2,23,Not Available,L,None,Free,Free,Antibacterial,"Litoria genimaculate, Litoria eucnemis, Australia",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)O,"['https://doi.org/10.1002/(sici)1099-1387(199804)4:2<111::aid-psc134>3.0.co;2-8', 'https://doi.org/10.1093/nar/gkn823']"
4391,"9620615, 18957441",1998,GLFVGVLAKVAAHVVPAIAEHF,Maculatin 1.1,22,Not Available,L,None,Free,Free,Antibacterial,"Litoria genimaculate, Litoria eucnemis, Australia",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,"['https://doi.org/10.1002/(sici)1099-1387(199804)4:2<111::aid-psc134>3.0.co;2-8', 'https://doi.org/10.1093/nar/gkn823']"
4414,"10951191, 18957441",2000,GLLDIVKKVVGAFGSL,Aurein 2.1,16,Not Available,L,None,Free,Free,Anticancer,"Southern bell frogLitoria aureaorLitoria raniformis, Australia",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O,"['https://doi.org/10.1046/j.1432-1327.2000.01536.x', 'https://doi.org/10.1093/nar/gkn823']"
4415,"22771617, 18957441",2012,GLLGLLGSVVSHVLPAITQHL,Maculatin 1.4,21,Not Available,L,None,Free,Free,Anticancer,"Blue-thighed frog,Litoria chloris, Australia",Not Available,Skin Cancer,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)O,"['https://doi.org/10.1016/j.peptides.2012.06.017', 'https://doi.org/10.1093/nar/gkn823']"
4416,"22771617, 18957441",2012,GLLGLLGSVVSHVVPAIVGHF,Maculatin 1.3,21,Not Available,L,None,Free,Free,Anticancer,"Blue-thighed frog,Litoria chloris, Australia",Not Available,Skin Cancer,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,"['https://doi.org/10.1016/j.peptides.2012.06.017', 'https://doi.org/10.1093/nar/gkn823']"
4417,"11738090, 18957441",2001,GLLGPLLKIAAKVGSNLL,CPF-ST3,18,Not Available,L,None,Free,Free,Anticancer,"Diploid clawed frogXenopus tropicalis, Africa",Not Available,Skin Cancer,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,"['https://doi.org/10.1016/s0167-4838(01)00272-2', 'https://doi.org/10.1093/nar/gkn823']"
4423,"18191970, 18957441",2008,GLLPCAESCVYIPCLTTVIGCSCKSKVCYKN,Vibi H,31,Not Available,L,None,Free,Free,Anticancer,Alpine violetViola biflora,Not Available,Lung Cancer,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1016/j.phytochem.2007.10.023', 'https://doi.org/10.1093/nar/gkn823']"
4392,"9620615, 18957441",1998,GLLQTIKEKLESLESLAKGIVSGIQA,Maculatin 3.1,26,Not Available,L,None,Free,Free,Anticancer,"Litoria genimaculate, Litoria eucnemis, Australia",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)O,"['https://doi.org/10.1002/(sici)1099-1387(199804)4:2<111::aid-psc134>3.0.co;2-8', 'https://doi.org/10.1093/nar/gkn823']"
4424,"9266696, 18957441",1997,GLLSVLGSVAKHVLPHVVPVIAEHL,Caerin 1.1,25,Not Available,L,None,Free,Free,Anticancer,Australian green tree frogLitoria splendida; Litoria rothii,Not Available,Lung Cancer,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)O,"['https://doi.org/10.1111/j.1432-1033.1997.00545.x', 'https://doi.org/10.1093/nar/gkn823']"
4425,"10601876, 18957441",2000,GLLSVLGSVAKHVLPHVVPVIAEKL,Caerin 1.10,25,Not Available,L,None,Free,Free,Anticancer,"Magnificent treefrog Litoria splendida, Australia",Not Available,Lung Cancer,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,"['https://doi.org/10.1046/j.1432-1327.2000.01010.x', 'https://doi.org/10.1093/nar/gkn823']"
4362,"19254736, 18957441",2009,GLMDTIKGVAKTVAASWLDKLKCKITGC,Ranatuerin-2Ya,28,Not Available,L,None,Free,Free,Antibacterial,"North America, leopard frog, Lithobates yavapaiensis",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CS)C(=O)O,"['https://doi.org/10.1016/j.toxicon.2009.02.018', 'https://doi.org/10.1093/nar/gkn823']"
4381,"21596752, 18957441",2011,GLPTCGETCTLGTCYVPDCSCSWPICMKN,Cliotide T3,29,Not Available,L,None,Free,Free,Antibacterial,Clitoria ternatea,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,N1CC(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@@H]3C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]4C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H]5C(=O)N[C@H](C(=O)N[C@H](C(=O)N6[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N7[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C1=O)CC(=O)N)CCCC[NH3])CCSC)CSSC5)[C@H](CC)C)CCC7)Cc1c[nH]c5c1cccc5)CO)CSSC4)CO)CSSC3)CC(=O)O)CCC6)C(C)C)Cc1ccc(cc1)O)[C@H](O)C)CC(C)C)[C@H](O)C)[C@H](O)C)CCC(=O)O)[C@H](O)C)CCC2)CC(C)C,"['https://doi.org/10.1074/jbc.M111.229922', 'https://doi.org/10.1093/nar/gkn823']"
4426,"21434649, 18957441",2011,GLPVCGETCAGGTCNTPGCSCSWPICTRN,Vaby A,29,Not Available,L,None,Free,Free,Anticancer,"African, the Ethiopian highlands, Viola abyssinica",Not Available,Fibrosarcoma,Not Available,Not Available,Not Available,Fibrous connective tissue ,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1021/np100790f', 'https://doi.org/10.1093/nar/gkn823']"
4427,"21434649, 18957441",2011,GLPVCGETCFGGTCNTPGCTCDPWPVCTRN,Vaby D,30,Not Available,L,None,Free,Free,Anticancer,"African, the Ethiopian highlands, Viola abyssinica",Not Available,Fibrosarcoma,Not Available,Not Available,Not Available,Fibrous connective tissue ,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N=CC(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1021/np100790f', 'https://doi.org/10.1093/nar/gkn823']"
4377,"21723349, 18957441",2011,GLPVCGETCVGGTCNTPGCACSWPVCTRN,Viba 15,29,Not Available,L,None,Free,Free,Antibacterial,Viola philippica,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1016/j.peptides.2011.06.016', 'https://doi.org/10.1093/nar/gkn823']"
4378,"21723349, 18957441",2011,GLPVCGETCVGGTCNTPGCGCSWPVCTRN,Viba17,29,Not Available,L,None,Free,Free,Antibacterial,Viola philippica,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1016/j.peptides.2011.06.016', 'https://doi.org/10.1093/nar/gkn823']"
4428,"9548831, 18957441",1998,GLPVCGETCVGGTCNTPGCSCSWPVCTRN,Varv peptide A,29,Not Available,L,None,Free,Free,Anticancer,"Viola arvensis,Viola odorata, Viola tricolor, Viola baoshanensis, Viola yedoensis, and Viola biflora",Not Available,Fibrosarcoma,Not Available,Not Available,Not Available,Fibrous connective tissue ,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1021/np970342r', 'https://doi.org/10.1093/nar/gkn823']"
4452,"17561225, 18957441",2007,GLWSKIKEAAKAAGKAALNAVTGLVNQGDQPS,Phylloseptin,32,Not Available,L,None,Free,Free,Anticancer,Hylomantis lemur (Hylidae: Phyllomedusinae,Not Available,Colorectal Cancer,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O,"['https://doi.org/10.1016/j.toxicon.2007.04.017', 'https://doi.org/10.1093/nar/gkn823']"
2846,23028527,2012,GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV,Adenoregulin,33,Linear,L,None,Free,Free,Antimicrobial,South American frog Phyllomedusa bicolor,PC-3,Prostate Cancer,LDH leakage assay,GI50 =1.24±0.23 µM,24-h,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1371/journal.pone.0044351
2847,23028527,2012,GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV,Adenoregulin,33,Linear,L,None,Free,Free,Antimicrobial,South American frog Phyllomedusa bicolor,LNCaP,Prostate Cancer,LDH leakage assay,GI50 =0.31±0.15 µM,24-h,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1371/journal.pone.0044351
2848,23028527,2012,GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV,Adenoregulin,33,Linear,L,None,Free,Free,Antimicrobial,South American frog Phyllomedusa bicolor,DU-145,Liver Cancer,LDH leakage assay,GI50 =0.91±0.04 µM,24-h,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1371/journal.pone.0044351
2849,23028527,2012,GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV,Adenoregulin,33,Linear,L,None,Free,Free,Antimicrobial,South American frog Phyllomedusa bicolor,MDA-MB-231,Breast Cancer,LDH leakage assay,GI50 =8.06±0.50 µM,24-h,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1371/journal.pone.0044351
2850,23028527,2012,GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV,Adenoregulin,33,Linear,L,None,Free,Free,Antimicrobial,South American frog Phyllomedusa bicolor,Raji,Lymphoma Cancer,LDH leakage assay,GI50 =2.57±0.75 µM,24-h,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1371/journal.pone.0044351
3640,22100226,2012,GMWKKILGHLIR,HAL-1/5,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 9±1 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3668,22100226,2012,GMWKKILGHLIR,HAL-1/5,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 44±5 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3696,22100226,2012,GMWKKILGHLIR,HAL-1/5,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Blood,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3643,22100226,2012,GMWKKILGKLIR,HAL-1/10,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 13±2 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3671,22100226,2012,GMWKKILGKLIR,HAL-1/10,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 60 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3699,22100226,2012,GMWKKILGKLIR,HAL-1/10,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3636,22100226,2012,GMWSKILGHLIK,HAL-1/6,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 15±1 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3664,22100226,2012,GMWSKILGHLIK,HAL-1/6,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 100 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3692,22100226,2012,GMWSKILGHLIK,HAL-1/6,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3634,22100226,2012,GMWSKILGHLIR,HAL-1,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 11±2 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3635,22100226,2012,gmwskilghlir,HAL-1/22,12,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 15±3 µM,48-h,Cervix,None,NCC(=O)N[C@H](CCSC)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CO)C(=O)N[C@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](Cc1[nH]cnc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3647,22100226,2012,GMWSKILGHLIR,HAL-1/29,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 > 100 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3662,22100226,2012,GMWSKILGHLIR,HAL-1,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 44±8 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3663,22100226,2012,gmwskilghlir,HAL-1/22,12,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Colon,None,NCC(=O)N[C@H](CCSC)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CO)C(=O)N[C@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](Cc1[nH]cnc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3675,22100226,2012,GMWSKILGHLIR,HAL-1/29,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,Not tested,48-h,Colon,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3690,22100226,2012,GMWSKILGHLIR,HAL-1,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 49±9 µM,48-h,Blood,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3691,22100226,2012,gmwskilghlir,HAL-1/22,12,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@H](CCSC)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CO)C(=O)N[C@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](Cc1[nH]cnc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3703,22100226,2012,GMWSKILGHLIR,HAL-1/29,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
4402,"20198492, 18957441",2010,GMWSKILGHLIR,Halictine 1,12,Not Available,L,None,Free,Free,Anticancer,"venom, the eusocial bee, Halictus sexcinctus",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)O,"['https://doi.org/10.1007/s00726-010-0519-1', 'https://doi.org/10.1093/nar/gkn823']"
3634,22100226,2012,GMWSKILGHLIR,HAL-1,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 11±2 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3635,22100226,2012,gmwskilghlir,HAL-1/22,12,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 15±3 µM,48-h,Cervix,None,NCC(=O)N[C@H](CCSC)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CO)C(=O)N[C@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](Cc1[nH]cnc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3647,22100226,2012,GMWSKILGHLIR,HAL-1/29,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 > 100 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3662,22100226,2012,GMWSKILGHLIR,HAL-1,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 44±8 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3663,22100226,2012,gmwskilghlir,HAL-1/22,12,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Colon,None,NCC(=O)N[C@H](CCSC)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CO)C(=O)N[C@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](Cc1[nH]cnc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3675,22100226,2012,GMWSKILGHLIR,HAL-1/29,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,Not tested,48-h,Colon,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3690,22100226,2012,GMWSKILGHLIR,HAL-1,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 49±9 µM,48-h,Blood,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3691,22100226,2012,gmwskilghlir,HAL-1/22,12,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@H](CCSC)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CO)C(=O)N[C@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](Cc1[nH]cnc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3703,22100226,2012,GMWSKILGHLIR,HAL-1/29,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
4402,"20198492, 18957441",2010,GMWSKILGHLIR,Halictine 1,12,Not Available,L,None,Free,Free,Anticancer,"venom, the eusocial bee, Halictus sexcinctus",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)O,"['https://doi.org/10.1007/s00726-010-0519-1', 'https://doi.org/10.1093/nar/gkn823']"
3637,22100226,2012,GMWSKILGHLKR,HAL-1/4,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 > 100 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3665,22100226,2012,GMWSKILGHLKR,HAL-1/4,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,Not tested,48-h,Colon,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3693,22100226,2012,GMWSKILGHLKR,HAL-1/4,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3638,22100226,2012,GMWSKILGKLIR,HAL-1/9,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 9±1 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3666,22100226,2012,GMWSKILGKLIR,HAL-1/9,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 50 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3694,22100226,2012,GMWSKILGKLIR,HAL-1/9,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 30±10 µM,48-h,Blood,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3639,22100226,2012,GMWSKILKHLIR,HAL-1/18,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 4±2 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3667,22100226,2012,GMWSKILKHLIR,HAL-1/18,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 18±2 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3695,22100226,2012,GMWSKILKHLIR,HAL-1/18,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3648,22100226,2012,GMWSKLLGHLLR,HAL-1/15,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 14±2 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3676,22100226,2012,GMWSKLLGHLLR,HAL-1/15,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3704,22100226,2012,GMWSKLLGHLLR,HAL-1/15,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Blood,None,NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3374,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,COLO-205,Colon Cancer,MTT/MTS assay,<5% cytotoxicity at 1 µM,24-h,Colon,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3375,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,COLO-205,Colon Cancer,MTT/MTS assay,<5% cytotoxicity at 10 µM,24-h,Colon,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3376,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,COLO-205,Colon Cancer,MTT/MTS assay,>20% cytotoxicity at 1 µM,48-h,Colon,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3377,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,COLO-205,Colon Cancer,MTT/MTS assay,~35% cytotoxicity at 10 µM,48-h,Colon,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3378,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,COLO-205,Colon Cancer,MTT/MTS assay,<5% cytotoxicity at 1 µM,72-h,Colon,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3379,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,COLO-205,Colon Cancer,MTT/MTS assay,~20% cytotoxicity at 10 µM,72-h,Colon,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3392,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,UM-UC-3,Bladder Cancer,MTT/MTS assay,~30% cytotoxicity at 1 µM,24-h,Bladder,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3393,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,UM-UC-3,Bladder Cancer,MTT/MTS assay,<30% cytotoxicity at 10 µM,24-h,Bladder,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3394,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,UM-UC-3,Bladder Cancer,MTT/MTS assay,<30% cytotoxicity at 1 µM,48-h,Bladder,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3395,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,UM-UC-3,Bladder Cancer,MTT/MTS assay,~50% cytotoxicity at 10 µM,48-h,Bladder,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3396,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,UM-UC-3,Bladder Cancer,MTT/MTS assay,>40% cytotoxicity at 1 µM,72-h,Bladder,WO2012042540A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3397,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,UM-UC-3,Bladder Cancer,MTT/MTS assay,~50% cytotoxicity at 10 µM,72-h,Bladder,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3410,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,HCT-116,Colon Cancer,MTT/MTS assay,>40% cytotoxicity at 1 µM,24-h,Colon,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3411,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,HCT-116,Colon Cancer,MTT/MTS assay,50% cytotoxicity at 10 µM,24-h,Colon,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3412,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,HCT-116,Colon Cancer,MTT/MTS assay,<20% cytotoxicity at 1 µM,48-h,Colon,WO2012042540A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3413,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,HCT-116,Colon Cancer,MTT/MTS assay,>20% cytotoxicity at 10 µM,48-h,Colon,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3414,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,HCT-116,Colon Cancer,MTT/MTS assay,>30% cytotoxicity at 1 µM,72-h,Colon,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3415,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,HCT-116,Colon Cancer,MTT/MTS assay,~40% cytotoxicity at 10 µM,72-h,Colon,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3428,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,SiHa,Cervical Cancer,MTT/MTS assay,>20% cytotoxicity at 1 µM,24-h,Cervix,WO2012042540A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3429,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,SiHa,Cervical Cancer,MTT/MTS assay,>40% cytotoxicity at 10 µM,24-h,Cervix,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3430,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,SiHa,Cervical Cancer,MTT/MTS assay,<20% cytotoxicity at 1 µM,48-h,Cervix,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3431,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,SiHa,Cervical Cancer,MTT/MTS assay,~50% cytotoxicity at 10 µM,48-h,Cervix,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3432,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,SiHa,Cervical Cancer,MTT/MTS assay,~20% cytotoxicity at 1 µM,72-h,Cervix,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3433,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,SiHa,Cervical Cancer,MTT/MTS assay,~45% cytotoxicity at 10 µM,72-h,Cervix,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3446,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,CaSki,Cervical Cancer,MTT/MTS assay,~20% cytotoxicity at 1 µM,24-h,Cervix,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3447,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,CaSki,Cervical Cancer,MTT/MTS assay,~40% cytotoxicity at 10 µM,24-h,Cervix,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3448,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,CaSki,Cervical Cancer,MTT/MTS assay,~20% cytotoxicity at 1 µM,48-h,Cervix,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3449,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,CaSki,Cervical Cancer,MTT/MTS assay,~55% cytotoxicity at 10 µM,48-h,Cervix,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3450,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,CaSki,Cervical Cancer,MTT/MTS assay,~20% cytotoxicity at 1 µM,72-h,Cervix,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3451,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,CaSki,Cervical Cancer,MTT/MTS assay,~45% cytotoxicity at 10 µM,72-h,Cervix,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3464,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,HTB-9,Bladder Cancer,MTT/MTS assay,40% cytotoxicity at 1 µM,24-h,Bladder,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3465,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,HTB-9,Bladder Cancer,MTT/MTS assay,~50% cytotoxicity at 10 µM,24-h,Bladder,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3466,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,HTB-9,Bladder Cancer,MTT/MTS assay,<20% cytotoxicity at 1 µM,48-h,Bladder,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3467,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,HTB-9,Bladder Cancer,MTT/MTS assay,20% cytotoxicity at 10 µM,48-h,Bladder,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3468,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,HTB-9,Bladder Cancer,MTT/MTS assay,~30% cytotoxicity at 1 µM,72-h,Bladder,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
3469,None,2012,GQVWEATATVNAIRGSVTPAVSQFNARTAD,MB30,30,Linear,L,None,Free,Free,Anticancer,Derived from the MPT63 secreted protein,HTB-9,Bladder Cancer,MTT/MTS assay,>40% cytotoxicity at 10 µM,72-h,Bladder,WO_2012042540_A2,NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O,Not Found
4393,"8910461, 18957441",1996,GRFKRFRKKFKKLFKKLSPVIPLLHLG,BMAP-27,27,Not Available,L,None,Free,Free,Antibacterial,CowBos taurus,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O,"['https://doi.org/10.1074/jbc.271.45.28375', 'https://doi.org/10.1093/nar/gkn823']"
1549,18656352,2008,KAQIRAMECNILGRKKRRQRRR,Tat-a5,22,Linear,L,None,Free,Free,Anticancer,HIV-Tat (49-57),HCT-116,Colon Cancer,MTT/MTS assay,~80% Cytotoxicity at 100 µM,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.bmcl.2008.07.017
3718,24176852,2013,YGRKKRRQRRRREADFFWSLCTADMS,KilerFLIP,26,linear,L,None,Free,Free,NA,NA,Jurkat,Blood Cancer,Not Available,NA,NA,Blood,None,N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1038/cddis.2013.401
4191,15467750,2004,GRKKRRQRRR,HIV-TAT48-57,10,Linear,L,None,Free,Free,Anticancer,Not Available,HeLa,Cervical Cancer,LDH leakage assay,7% apoptosis at 10 µM,16 to 24-h,Cervix,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1207999
4192,15467750,2004,GRKKRRQRRR,HIV-TAT48-57,10,Linear,L,None,Free,Free,Anticancer,Not Available,HeLa,Cervical Cancer,LDH leakage assay,15% apoptosis at 20 µM,16 to 24-h,Cervix,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1207999
4193,15467750,2004,GRKKRRQRRR,HIV-TAT48-57,10,Linear,L,None,Free,Free,Anticancer,Not Available,HeLa,Cervical Cancer,LDH leakage assay,35% apoptosis at 30 µM,16 to 24-h,Cervix,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1207999
4194,15467750,2004,GRKKRRQRRR,HIV-TAT48-57,10,Linear,L,None,Free,Free,Anticancer,Not Available,HeLa,Cervical Cancer,LDH leakage assay,65% apoptosis at 50 µM,16 to 24-h,Cervix,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1207999
4195,15467750,2004,GRKKRRQRRRGGWMWVTNLRTD,TAT-Ras-GAP317-326,22,Linear,L,None,Free,Free,Anticancer,Not Available,HeLa,Cervical Cancer,LDH leakage assay,15% apoptosis at 10 µM,16 to 24-h,Cervix,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O,https://doi.org/10.1038/sj.onc.1207999
4196,15467750,2004,GRKKRRQRRRGGWMWVTNLRTD,TAT-Ras-GAP317-326,22,Linear,L,None,Free,Free,Anticancer,Not Available,HeLa,Cervical Cancer,LDH leakage assay,47% apoptosis at 20 µM,16 to 24-h,Cervix,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O,https://doi.org/10.1038/sj.onc.1207999
4197,15467750,2004,GRKKRRQRRRGGWMWVTNLRTD,TAT-Ras-GAP317-326,22,Linear,L,None,Free,Free,Anticancer,Not Available,HeLa,Cervical Cancer,LDH leakage assay,72% apoptosis at 30 µM,16 to 24-h,Cervix,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O,https://doi.org/10.1038/sj.onc.1207999
4198,15467750,2004,GRKKRRQRRRGGWMWVTNLRTD,TAT-Ras-GAP317-326,22,Linear,L,None,Free,Free,Anticancer,Not Available,HeLa,Cervical Cancer,LDH leakage assay,79% apoptosis at 50 µM,16 to 24-h,Cervix,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O,https://doi.org/10.1038/sj.onc.1207999
4604,12417587,2003,YGRKKRRQRRR,Tat (47-57),11,Linear,L,None,Free,Free,Antimicrobial,Synthetic,HeLa,Cervical Cancer,MTT/MTS assay,at 1 µM 90-100% viablity,6-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1074/jbc.M208762200
4606,12417587,2003,YGRKKRRQRRR,Tat (47-57),11,Linear,L,None,Free,Free,Antimicrobial,Synthetic,HeLa,Cervical Cancer,MTT/MTS assay,at 10 µM 80% viablity,6-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1074/jbc.M208762200
4608,12417587,2003,YGRKKRRQRRR,Tat (47-57),11,Linear,L,None,Free,Free,Antimicrobial,Synthetic,HeLa,Cervical Cancer,MTT/MTS assay,at 100 µM 60% viablity,6-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1074/jbc.M208762200
4195,15467750,2004,GRKKRRQRRRGGWMWVTNLRTD,TAT-Ras-GAP317-326,22,Linear,L,None,Free,Free,Anticancer,Not Available,HeLa,Cervical Cancer,LDH leakage assay,15% apoptosis at 10 µM,16 to 24-h,Cervix,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O,https://doi.org/10.1038/sj.onc.1207999
4196,15467750,2004,GRKKRRQRRRGGWMWVTNLRTD,TAT-Ras-GAP317-326,22,Linear,L,None,Free,Free,Anticancer,Not Available,HeLa,Cervical Cancer,LDH leakage assay,47% apoptosis at 20 µM,16 to 24-h,Cervix,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O,https://doi.org/10.1038/sj.onc.1207999
4197,15467750,2004,GRKKRRQRRRGGWMWVTNLRTD,TAT-Ras-GAP317-326,22,Linear,L,None,Free,Free,Anticancer,Not Available,HeLa,Cervical Cancer,LDH leakage assay,72% apoptosis at 30 µM,16 to 24-h,Cervix,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O,https://doi.org/10.1038/sj.onc.1207999
4198,15467750,2004,GRKKRRQRRRGGWMWVTNLRTD,TAT-Ras-GAP317-326,22,Linear,L,None,Free,Free,Anticancer,Not Available,HeLa,Cervical Cancer,LDH leakage assay,79% apoptosis at 50 µM,16 to 24-h,Cervix,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O,https://doi.org/10.1038/sj.onc.1207999
4511,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-231,Breast Cancer,MTT/MTS assay,5% cytotoxic at 5 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4512,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-231,Breast Cancer,MTT/MTS assay,5% cytotoxic at 10 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4513,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-231,Breast Cancer,MTT/MTS assay,30-35% cytotoxic at 25 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4514,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-231,Breast Cancer,MTT/MTS assay,60% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4515,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,T-47D,Breast Cancer,MTT/MTS assay,5-10% cytotoxic at 5 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4516,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,T-47D,Breast Cancer,MTT/MTS assay,10% cytotoxic at 10 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4517,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,T-47D,Breast Cancer,MTT/MTS assay,30-35% cytotoxic at 25 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4518,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,T-47D,Breast Cancer,MTT/MTS assay,60% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4519,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,SKBR-3,Breast Cancer,MTT/MTS assay,30% cytotoxic at 5 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4520,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,SKBR-3,Breast Cancer,MTT/MTS assay,50% cytotoxic at 10 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4521,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,SKBR-3,Breast Cancer,MTT/MTS assay,70% cytotoxic at 25 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4522,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,SKBR-3,Breast Cancer,MTT/MTS assay,80-85% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4523,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-468,Breast Cancer,MTT/MTS assay,30% cytotoxic at 5 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4524,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-468,Breast Cancer,MTT/MTS assay,40-50% cytotoxic at 10 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4525,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-468,Breast Cancer,MTT/MTS assay,60-70% cytotoxic at 25 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4526,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-468,Breast Cancer,MTT/MTS assay,80-85% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4527,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,4T1,Breast Cancer,MTT/MTS assay,15-20% cytotoxic at 5 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4528,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,4T1,Breast Cancer,MTT/MTS assay,40-50% cytotoxic at 10 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4529,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,4T1,Breast Cancer,MTT/MTS assay,80% cytotoxic at 25 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4530,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,4T1,Breast Cancer,MTT/MTS assay,85-90% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4531,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-231,Breast Cancer,MTT/MTS assay,~0% cytotoxic at 5 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4570,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MCF-7,Breast Cancer,MTT/MTS assay,70% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4573,22023734,2011,GRRKRKWLRRIGKGVKIIGGAALDHL,NRC-03,26,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MCF-7-TX400,Breast Cancer,MTT/MTS assay,60-70% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4347,None,2009,NYQWVPYQGRVPYPRGGLLkLLKklLKKLlKL,Sema3A(aa363-377) -nLytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,BxPC-3,Pancreatic Cancer,WST-1 assay,IC50= 12.5 µM,48-h,Pancreatic,WO_2010_064207_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
4348,None,2009,NYQWVPYQGRVPYPRGGLLkLLKklLKKLlKL,Sema3A(aa363-377) -nLytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,CFPAC-I,Pancreatic Cancer,WST-1 assay,IC50= 10.6 µM,48-h,Pancreatic,WO_2010_064207_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
4349,None,2009,NYQWVPYQGRVPYPRGGLLkLLKklLKKLlKL,Sema3A(aa363-377) -nLytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,Pane- 1,Breast Cancer,WST-1 assay,IC50= 13.1 µM,48-h,Breast,WO_2010_064207_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
4350,None,2009,NYQWVPYQGRVPYPRGGLLkLLKklLKKLlKL,Sema3A(aa363-377) -nLytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,SU.86.86,Pancreatic Cancer,WST-1 assay,IC50= 7.9 µM,48-h,Pancreatic,WO_2010_064207_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
4351,None,2009,GRVPYPRGGLLkLLKklLKKLlKL,Sema3A(aa371-377) -nLytic,24,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,BxPC-3,Pancreatic Cancer,WST-1 assay,IC50= 14.7 µM,48-h,Pancreatic,WO_2010_064207_A2,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
4352,None,2009,GRVPYPRGGLLkLLKklLKKLlKL,Sema3A(aa371-377) -nLytic,24,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,CFPAC-I,Pancreatic Cancer,WST-1 assay,IC50= 9.2 µM,48-h,Pancreatic,WO_2010_064207_A2,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
4353,None,2009,GRVPYPRGGLLkLLKklLKKLlKL,Sema3A(aa371-377) -nLytic,24,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,Pane- 1,Breast Cancer,WST-1 assay,IC50= 14.1 µM,48-h,Breast,WO_2010_064207_A2,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
4354,None,2009,GRVPYPRGGLLkLLKklLKKLlKL,Sema3A(aa371-377) -nLytic,24,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,SU.86.86,Pancreatic Cancer,WST-1 assay,IC50= 8.0 µM,48-h,Pancreatic,WO_2010_064207_A2,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
4204,15867360,2005,GSEGPLKPGARIFSFDGKDVLRHPT,hP5,25,Linear,L,None,Free,Free,Antiangiogenesis,Human endostatin peptides,BxPC-3,Pancreatic Cancer,Matrigel Assay,29% inhibition at 7 mg/kg/d,672-h,Pancreatic,None,NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)O,https://doi.org/10.1158/0008-5472.CAN-04-1833
4379,"21723349, 18957441",2011,GSIPCEGSCVFIPCISAIIGCSCSNKVCYKN,Viphi G,31,Not Available,L,None,Free,Free,Antibacterial,Viola philippica,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1016/j.peptides.2011.06.016', 'https://doi.org/10.1093/nar/gkn823']"
4375,"21723349, 18957441",2011,GSIPCGESCVFIPCISAIIGCSCSSKVCYKN,Viphi F,31,Not Available,L,None,Free,Free,Antibacterial,Viola philippica,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1016/j.peptides.2011.06.016', 'https://doi.org/10.1093/nar/gkn823']"
4373,"21723349, 18957441",2011,GSIPCGESCVFIPCISAVIGCSCSNKVCYKN,Viphi E,31,Not Available,L,None,Free,Free,Antibacterial,Viola philippica,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1016/j.peptides.2011.06.016', 'https://doi.org/10.1093/nar/gkn823']"
4374,"21723349, 18957441",2011,GSIPCGESCVFIPCISSVIGCACKSKVCYKN,Viphi F,31,Not Available,L,None,Free,Free,Antibacterial,Viola philippica,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CS)C1=N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)OO1,"['https://doi.org/10.1016/j.peptides.2011.06.016', 'https://doi.org/10.1093/nar/gkn823']"
4418,"18191970, 18957441",2008,GTFPCGESCVFIPCLTSAIGCSCKSKVCYKN,Vibi G,31,Not Available,L,None,Free,Free,Anticancer,Alpine violetViola biflora,Not Available,Skin Cancer,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)O,"['https://doi.org/10.1016/j.phytochem.2007.10.023', 'https://doi.org/10.1093/nar/gkn823']"
3587,22100226,2012,GTGLPMSERRKIMLMMR,MAC2,17,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 > 100 µM,48-h,Cervix,None,NCC(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N.C.C.C.CC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N.CCN=C,https://doi.org/10.1016/j.peptides.2011.11.002
3603,22100226,2012,GTGLPMSERRKIMLMMR,MAC2,17,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 100 µM,48-h,Colon,None,NCC(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N.C.C.C.CC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N.CCN=C,https://doi.org/10.1016/j.peptides.2011.11.002
3619,22100226,2012,GTGLPMSERRKIMLMMR,MAC2,17,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 32 µM,48-h,Blood,None,NCC(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N.C.C.C.CC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N.CCN=C,https://doi.org/10.1016/j.peptides.2011.11.002
4386,"22100226, 18957441",2012,GTGLPMSERRKIMLMMR,Macropin 2,17,Not Available,L,None,Free,Free,Antibacterial,"Venom, the solitary beeMacropis fulvipes",Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N.C.C.C.CC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)O.CCN=C,"['https://doi.org/10.1016/j.peptides.2011.11.002', 'https://doi.org/10.1093/nar/gkn823']"
4577,21928125,2012,GVGSPYVSRLLGICL,p776,15,Linear,L,None,Free,Free,Antitumor,Synthetic Peptide,Not Available,Tumor,ELISPOT assay,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1007/s00262-011-1113-4
4396,"20575512, 18957441",2010,GVIPCGESCVFIPCISSVLGCSCKNKVCYRD,Psyle E,31,Not Available,L,None,Free,Free,Antibacterial,Psychotria leptothyrsa,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)O,"['https://doi.org/10.1021/np9007365', 'https://doi.org/10.1093/nar/gkn823']"
4421,"10075760, 18957441",1999,GVPICGETCTLGTCYTAGCSCSWPVCTRN,Varv peptide F,29,Not Available,L,None,Free,Free,Anticancer,Viola arvensis,Not Available,Leukemia Cancer,Not Available,Not Available,Not Available,Not Available,None,N1CC(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@@H]3C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]4C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H]5C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N6[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C1=O)CC(=O)N)CCCNC(=[NH2])N)[C@H](O)C)CSSC5)C(C)C)CCC6)Cc1c[nH]c5c1cccc5)CO)CSSC4)CO)CSSC3)C)[C@H](O)C)Cc1ccc(cc1)O)[C@H](O)C)CC(C)C)[C@H](O)C)[C@H](O)C)CCC(=O)O)[C@H](CC)C)CCC2)C(C)C,"['https://doi.org/10.1021/np9803878', 'https://doi.org/10.1093/nar/gkn823']"
2886,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,91.8% Cell viability at 12.5 µM,24-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2887,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,84.1% Cell viability at 25 µM,24-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2888,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,76.3% Cell viability at 50 µM,24-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2889,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,71.5 % Cell viability at 75 µM,24-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2890,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,54.2 % Cell viability at 100 µM,24-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2891,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,87.3 % Cell viability at 25 µM,48-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2892,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,75.6 % Cell viability at 50 µM,48-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2893,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,62.8 % Cell viability at 75 µM,48-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2894,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,54.3 % Cell viability at 100 µM,48-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2895,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,48.6 % Cell viability at 100 µM,48-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2896,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,72.1 % Cell viability at 12.5 µM,72-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2897,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,63.3 % Cell viability at 25 µM,72-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2898,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,49.7 % Cell viability at 50 µM,72-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2899,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,41.1 % Cell viability at 75 µM,72-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2900,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,35.2 % Cell viability at 100 µM,72-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
4420,"7916722, 18957441",1993,GWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLK,Cecropin 2,39,Not Available,L,None,Free,Free,Antibacterial,"The Medfly, Ceratitis capitata; also housefly, Musca domestica",Not Available,Leukemia Cancer,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1016/0378-1119(93)90100-h', 'https://doi.org/10.1093/nar/gkn823']"
4551,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-231,Breast Cancer,MTT/MTS assay,~5% cytotoxic at 10 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4552,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-231,Breast Cancer,MTT/MTS assay,10% cytotoxic at 25 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4553,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-231,Breast Cancer,MTT/MTS assay,10-15% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4554,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,T-47D,Breast Cancer,MTT/MTS assay,~0% cytotoxic at 5 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4555,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,T-47D,Breast Cancer,MTT/MTS assay,~0% cytotoxic at 10 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4556,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,T-47D,Breast Cancer,MTT/MTS assay,10% cytotoxic at 25 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4557,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,T-47D,Breast Cancer,MTT/MTS assay,10-15% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4558,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,SKBR-3,Breast Cancer,MTT/MTS assay,10% cytotoxic at 5 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4559,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,SKBR-3,Breast Cancer,MTT/MTS assay,10% cytotoxic at 10 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4560,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,SKBR-3,Breast Cancer,MTT/MTS assay,10-15% cytotoxic at 25 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4561,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,SKBR-3,Breast Cancer,MTT/MTS assay,15-20% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4562,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-468,Breast Cancer,MTT/MTS assay,~5% cytotoxic at 5 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4563,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-468,Breast Cancer,MTT/MTS assay,~5% cytotoxic at 10 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4564,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-468,Breast Cancer,MTT/MTS assay,5% cytotoxic at 25 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4565,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-468,Breast Cancer,MTT/MTS assay,10-15% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4566,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,4T1,Breast Cancer,MTT/MTS assay,~0% cytotoxic at 5 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4567,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,4T1,Breast Cancer,MTT/MTS assay,~0% cytotoxic at 10 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4568,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,4T1,Breast Cancer,MTT/MTS assay,5-10% cytotoxic at 25 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4569,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,4T1,Breast Cancer,MTT/MTS assay,20% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4572,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MCF-7,Breast Cancer,MTT/MTS assay,0% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4575,22023734,2011,GWRTLLKKAEVKTVGKLALKHYL,NRC-13,23,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MCF-7-TX400,Breast Cancer,MTT/MTS assay,~5% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4419,"12235362, 18957441",2002,HGVSGHGQHGVHG,Alloferon 1,13,Not Available,L,None,Free,Free,Antibacterial,Blow flyCalliphora vicina,Not Available,Skin Cancer,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)O,"['https://doi.org/10.1073/pnas.192301899', 'https://doi.org/10.1093/nar/gkn823']"
4184,15313924,2004,HHPHG,HHPHG,5,Linear,L,None,Free,Free,Antiangiogenesis and Antitumor,Synthetic Peptide,Not Available,Tumor,Tropomyosin binding assay,IC50=92 µM,Not Available,Not Available,None,N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)O,https://doi.org/10.1158/0008-5472.CAN-04-0440
4185,15313924,2004,HHPHGHHPHG,(HHPHG)2,10,Linear,L,None,Free,Free,Antiangiogenesis and Antitumor,Synthetic Peptide,Not Available,Tumor,Tropomyosin binding assay,IC50=11.6 µM,Not Available,Not Available,None,N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)O,https://doi.org/10.1158/0008-5472.CAN-04-0440
4186,15313924,2004,HHPHGHHPHG,(HHPHG)2,10,Linear,L,None,Amidation,Acetylation,Antiangiogenesis and Antitumor,Synthetic Peptide,Not Available,Tumor,Tropomyosin binding assay,IC50=26.9 µM,Not Available,Not Available,None,C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N,https://doi.org/10.1158/0008-5472.CAN-04-0440
4187,15313924,2004,HHPHGHHPHGHHPHG,(HHPHG)3,15,Linear,L,None,Free,Free,Antiangiogenesis and Antitumor,Synthetic Peptide,Not Available,Tumor,Tropomyosin binding assay,IC50=1.25 µM,Not Available,Not Available,None,N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)O,https://doi.org/10.1158/0008-5472.CAN-04-0440
4188,15313924,2004,HHPHGHHPHGHHPHG,(HHPHG)3,15,Linear,L,None,Amidation,Acetylation,Antiangiogenesis and Antitumor,Synthetic Peptide,Not Available,Tumor,Tropomyosin binding assay,IC50=1.56 µM,Not Available,Not Available,None,C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N,https://doi.org/10.1158/0008-5472.CAN-04-0440
4189,15313924,2004,HHPHGHHPHGHHPHGHHPHG,(HHPHG)4,20,Linear,L,None,Free,Free,Antiangiogenesis and Antitumor,Synthetic Peptide,Not Available,Tumor,Tropomyosin binding assay,IC50=0.256 µM,Not Available,Not Available,None,N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)[C@H]1OOC(=O)CNC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H]3N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN1)Cc1[nH]cnc1)Cc1[nH]cnc1)CCC3)Cc1[nH]cnc1)Cc1[nH]cnc1)Cc1[nH]cnc1)CCC2)Cc1[nH]cnc1,https://doi.org/10.1158/0008-5472.CAN-04-0440
4190,15313924,2004,HHPHGHHPHGHHPHGHHPHG,(HHPHG)4,20,Linear,L,None,Amidation,Acetylation,Antiangiogenesis and Antitumor,Synthetic Peptide,Not Available,Tumor,Tropomyosin binding assay,IC50=0.245 µM,Not Available,Not Available,None,C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N,https://doi.org/10.1158/0008-5472.CAN-04-0440
4185,15313924,2004,HHPHGHHPHG,(HHPHG)2,10,Linear,L,None,Free,Free,Antiangiogenesis and Antitumor,Synthetic Peptide,Not Available,Tumor,Tropomyosin binding assay,IC50=11.6 µM,Not Available,Not Available,None,N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)O,https://doi.org/10.1158/0008-5472.CAN-04-0440
4186,15313924,2004,HHPHGHHPHG,(HHPHG)2,10,Linear,L,None,Amidation,Acetylation,Antiangiogenesis and Antitumor,Synthetic Peptide,Not Available,Tumor,Tropomyosin binding assay,IC50=26.9 µM,Not Available,Not Available,None,C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N,https://doi.org/10.1158/0008-5472.CAN-04-0440
4187,15313924,2004,HHPHGHHPHGHHPHG,(HHPHG)3,15,Linear,L,None,Free,Free,Antiangiogenesis and Antitumor,Synthetic Peptide,Not Available,Tumor,Tropomyosin binding assay,IC50=1.25 µM,Not Available,Not Available,None,N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)O,https://doi.org/10.1158/0008-5472.CAN-04-0440
4188,15313924,2004,HHPHGHHPHGHHPHG,(HHPHG)3,15,Linear,L,None,Amidation,Acetylation,Antiangiogenesis and Antitumor,Synthetic Peptide,Not Available,Tumor,Tropomyosin binding assay,IC50=1.56 µM,Not Available,Not Available,None,C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N,https://doi.org/10.1158/0008-5472.CAN-04-0440
4189,15313924,2004,HHPHGHHPHGHHPHGHHPHG,(HHPHG)4,20,Linear,L,None,Free,Free,Antiangiogenesis and Antitumor,Synthetic Peptide,Not Available,Tumor,Tropomyosin binding assay,IC50=0.256 µM,Not Available,Not Available,None,N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)[C@H]1OOC(=O)CNC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H]3N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN1)Cc1[nH]cnc1)Cc1[nH]cnc1)CCC3)Cc1[nH]cnc1)Cc1[nH]cnc1)Cc1[nH]cnc1)CCC2)Cc1[nH]cnc1,https://doi.org/10.1158/0008-5472.CAN-04-0440
4190,15313924,2004,HHPHGHHPHGHHPHGHHPHG,(HHPHG)4,20,Linear,L,None,Amidation,Acetylation,Antiangiogenesis and Antitumor,Synthetic Peptide,Not Available,Tumor,Tropomyosin binding assay,IC50=0.245 µM,Not Available,Not Available,None,C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N,https://doi.org/10.1158/0008-5472.CAN-04-0440
4187,15313924,2004,HHPHGHHPHGHHPHG,(HHPHG)3,15,Linear,L,None,Free,Free,Antiangiogenesis and Antitumor,Synthetic Peptide,Not Available,Tumor,Tropomyosin binding assay,IC50=1.25 µM,Not Available,Not Available,None,N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)O,https://doi.org/10.1158/0008-5472.CAN-04-0440
4188,15313924,2004,HHPHGHHPHGHHPHG,(HHPHG)3,15,Linear,L,None,Amidation,Acetylation,Antiangiogenesis and Antitumor,Synthetic Peptide,Not Available,Tumor,Tropomyosin binding assay,IC50=1.56 µM,Not Available,Not Available,None,C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N,https://doi.org/10.1158/0008-5472.CAN-04-0440
4189,15313924,2004,HHPHGHHPHGHHPHGHHPHG,(HHPHG)4,20,Linear,L,None,Free,Free,Antiangiogenesis and Antitumor,Synthetic Peptide,Not Available,Tumor,Tropomyosin binding assay,IC50=0.256 µM,Not Available,Not Available,None,N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)[C@H]1OOC(=O)CNC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H]3N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN1)Cc1[nH]cnc1)Cc1[nH]cnc1)CCC3)Cc1[nH]cnc1)Cc1[nH]cnc1)Cc1[nH]cnc1)CCC2)Cc1[nH]cnc1,https://doi.org/10.1158/0008-5472.CAN-04-0440
4190,15313924,2004,HHPHGHHPHGHHPHGHHPHG,(HHPHG)4,20,Linear,L,None,Amidation,Acetylation,Antiangiogenesis and Antitumor,Synthetic Peptide,Not Available,Tumor,Tropomyosin binding assay,IC50=0.245 µM,Not Available,Not Available,None,C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N,https://doi.org/10.1158/0008-5472.CAN-04-0440
4189,15313924,2004,HHPHGHHPHGHHPHGHHPHG,(HHPHG)4,20,Linear,L,None,Free,Free,Antiangiogenesis and Antitumor,Synthetic Peptide,Not Available,Tumor,Tropomyosin binding assay,IC50=0.256 µM,Not Available,Not Available,None,N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)[C@H]1OOC(=O)CNC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H]3N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN1)Cc1[nH]cnc1)Cc1[nH]cnc1)CCC3)Cc1[nH]cnc1)Cc1[nH]cnc1)Cc1[nH]cnc1)CCC2)Cc1[nH]cnc1,https://doi.org/10.1158/0008-5472.CAN-04-0440
4190,15313924,2004,HHPHGHHPHGHHPHGHHPHG,(HHPHG)4,20,Linear,L,None,Amidation,Acetylation,Antiangiogenesis and Antitumor,Synthetic Peptide,Not Available,Tumor,Tropomyosin binding assay,IC50=0.245 µM,Not Available,Not Available,None,C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N,https://doi.org/10.1158/0008-5472.CAN-04-0440
4205,15867360,2005,HPTWPQKSVWHGSDPNGRRLTESY,hP6,24,Linear,L,None,Free,Free,Antiangiogenesis,Human endostatin peptides,BxPC-3,Pancreatic Cancer,Matrigel Assay,No inhibition at 7 mg/kg/d,672-h,Pancreatic,None,N[C@@H](Cc1[nH]cnc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1158/0008-5472.CAN-04-1833
4200,15867360,2005,HSHRDFQPVLHLVALNSPLSGGMRG,hP1,25,Linear,L,None,Free,Free,Antiangiogenesis,Human endostatin peptides,BxPC-3,Pancreatic Cancer,Matrigel Assay,39% inhibition at 7 mg/kg/d,672-h,Pancreatic,None,N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)O,https://doi.org/10.1158/0008-5472.CAN-04-1833
No data available in table,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found
4438,"16129513, 18957441",2005,IDWKKLLDAAKQIL,Polybia-MPI,14,Not Available,L,None,Free,Free,Antibacterial,"venom, social wasp,Polybia paulista",Not Available,Breast Cancer,Not Available,Not Available,Not Available,Not Available,None,N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O,"['https://doi.org/10.1016/j.peptides.2005.04.026', 'https://doi.org/10.1093/nar/gkn823']"
4469,22076954,2011,IELLQARGGC-Pem,Peptide-1,10,Linear,L,Pem= Pemetrexed,Amidation,Free,Anticancer,Synthetic,HL-60,Leukemia Cancer,MTT/MTS assay,IC50 = 2.17 µM,3-h,Blood,None,NA,https://doi.org/10.1002/psc.1407
4470,22076954,2011,IELLQARGGC-Pem-GGRRRRRRRR,Peptide-2,10,Linear,L,Pem= Pemetrexed,Amidation,Free,Anticancer,Synthetic,HL-60,Leukemia Cancer,MTT/MTS assay,IC50 = 2.64 µM,3-h,Blood,None,NA,https://doi.org/10.1002/psc.1407
4472,22076954,2011,IELLQARGGC-Pem,Peptide-1,10,Linear,L,Pem= Pemetrexed,Amidation,Free,Anticancer,Synthetic,NCI-H358,Lung Cancer,MTT/MTS assay,IC50 = 4.63 mM,3-h,Lung,None,NA,https://doi.org/10.1002/psc.1407
4473,22076954,2011,IELLQARGGC-Pem-GGRRRRRRRR,Peptide-2,20,Linear,L,Pem= Pemetrexed,Amidation,Free,Anticancer,Synthetic,NCI-H358,Lung Cancer,MTT/MTS assay,IC50 = 2.19 µM,3-h,Lung,None,NA,https://doi.org/10.1002/psc.1407
4470,22076954,2011,IELLQARGGC-Pem-GGRRRRRRRR,Peptide-2,10,Linear,L,Pem= Pemetrexed,Amidation,Free,Anticancer,Synthetic,HL-60,Leukemia Cancer,MTT/MTS assay,IC50 = 2.64 µM,3-h,Blood,None,NA,https://doi.org/10.1002/psc.1407
4473,22076954,2011,IELLQARGGC-Pem-GGRRRRRRRR,Peptide-2,20,Linear,L,Pem= Pemetrexed,Amidation,Free,Anticancer,Synthetic,NCI-H358,Lung Cancer,MTT/MTS assay,IC50 = 2.19 µM,3-h,Lung,None,NA,https://doi.org/10.1002/psc.1407
1526,16637646,2006,IGKEFKRIVQRIKDFLRNLVPRTES,LL-37(13-37),25,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KBv,Tumor,MTT/MTS assay,LC50=39 µM,24-h,Not Available,None,N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1021/ja0584875
1532,16637646,2006,IGKEFKRIVQRIKDFLRNLVPRTES,LL-37(13-37),25,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KB,Oral Cancer,MTT/MTS assay,LC50=40 µM,24-h,Not Available,None,N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1021/ja0584875
1538,16637646,2006,IGKEFKRIVQRIKDFLRNLVPRTES,LL-37(13-37),25,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",HBMEC,Prostate Cancer,MTT/MTS assay,LC50=38 µM,24-h,Not Available,None,N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1021/ja0584875
5002,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,MCF-7,Breast Cancer,MTT/MTS assay,LC50= 21 at 100 µM,72-h,Breast,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
5004,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,LNCaP,Prostate cancer,MTT/MTS assay,LC50= 27 at 100 µM,72-h,Prostate,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
5006,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,OVRCAR-3,Ovarian Cancer,MTT/MTS assay,LC50= 24 at 100 µM,72-h,Ovary,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
4398,"11835991, 18957441",2002,ILGPVISTIGGVLGGLLKNL,Maximin H1,27,Not Available,L,None,Free,Free,Antibacterial,Bombina maxima,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)O,"['https://doi.org/10.1016/s0196-9781(01)00641-6', 'https://doi.org/10.1093/nar/gkn823']"
4439,"19341344, 18957441",2009,ILPILSLIGGLLGK,Temporin-1CEb,17,Not Available,L,None,Free,Free,Antimicrobial,"Rana chensinensis, China, Asia",Not Available,Breast Cancer,Not Available,Not Available,Not Available,Not Available,None,N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.2108/zsj.26.220', 'https://doi.org/10.1093/nar/gkn823']"
1812,None,2005,ILPWKWPWWPWRR,Indolicidin,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =64 µg/ml,24-h,Breast,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)CCCNC(=[NH2])N)Cc4c[nH]c5c4cccc5)CCC3)Cc3c[nH]c4c3cccc4)Cc3c[nH]c4c3cccc4)CCC2)Cc2c[nH]c3c2cccc3)CCCC[NH3])Cc2c[nH]c3c2cccc3)CCC1)CC(C)C)[C@H](CC)C,Not Found
1827,None,2005,ILPWKWPWWPWRR,Indolocidin-ac,13,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =12 µg/ml,24-h,Breast,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)CCCNC(=[NH2])N)Cc4c[nH]c5c4cccc5)CCC3)Cc3c[nH]c4c3cccc4)Cc3c[nH]c4c3cccc4)CCC2)Cc2c[nH]c3c2cccc3)CCCC[NH3])Cc2c[nH]c3c2cccc3)CCC1)CC(C)C)[C@H](CC)C,Not Found
1964,None,2005,ILPWKWPWWPWRR,Indolicidin,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =345 µg/ml,24-h,Colon,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)CCCNC(=[NH2])N)Cc4c[nH]c5c4cccc5)CCC3)Cc3c[nH]c4c3cccc4)Cc3c[nH]c4c3cccc4)CCC2)Cc2c[nH]c3c2cccc3)CCCC[NH3])Cc2c[nH]c3c2cccc3)CCC1)CC(C)C)[C@H](CC)C,Not Found
1979,None,2005,ILPWKWPWWPWRR,Indolocidin-ac,13,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =30 µg/ml,24-h,Colon,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)CCCNC(=[NH2])N)Cc4c[nH]c5c4cccc5)CCC3)Cc3c[nH]c4c3cccc4)Cc3c[nH]c4c3cccc4)CCC2)Cc2c[nH]c3c2cccc3)CCCC[NH3])Cc2c[nH]c3c2cccc3)CCC1)CC(C)C)[C@H](CC)C,Not Found
2116,None,2005,ILPWKWPWWPWRR,Indolicidin,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =200 µg/ml,24-h,Skin,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)CCCNC(=[NH2])N)Cc4c[nH]c5c4cccc5)CCC3)Cc3c[nH]c4c3cccc4)Cc3c[nH]c4c3cccc4)CCC2)Cc2c[nH]c3c2cccc3)CCCC[NH3])Cc2c[nH]c3c2cccc3)CCC1)CC(C)C)[C@H](CC)C,Not Found
2131,None,2005,ILPWKWPWWPWRR,Indolocidin-ac,13,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =180 µg/ml,24-h,Skin,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)CCCNC(=[NH2])N)Cc4c[nH]c5c4cccc5)CCC3)Cc3c[nH]c4c3cccc4)Cc3c[nH]c4c3cccc4)CCC2)Cc2c[nH]c3c2cccc3)CCCC[NH3])Cc2c[nH]c3c2cccc3)CCC1)CC(C)C)[C@H](CC)C,Not Found
2268,None,2005,ILPWKWPWWPWRR,Indolicidin,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =200 µg/ml,24-h,Skin,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)CCCNC(=[NH2])N)Cc4c[nH]c5c4cccc5)CCC3)Cc3c[nH]c4c3cccc4)Cc3c[nH]c4c3cccc4)CCC2)Cc2c[nH]c3c2cccc3)CCCC[NH3])Cc2c[nH]c3c2cccc3)CCC1)CC(C)C)[C@H](CC)C,Not Found
2283,None,2005,ILPWKWPWWPWRR,Indolocidin-ac,13,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =180 µg/ml,24-h,Skin,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)CCCNC(=[NH2])N)Cc4c[nH]c5c4cccc5)CCC3)Cc3c[nH]c4c3cccc4)Cc3c[nH]c4c3cccc4)CCC2)Cc2c[nH]c3c2cccc3)CCCC[NH3])Cc2c[nH]c3c2cccc3)CCC1)CC(C)C)[C@H](CC)C,Not Found
2420,None,2005,ILPWKWPWWPWRR,Indolicidin,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =270 µg/ml,24-h,Lung,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)CCCNC(=[NH2])N)Cc4c[nH]c5c4cccc5)CCC3)Cc3c[nH]c4c3cccc4)Cc3c[nH]c4c3cccc4)CCC2)Cc2c[nH]c3c2cccc3)CCCC[NH3])Cc2c[nH]c3c2cccc3)CCC1)CC(C)C)[C@H](CC)C,Not Found
2435,None,2005,ILPWKWPWWPWRR,Indolocidin-ac,13,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =64 µg/ml,24-h,Lung,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)CCCNC(=[NH2])N)Cc4c[nH]c5c4cccc5)CCC3)Cc3c[nH]c4c3cccc4)Cc3c[nH]c4c3cccc4)CCC2)Cc2c[nH]c3c2cccc3)CCCC[NH3])Cc2c[nH]c3c2cccc3)CCC1)CC(C)C)[C@H](CC)C,Not Found
2563,None,2005,ILPWKWPWWPWRR,Indolicidin,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =290 µg/ml,24-h,Prostate,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)CCCNC(=[NH2])N)Cc4c[nH]c5c4cccc5)CCC3)Cc3c[nH]c4c3cccc4)Cc3c[nH]c4c3cccc4)CCC2)Cc2c[nH]c3c2cccc3)CCCC[NH3])Cc2c[nH]c3c2cccc3)CCC1)CC(C)C)[C@H](CC)C,Not Found
2578,None,2005,ILPWKWPWWPWRR,Indolocidin-ac,13,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =31 µg/ml,24-h,Prostate,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)CCCNC(=[NH2])N)Cc4c[nH]c5c4cccc5)CCC3)Cc3c[nH]c4c3cccc4)Cc3c[nH]c4c3cccc4)CCC2)Cc2c[nH]c3c2cccc3)CCCC[NH3])Cc2c[nH]c3c2cccc3)CCC1)CC(C)C)[C@H](CC)C,Not Found
2706,None,2005,ILPWKWPWWPWRR,Indolicidin,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =345 µg/ml,24-h,Cervix,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)CCCNC(=[NH2])N)Cc4c[nH]c5c4cccc5)CCC3)Cc3c[nH]c4c3cccc4)Cc3c[nH]c4c3cccc4)CCC2)Cc2c[nH]c3c2cccc3)CCCC[NH3])Cc2c[nH]c3c2cccc3)CCC1)CC(C)C)[C@H](CC)C,Not Found
2721,None,2005,ILPWKWPWWPWRR,Indolocidin-ac,13,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =20 µg/ml,24-h,Cervix,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)CCCNC(=[NH2])N)Cc4c[nH]c5c4cccc5)CCC3)Cc3c[nH]c4c3cccc4)Cc3c[nH]c4c3cccc4)CCC2)Cc2c[nH]c3c2cccc3)CCCC[NH3])Cc2c[nH]c3c2cccc3)CCC1)CC(C)C)[C@H](CC)C,Not Found
1424,"14508884, 21403917",2003,ILRWPWWPWRRK,OmigaNAn MBI-226,12,Linear,L,None,Amidation,Free,Antimicrobial,Helical peptide with a predominance of one or more amino acids tryptophane-rich,U-937,Lymphoma Cancer,MTT/MTS assay,27% Cytotoxicity at 0.5 µg/ml,6-h,Blood,None,N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N,"['Not Found', 'Not Found']"
4595,21403917,2011,ILRWPWWPWRRK,Omiganan MBI-226,12,Linear,L,None,Amidation,Free,Antimicrobial,Bovine neutrophils,U-937,Lymphoma Cancer,MTT/MTS assay,IC50 =80-85 µg/ml,Not Available,Blood,None,N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
4368,"22467870, 18957441",2012,IPCGESCVWIPCISGMFGCSCKDKVCYS,ChaC11,29,Not Available,L,None,Free,Free,Antibacterial,Chassalia chartacea,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)O,"['https://doi.org/10.1074/jbc.M111.338970', 'https://doi.org/10.1093/nar/gkn823']"
4366,"22467870, 18957441",2012,IPCGESCVWIPCITAIAGCSCKNKVCYT,ChaC7,29,Not Available,L,None,Free,Free,Antibacterial,Chassalia chartacea,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)O,"['https://doi.org/10.1074/jbc.M111.338970', 'https://doi.org/10.1093/nar/gkn823']"
3834,20515045,2010,IVRRADRAAVP,ES-2,11,Linear,L,None,Free,Free,Antitumor,Endostatin derived synthetic peptide,BAE,Tumor,MTT/MTS assay,60% inhibition at 2.5µg/ml,NA,Not Available,None,N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)O,https://doi.org/10.1021/bc900292y
3835,20515045,2010,IVRRADRAAVP,ES-2,11,Linear,L,None,Free,Free,Antitumor,Endostatin derived synthetic peptide,BAE,Tumor,MTT/MTS assay,60% inhibition at 5µg/ml,NA,Not Available,None,N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)O,https://doi.org/10.1021/bc900292y
3836,20515045,2010,IVRRADRAAVP,ES-2,11,Linear,L,None,Free,Free,Antitumor,Endostatin derived synthetic peptide,BAE,Tumor,MTT/MTS assay,60% inhibition at 10µg/ml,NA,Not Available,None,N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)O,https://doi.org/10.1021/bc900292y
3837,20515045,2010,ACDCRGDCFCGGGGIVRRADRAAVP,AP,25,Linear,L,None,Free,Free,Antitumor,Endostatin derived synthetic peptide,BAE,Tumor,MTT/MTS assay,50% inhibition at 2.5µg/ml,NA,Not Available,None,N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)O,https://doi.org/10.1021/bc900292y
3838,20515045,2010,ACDCRGDCFCGGGGIVRRADRAAVP,AP,25,Linear,L,None,Free,Free,Antitumor,Endostatin derived synthetic peptide,BAE,Tumor,MTT/MTS assay,40% inhibition at 5µg/ml,NA,Not Available,None,N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)O,https://doi.org/10.1021/bc900292y
3839,20515045,2010,ACDCRGDCFCGGGGIVRRADRAAVP,AP,25,Linear,L,None,Free,Free,Antitumor,Endostatin derived synthetic peptide,BAE,Tumor,MTT/MTS assay,75% inhibition at 10µg/ml,NA,Not Available,None,N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)O,https://doi.org/10.1021/bc900292y
3840,20515045,2010,ACDCRGDCFCGGGGIVRRADRAAVP,AP(O),25,"Cyclic(C2-C10,C",L,None,Free,Free,Antitumor,Endostatin derived synthetic peptide,BAE,Tumor,MTT/MTS assay,40% inhibition at 2.5µg/ml,NA,Not Available,None,N[C@@H](C)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H]2NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CC(=O)O)CSSC2)CCCN=C)CC(=O)O)Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)O,https://doi.org/10.1021/bc900292y
3841,20515045,2010,ACDCRGDCFCGGGGIVRRADRAAVP,AP(O),25,"Cyclic(C2-C10,C",L,None,Free,Free,Antitumor,Endostatin derived synthetic peptide,BAE,Tumor,MTT/MTS assay,42% inhibition at 5µg/ml,NA,Not Available,None,N[C@@H](C)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H]2NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CC(=O)O)CSSC2)CCCN=C)CC(=O)O)Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)O,https://doi.org/10.1021/bc900292y
3842,20515045,2010,ACDCRGDCFCGGGGIVRRADRAAVP,AP(O),25,"Cyclic(C2-C10,C",L,None,Free,Free,Antitumor,Endostatin derived synthetic peptide,BAE,Tumor,MTT/MTS assay,52% inhibition at 10µg/ml,NA,Not Available,None,N[C@@H](C)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H]2NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CC(=O)O)CSSC2)CCCN=C)CC(=O)O)Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)O,https://doi.org/10.1021/bc900292y
3288,19527490,2009,KAAKKAAKAAKKAAKAAKKAA,KW5,21,Linear,L,None,Free,Free,Anticancer,Bovine lactoferrin (Lf-B),FEMX,Skin Cancer,MTT/MTS assay,IC50 =30±3 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1186/1471-2407-9-183
3289,19527490,2009,KAAKKAAKAAKKAAKAAKKAA,KW5,21,Linear,L,None,Free,Free,Anticancer,Synthetic peptide,HT-29,Colon Cancer,MTT/MTS assay,IC50 =55±14 µM,NA,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1186/1471-2407-9-183
4478,22057278,2011,KAAKKAWKAAKKAAKWWKKAA,Z4,21,Linear,L,None,Free,Free,Anticancer,Synthetic,Meth A,Skin Cancer,MTT/MTS assay,EC50 =155 µM,Not Available,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4488,22057278,2011,KAAKKAWKAAKKAAKWWKKAA,Z4,21,Linear,L,None,Free,Free,Anticancer,Synthetic,MT-1,Breast Cancer,MTT/MTS assay,EC50 =68 µM,Not Available,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4498,22057278,2011,KAAKKAWKAAKKAAKWWKKAA,Z4,21,Linear,L,None,Free,Free,Anticancer,Synthetic,HT-29,Colon Cancer,MTT/MTS assay,EC50 =173 µM,Not Available,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4481,22057278,2011,KAAKKAWKAAKKAWKAAKKAA,Z7,21,Linear,L,None,Free,Free,Anticancer,Synthetic,Meth A,Skin Cancer,MTT/MTS assay,EC50 =15 µM,Not Available,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4491,22057278,2011,KAAKKAWKAAKKAWKAAKKAA,Z7,21,Linear,L,None,Free,Free,Anticancer,Synthetic,MT-1,Breast Cancer,MTT/MTS assay,EC50 =15 µM,Not Available,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4501,22057278,2011,KAAKKAWKAAKKAWKAAKKAA,Z7,21,Linear,L,None,Free,Free,Anticancer,Synthetic,HT-29,Colon Cancer,MTT/MTS assay,EC50 =21 µM,Not Available,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4477,22057278,2011,KAAKKAWKAWKKAAKAAWKKAA,Z3,21,Linear,L,None,Free,Free,Anticancer,Synthetic,Meth A,Skin Cancer,MTT/MTS assay,EC50 >211 µM,Not Available,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4487,22057278,2011,KAAKKAWKAWKKAAKAAWKKAA,Z3,21,Linear,L,None,Free,Free,Anticancer,Synthetic,MT-1,Breast Cancer,MTT/MTS assay,EC50 =128 µM,Not Available,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4497,22057278,2011,KAAKKAWKAWKKAAKAAWKKAA,Z3,21,Linear,L,None,Free,Free,Anticancer,Synthetic,HT-29,Colon Cancer,MTT/MTS assay,EC50 >211 µM,Not Available,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4479,22057278,2011,KAAKKAWKWAKKAAKWAKKAA,Z5,21,Linear,L,None,Free,Free,Anticancer,Synthetic,Meth A,Skin Cancer,MTT/MTS assay,EC50 =42 µM,Not Available,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4489,22057278,2011,KAAKKAWKWAKKAAKWAKKAA,Z5,21,Linear,L,None,Free,Free,Anticancer,Synthetic,MT-1,Breast Cancer,MTT/MTS assay,EC50 =28 µM,Not Available,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4499,22057278,2011,KAAKKAWKWAKKAAKWAKKAA,Z5,21,Linear,L,None,Free,Free,Anticancer,Synthetic,HT-29,Colon Cancer,MTT/MTS assay,EC50 =67 µM,Not Available,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4475,22057278,2011,KAAKKWAKAAKKAAKAWKKAA,Z1,21,Linear,L,None,Free,Free,Anticancer,Synthetic,Meth A,Skin Cancer,MTT/MTS assay,EC50 >211 µM,Not Available,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4485,22057278,2011,KAAKKWAKAAKKWAKAWKKAA,Z1,21,Linear,L,None,Free,Free,Anticancer,Synthetic,MT-1,Breast Cancer,MTT/MTS assay,EC50 =186 µM,Not Available,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4495,22057278,2011,KAAKKWAKAAKKWAKAWKKAA,Z1,21,Linear,L,None,Free,Free,Anticancer,Synthetic,HT-29,Colon Cancer,MTT/MTS assay,EC50 >211 µM,Not Available,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4476,22057278,2011,KAAKKWAKAWKKAAKAWKKAA,Z2,21,Linear,L,None,Free,Free,Anticancer,Synthetic,Meth A,Skin Cancer,MTT/MTS assay,EC50 >211 µM,Not Available,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4486,22057278,2011,KAAKKWAKAWKKAAKAWKKAA,Z2,21,Linear,L,None,Free,Free,Anticancer,Synthetic,MT-1,Breast Cancer,MTT/MTS assay,EC50 =173 µM,Not Available,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4496,22057278,2011,KAAKKWAKAWKKAAKAWKKAA,Z2,21,Linear,L,None,Free,Free,Anticancer,Synthetic,HT-29,Colon Cancer,MTT/MTS assay,EC50 >211 µM,Not Available,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
1880,None,2005,KAKLAKKALAKLL,FLAK92B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2032,None,2005,KAKLAKKALAKLL,FLAK92B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2184,None,2005,KAKLAKKALAKLL,FLAK92B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2336,None,2005,KAKLAKKALAKLL,FLAK92B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2489,None,2005,KAKLAKKALAKLL,FLAK92B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2632,None,2005,KAKLAKKALAKLL,FLAK92B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2775,None,2005,KAKLAKKALAKLL,FLAK92B,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1861,None,2005,KAKLF,FLAK92,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2013,None,2005,KAKLF,FLAK92,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2165,None,2005,KAKLF,FLAK92,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2317,None,2005,KAKLF,FLAK92,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2470,None,2005,KAKLF,FLAK92,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2613,None,2005,KAKLF,FLAK92,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2756,None,2005,KAKLF,FLAK92,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
5015,24676901,2014,KAQ-Dip-QKQAW,LTX-328,8,Linear,L,Dip = diphenylalanine,Amidation,Free,Antimicrobial,Synthetic peptide,Fem-X,Skin Cancer,MTT/MTS assay,IC50= >350 µM,5–60 Min,Skin,None,NA,https://doi.org/10.1007/s00262-014-1540-0
1547,18656352,2008,KAQIRAMECNIL,A5,12,Linear,L,None,Free,Free,Anticancer,Cyclin B (285-296),HCT-116,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1016/j.bmcl.2008.07.017
1549,18656352,2008,KAQIRAMECNILGRKKRRQRRR,Tat-a5,22,Linear,L,None,Free,Free,Anticancer,HIV-Tat (49-57),HCT-116,Colon Cancer,MTT/MTS assay,~80% Cytotoxicity at 100 µM,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.bmcl.2008.07.017
1549,18656352,2008,KAQIRAMECNILGRKKRRQRRR,Tat-a5,22,Linear,L,None,Free,Free,Anticancer,HIV-Tat (49-57),HCT-116,Colon Cancer,MTT/MTS assay,~80% Cytotoxicity at 100 µM,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.bmcl.2008.07.017
1898,None,2005,KFKKLAKKF,Modelin-8D,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2050,None,2005,KFKKLAKKF,Modelin-8D,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2202,None,2005,KFKKLAKKF,Modelin-8D,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2354,None,2005,KFKKLAKKF,Modelin-8D,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2507,None,2005,KFKKLAKKF,Modelin-8D,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2650,None,2005,KFKKLAKKF,Modelin-8D,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2793,None,2005,KFKKLAKKF,Modelin-8D,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
1899,None,2005,KFKKLAKKW,Modelin-8E,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N,Not Found
2051,None,2005,KFKKLAKKW,Modelin-8E,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =70 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N,Not Found
2203,None,2005,KFKKLAKKW,Modelin-8E,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N,Not Found
2355,None,2005,KFKKLAKKW,Modelin-8E,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N,Not Found
2508,None,2005,KFKKLAKKW,Modelin-8E,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N,Not Found
2651,None,2005,KFKKLAKKW,Modelin-8E,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N,Not Found
2794,None,2005,KFKKLAKKW,Modelin-8E,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =510 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N,Not Found
1838,None,2005,KIAKVALAKLGIGAVLKVLTTGL,PYL-ME,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =635 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1990,None,2005,KIAKVALAKLGIGAVLKVLTTGL,PYL-ME,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2142,None,2005,KIAKVALAKLGIGAVLKVLTTGL,PYL-ME,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2294,None,2005,KIAKVALAKLGIGAVLKVLTTGL,PYL-ME,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2447,None,2005,KIAKVALAKLGIGAVLKVLTTGL,PYL-ME,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2590,None,2005,KIAKVALAKLGIGAVLKVLTTGL,PYL-ME,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,Not Available,24-h,Prostate,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2733,None,2005,KIAKVALAKLGIGAVLKVLTTGL,PYL-ME,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
4174,14991605,2004,KIFGSLAFL,p369-CTL-A2xneu,9,Linear,L,None,Free,Free,Antitumor,Synthetic Peptide,N202.A2,Tumor,Peptide dose curve assay,0.1% Inhibition at 10-10 M,Not Available,Not Available,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/eji.200324427
4175,14991605,2004,KIFGSLAFL,p369-CTL-A2xneu,9,Linear,L,None,Free,Free,Antitumor,Synthetic Peptide,N202.A2,Tumor,Peptide dose curve assay,1% Inhibition at 10-9 M,Not Available,Not Available,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/eji.200324427
4176,14991605,2004,KIFGSLAFL,p369-CTL-A2xneu,9,Linear,L,None,Free,Free,Antitumor,Synthetic Peptide,N202.A2,Tumor,Peptide dose curve assay,5% Inhibition at 10-8 M,Not Available,Not Available,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/eji.200324427
4177,14991605,2004,KIFGSLAFL,p369-CTL-A2xneu,9,Linear,L,None,Free,Free,Antitumor,Synthetic Peptide,N202.A2,Tumor,Peptide dose curve assay,10% Inhibition at 10-7 M,Not Available,Not Available,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/eji.200324427
4178,14991605,2004,KIFGSLAFL,p369-CTL-A2xneu,9,Linear,L,None,Free,Free,Antitumor,Synthetic Peptide,N202.A2,Tumor,Peptide dose curve assay,20% Inhibition at 10-6 M,Not Available,Not Available,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/eji.200324427
4179,14991605,2004,KIFGSLAFL,p369-CTL-A2xFVB,9,Linear,L,None,Free,Free,Antitumor,Synthetic Peptide,N202.A2,Tumor,Peptide dose curve assay,8% Inhibition at 10-10 M,Not Available,Not Available,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/eji.200324427
4180,14991605,2004,KIFGSLAFL,p369-CTL-A2xFVB,9,Linear,L,None,Free,Free,Antitumor,Synthetic Peptide,N202.A2,Tumor,Peptide dose curve assay,25% Inhibition at 10-9 M,Not Available,Not Available,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/eji.200324427
4181,14991605,2004,KIFGSLAFL,p369-CTL-A2xFVB,9,Linear,L,None,Free,Free,Antitumor,Synthetic Peptide,N202.A2,Tumor,Peptide dose curve assay,80% Inhibition at 10-8 M,Not Available,Not Available,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/eji.200324427
4182,14991605,2004,KIFGSLAFL,p369-CTL-A2xFVB,9,Linear,L,None,Free,Free,Antitumor,Synthetic Peptide,N202.A2,Tumor,Peptide dose curve assay,85% Inhibition at 10-7 M,Not Available,Not Available,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/eji.200324427
4183,14991605,2004,KIFGSLAFL,p369-CTL-A2xFVB,9,Linear,L,None,Free,Free,Antitumor,Synthetic Peptide,N202.A2,Tumor,Peptide dose curve assay,92% Inhibition at 10-6 M,Not Available,Not Available,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/eji.200324427
3793,23893605,2013,KILRGVAKKILRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Anticancer,NK-2 variants,E42/02,Skin Cancer,MTT/MTS assay,IC50= 10.6±0.4 µM,30-Min,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3799,23893605,2013,KILRGVAKKILRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Anticancer,NK-2 variants,E42/02,Skin Cancer,MTT/MTS assay,IC50= 13.0±1.0 µM,2-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3805,23893605,2013,KILRGVAKKILRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Anticancer,NK-2 variants,E42/02,Skin Cancer,MTT/MTS assay,IC50= 12.1±1.6 µM,4-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3811,23893605,2013,KILRGVAKKILRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Anticancer,NK-2 variants,E42/02,Skin Cancer,MTT/MTS assay,IC50= 3.7± 4.3 µM,24-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3329,23893605,2013,KILRGVAKKIMRTFLRRILTGKK,C7A-Δ,24,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 =7.5 ± 0.4 µM,30-Min,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3330,23893605,2013,KILRGVAKKIMRTFLRRILTGKK,C7A-Δ,24,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 =13.8 ± 2.0 µM,2-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3331,23893605,2013,KILRGVAKKIMRTFLRRILTGKK,C7A-Δ,24,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 =9.3 ± 1.5 µM,4-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3332,23893605,2013,KILRGVAKKIMRTFLRRILTGKK,C7A-Δ,24,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 =13.1 ± 0.9 µM,24-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3795,23893605,2013,KILRGVAKKIMRTFLRRILTGKK,C7A- Δ,23,Linear,L,None,Amidation,Free,Anticancer,NK-2 variants,E42/02,Skin Cancer,MTT/MTS assay,IC50= 7.5±0.4 µM,30-Min,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3801,23893605,2013,KILRGVAKKIMRTFLRRILTGKK,C7A- Δ,23,Linear,L,None,Amidation,Free,Anticancer,NK-2 variants,E42/02,Skin Cancer,MTT/MTS assay,IC50= 13.8±2.0 µM,2-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3807,23893605,2013,KILRGVAKKIMRTFLRRILTGKK,C7A- Δ,23,Linear,L,None,Amidation,Free,Anticancer,NK-2 variants,E42/02,Skin Cancer,MTT/MTS assay,IC50= 9.3±1.5 µM,4-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3813,23893605,2013,KILRGVAKKIMRTFLRRILTGKK,C7A- Δ,23,Linear,L,None,Amidation,Free,Anticancer,NK-2 variants,E42/02,Skin Cancer,MTT/MTS assay,IC50= 13.1±0.9 µM,24-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3321,23893605,2013,KILRGVAKKIMRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 =10.6 ± 0.4 µM,30-Min,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3322,23893605,2013,KILRGVAKKIMRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 =13.0 ± 1.0 µM,2-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3323,23893605,2013,KILRGVAKKIMRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 =12.1 ± 1.6 µM,4-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3324,23893605,2013,KILRGVAKKIMRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 =37 ± 4.3 µM,24-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
5016,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HCT-116,Colorectal Cancer,Cell Viability assay,Cell viability >50% at 25μM approx,1-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5018,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A-Δ,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HCT-116,Colorectal Cancer,Cell Viability assay,Cell viability >50% at 12.5μM approx.,1-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5019,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC24,Colorectal Cancer,Cell Viability assay,Cell viability >60% at 25μM approx,1-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5021,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A-Δ,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC24,Colorectal Cancer,Cell Viability assay,Cell viability >60% at 25μM approx,1-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5022,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC40,Colorectal Cancer,Cell Viability assay,Cell viability >60% at 25μM approx,1-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5024,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A-Δ,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC40,Colorectal Cancer,Cell Viability assay,Cell viability >50% at 25μM approx,1-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5025,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC60,Colorectal Cancer,Cell Viability assay,Cell viability >50% at 25μM approx,1-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5027,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A-Δ,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC60,Colorectal Cancer,Cell Viability assay,Cell viability >50% at 25μM approx,1-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5028,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC32,Colorectal Cancer,Cell Viability assay,Cell viability >60% at 25μM approx,1-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5030,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A-Δ,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC32,Colorectal Cancer,Cell Viability assay,Cell viability =50% at 12.5μM approx.,1-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5031,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HCT-116,Colorectal Cancer,Cell Viability assay,Cell viability >40% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5033,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A-Δ,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HCT-116,Colorectal Cancer,Cell Viability assay,Cell viability >50% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5034,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC18,Colorectal Cancer,Cell Viability assay,Cell viability >55% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5036,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A-Δ,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC18,Colorectal Cancer,Cell Viability assay,Cell viability >75% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5037,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC24,Colorectal Cancer,Cell Viability assay,Cell viability >55% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5039,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A-Δ,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC24,Colorectal Cancer,Cell Viability assay,Cell viability >70% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5040,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC40,Colorectal Cancer,Cell Viability assay,Cell viability >45% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5042,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A-Δ,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC40,Colorectal Cancer,Cell Viability assay,Cell viability >85% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5043,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC60,Colorectal Cancer,Cell Viability assay,Cell viability >70% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5045,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A-Δ,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC60,Colorectal Cancer,Cell Viability assay,Cell viability >70% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5046,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC113,Colorectal Cancer,Cell Viability assay,Cell viability >80% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5048,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A-Δ,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC113,Colorectal Cancer,Cell Viability assay,Cell viability >70% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5049,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC32,Colorectal Cancer,Cell Viability assay,Cell viability >55% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5051,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A-Δ,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC32,Colorectal Cancer,Cell Viability assay,Cell viability >85% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5052,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC107,Colorectal Cancer,Cell Viability assay,Cell viability >50% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5054,24962950,2014,KILRGVAKKIMRTFLRRISKDILTGKK,C7A-Δ,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC107,Colorectal Cancer,Cell Viability assay,Cell viability >70% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
3325,23893605,2013,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21K,27,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 =8.4 ± 0.2 µM,30-Min,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3326,23893605,2013,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21K,27,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 =12.3 ± 2.0 µM,2-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3327,23893605,2013,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21K,27,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 =8.3 ± 0.5 µM,4-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3328,23893605,2013,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21K,27,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 =12.3 ± 1.0 µM,24-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3794,23893605,2013,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21k,27,Linear,L,None,Amidation,Free,Anticancer,NK-2 variants,E42/02,Skin Cancer,MTT/MTS assay,IC50= 8.4±0.2 µM,30-Min,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3800,23893605,2013,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21k,27,Linear,L,None,Amidation,Free,Anticancer,NK-2 variants,E42/02,Skin Cancer,MTT/MTS assay,IC50= 12.3±2.0 µM,2-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3806,23893605,2013,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21k,27,Linear,L,None,Amidation,Free,Anticancer,NK-2 variants,E42/02,Skin Cancer,MTT/MTS assay,IC50= 8.3±0.5 µM,4-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3812,23893605,2013,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21k,27,Linear,L,None,Amidation,Free,Anticancer,NK-2 variants,E42/02,Skin Cancer,MTT/MTS assay,IC50= 12.3±1.0 µM,24-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
5017,24962950,2014,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21K,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HCT-116,Colorectal Cancer,Cell Viability assay,Cell viability =50% at 12.5μM approx.,1-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5020,24962950,2014,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21K,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC24,Colorectal Cancer,Cell Viability assay,Cell viability >50% at 25μM approx,1-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5023,24962950,2014,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21K,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC40,Colorectal Cancer,Cell Viability assay,Cell viability >50% at 25μM approx,1-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5026,24962950,2014,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21K,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC60,Colorectal Cancer,Cell Viability assay,Cell viability >50% at 25μM approx,1-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5029,24962950,2014,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21K,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC32,Colorectal Cancer,Cell Viability assay,Cell viability =50% at 12.5μM approx.,1-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5032,24962950,2014,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21K,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HCT-116,Colorectal Cancer,Cell Viability assay,Cell viability >40% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5035,24962950,2014,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21K,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC18,Colorectal Cancer,Cell Viability assay,Cell viability >55% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5038,24962950,2014,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21K,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC24,Colorectal Cancer,Cell Viability assay,Cell viability >55% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5041,24962950,2014,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21K,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC40,Colorectal Cancer,Cell Viability assay,Cell viability >80% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5044,24962950,2014,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21K,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC60,Colorectal Cancer,Cell Viability assay,Cell viability >60% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5047,24962950,2014,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21K,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC113,Colorectal Cancer,Cell Viability assay,Cell viability >65% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5050,24962950,2014,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21K,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC32,Colorectal Cancer,Cell Viability assay,Cell viability >80% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
5053,24962950,2014,KILRGVAKKIMRTFLRRISKKILTGKK,C7A-D21K,27,Linear,L,None,Amidation,Free,Antitumor,NK-2 peptide based derivatives,HROC107,Colorectal Cancer,Cell Viability assay,Cell viability >65% at 12.5μM approx,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.18632/oncotarget.2039
1428,16269280,2005,KILRGVCKKIMRTFLRRISKDILTGKK,NK-2,27,Linear,L,None,Amidation,Free,Antibacterial,NK-lysin,NB LA-N-1,Colorectal Cancer,PI-uptake assay,LD50=1-4 µM,Not Available,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.febslet.2005.09.084
1429,16269280,2005,KILRGVCKKIMRTFLRRISKDILTGKK,NK-2,27,Linear,L,None,Amidation,Free,Antibacterial,NK-lysin,SH-SY5Y,Brain Tumor,PI-uptake assay,LD50=1-4 µM,Not Available,Brain,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.febslet.2005.09.084
1430,16269280,2005,KILRGVCKKIMRTFLRRISKDILTGKK,NK-2,27,Linear,L,None,Amidation,Free,Antibacterial,NK-lysin,U-937,Lymphoma Cancer,PI-uptake assay,LD50=30 µM,Not Available,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.febslet.2005.09.084
1431,16269280,2005,KILRGVCKKIMRTFLRRISKDILTGKK,NK-2,27,Linear,L,None,Amidation,Free,Antibacterial,NK-lysin,SW-480,Leukemia Cancer,PI-uptake assay,LD50=1-4 µM,Not Available,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.febslet.2005.09.084
3317,23893605,2013,KILRGVCKKIMRTFLRRISKDILTGKK,NK-2,27,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 = ~70 µM,30-Min,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3318,23893605,2013,KILRGVCKKIMRTFLRRISKDILTGKK,NK-2,27,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 = ~50 µM,2-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3319,23893605,2013,KILRGVCKKIMRTFLRRISKDILTGKK,NK-2,27,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 = ~50 µM,4-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3320,23893605,2013,KILRGVCKKIMRTFLRRISKDILTGKK,NK-2,27,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 = ~40 µM,24-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3789,23893605,2013,KILRGVCKKIMRTFLRRISKDILTGKK,NK-2,27,Linear,L,None,Amidation,Free,Anticancer,Residue of 39-65 of porcine NK-lysine,E42/02,Skin Cancer,MTT/MTS assay,IC50= 4.3±0.3 µM,4-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3792,23893605,2013,KILRGVCKKIMRTFLRRISKDILTGKK,NK-2,27,Linear,L,None,Amidation,Free,Anticancer,Residue of 39-65 of porcine NK-lysine,E42/02,Skin Cancer,MTT/MTS assay,IC50= 70 µM (approx),30-Min,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3798,23893605,2013,KILRGVCKKIMRTFLRRISKDILTGKK,NK-2,27,Linear,L,None,Amidation,Free,Anticancer,Residue of 39-65 of porcine NK-lysine,E42/02,Skin Cancer,MTT/MTS assay,IC50= 50 µM (approx),2-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3804,23893605,2013,KILRGVCKKIMRTFLRRISKDILTGKK,NK-2,27,Linear,L,None,Amidation,Free,Anticancer,Residue of 39-65 of porcine NK-lysine,E42/02,Skin Cancer,MTT/MTS assay,IC50= 50 µM (approx),4-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3810,23893605,2013,KILRGVCKKIMRTFLRRISKDILTGKK,NK-2,27,Linear,L,None,Amidation,Free,Anticancer,Residue of 39-65 of porcine NK-lysine,E42/02,Skin Cancer,MTT/MTS assay,IC50= 40 µM (approx),24-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3333,23893605,2013,KISKRILTGKK,NK11,11,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 >>100 µM,30-Min,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3334,23893605,2013,KISKRILTGKK,NK11,11,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 >>100 µM,2-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3335,23893605,2013,KISKRILTGKK,NK11,11,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 >>100 µM,4-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3336,23893605,2013,KISKRILTGKK,NK11,11,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 >>100 µM,24-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3790,23893605,2013,KISKRILTGKK,NK-11,11,Linear,L,None,Amidation,Free,Anticancer,NK2 derived inactive control peptide,E42/02,Skin Cancer,MTT/MTS assay,IC-50 >> 100 µM,4-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3796,23893605,2013,KISKRILTGKK,NK-11,11,Linear,L,None,Amidation,Free,Anticancer,NK2 derived inactive control peptide,E42/02,Skin Cancer,MTT/MTS assay,IC-50>> 100 µM,30-Min,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3802,23893605,2013,KISKRILTGKK,NK-11,11,Linear,L,None,Amidation,Free,Anticancer,NK2 derived inactive control peptide,E42/02,Skin Cancer,MTT/MTS assay,IC-50 >> 100 µM,2-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3808,23893605,2013,KISKRILTGKK,NK-11,11,Linear,L,None,Amidation,Free,Anticancer,NK2 derived inactive control peptide,E42/02,Skin Cancer,MTT/MTS assay,IC-50 >> 100 µM,4-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3814,23893605,2013,KISKRILTGKK,NK-11,11,Linear,L,None,Amidation,Free,Anticancer,NK2 derived inactive control peptide,E42/02,Skin Cancer,MTT/MTS assay,IC50 >> 100 µM,24-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1002/psc.2540
3271,18815734,2008,KKKFPWWWPFKKK,PST13-RK,13,Linear,L,None,Amidation,Free,Antimicrobial,Derivative of tritrpticin,A-549,Lung Cancer,MTT/MTS assay,IC50 =90 µg/ml,NA,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s10529-008-9848-5
3272,18815734,2008,KKKFPWWWPFKKK,PST13-RK,13,Linear,L,None,Amidation,Free,Antimicrobial,Derivative of tritrpticin,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50 =80 µg/ml,NA,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s10529-008-9848-5
3274,18815734,2008,KKKFPWWWPFKKKCKKKFPWWWPFKKKC,di-PST13-RK-C,28,Linear,L,None,Amidation,Free,Antimicrobial,Derivative of tritrpticin,A-549,Lung Cancer,MTT/MTS assay,IC50 =17 µg/ml,NA,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N,https://doi.org/10.1007/s10529-008-9848-5
3275,18815734,2008,KKKFPWWWPFKKKCKKKFPWWWPFKKKC,di-PST13-RK-C,28,Linear,L,None,Amidation,Free,Antimicrobial,Derivative of tritrpticin,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50 =17 µg/ml,NA,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N,https://doi.org/10.1007/s10529-008-9848-5
3277,18815734,2008,KKKFPWWWPFKKKKKKFPWWWPFKKKK,di-PST13-RK-K,27,Linear,L,None,Amidation,Free,Antimicrobial,Derivative of tritrpticin,A-549,Lung Cancer,MTT/MTS assay,IC50 =15 µg/ml,NA,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s10529-008-9848-5
3278,18815734,2008,KKKFPWWWPFKKKKKKFPWWWPFKKKK,di-PST13-RK-K,27,Linear,L,None,Amidation,Free,Antimicrobial,Derivative of tritrpticin,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50 =10 µg/ml,NA,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s10529-008-9848-5
3274,18815734,2008,KKKFPWWWPFKKKCKKKFPWWWPFKKKC,di-PST13-RK-C,28,Linear,L,None,Amidation,Free,Antimicrobial,Derivative of tritrpticin,A-549,Lung Cancer,MTT/MTS assay,IC50 =17 µg/ml,NA,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N,https://doi.org/10.1007/s10529-008-9848-5
3275,18815734,2008,KKKFPWWWPFKKKCKKKFPWWWPFKKKC,di-PST13-RK-C,28,Linear,L,None,Amidation,Free,Antimicrobial,Derivative of tritrpticin,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50 =17 µg/ml,NA,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N,https://doi.org/10.1007/s10529-008-9848-5
3277,18815734,2008,KKKFPWWWPFKKKKKKFPWWWPFKKKK,di-PST13-RK-K,27,Linear,L,None,Amidation,Free,Antimicrobial,Derivative of tritrpticin,A-549,Lung Cancer,MTT/MTS assay,IC50 =15 µg/ml,NA,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s10529-008-9848-5
3278,18815734,2008,KKKFPWWWPFKKKKKKFPWWWPFKKKK,di-PST13-RK-K,27,Linear,L,None,Amidation,Free,Antimicrobial,Derivative of tritrpticin,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50 =10 µg/ml,NA,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s10529-008-9848-5
1911,None,2005,KKVVFKVKFK,KSL-1,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =340 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2063,None,2005,KKVVFKVKFK,KSL-1,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2215,None,2005,KKVVFKVKFK,KSL-1,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =700 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2367,None,2005,KKVVFKVKFK,KSL-1,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =700 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2520,None,2005,KKVVFKVKFK,KSL-1,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =720 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2663,None,2005,KKVVFKVKFK,KSL-1,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
2806,None,2005,KKVVFKVKFK,KSL-1,10,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N,Not Found
3308,21453492,2011,KKWWKKW-Dip-K,LTX-315,9,Linear,L,Dip = diphenylalanine,Amidation,Free,Antimicrobial,Synthetic peptide,HT-29,Colon Cancer,MTT/MTS assay,IC50 =38 ± 3 µM,30-Min,Colon,None,NA,https://doi.org/10.1186/1471-2407-11-116
3309,21453492,2011,KKWWKKW-Dip-K,LTX-315,9,Linear,L,Dip = diphenylalanine,Amidation,Free,Antimicrobial,Synthetic peptide,MT-1,Breast Cancer,MTT/MTS assay,IC50 =31 ± 3 µM,30-Min,Breast,None,NA,https://doi.org/10.1186/1471-2407-11-116
3310,21453492,2011,KKWWKKW-Dip-K,LTX-315,9,Linear,L,Dip = diphenylalanine,Amidation,Free,Antimicrobial,Synthetic peptide,Kelly,Brain Tumor,MTT/MTS assay,IC50 =14 ± 1 µM,30-Min,Brain,None,NA,https://doi.org/10.1186/1471-2407-11-116
5012,24676901,2014,KKWWKKW-Dip-K,LTX-315,9,Linear,L,Dip = diphenylalanine,Amidation,Free,Antimicrobial,Synthetic peptide,B16F1,Skin Cancer,MTT/MTS assay,IC50=13.3 µM,30-Min,Skin,None,NA,https://doi.org/10.1007/s00262-014-1540-0
5013,24676901,2014,KKWWKKW-Dip-K,LTX-315,9,Linear,L,Dip = diphenylalanine,Amidation,Free,Antimicrobial,Synthetic peptide,A375,Skin Cancer,MTT/MTS assay,IC50=12.7 µM,30-Min,Skin,None,NA,https://doi.org/10.1007/s00262-014-1540-0
5014,24676901,2014,KKWWKKW-Dip-K,LTX-315,9,Linear,L,Dip = diphenylalanine,Amidation,Free,Antimicrobial,Synthetic peptide,Fem-X,Skin Cancer,MTT/MTS assay,IC50=15.3 µM,30-Min,Skin,None,NA,https://doi.org/10.1007/s00262-014-1540-0
3773,22933412,2012,"KKWβ2,2WKK",c1,7,Cyclic,L,"(2,2-di(naphthalen-2-ylmethyl)-3-amino-propionic acid)",Free,Free,Anticancer,"KKWβ2,2WKK",Ramos,Lymphoma Cancer,MTT/MTS assay,IC50= 10±2 µMol/L,NA,Blood,None,NA,https://doi.org/10.1002/psc.2441
3781,22933412,2012,"KKWβ2,2WKK",c1,7,Linear,L,"(2,2-di(naphthalen-2-ylmethyl)-3-amino-propionic acid)",Amidation,Free,Anticancer,"KKWβ2,2WKK",Ramos,Lymphoma Cancer,MTT/MTS assay,IC50= 22±5 µMol/L,NA,Blood,None,NA,https://doi.org/10.1002/psc.2441
No data available in table,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found
1889,None,2005,KLAKKLAKLAKLAKAL,Modelin-5,16,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =61 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1890,None,2005,KLAKKLAKLAKLAKAL,Modelin-5-CO2H,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =320 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2041,None,2005,KLAKKLAKLAKLAKAL,Modelin-5,16,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2042,None,2005,KLAKKLAKLAKLAKAL,Modelin-5-CO2H,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =370 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2193,None,2005,KLAKKLAKLAKLAKAL,Modelin-5,16,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2194,None,2005,KLAKKLAKLAKLAKAL,Modelin-5-CO2H,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =220 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2345,None,2005,KLAKKLAKLAKLAKAL,Modelin-5,16,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2346,None,2005,KLAKKLAKLAKLAKAL,Modelin-5-CO2H,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =220 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2498,None,2005,KLAKKLAKLAKLAKAL,Modelin-5,16,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =74 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2499,None,2005,KLAKKLAKLAKLAKAL,Modelin-5-CO2H,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =470 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2641,None,2005,KLAKKLAKLAKLAKAL,Modelin-5,16,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =145 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2642,None,2005,KLAKKLAKLAKLAKAL,Modelin-5-CO2H,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =450 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2784,None,2005,KLAKKLAKLAKLAKAL,Modelin-5,16,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =275 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2785,None,2005,KLAKKLAKLAKLAKAL,Modelin-5-CO2H,16,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =550 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1709,11691780,2001,KLAKLAKKLAKLAK,DP1,14,Linear,L,None,Free,Free,Antimicrobial,Protein transduction domain,MCA205,Renal Cancer,MTT/MTS assay,LC50 =< 50 µM,168-h,Renal,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1881,None,2005,KLALKLALKALKAAKLA,FLAK99,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =160 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,Not Found
2033,None,2005,KLALKLALKALKAAKLA,FLAK99,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =235 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,Not Found
2185,None,2005,KLALKLALKALKAAKLA,FLAK99,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =190 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,Not Found
2337,None,2005,KLALKLALKALKAAKLA,FLAK99,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =190 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,Not Found
2490,None,2005,KLALKLALKALKAAKLA,FLAK99,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =185 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,Not Found
2633,None,2005,KLALKLALKALKAAKLA,FLAK99,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =74 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,Not Found
2776,None,2005,KLALKLALKALKAAKLA,FLAK99,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =320 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,Not Found
4395,"20575512, 18957441",2010,KLCGETCFKFKCYTPGCSCSYPFCK,Psyle C,25,Not Available,L,None,Free,Free,Antibacterial,Psychotria leptothyrsa,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1021/np9007365', 'https://doi.org/10.1093/nar/gkn823']"
1887,None,2005,KLLKLLLKLYKKLLKLL,FLAK100-CO2H,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =135 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2039,None,2005,KLLKLLLKLYKKLLKLL,FLAK100-CO2H,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =345 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2191,None,2005,KLLKLLLKLYKKLLKLL,FLAK100-CO2H,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =520 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2343,None,2005,KLLKLLLKLYKKLLKLL,FLAK100-CO2H,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =520 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2496,None,2005,KLLKLLLKLYKKLLKLL,FLAK100-CO2H,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,Not Available,24-h,Lung,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2639,None,2005,KLLKLLLKLYKKLLKLL,FLAK100-CO2H,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =260 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2782,None,2005,KLLKLLLKLYKKLLKLL,FLAK100-CO2H,17,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1442,12646578,2003,KlllKLKlKlLK,"l3,4,8,10K5L7",12,Linear,Mix,None,Free,Free,Antibacterial,Diastereomeric peptide,B16-F10,Skin Cancer,XTT assay,LC50 = 100 µM,24-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1074/jbc.M211204200
1444,12646578,2003,KLllKLKlKlLK,"l3,4,8,10K5L7",12,Linear,Mix,None,Free,Free,Antibacterial,Diastereomeric peptide,D-122,Lung Cancer,XTT assay,LC50 = >50 µM,24-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1074/jbc.M211204200
1442,12646578,2003,KlllKLKlKlLK,"l3,4,8,10K5L7",12,Linear,Mix,None,Free,Free,Antibacterial,Diastereomeric peptide,B16-F10,Skin Cancer,XTT assay,LC50 = 100 µM,24-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1074/jbc.M211204200
1444,12646578,2003,KLllKLKlKlLK,"l3,4,8,10K5L7",12,Linear,Mix,None,Free,Free,Antibacterial,Diastereomeric peptide,D-122,Lung Cancer,XTT assay,LC50 = >50 µM,24-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1074/jbc.M211204200
2855,22084165,2011,KLlLKlLkkLLKlLKKK,Lytik,17,Linear,Mix,None,Free,Free,Anticancer,Interleukin-4 receptor a (IL-4Ra) chain,BXPC-3,Pancreatic Cancer,WST-1 assay,IC50=37.1 µMol/L,24-h,Pancreatic,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
2856,22084165,2011,KLlLKlLkkLLKlLKKK,Lytik,17,Linear,Mix,None,Free,Free,Anticancer,Interleukin-4 receptor a (IL-4Ra) chain,SU.86.86,Pancreatic Cancer,WST-1 assay,IC50=28.0 µMol/L,24-h,Pancreatic,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
2857,22084165,2011,KLlLKlLkkLLKlLKKK,Lytik,17,Linear,Mix,None,Free,Free,Anticancer,Bovine lactoferrin (Lf-B),KB,Oral Cancer,WST-1 assay,IC50=37.4 µMol/L,24-h,Oral mucosa,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
2858,22084165,2011,KLlLKlLkkLLKlLKKK,Lytik,17,Linear,Mix,None,Free,Free,Anticancer,Interleukin-4 receptor a (IL-4Ra) chain,T98G,Brain Tumor,WST-1 assay,IC50=77.3 µMol/L,24-h,Brain,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
2859,22084165,2011,KLlLKlLkkLLKlLKKK,Lytik,17,Linear,Mix,None,Free,Free,Anticancer,Interleukin-4 receptor a (IL-4Ra) chain,A-172,Brain Tumor,WST-1 assay,IC50=30.5 µMol/L,24-h,Brain,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
2860,22084165,2011,KLlLKlLkkLLKlLKKK,Lytik,17,Linear,Mix,None,Free,Free,Anticancer,Interleukin-4 receptor a (IL-4Ra) chain,H-322,Lung Cancer,WST-1 assay,IC50=27.1 µMol/L,24-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
2861,22084165,2011,KLlLKlLkkLLKlLKKK,Lytik,17,Linear,Mix,None,Free,Free,Anticancer,Interleukin-4 receptor a (IL-4Ra) chain,MDA-MB-231,Breast Cancer,WST-1 assay,IC50=18.5 µMol/L,24-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
2862,22084165,2011,KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK,IL-4RaÐlytic hybrid peptide,33,Linear,Mix,None,Free,Free,Anticancer,Interleukin-4 receptor a (IL-4Ra) chain,BXPC-3,Pancreatic Cancer,WST-1 assay,IC50=6.8 µMol/L,24-h,Pancreatic,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
2863,22084165,2011,KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK,IL-4RaÐlytic hybrid peptide,33,Linear,Mix,None,Free,Free,Anticancer,Interleukin-4 receptor a (IL-4Ra) chain,SU.86.86,Pancreatic Cancer,WST-1 assay,IC50=7.5 µMol/L,24-h,Pancreatic,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
2864,22084165,2011,KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK,IL-4RaÐlytic hybrid peptide,33,Linear,Mix,None,Free,Free,Anticancer,Bovine lactoferrin (Lf-B),KB,Oral Cancer,WST-1 assay,IC50=13.2 µMol/L,24-h,Oral mucosa,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
2865,22084165,2011,KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK,IL-4RaÐlytic hybrid peptide,33,Linear,Mix,None,Free,Free,Anticancer,Interleukin-4 receptor a (IL-4Ra) chain,T98G,Brain Tumor,WST-1 assay,IC50=18.5 µMol/L,24-h,Brain,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
2866,22084165,2011,KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK,IL-4RaÐlytic hybrid peptide,33,Linear,Mix,None,Free,Free,Anticancer,Interleukin-4 receptor a (IL-4Ra) chain,A-172,Brain Tumor,WST-1 assay,IC50=6.8 µMol/L,24-h,Brain,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
2867,22084165,2011,KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK,IL-4RaÐlytic hybrid peptide,33,Linear,Mix,None,Free,Free,Anticancer,Interleukin-4 receptor a (IL-4Ra) chain,H-322,Lung Cancer,WST-1 assay,IC50=3.6 µMol/L,24-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
2868,22084165,2011,KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK,IL-4RaÐlytic hybrid peptide,33,Linear,Mix,None,Free,Free,Anticancer,Interleukin-4 receptor a (IL-4Ra) chain,MDA-MB-231,Breast Cancer,WST-1 assay,IC50=5.7 µMol/L,24-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
2901,21849092,2011,KLlLKlLkkLLKlLKKK,Lytik,17,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),BT-474,Breast Cancer,WST-1 assay,IC50= 34.5 µM,72-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2902,21849092,2011,KLlLKlLkkLLKlLKKK,Lytik,17,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),T-47D,Breast Cancer,WST-1 assay,IC50= 14.1 µM,72-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2903,21849092,2011,KLlLKlLkkLLKlLKKK,Lytik,17,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),SK-BR-3,Breast Cancer,WST-1 assay,IC50= 25.7 µM,72-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2904,21849092,2011,KLlLKlLkkLLKlLKKK,Lytik,17,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),MDA-MB-231,Breast Cancer,WST-1 assay,IC50= 27.0 µM,72-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2905,21849092,2011,KLlLKlLkkLLKlLKKK,Lytik,17,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),BT-20,Breast Cancer,WST-1 assay,IC50= 20.0 µM,72-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2906,21849092,2011,KLlLKlLkkLLKlLKKK,Lytik,17,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),ZR75-1,Breast Cancer,WST-1 assay,IC50= 19.4 µM,72-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2907,21849092,2011,KLlLKlLkkLLKlLKKK,Lytik,17,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),SF-295,Brain Tumor,WST-1 assay,IC50= 19.1 µM,72-h,Brain,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2908,21849092,2011,KLlLKlLkkLLKlLKKK,Lytik,17,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),SN-19,Brain Tumor,WST-1 assay,IC50= 21.9 µM,72-h,Brain,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2909,21849092,2011,KLlLKlLkkLLKlLKKK,Lytik,17,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),U-251,Brain Tumor,WST-1 assay,IC50= 17.0 µM,72-h,Brain,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2910,21849092,2011,KLlLKlLkkLLKlLKKK,Lytik,17,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),HuCCT-1,Human epithelial Cancer,WST-1 assay,IC50= 17.1 µM,72-h,Bileduct,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2911,21849092,2011,KLlLKlLkkLLKlLKKK,Lytik,17,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),LNCaP,Prostate Cancer,WST-1 assay,IC50= 15.8 µM,72-h,Prostate,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2912,21849092,2011,KLlLKlLkkLLKlLKKK,Lytik,17,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),COLO-587,Human epithelial Cancer,WST-1 assay,IC50= 13.5 µM,72-h,Pancreatic,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2913,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),BT-474,Breast Cancer,WST-1 assay,IC50= 8.8 µM,72-h,Breast,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2914,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),T-47D,Breast Cancer,WST-1 assay,IC50= 4.0 µM,72-h,Breast,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2915,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),SK-BR-3,Breast Cancer,WST-1 assay,IC50= 6.5 µM,72-h,Breast,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2916,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),MDA-MB-231,Breast Cancer,WST-1 assay,IC50= 7.8 µM,72-h,Breast,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2917,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),BT-20,Breast Cancer,WST-1 assay,IC50= 4.8 µM,72-h,Breast,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2918,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),ZR75-1,Breast Cancer,WST-1 assay,IC50= 9.3 µM,72-h,Breast,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2919,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),SF-295,Brain Tumor,WST-1 assay,IC50= 6.3 µM,72-h,Brain,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2920,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),SN-19,Brain Tumor,WST-1 assay,IC50= 7.8 µM,72-h,Brain,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2921,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),U-251,Brain Tumor,WST-1 assay,IC50=7.0 µM,72-h,Brain,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2922,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),HuCCT-1,Human epithelial Cancer,WST-1 assay,IC50= 8.3 µM,72-h,Bileduct,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2923,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),LNCaP,Prostate Cancer,WST-1 assay,IC50= 6.2 µM,72-h,Prostate,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2924,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),COLO-587,Human epithelial Cancer,WST-1 assay,IC50=6.4 µM,72-h,Pancreatic,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
4335,None,2009,YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB-Lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,H-322,Lung Cancer,WST-1 assay,IC50= 6.8 µM,Not Available,Lung,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4336,None,2009,YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB-Lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,BT-20,Breast Cancer,WST-1 assay,IC50= 6.5 µM,Not Available,Breast,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4337,None,2009,YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB-Lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,U-251,Brain Tumor,WST-1 assay,IC50= 12 µM,Not Available,Brain,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4338,None,2009,YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB-Lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,BxPC-3,Pancreatic Cancer,WST-1 assay,IC50= 12 µM,Not Available,Pancreatic,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4339,None,2009,YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB-Lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,SU.86.86,Pancreatic Cancer,WST-1 assay,IC50= 12 µM,Not Available,Pancreatic,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4340,None,2009,YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB-Lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,LNCaP,Prostate Cancer,WST-1 assay,IC50= 10 µM,Not Available,Prostate,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4341,None,2009,YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB(H2R)-lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,H-322,Lung Cancer,WST-1 assay,IC50= 3.2 µM,Not Available,Lung,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4342,None,2009,YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB(H2R)-lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,BT-20,Breast Cancer,WST-1 assay,IC50= 1.9 µM,Not Available,Breast,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4343,None,2009,YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB(H2R)-lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,U-251,Brain Tumor,WST-1 assay,IC50= 8.4 µM,Not Available,Brain,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4344,None,2009,YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB(H2R)-lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,BxPC-3,Pancreatic Cancer,WST-1 assay,IC50= 6.6 µM,Not Available,Pancreatic,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4345,None,2009,YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB(H2R)-lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,SU.86.86,Pancreatic Cancer,WST-1 assay,IC50= 7.4 µM,Not Available,Pancreatic,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4346,None,2009,YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB(H2R)-lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,LNCaP,Prostate Cancer,WST-1 assay,IC50= 4.8 µM,Not Available,Prostate,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4599,21351323,2011,YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EGFR-lytic,32,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,MDA-MB-231,Breast Cancer,ELISA,IC50 =0.12 µM,60-Min,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1002/psc.1349
4600,21351323,2011,YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EGFR-lytic,32,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,MDA-MB-231,Breast Cancer,ELISA,IC50 =0.46 µM,15-Min,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1002/psc.1349
1441,12646578,2003,KLlRLLkkLlRLlLK,"l3,10,13K7,8K4R2L9",15,Linear,Mix,None,Free,Free,Antibacterial,Diastereomeric peptide,B16-F10,Skin Cancer,XTT assay,LC50 = 2.5 µM,24-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1074/jbc.M211204200
1443,12646578,2003,KLlRLLkkLlRLlLK,"l3,10,13K7,8K4R2L9",15,Linear,Mix,None,Free,Free,Antibacterial,Diastereomeric peptide,D-122,Lung Cancer,XTT assay,LC50= 4.5 µM,24-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1074/jbc.M211204200
3642,22100226,2012,KMWSKILGHLIR,HAL-1/17,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 35±3 µM,48-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3670,22100226,2012,KMWSKILGHLIR,HAL-1/17,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 100 µM,48-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3698,22100226,2012,KMWSKILGHLIR,HAL-1/17,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3511,22100226,2012,KNWKK-Aib-LKK-Aib-IK-Aib-VK,LL-III/22,15,Linear,L,Aib = 1-amino-isobutyric acid,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 11±7 µM,48-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3536,22100226,2012,KNWKK-Aib-LKK-Aib-IK-Aib-VK,LL-III/22,15,Linear,L,Aib = 1-amino-isobutyric acid,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 100 µM,48-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3561,22100226,2012,KNWKK-Aib-LKK-Aib-IK-Aib-VK,LL-III/22,15,Linear,L,Aib = 1-amino-isobutyric acid,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 25±4 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3503,22100226,2012,KNWKKILGKIIKVVK,LL-III/10,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 9±4 µM,48-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3528,22100226,2012,KNWKKILGKIIKVVK,LL-III/10,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,Not tested,48-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3553,22100226,2012,KNWKKILGKIIKVVK,LL-III/10,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 9 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3509,22100226,2012,KNWKKILKKIIKVVK,LL-III/18,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 3 µM,48-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3534,22100226,2012,KNWKKILKKIIKVVK,LL-III/18,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,Not tested,48-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3559,22100226,2012,KNWKKILKKIIKVVK,LL-III/18,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 7±2 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
2862,22084165,2011,KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK,IL-4RaÐlytic hybrid peptide,33,Linear,Mix,None,Free,Free,Anticancer,Interleukin-4 receptor a (IL-4Ra) chain,BXPC-3,Pancreatic Cancer,WST-1 assay,IC50=6.8 µMol/L,24-h,Pancreatic,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
2863,22084165,2011,KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK,IL-4RaÐlytic hybrid peptide,33,Linear,Mix,None,Free,Free,Anticancer,Interleukin-4 receptor a (IL-4Ra) chain,SU.86.86,Pancreatic Cancer,WST-1 assay,IC50=7.5 µMol/L,24-h,Pancreatic,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
2864,22084165,2011,KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK,IL-4RaÐlytic hybrid peptide,33,Linear,Mix,None,Free,Free,Anticancer,Bovine lactoferrin (Lf-B),KB,Oral Cancer,WST-1 assay,IC50=13.2 µMol/L,24-h,Oral mucosa,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
2865,22084165,2011,KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK,IL-4RaÐlytic hybrid peptide,33,Linear,Mix,None,Free,Free,Anticancer,Interleukin-4 receptor a (IL-4Ra) chain,T98G,Brain Tumor,WST-1 assay,IC50=18.5 µMol/L,24-h,Brain,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
2866,22084165,2011,KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK,IL-4RaÐlytic hybrid peptide,33,Linear,Mix,None,Free,Free,Anticancer,Interleukin-4 receptor a (IL-4Ra) chain,A-172,Brain Tumor,WST-1 assay,IC50=6.8 µMol/L,24-h,Brain,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
2867,22084165,2011,KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK,IL-4RaÐlytic hybrid peptide,33,Linear,Mix,None,Free,Free,Anticancer,Interleukin-4 receptor a (IL-4Ra) chain,H-322,Lung Cancer,WST-1 assay,IC50=3.6 µMol/L,24-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
2868,22084165,2011,KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK,IL-4RaÐlytic hybrid peptide,33,Linear,Mix,None,Free,Free,Anticancer,Interleukin-4 receptor a (IL-4Ra) chain,MDA-MB-231,Breast Cancer,WST-1 assay,IC50=5.7 µMol/L,24-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-11-0363
3119,23993331,2013,KRLRRVWRRWR,MAP-04-04,11,Linear,L,None,Amidation,Free,Antimicrobial,Analogs of Ixosin-B amide,MCF-7,Breast Cancer,MTT/MTS assay,Cell viability >80% at 50 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.bmcl.2013.07.063
3120,23993331,2013,KRLRRVWRRWR,MAP-04-04,11,Linear,L,None,Amidation,Free,Antimicrobial,Analogs of Ixosin-B amide,MCF-7,Breast Cancer,MTT/MTS assay,Cell viability >80% at 75 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.bmcl.2013.07.063
3121,23993331,2013,KRLRRVWRRWR,MAP-04-04,11,Linear,L,None,Amidation,Free,Antimicrobial,Analogs of Ixosin-B amide,MCF-7,Breast Cancer,MTT/MTS assay,Cell viability >80% at 100 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.bmcl.2013.07.063
4440,"15700822, 18957441",2004,"KSCCKNTTGRNIYNTCRFAGGSRERCAKLSGCKIISAST
CPSDYPK",Viscotoxin B2,46,Not Available,L,None,Free,Free,Anticancer,Viscum coloratum (Kom.) Nakai,Not Available,Breast Cancer,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]3NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CSSC2)CCCCN)CC(=O)N)[C@H](O)C)[C@H](O)C)CCCNC(=N)N)CC(=O)N)[C@H](CC)C)Cc1ccc(cc1)O)CC(=O)N)[C@H](O)C)CSSC3)CCCNC(=N)N)Cc1ccccc1)C)CO)CCCNC(=N)N)CCC(=O)O)CCCNC(=N)N)C)CCCCN)CC(C)C)CO)CCCCN)[C@H](CC)C)[C@H](CC)C)CO)C)CO)[C@H](O)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(cc1)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)O,"['Not Found', 'https://doi.org/10.1093/nar/gkn823']"
4441,"5719166, 18957441",1968,"KSCCPNTTGRNIYNACRLTGAPRPTCAKLSGCKIISGST
CPSDYPK",Viscotoxin A3,46,Not Available,L,None,Free,Free,Antibacterial,"The European mistletoe, Viscum album",Not Available,Breast Cancer,Not Available,Not Available,Not Available,Not Available,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@@H]1C(=O)N[C@@H]2C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]4C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N5[C@H](C(=O)N[C@H](C(=O)N6[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N7[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N8[C@H](C(=O)N[C@H](C(=O)O)CCCC[NH3])CCC8)Cc8ccc(cc8)O)CC(=O)O)CO)CCC7)CSSC1)[C@H](O)C)CO)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CSSC2)CO)CC(C)C)CCCC[NH3])C)CSSC4)[C@H](O)C)CCC6)CCCNC(=[NH2])N)CCC5)C)[C@H](O)C)CC(C)C)CCCNC(=[NH2])N)C)CC(=O)N)Cc1ccc(cc1)O)[C@H](CC)C)CC(=O)N)CCCNC(=[NH2])N)[C@H](O)C)[C@H](O)C)CC(=O)N)CCC3)CO)CCCC[NH3],"['https://doi.org/10.3891/acta.chem.scand.22-2624', 'https://doi.org/10.1093/nar/gkn823']"
4442,"9348108, 18957441",1997,"KSCCPNTTGRNIYNTCRFAGGSRERCAKLSGCKIISAST
CPSDYPK",Viscotoxin C1,46,Not Available,L,None,Free,Free,Antibacterial,The Asiatic Viscum album ssp Coloratum ohwi,Not Available,Breast Cancer,Not Available,Not Available,Not Available,Not Available,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@@H]1C(=O)N[C@@H]2C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]4C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N5[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N6[C@H](C(=O)N[C@H](C(=O)O)CCCC[NH3])CCC6)Cc6ccc(cc6)O)CC(=O)O)CO)CCC5)CSSC1)[C@H](O)C)CO)C)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CSSC2)CO)CC(C)C)CCCC[NH3])C)CSSC4)CCCNC(=[NH2])N)CCC(=O)O)CCCNC(=[NH2])N)CO)C)Cc1ccccc1)CCCNC(=[NH2])N)[C@H](O)C)CC(=O)N)Cc1ccc(cc1)O)[C@H](CC)C)CC(=O)N)CCCNC(=[NH2])N)[C@H](O)C)[C@H](O)C)CC(=O)N)CCC3)CO)CCCC[NH3],"['https://doi.org/10.1515/bchm.1997.378.9.989', 'https://doi.org/10.1093/nar/gkn823']"
4444,"9348108, 18957441",1997,"KSCCPNTTGRNIYNTCRFGGGSREVCARISGCKIISAST
CPSDYPK",Viscotoxin 1-PS,46,Not Available,L,None,Free,Free,Antibacterial,Viscum album L,Not Available,Breast Cancer,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]3NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]4N(C(=O)[C@@H](NC1=O)CSSC2)CCC4)CC(=O)N)[C@H](O)C)[C@H](O)C)CCCNC(=N)N)CC(=O)N)[C@H](CC)C)Cc1ccc(cc1)O)CC(=O)N)[C@H](O)C)CSSC3)CCCNC(=N)N)Cc1ccccc1)CO)CCCNC(=N)N)CCC(=O)O)C(C)C)C)CCCNC(=N)N)[C@H](CC)C)CO)CCCCN)[C@H](CC)C)[C@H](CC)C)CO)C)CO)[C@H](O)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(cc1)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1515/bchm.1997.378.9.989', 'https://doi.org/10.1093/nar/gkn823']"
4445,"9348108, 18957441",1997,"KSCCPNTTGRNIYNTCRFGGGSRQVCASLSGCKIISAST
CPSDYPK",Viscotoxin A2,46,Not Available,L,None,Free,Free,Antibacterial,Viscum album L,Not Available,Colorectal Cancer,Not Available,Not Available,Not Available,Not Available,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@@H]1C(=O)N[C@@H]2C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]4C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N5[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N6[C@H](C(=O)N[C@H](C(=O)O)CCCC[NH3])CCC6)Cc6ccc(cc6)O)CC(=O)O)CO)CCC5)CSSC1)[C@H](O)C)CO)C)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CSSC2)CO)CC(C)C)CO)C)CSSC4)C(C)C)CCC(=O)N)CCCNC(=[NH2])N)CO)Cc1ccccc1)CCCNC(=[NH2])N)[C@H](O)C)CC(=O)N)Cc1ccc(cc1)O)[C@H](CC)C)CC(=O)N)CCCNC(=[NH2])N)[C@H](O)C)[C@H](O)C)CC(=O)N)CCC3)CO)CCCC[NH3],"['https://doi.org/10.1515/bchm.1997.378.9.989', 'https://doi.org/10.1093/nar/gkn823']"
4446,"1710983, 18957441",1991,"KSCCPNTTGRNIYNTCRLGGGSRERCASLSGCKIISAST
CPSDYPK",Viscotoxin B,46,Not Available,L,None,Free,Free,Anticancer,Viscum album L,Not Available,Colorectal Cancer,Not Available,Not Available,Not Available,Not Available,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@@H]1C(=O)N[C@@H]2C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]4C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N5[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N6[C@H](C(=O)N[C@H](C(=O)O)CCCC[NH3])CCC6)Cc6ccc(cc6)O)CC(=O)O)CO)CCC5)CSSC1)[C@H](O)C)CO)C)CO)[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CSSC2)CO)CC(C)C)CO)C)CSSC4)CCCNC(=[NH2])N)CCC(=O)O)CCCNC(=[NH2])N)CO)CC(C)C)CCCNC(=[NH2])N)[C@H](O)C)CC(=O)N)Cc1ccc(cc1)O)[C@H](CC)C)CC(=O)N)CCCNC(=[NH2])N)[C@H](O)C)[C@H](O)C)CC(=O)N)CCC3)CO)CCCC[NH3],"['https://doi.org/10.1111/j.1432-1033.1991.tb16049.x', 'https://doi.org/10.1093/nar/gkn823']"
4443,"9348108, 18957441",1997,"KSCCPNTTGRNIYNTCRLTGSSRETCAKLSGCKIISAST
CPSNYPK",Viscotoxin A1,46,Not Available,L,None,Free,Free,Antibacterial,Viscum album L,Not Available,Breast Cancer,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]3NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]4N(C(=O)[C@@H](NC1=O)CSSC2)CCC4)CC(=O)N)[C@H](O)C)[C@H](O)C)CCCNC(=N)N)CC(=O)N)[C@H](CC)C)Cc1ccc(cc1)O)CC(=O)N)[C@H](O)C)CSSC3)CCCNC(=N)N)CC(C)C)[C@H](O)C)CO)CO)CCCNC(=N)N)CCC(=O)O)[C@H](O)C)C)CCCCN)CC(C)C)CO)CCCCN)[C@H](CC)C)[C@H](CC)C)CO)C)CO)[C@H](O)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccc(cc1)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1515/bchm.1997.378.9.989', 'https://doi.org/10.1093/nar/gkn823']"
4447,"3985614, 18957441",1985,"KSCCRNTWARNCYNVCRLPGTISREICAKKCDCKIISGT
TCPSDYPK",Pyrularia thionin,47,Not Available,L,None,Free,Free,Antibacterial,"Nuts,Pyrularia pubera",Not Available,Colorectal Cancer,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2NC(=O)[C@@H](NC(=O)[C@H]3NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]4NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H]5N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CSSC2)CCCNC(=N)N)CC(=O)N)[C@H](O)C)Cc1c2c([nH]c1)cccc2)C)CCCNC(=N)N)CC(=O)N)CSSC3)Cc1ccc(cc1)O)CC(=O)N)C(C)C)CSSC4)CCCNC(=N)N)CC(C)C)CCC5)[C@H](O)C)[C@H](CC)C)CO)CCCNC(=N)N)CCC(=O)O)[C@H](CC)C)C)CCCCN)CCCCN)CC(=O)O)CCCCN)[C@H](CC)C)[C@H](CC)C)CO)[C@H](O)C)[C@H](O)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(cc1)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)O,"['https://doi.org/10.1016/0003-9861(85)90136-5', 'https://doi.org/10.1093/nar/gkn823']"
4448,"8245827, 18957441",1993,KSSAYSLQMGATAIKQVKKLFKKWGW,Plantaricin A,26,Not Available,L,None,Free,Free,Antibacterial,"Lactobacillus plantarumC11, WCFS1, V90",Not Available,Colorectal Cancer,Not Available,Not Available,Not Available,Not Available,None,N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C=O)Cc1c[nH]c2c1cccc2)Cc1c[nH]c2c1cccc2)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])CCCC[NH3])C(C)C)CCC(=O)N)CCCC[NH3])[C@H](CC)C)C)[C@H](O)C)C)CCSC)CCC(=O)N)CC(C)C)CO)Cc1ccc(cc1)O)C)CO)CO)CCCC[NH3],"['https://doi.org/10.1099/00221287-139-9-1973', 'https://doi.org/10.1093/nar/gkn823']"
4449,"16269344, 18957441",2005,KTCENLADTFRGPCFATSNC,Lunatusin,20,Not Available,L,None,Free,Free,Antimicrobial,Phaseolus lunatus L. (lima bean),Not Available,Colorectal Cancer,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)O,"['https://doi.org/10.1016/j.peptides.2005.03.004', 'https://doi.org/10.1093/nar/gkn823']"
4450,"15949629, 18957441",2005,KTCENLADTY,Sesquin,10,Not Available,L,None,Free,Free,Antimicrobial,"Seeds, Vigna sesquipedalis, ground bean",Not Available,Colorectal Cancer,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,"['https://doi.org/10.1016/j.peptides.2005.01.003', 'https://doi.org/10.1093/nar/gkn823']"
1825,None,2005,KTKLFKKFAKKLAKKLKKLAKKL,SHIVA 10 (1-16) Ac,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =29 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1977,None,2005,KTKLFKKFAKKLAKKLKKLAKKL,SHIVA 10 (1-16) Ac,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =35 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2129,None,2005,KTKLFKKFAKKLAKKLKKLAKKL,SHIVA 10 (1-16) Ac,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =76 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2281,None,2005,KTKLFKKFAKKLAKKLKKLAKKL,SHIVA 10 (1-16) Ac,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =76 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2433,None,2005,KTKLFKKFAKKLAKKLKKLAKKL,SHIVA 10 (1-16),23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =64 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2576,None,2005,KTKLFKKFAKKLAKKLKKLAKKL,SHIVA 10 (1-16) Ac,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =28 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2719,None,2005,KTKLFKKFAKKLAKKLKKLAKKL,SHIVA 10 (1-16) Ac,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =97 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
3206,22413859,2012,KVKVKVKVpPTKVKVKVK,SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,A-549,Lung Cancer,MTT/MTS assay,NA,24-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3207,22413859,2012,KVKVKVKVpPTKVKVKVK,SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Bovine lactoferrin (Lf-B),KB,Oral Cancer,MTT/MTS assay,NA,24-h,Oral mucosa,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3216,22413859,2012,KVKVKVKVpPTKVKVKVK,SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,MCF-7,Breast Cancer,MTT/MTS assay,IC50 =8.1±0.8 µM,24-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3217,22413859,2012,KVKVKVKVpPTKVKVKVK,SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,MDA-MB-436,Breast Cancer,MTT/MTS assay,IC50 =5.6±0.5 µM,24-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3218,22413859,2012,kvkvkvkvPptkvkvkvk,D-SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,A-549,Lung Cancer,MTT/MTS assay,IC50 =3.2±0.6 µM,24-h,Lung,None,N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3219,22413859,2012,kvkvkvkvPptkvkvkvk,D-SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,KB,Oral Cancer,MTT/MTS assay,IC50 =4.5±0.5 µM,24-h,Oral mucosa,None,N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3220,22413859,2012,kvkvkvkvPptkvkvkvk,D-SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,MCF-7,Breast Cancer,MTT/MTS assay,IC50 =4.7±0.4 µM,24-h,Breast,None,N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3221,22413859,2012,kvkvkvkvPptkvkvkvk,D-SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,MDA-MB-436,Breast Cancer,MTT/MTS assay,IC50 =3.2±0.4 µM,24-h,Breast,None,N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3222,22413859,2012,KVKVKVKVPPTKVKVKVK,SVS-2,18,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,A-549,Lung Cancer,MTT/MTS assay,IC50 >100 µM,24-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3223,22413859,2012,KVKVKVKVPPTKVKVKVK,SVS-2,18,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,KB,Oral Cancer,MTT/MTS assay,IC50 >100 µM,24-h,Oral mucosa,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3224,22413859,2012,KVKVKVKVPPTKVKVKVK,SVS-2,18,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,MCF-7,Breast Cancer,MTT/MTS assay,IC50 >100 µM,24-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3225,22413859,2012,KVKVKVKVPPTKVKVKVK,SVS-2,18,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,MDA-MB-436,Breast Cancer,MTT/MTS assay,IC50 >100 µM,24-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3206,22413859,2012,KVKVKVKVpPTKVKVKVK,SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,A-549,Lung Cancer,MTT/MTS assay,NA,24-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3207,22413859,2012,KVKVKVKVpPTKVKVKVK,SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Bovine lactoferrin (Lf-B),KB,Oral Cancer,MTT/MTS assay,NA,24-h,Oral mucosa,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3216,22413859,2012,KVKVKVKVpPTKVKVKVK,SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,MCF-7,Breast Cancer,MTT/MTS assay,IC50 =8.1±0.8 µM,24-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3217,22413859,2012,KVKVKVKVpPTKVKVKVK,SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,MDA-MB-436,Breast Cancer,MTT/MTS assay,IC50 =5.6±0.5 µM,24-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3218,22413859,2012,kvkvkvkvPptkvkvkvk,D-SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,A-549,Lung Cancer,MTT/MTS assay,IC50 =3.2±0.6 µM,24-h,Lung,None,N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3219,22413859,2012,kvkvkvkvPptkvkvkvk,D-SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,KB,Oral Cancer,MTT/MTS assay,IC50 =4.5±0.5 µM,24-h,Oral mucosa,None,N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3220,22413859,2012,kvkvkvkvPptkvkvkvk,D-SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,MCF-7,Breast Cancer,MTT/MTS assay,IC50 =4.7±0.4 µM,24-h,Breast,None,N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3221,22413859,2012,kvkvkvkvPptkvkvkvk,D-SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,MDA-MB-436,Breast Cancer,MTT/MTS assay,IC50 =3.2±0.4 µM,24-h,Breast,None,N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3222,22413859,2012,KVKVKVKVPPTKVKVKVK,SVS-2,18,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,A-549,Lung Cancer,MTT/MTS assay,IC50 >100 µM,24-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3223,22413859,2012,KVKVKVKVPPTKVKVKVK,SVS-2,18,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,KB,Oral Cancer,MTT/MTS assay,IC50 >100 µM,24-h,Oral mucosa,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3224,22413859,2012,KVKVKVKVPPTKVKVKVK,SVS-2,18,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,MCF-7,Breast Cancer,MTT/MTS assay,IC50 >100 µM,24-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3225,22413859,2012,KVKVKVKVPPTKVKVKVK,SVS-2,18,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,MDA-MB-436,Breast Cancer,MTT/MTS assay,IC50 >100 µM,24-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3206,22413859,2012,KVKVKVKVpPTKVKVKVK,SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,A-549,Lung Cancer,MTT/MTS assay,NA,24-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3207,22413859,2012,KVKVKVKVpPTKVKVKVK,SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Bovine lactoferrin (Lf-B),KB,Oral Cancer,MTT/MTS assay,NA,24-h,Oral mucosa,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3216,22413859,2012,KVKVKVKVpPTKVKVKVK,SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,MCF-7,Breast Cancer,MTT/MTS assay,IC50 =8.1±0.8 µM,24-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3217,22413859,2012,KVKVKVKVpPTKVKVKVK,SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,MDA-MB-436,Breast Cancer,MTT/MTS assay,IC50 =5.6±0.5 µM,24-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3218,22413859,2012,kvkvkvkvPptkvkvkvk,D-SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,A-549,Lung Cancer,MTT/MTS assay,IC50 =3.2±0.6 µM,24-h,Lung,None,N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3219,22413859,2012,kvkvkvkvPptkvkvkvk,D-SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,KB,Oral Cancer,MTT/MTS assay,IC50 =4.5±0.5 µM,24-h,Oral mucosa,None,N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3220,22413859,2012,kvkvkvkvPptkvkvkvk,D-SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,MCF-7,Breast Cancer,MTT/MTS assay,IC50 =4.7±0.4 µM,24-h,Breast,None,N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3221,22413859,2012,kvkvkvkvPptkvkvkvk,D-SVS-1,18,Linear,Mix,None,Amidation,Free,Antimicrobial,Synthetic peptide,MDA-MB-436,Breast Cancer,MTT/MTS assay,IC50 =3.2±0.4 µM,24-h,Breast,None,N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@@H]1C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3222,22413859,2012,KVKVKVKVPPTKVKVKVK,SVS-2,18,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,A-549,Lung Cancer,MTT/MTS assay,IC50 >100 µM,24-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3223,22413859,2012,KVKVKVKVPPTKVKVKVK,SVS-2,18,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,KB,Oral Cancer,MTT/MTS assay,IC50 >100 µM,24-h,Oral mucosa,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3224,22413859,2012,KVKVKVKVPPTKVKVKVK,SVS-2,18,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,MCF-7,Breast Cancer,MTT/MTS assay,IC50 >100 µM,24-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
3225,22413859,2012,KVKVKVKVPPTKVKVKVK,SVS-2,18,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic peptide,MDA-MB-436,Breast Cancer,MTT/MTS assay,IC50 >100 µM,24-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1021/ja210569f
1125,12005420,2001,KWFKKIPKFLHLAKKF,N-3,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=17 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1147,12005420,2001,KWFKKIPKFLHLAKKF,N-3,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=17 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1169,12005420,2001,KWFKKIPKFLHLAKKF,N-3,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=11 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1150,12005420,2001,KWFKKIPKFLHLLKKF,N-3L,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=4 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCCC1.C(O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1172,12005420,2001,KWFKKIPKFLHLLKKF,N-3L,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=4.2 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCCC1.C(O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1120,12005420,2001,KWKFKKIPKFLHLAKKF,P18,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=8 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1142,12005420,2001,KWKFKKIPKFLHLAKKF,P18,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=4 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1164,12005420,2001,KWKFKKIPKFLHLAKKF,P18,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=3.5 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1323,18315881,2008,KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antimicrobial,Chinese oak silk moth,486P,Bladder Cancer,WST-1 assay,IC50=161.76 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1324,18315881,2008,KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antimicrobial,Chinese oak silk moth,RT4,Bladder Cancer,WST-1 assay,IC50=184.81 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1325,18315881,2008,KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antimicrobial,Chinese oak silk moth,647V,Bladder Cancer,WST-1 assay,IC50=115.12 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1326,18315881,2008,KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antimicrobial,Chinese oak silk moth,J82,Bladder Cancer,WST-1 assay,IC50=97.93 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1335,18315881,2008,KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antimicrobial,Chinese oak silk moth,486P,Bladder Cancer,Cell Viability assay,IC50=87.47 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1336,18315881,2008,KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antimicrobial,Chinese oak silk moth,RT4,Bladder Cancer,Cell Viability assay,IC50=92.9 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1337,18315881,2008,KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antimicrobial,Chinese oak silk moth,647V,Bladder Cancer,Cell Viability assay,IC50=61.86 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1338,18315881,2008,KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antimicrobial,Chinese oak silk moth,J82,Bladder Cancer,Cell Viability assay,IC50=77.51 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1347,18315881,2008,KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antimicrobial,Chinese oak silk moth,486P,Bladder Cancer,LDH leakage assay,IC50=232.4 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1348,18315881,2008,KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antimicrobial,Chinese oak silk moth,RT4,Bladder Cancer,LDH leakage assay,IC50=240.4 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1349,18315881,2008,KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antimicrobial,Chinese oak silk moth,647V,Bladder Cancer,LDH leakage assay,IC50=181.1 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1351,18315881,2008,KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antimicrobial,Chinese oak silk moth,J82,Bladder Cancer,LDH leakage assay,Cytotoxicity=196.3 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1210,9352466,1997,KWKKFLKIGIGKFLHLAKKF,P8,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H69,Lung Cancer,MTT/MTS assay,IC50=2.6 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1220,9352466,1997,KWKKFLKIGIGKFLHLAKKF,P8,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H128,Lung Cancer,MTT/MTS assay,IC50=2.3 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1230,9352466,1997,KWKKFLKIGIGKFLHLAKKF,P8,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H146,Lung Cancer,MTT/MTS assay,IC50=1.8 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
2043,None,2005,KWKKLAKKW,FLAK120,9,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =240 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N,Not Found
3356,None,2004,KWKKLLKKPPPLLKKLLKKL,Synthetic peptide,20,Linear,L,None,Amidation,Free,"Antimicrobial and Anticancer, antibacterial, antifungal",Synthetic peptide,Calu-6,Lung Cancer,MTT/MTS assay,35% survival rate at 10 µM,NA,Lung,US_6800727_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
3357,None,2004,KWKKLLKKPPPLLKKLLKKL,Synthetic peptide,20,Linear,L,None,Amidation,Free,"Antimicrobial and Anticancer, antibacterial, antifungal",Synthetic peptide,Calu-6,Lung Cancer,MTT/MTS assay,0% survival rate at 100 µM,NA,Lung,US_6800727_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
3358,None,2004,KWKKLLKKPPPLLKKLLKKL,Synthetic peptide,20,Linear,L,None,Amidation,Free,"Antimicrobial and Anticancer, antibacterial, antifungal",Synthetic peptide,Jurkat,Blood Cancer,MTT/MTS assay,~60% survival rate at 10 µM,NA,Blood,US_6800727_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
3359,None,2004,KWKKLLKKPPPLLKKLLKKL,Synthetic peptide,20,Linear,L,None,Free,Free,"Antimicrobial and Anticancer, antibacterial, antifungal",Synthetic peptide,Jurkat,Blood Cancer,MTT/MTS assay,0% survival rate at 100 µM,NA,Blood,US_6800727_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
3360,None,2004,KWKKLLKKPPPLLKKLLKKL,Synthetic peptide,20,Linear,L,None,Free,Free,"Antimicrobial and Anticancer, antibacterial, antifungal",Synthetic peptide,SNU-601,Gastric Cancer,MTT/MTS assay,~20% survival rate at 10 µM,NA,Stomach,US_6800727_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
3361,None,2004,KWKKLLKKPPPLLKKLLKKL,Synthetic peptide,20,Linear,L,None,Free,Free,"Antimicrobial and Anticancer, antibacterial, antifungal",Synthetic peptide,SNU-601,Gastric Cancer,MTT/MTS assay,0% survival rate at 100 µM,NA,Stomach,US_6800727_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1873,None,2005,KWKLAKKALALL,FLAK93B,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2025,None,2005,KWKLAKKALALL,FLAK93B,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =38 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2177,None,2005,KWKLAKKALALL,FLAK93B,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =38 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2329,None,2005,KWKLAKKALALL,FLAK93B,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =38 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2482,None,2005,KWKLAKKALALL,FLAK93B,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =115 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2625,None,2005,KWKLAKKALALL,FLAK93B,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =60 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2768,None,2005,KWKLAKKALALL,FLAK93B,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =55 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1119,12005420,2001,KWKLFKKIPKFLHSAKKF,CA-MA-P,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=20 µM,48-h,Breast,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1034/j.1399-3011.2001.00934.x
1121,12005420,2001,KWKLFKKILKFLHLAKKF,[L9]-P18,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=3 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1122,12005420,2001,KWKLFKKISKFLHLAKKF,[S9]-P18,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=4 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1131,12005420,2001,KWKLFKKIPFLHLAKKF,C-1,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=26 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1132,12005420,2001,KWKLFKKIPKFLHLAKK,C-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=38 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1133,12005420,2001,KWKLFKKIPLHLAKKF,C-3,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=79 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1134,12005420,2001,KWKLFKKIPKFLHLAK,C-4,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=54 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1135,12005420,2001,KWKLFKKIPHLAKKF,C-5,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=100 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1136,12005420,2001,KWKLFKKIPKFLHLA,C-6,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=47 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1137,12005420,2001,KWKLFKKIPLAKKF,C-7,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=100. <µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1138,12005420,2001,KWKLFKKIPKFLHL,C-8,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=83 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1139,12005420,2001,KWKLFKKIPLKKF,C-9,13,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=100. <µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1140,12005420,2001,KWKLFKKIPKFLH,C-10,13,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=100. <µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1141,12005420,2001,KWKLFKKIPKFLHSAKKF,CA-MA-P,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=20 µM,48-h,Blood,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1034/j.1399-3011.2001.00934.x
1143,12005420,2001,KWKLFKKILKFLHLAKKF,[L9]-P18,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=9 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1144,12005420,2001,KWKLFKKISKFLHLAKKF,[S9]-P18,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=7 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1153,12005420,2001,KWKLFKKIPFLHLAKKF,C-1,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=32 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1154,12005420,2001,KWKLFKKIPKFLHLAKK,C-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=26 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1155,12005420,2001,KWKLFKKIPLHLAKKF,C-3,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=74 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1156,12005420,2001,KWKLFKKIPKFLHLAK,C-4,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=31 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1157,12005420,2001,KWKLFKKIPHLAKKF,C-5,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=81 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1158,12005420,2001,KWKLFKKIPKFLHLA,C-6,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=21 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1159,12005420,2001,KWKLFKKIPLAKKF,C-7,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=100.0 <µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1160,12005420,2001,KWKLFKKIPKFLHL,C-8,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=54 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1161,12005420,2001,KWKLFKKIPLKKF,C-9,13,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=100.0 <µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1162,12005420,2001,KWKLFKKIPKFLH,C-10,13,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=100.0 <µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1163,12005420,2001,KWKLFKKIPKFLHSAKKF,CA-MA-P,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=25 µM,48-h,Blood,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1034/j.1399-3011.2001.00934.x
1165,12005420,2001,KWKLFKKILKFLHLAKKF,[L9]-P18,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=3 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1166,12005420,2001,KWKLFKKISKFLHLAKKF,[S9]-P18,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=3 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1175,12005420,2001,KWKLFKKIPFLHLAKKF,C-1,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=31 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1176,12005420,2001,KWKLFKKIPKFLHLAKK,C-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=23 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1177,12005420,2001,KWKLFKKIPLHLAKKF,C-3,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=62 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1178,12005420,2001,KWKLFKKIPKFLHLAK,C-4,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=25 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1179,12005420,2001,KWKLFKKIPHLAKKF,C-5,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=67 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1180,12005420,2001,KWKLFKKIPKFLHLA,C-6,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=27 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1181,12005420,2001,KWKLFKKIPLAKKF,C-7,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=100.0 <µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1182,12005420,2001,KWKLFKKIPKFLHL,C-8,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=30 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1183,12005420,2001,KWKLFKKIPLKKF,C-9,13,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=100.0 <µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1184,12005420,2001,KWKLFKKIPKFLH,C-10,13,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=100.0 <µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1185,10675500,2000,KWKLFKKIGIGKFLHSAKKF,CA-MA,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,K-562,Leukemia Cancer,MTT/MTS assay,IC50=65 µM,72-h,Blood,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1186,10675500,2000,KWKLFKKIKFLHSAKKF,CA-MA1,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,K-562,Leukemia Cancer,MTT/MTS assay,IC50=85.3 µM,72-h,Blood,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1187,10675500,2000,KWKLFKKIPKFLHSAKKF,CA-MA2,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,K-562,Leukemia Cancer,MTT/MTS assay,IC50=35.1 µM,72-h,Blood,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1188,10675500,2000,KWKLFKKIGPGKFLHSAKKF,CA-MA3,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,K-562,Leukemia Cancer,MTT/MTS assay,IC50=>100 µM,72-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1016/s0005-2736(99)00210-2
1189,10675500,2000,KWKLFKKIGIGKFLHSAKKF,CA-MA,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,A-549,Lung Cancer,MTT/MTS assay,IC50=60 µM,72-h,Lung,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1190,10675500,2000,KWKLFKKIKFLHSAKKF,CA-MA1,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,A-549,Lung Cancer,MTT/MTS assay,IC50=100 µM,72-h,Lung,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1191,10675500,2000,KWKLFKKIPKFLHSAKKF,CA-MA2,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,A-549,Lung Cancer,MTT/MTS assay,IC50=25 µM,72-h,Lung,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1192,10675500,2000,KWKLFKKIGPGKFLHSAKKF,CA-MA3,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,A-549,Lung Cancer,MTT/MTS assay,IC50=>100 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1016/s0005-2736(99)00210-2
1193,10675500,2000,KWKLFKKIGIGKFLHSAKKF,CA-MA,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,Jurkat,Blood Cancer,MTT/MTS assay,IC50=30 µM,72-h,Blood,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1194,10675500,2000,KWKLFKKIKFLHSAKKF,CA-MA1,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,Jurkat,Blood Cancer,MTT/MTS assay,IC50=65 µM,72-h,Blood,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1195,10675500,2000,KWKLFKKIPKFLHSAKKF,CA-MA2,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,Jurkat,Blood Cancer,MTT/MTS assay,IC50=20 µM,72-h,Blood,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1196,10675500,2000,KWKLFKKIGPGKFLHSAKKF,CA-MA3,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,Jurkat,Blood Cancer,MTT/MTS assay,IC50=75 µM,72-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1016/s0005-2736(99)00210-2
1197,10675500,2000,KWKLFKKIGIGKFLHSAKKF,CA-MA,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=44 µM,72-h,Breast,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1198,10675500,2000,KWKLFKKIKFLHSAKKF,CA-MA1,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=100 µM,72-h,Breast,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1199,10675500,2000,KWKLFKKIPKFLHSAKKF,CA-MA2,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=28 µM,72-h,Breast,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1200,10675500,2000,KWKLFKKIGPGKFLHSAKKF,CA-MA3,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=>100 µM,72-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1016/s0005-2736(99)00210-2
1201,9352466,1997,KWKLFKKIGIGKFLHSAKKF,CA-MA,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H69,Lung Cancer,MTT/MTS assay,IC50=15.8 µM,72-h,Lung,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1202,9352466,1997,KWKLFKKIGIGAVLKVLTTG,CA-ME,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H69,Lung Cancer,MTT/MTS assay,IC50=32.2 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1203,9352466,1997,KWKLFKKIGIGAVLKVLKKG,P1,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H69,Lung Cancer,MTT/MTS assay,IC50=3.4 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1204,9352466,1997,KWKLFKKIGIGKFLHSATTF,P2,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H69,Lung Cancer,MTT/MTS assay,IC50=36.2 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1205,9352466,1997,KWKLFKKIGIGAFLHSAKKF,P3,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H69,Lung Cancer,MTT/MTS assay,IC50=9.3 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1206,9352466,1997,KWKLFKKIGIGKFLHLAKKF,P4,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H69,Lung Cancer,MTT/MTS assay,IC50=1.9 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1207,9352466,1997,KWKLFKKIGIGAFLHLAKKF,P5,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H69,Lung Cancer,MTT/MTS assay,IC50=2.9 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1208,9352466,1997,KWKLFKKIGIGKFKLAKKF,P6,19,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H69,Lung Cancer,MTT/MTS assay,IC50=1.7 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1209,9352466,1997,KWKLFAKIGIGKFLHLAKKF,P7,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H69,Lung Cancer,MTT/MTS assay,IC50=3.1 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1211,9352466,1997,KWKLFKKIGIGKFLHSAKKF,CA-MA,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H128,Lung Cancer,MTT/MTS assay,IC50=16.1 µM,72-h,Lung,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1212,9352466,1997,KWKLFKKIGIGAVLKVLTTG,CA-ME,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H128,Lung Cancer,MTT/MTS assay,IC50=28.6 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1213,9352466,1997,KWKLFKKIGIGAVLKVLKKG,P1,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H128,Lung Cancer,MTT/MTS assay,IC50=3.5 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1214,9352466,1997,KWKLFKKIGIGKFLHSATTF,P2,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H128,Lung Cancer,MTT/MTS assay,IC50=37.9 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1215,9352466,1997,KWKLFKKIGIGAFLHSAKKF,P3,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H128,Lung Cancer,MTT/MTS assay,IC50=9.3 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1216,9352466,1997,KWKLFKKIGIGKFLHLAKKF,P4,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H128,Lung Cancer,MTT/MTS assay,IC50=1.3 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1217,9352466,1997,KWKLFKKIGIGAFLHLAKKF,P5,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H128,Lung Cancer,MTT/MTS assay,IC50=2.9 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1218,9352466,1997,KWKLFKKIGIGKFKLAKKF,P6,19,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H128,Lung Cancer,MTT/MTS assay,IC50=2 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1219,9352466,1997,KWKLFAKIGIGKFLHLAKKF,P7,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H128,Lung Cancer,MTT/MTS assay,IC50=2.4 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1221,9352466,1997,KWKLFKKIGIGKFLHSAKKF,CA-MA,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H146,Lung Cancer,MTT/MTS assay,IC50=15.8 µM,72-h,Lung,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1222,9352466,1997,KWKLFKKIGIGAVLKVLTTG,CA-ME,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H146,Lung Cancer,MTT/MTS assay,IC50=28.6 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1223,9352466,1997,KWKLFKKIGIGAVLKVLKKG,P1,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H146,Lung Cancer,MTT/MTS assay,IC50=4.5 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1224,9352466,1997,KWKLFKKIGIGKFLHSATTF,P2,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H146,Lung Cancer,MTT/MTS assay,IC50=47.7 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1225,9352466,1997,KWKLFKKIGIGAFLHSAKKF,P3,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H146,Lung Cancer,MTT/MTS assay,IC50=10.9 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1226,9352466,1997,KWKLFKKIGIGKFLHLAKKF,P4,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H146,Lung Cancer,MTT/MTS assay,IC50=2.8 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1227,9352466,1997,KWKLFKKIGIGAFLHLAKKF,P5,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H146,Lung Cancer,MTT/MTS assay,IC50=3.2 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1228,9352466,1997,KWKLFKKIGIGKFKLAKKF,P6,19,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H146,Lung Cancer,MTT/MTS assay,IC50=3.1 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1229,9352466,1997,KWKLFAKIGIGKFLHLAKKF,P7,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H146,Lung Cancer,MTT/MTS assay,IC50=2.4 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1317,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),486P,Bladder Cancer,WST-1 assay,IC50=251.47 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1318,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),RT4,Bladder Cancer,WST-1 assay,IC50=231.26 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1319,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),647V,Bladder Cancer,WST-1 assay,IC50=185.39 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1320,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),J82,Bladder Cancer,WST-1 assay,IC50=212.07 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1329,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),486P,Bladder Cancer,Cell Viability assay,IC50=69.2 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1330,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),RT4,Bladder Cancer,Cell Viability assay,IC50=96.22 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1331,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),647V,Bladder Cancer,Cell Viability assay,IC50=28.74 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1332,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),J82,Bladder Cancer,Cell Viability assay,IC50=99.01 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1341,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),486P,Bladder Cancer,LDH leakage assay,IC50=373.3/ µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1342,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),RT4,Bladder Cancer,LDH leakage assay,IC50=289.3 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1343,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),647V,Bladder Cancer,LDH leakage assay,IC50=200.7 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1344,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),J82,Bladder Cancer,LDH leakage assay,IC50=319.2 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1803,None,2005,KWKLFKKIGAVLKVL,CAME-15,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =45 µg/ml,24-h,Breast,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],Not Found
1819,None,2005,KWKLFKKKTKLFKKFAKKLAKKL,CA (1-7) Shiva10 (1-16),23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1826,None,2005,KWKLFKKKTKLFKKFAKKLAKKL,CA(1-7) Shiva10(1-16)-COOH,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =63 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1837,None,2005,KWKLFKKALKKLKKALKKAL,CA(1-& HECATE(11/23),20,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =11 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1862,None,2005,KWKLF,FLAK93,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =600 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
1955,None,2005,KWKLFKKIGAVLKVL,CAME-15,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],Not Found
1209,9352466,1997,KWKLFAKIGIGKFLHLAKKF,P7,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H69,Lung Cancer,MTT/MTS assay,IC50=3.1 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1219,9352466,1997,KWKLFAKIGIGKFLHLAKKF,P7,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H128,Lung Cancer,MTT/MTS assay,IC50=2.4 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1229,9352466,1997,KWKLFAKIGIGKFLHLAKKF,P7,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H146,Lung Cancer,MTT/MTS assay,IC50=2.4 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1837,None,2005,KWKLFKKALKKLKKALKKAL,CA(1-& HECATE(11/23),20,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =11 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1989,None,2005,KWKLFKKALKKLKKALKKAL,CA(1-& HECATE(11/23),20,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =54 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2141,None,2005,KWKLFKKALKKLKKALKKAL,CA(1-& HECATE(11/23),20,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =100 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2293,None,2005,KWKLFKKALKKLKKALKKAL,CA(1-& HECATE(11/23),20,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =100 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2446,None,2005,KWKLFKKALKKLKKALKKAL,CA(1-& HECATE(11/23),20,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =52 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2589,None,2005,KWKLFKKALKKLKKALKKAL,CA(1-& HECATE(11/23),20,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =18 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2732,None,2005,KWKLFKKALKKLKKALKKAL,CA(1-& HECATE(11/23),20,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =130 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1317,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),486P,Bladder Cancer,WST-1 assay,IC50=251.47 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1318,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),RT4,Bladder Cancer,WST-1 assay,IC50=231.26 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1319,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),647V,Bladder Cancer,WST-1 assay,IC50=185.39 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1320,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),J82,Bladder Cancer,WST-1 assay,IC50=212.07 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1329,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),486P,Bladder Cancer,Cell Viability assay,IC50=69.2 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1330,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),RT4,Bladder Cancer,Cell Viability assay,IC50=96.22 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1331,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),647V,Bladder Cancer,Cell Viability assay,IC50=28.74 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1332,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),J82,Bladder Cancer,Cell Viability assay,IC50=99.01 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1341,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),486P,Bladder Cancer,LDH leakage assay,IC50=373.3/ µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1342,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),RT4,Bladder Cancer,LDH leakage assay,IC50=289.3 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1343,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),647V,Bladder Cancer,LDH leakage assay,IC50=200.7 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
1344,18315881,2008,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Amidation,Free,Antimicrobial,Hyalophora Cecropia(silkmoth),J82,Bladder Cancer,LDH leakage assay,IC50=319.2 µg/ml,48-h,Bladder,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1186/1471-2490-8-5
5007,24661024,2014,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Free,Free,Antimicrobial,Isolated from the giant silk moth Hyalophora cecropia,SCC12,Skin Cancer,MTT/MTS assay,IC50=1 µM,48-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1111/exd.12384
5008,24661024,2014,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Free,Free,Antimicrobial,Isolated from the giant silk moth Hyalophora cecropia,SCC25,Skin Cancer,MTT/MTS assay,IC50=2.2 µM,48-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1111/exd.12384
5009,24661024,2014,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Free,Free,Antimicrobial,Isolated from the giant silk moth Hyalophora cecropia,SCC25,Skin Cancer,Cell Viability assay,0.6 ± 0.6% cell growth inhibition at 10 µM,48-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1111/exd.12384
5010,24661024,2014,KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK,Cecropin A,37,Linear,L,None,Free,Free,Antimicrobial,Isolated from the giant silk moth Hyalophora cecropia,SCC25,Skin Cancer,Cell Viability assay,107.0 ± 5.0% cell growth inhibition at 1 µM,24-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1111/exd.12384
1803,None,2005,KWKLFKKIGAVLKVL,CAME-15,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =45 µg/ml,24-h,Breast,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],Not Found
1955,None,2005,KWKLFKKIGAVLKVL,CAME-15,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],Not Found
2107,None,2005,KWKLFKKIGAVLKVL,CAME-15,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =40 µg/ml,24-h,Skin,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],Not Found
2259,None,2005,KWKLFKKIGAVLKVL,CAME-15,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =40 µg/ml,24-h,Skin,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],Not Found
2411,None,2005,KWKLFKKIGAVLKVL,CAME-15,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =65 µg/ml,24-h,Lung,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],Not Found
2554,None,2005,KWKLFKKIGAVLKVL,CAME-15,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =40 µg/ml,24-h,Prostate,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],Not Found
2697,None,2005,KWKLFKKIGAVLKVL,CAME-15,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =30 µg/ml,24-h,Cervix,US_06875744_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],Not Found
2878,20212453,2010,KWKLFKKIGAVLKVL,Camel,15,Linear,L,None,Free,Free,Antimicrobial,Ceropin-Melittin hybrid,B16-F10,Skin Cancer,MTT/MTS assay,LC50 = 1.75 µM,24-h,Skin,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1038/labinvest.2010.58
2879,20212453,2010,KWKLFKKIGAVLKVL,Camel,15,Linear,L,None,Free,Free,Antimicrobial,Ceropin-Melittin hybrid,RENCA,Renal Cancer,MTT/MTS assay,LC50 = 1.3 µM,24-h,Renal,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1038/labinvest.2010.58
2880,20212453,2010,KWKLFKKIGAVLKVL,Camel,15,Linear,L,None,Free,Free,Antimicrobial,Ceropin-Melittin hybrid,4T1,Breast Cancer,MTT/MTS assay,LC50 = 6.2 µM,24-h,Breast,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1038/labinvest.2010.58
2881,20212453,2010,KWKLFKKIGAVLKVL,Camel,15,Linear,L,None,Free,Free,Antimicrobial,Ceropin-Melittin hybrid,WM1158,Skin Cancer,MTT/MTS assay,LC50 = 4.1 µM,24-h,Skin,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)C(C)C)CCCC[NH3])CC(C)C)C(C)C)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1038/labinvest.2010.58
1207,9352466,1997,KWKLFKKIGIGAFLHLAKKF,P5,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H69,Lung Cancer,MTT/MTS assay,IC50=2.9 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1217,9352466,1997,KWKLFKKIGIGAFLHLAKKF,P5,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H128,Lung Cancer,MTT/MTS assay,IC50=2.9 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1227,9352466,1997,KWKLFKKIGIGAFLHLAKKF,P5,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H146,Lung Cancer,MTT/MTS assay,IC50=3.2 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1205,9352466,1997,KWKLFKKIGIGAFLHSAKKF,P3,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H69,Lung Cancer,MTT/MTS assay,IC50=9.3 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1215,9352466,1997,KWKLFKKIGIGAFLHSAKKF,P3,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H128,Lung Cancer,MTT/MTS assay,IC50=9.3 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1225,9352466,1997,KWKLFKKIGIGAFLHSAKKF,P3,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H146,Lung Cancer,MTT/MTS assay,IC50=10.9 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1203,9352466,1997,KWKLFKKIGIGAVLKVLKKG,P1,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H69,Lung Cancer,MTT/MTS assay,IC50=3.4 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1213,9352466,1997,KWKLFKKIGIGAVLKVLKKG,P1,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H128,Lung Cancer,MTT/MTS assay,IC50=3.5 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1223,9352466,1997,KWKLFKKIGIGAVLKVLKKG,P1,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H146,Lung Cancer,MTT/MTS assay,IC50=4.5 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1202,9352466,1997,KWKLFKKIGIGAVLKVLTTG,CA-ME,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H69,Lung Cancer,MTT/MTS assay,IC50=32.2 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1212,9352466,1997,KWKLFKKIGIGAVLKVLTTG,CA-ME,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H128,Lung Cancer,MTT/MTS assay,IC50=28.6 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1222,9352466,1997,KWKLFKKIGIGAVLKVLTTG,CA-ME,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H146,Lung Cancer,MTT/MTS assay,IC50=28.6 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1208,9352466,1997,KWKLFKKIGIGKFKLAKKF,P6,19,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H69,Lung Cancer,MTT/MTS assay,IC50=1.7 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1218,9352466,1997,KWKLFKKIGIGKFKLAKKF,P6,19,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H128,Lung Cancer,MTT/MTS assay,IC50=2 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1228,9352466,1997,KWKLFKKIGIGKFKLAKKF,P6,19,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H146,Lung Cancer,MTT/MTS assay,IC50=3.1 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1206,9352466,1997,KWKLFKKIGIGKFLHLAKKF,P4,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H69,Lung Cancer,MTT/MTS assay,IC50=1.9 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1216,9352466,1997,KWKLFKKIGIGKFLHLAKKF,P4,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H128,Lung Cancer,MTT/MTS assay,IC50=1.3 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1226,9352466,1997,KWKLFKKIGIGKFLHLAKKF,P4,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H146,Lung Cancer,MTT/MTS assay,IC50=2.8 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1185,10675500,2000,KWKLFKKIGIGKFLHSAKKF,CA-MA,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,K-562,Leukemia Cancer,MTT/MTS assay,IC50=65 µM,72-h,Blood,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1189,10675500,2000,KWKLFKKIGIGKFLHSAKKF,CA-MA,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,A-549,Lung Cancer,MTT/MTS assay,IC50=60 µM,72-h,Lung,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1193,10675500,2000,KWKLFKKIGIGKFLHSAKKF,CA-MA,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,Jurkat,Blood Cancer,MTT/MTS assay,IC50=30 µM,72-h,Blood,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1197,10675500,2000,KWKLFKKIGIGKFLHSAKKF,CA-MA,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=44 µM,72-h,Breast,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1201,9352466,1997,KWKLFKKIGIGKFLHSAKKF,CA-MA,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H69,Lung Cancer,MTT/MTS assay,IC50=15.8 µM,72-h,Lung,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1211,9352466,1997,KWKLFKKIGIGKFLHSAKKF,CA-MA,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H128,Lung Cancer,MTT/MTS assay,IC50=16.1 µM,72-h,Lung,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1221,9352466,1997,KWKLFKKIGIGKFLHSAKKF,CA-MA,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H146,Lung Cancer,MTT/MTS assay,IC50=15.8 µM,72-h,Lung,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
3350,None,2004,KWKLFKKIGIGKFLHSAKKF,CA-MA,20,Linear,L,None,Amidation,Free,"Antimicrobial and Anticancer, antibacterial, antifungal",Ceropin-Melittin hybrid,Calu-6,Lung Cancer,MTT/MTS assay,~90% survival rate at 10 µM,NA,Lung,US_6800727_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],Not Found
3351,None,2004,KWKLFKKIGIGKFLHSAKKF,CA-MA,20,Linear,L,None,Amidation,Free,"Antimicrobial and Anticancer, antibacterial, antifungal",Ceropin-Melittin hybrid,Calu-6,Lung Cancer,MTT/MTS assay,<20% survival rate at 100 µM,NA,Lung,US_6800727_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],Not Found
3352,None,2004,KWKLFKKIGIGKFLHSAKKF,CA-MA,20,Linear,L,None,Amidation,Free,"Antimicrobial and Anticancer, antibacterial, antifungal",Ceropin-Melittin hybrid,Jurkat,Blood Cancer,MTT/MTS assay,100% survival rate at 10 µM,NA,Blood,US_6800727_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],Not Found
3353,None,2004,KWKLFKKIGIGKFLHSAKKF,CA-MA,20,Linear,L,None,Amidation,Free,"Antimicrobial and Anticancer, antibacterial, antifungal",Ceropin-Melittin hybrid,Jurkat,Blood Cancer,MTT/MTS assay,0% survival rate at 100 µM,NA,Blood,US_6800727_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],Not Found
3354,None,2004,KWKLFKKIGIGKFLHSAKKF,CA-MA,20,Linear,L,None,Amidation,Free,"Antimicrobial and Anticancer, antibacterial, antifungal",Ceropin-Melittin hybrid,SNU-601,Gastric Cancer,MTT/MTS assay,~80% survival rate at 10 µM,NA,Stomach,US_6800727_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],Not Found
3355,None,2004,KWKLFKKIGIGKFLHSAKKF,CA-MA,20,Linear,L,None,Amidation,Free,"Antimicrobial and Anticancer, antibacterial, antifungal",Ceropin-Melittin hybrid,SNU-601,Gastric Cancer,MTT/MTS assay,10% survival rate at 100 µM,NA,Stomach,US_6800727_B2,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],Not Found
1204,9352466,1997,KWKLFKKIGIGKFLHSATTF,P2,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H69,Lung Cancer,MTT/MTS assay,IC50=36.2 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1214,9352466,1997,KWKLFKKIGIGKFLHSATTF,P2,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H128,Lung Cancer,MTT/MTS assay,IC50=37.9 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1224,9352466,1997,KWKLFKKIGIGKFLHSATTF,P2,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A-Magainin 2,NCI-H146,Lung Cancer,MTT/MTS assay,IC50=47.7 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1111/j.1399-3011.1997.tb01469.x
1188,10675500,2000,KWKLFKKIGPGKFLHSAKKF,CA-MA3,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,K-562,Leukemia Cancer,MTT/MTS assay,IC50=>100 µM,72-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1016/s0005-2736(99)00210-2
1192,10675500,2000,KWKLFKKIGPGKFLHSAKKF,CA-MA3,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,A-549,Lung Cancer,MTT/MTS assay,IC50=>100 µM,72-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1016/s0005-2736(99)00210-2
1196,10675500,2000,KWKLFKKIGPGKFLHSAKKF,CA-MA3,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,Jurkat,Blood Cancer,MTT/MTS assay,IC50=75 µM,72-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1016/s0005-2736(99)00210-2
1200,10675500,2000,KWKLFKKIGPGKFLHSAKKF,CA-MA3,20,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=>100 µM,72-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1016/s0005-2736(99)00210-2
1186,10675500,2000,KWKLFKKIKFLHSAKKF,CA-MA1,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,K-562,Leukemia Cancer,MTT/MTS assay,IC50=85.3 µM,72-h,Blood,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1190,10675500,2000,KWKLFKKIKFLHSAKKF,CA-MA1,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,A-549,Lung Cancer,MTT/MTS assay,IC50=100 µM,72-h,Lung,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1194,10675500,2000,KWKLFKKIKFLHSAKKF,CA-MA1,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,Jurkat,Blood Cancer,MTT/MTS assay,IC50=65 µM,72-h,Blood,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1198,10675500,2000,KWKLFKKIKFLHSAKKF,CA-MA1,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=100 µM,72-h,Breast,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCC[NH3])CCCC[NH3])C)CO)Cc1[nH]cnc1)CC(C)C)Cc1ccccc1)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1121,12005420,2001,KWKLFKKILKFLHLAKKF,[L9]-P18,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=3 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1143,12005420,2001,KWKLFKKILKFLHLAKKF,[L9]-P18,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=9 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1165,12005420,2001,KWKLFKKILKFLHLAKKF,[L9]-P18,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=3 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1131,12005420,2001,KWKLFKKIPFLHLAKKF,C-1,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=26 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1153,12005420,2001,KWKLFKKIPFLHLAKKF,C-1,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=32 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1175,12005420,2001,KWKLFKKIPFLHLAKKF,C-1,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=31 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1135,12005420,2001,KWKLFKKIPHLAKKF,C-5,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=100 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1157,12005420,2001,KWKLFKKIPHLAKKF,C-5,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=81 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1179,12005420,2001,KWKLFKKIPHLAKKF,C-5,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=67 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1119,12005420,2001,KWKLFKKIPKFLHSAKKF,CA-MA-P,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=20 µM,48-h,Breast,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1034/j.1399-3011.2001.00934.x
1132,12005420,2001,KWKLFKKIPKFLHLAKK,C-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=38 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1134,12005420,2001,KWKLFKKIPKFLHLAK,C-4,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=54 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1136,12005420,2001,KWKLFKKIPKFLHLA,C-6,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=47 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1138,12005420,2001,KWKLFKKIPKFLHL,C-8,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=83 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1140,12005420,2001,KWKLFKKIPKFLH,C-10,13,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=100. <µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1141,12005420,2001,KWKLFKKIPKFLHSAKKF,CA-MA-P,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=20 µM,48-h,Blood,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1034/j.1399-3011.2001.00934.x
1154,12005420,2001,KWKLFKKIPKFLHLAKK,C-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=26 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1156,12005420,2001,KWKLFKKIPKFLHLAK,C-4,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=31 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1158,12005420,2001,KWKLFKKIPKFLHLA,C-6,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=21 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1160,12005420,2001,KWKLFKKIPKFLHL,C-8,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=54 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1162,12005420,2001,KWKLFKKIPKFLH,C-10,13,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=100.0 <µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1163,12005420,2001,KWKLFKKIPKFLHSAKKF,CA-MA-P,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=25 µM,48-h,Blood,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1034/j.1399-3011.2001.00934.x
1176,12005420,2001,KWKLFKKIPKFLHLAKK,C-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=23 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1178,12005420,2001,KWKLFKKIPKFLHLAK,C-4,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=25 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1180,12005420,2001,KWKLFKKIPKFLHLA,C-6,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=27 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1182,12005420,2001,KWKLFKKIPKFLHL,C-8,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=30 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1184,12005420,2001,KWKLFKKIPKFLH,C-10,13,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=100.0 <µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1187,10675500,2000,KWKLFKKIPKFLHSAKKF,CA-MA2,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,K-562,Leukemia Cancer,MTT/MTS assay,IC50=35.1 µM,72-h,Blood,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1191,10675500,2000,KWKLFKKIPKFLHSAKKF,CA-MA2,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,A-549,Lung Cancer,MTT/MTS assay,IC50=25 µM,72-h,Lung,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1195,10675500,2000,KWKLFKKIPKFLHSAKKF,CA-MA2,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,Jurkat,Blood Cancer,MTT/MTS assay,IC50=20 µM,72-h,Blood,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1199,10675500,2000,KWKLFKKIPKFLHSAKKF,CA-MA2,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=28 µM,72-h,Breast,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
3290,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Bovine lactoferrin (Lf-B),M14,Skin Cancer,MTT/MTS assay,92.2 ± 1.02% cell viability at 10 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3291,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,71.1 ± 2.84% cell viability at 20 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3292,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,50 ± 3.09% cell viability at 40 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3293,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,31.5 ± 1.49% cell viability at 60 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3294,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,13.8 ± 1.44% cell viability at 80 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3295,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,86 ± 0.57% cell viability at 10 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3296,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,63.8 ± 0.8% cell viability at 20 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3297,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,47.5 ± 1.66% cell viability at 40 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3298,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,26.9 ± 0.5% cell viability at 60 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3299,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,6.5 ± 1.07% cell viability at 80 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
1132,12005420,2001,KWKLFKKIPKFLHLAKK,C-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=38 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1134,12005420,2001,KWKLFKKIPKFLHLAK,C-4,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=54 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1136,12005420,2001,KWKLFKKIPKFLHLA,C-6,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=47 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1138,12005420,2001,KWKLFKKIPKFLHL,C-8,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=83 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1154,12005420,2001,KWKLFKKIPKFLHLAKK,C-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=26 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1156,12005420,2001,KWKLFKKIPKFLHLAK,C-4,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=31 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1158,12005420,2001,KWKLFKKIPKFLHLA,C-6,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=21 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1160,12005420,2001,KWKLFKKIPKFLHL,C-8,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=54 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1176,12005420,2001,KWKLFKKIPKFLHLAKK,C-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=23 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1178,12005420,2001,KWKLFKKIPKFLHLAK,C-4,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=25 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1180,12005420,2001,KWKLFKKIPKFLHLA,C-6,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=27 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1182,12005420,2001,KWKLFKKIPKFLHL,C-8,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=30 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
3290,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Bovine lactoferrin (Lf-B),M14,Skin Cancer,MTT/MTS assay,92.2 ± 1.02% cell viability at 10 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3291,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,71.1 ± 2.84% cell viability at 20 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3292,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,50 ± 3.09% cell viability at 40 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3293,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,31.5 ± 1.49% cell viability at 60 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3294,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,13.8 ± 1.44% cell viability at 80 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3295,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,86 ± 0.57% cell viability at 10 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3296,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,63.8 ± 0.8% cell viability at 20 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3297,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,47.5 ± 1.66% cell viability at 40 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3298,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,26.9 ± 0.5% cell viability at 60 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3299,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,6.5 ± 1.07% cell viability at 80 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
1132,12005420,2001,KWKLFKKIPKFLHLAKK,C-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=38 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1134,12005420,2001,KWKLFKKIPKFLHLAK,C-4,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=54 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1136,12005420,2001,KWKLFKKIPKFLHLA,C-6,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=47 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1154,12005420,2001,KWKLFKKIPKFLHLAKK,C-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=26 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1156,12005420,2001,KWKLFKKIPKFLHLAK,C-4,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=31 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1158,12005420,2001,KWKLFKKIPKFLHLA,C-6,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=21 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1176,12005420,2001,KWKLFKKIPKFLHLAKK,C-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=23 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1178,12005420,2001,KWKLFKKIPKFLHLAK,C-4,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=25 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1180,12005420,2001,KWKLFKKIPKFLHLA,C-6,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=27 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
3290,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Bovine lactoferrin (Lf-B),M14,Skin Cancer,MTT/MTS assay,92.2 ± 1.02% cell viability at 10 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3291,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,71.1 ± 2.84% cell viability at 20 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3292,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,50 ± 3.09% cell viability at 40 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3293,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,31.5 ± 1.49% cell viability at 60 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3294,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,13.8 ± 1.44% cell viability at 80 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3295,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,86 ± 0.57% cell viability at 10 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3296,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,63.8 ± 0.8% cell viability at 20 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3297,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,47.5 ± 1.66% cell viability at 40 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3298,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,26.9 ± 0.5% cell viability at 60 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3299,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,6.5 ± 1.07% cell viability at 80 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
1132,12005420,2001,KWKLFKKIPKFLHLAKK,C-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=38 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1134,12005420,2001,KWKLFKKIPKFLHLAK,C-4,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=54 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1154,12005420,2001,KWKLFKKIPKFLHLAKK,C-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=26 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1156,12005420,2001,KWKLFKKIPKFLHLAK,C-4,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=31 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1176,12005420,2001,KWKLFKKIPKFLHLAKK,C-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=23 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1178,12005420,2001,KWKLFKKIPKFLHLAK,C-4,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=25 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
3290,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Bovine lactoferrin (Lf-B),M14,Skin Cancer,MTT/MTS assay,92.2 ± 1.02% cell viability at 10 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3291,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,71.1 ± 2.84% cell viability at 20 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3292,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,50 ± 3.09% cell viability at 40 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3293,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,31.5 ± 1.49% cell viability at 60 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3294,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,13.8 ± 1.44% cell viability at 80 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3295,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,86 ± 0.57% cell viability at 10 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3296,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,63.8 ± 0.8% cell viability at 20 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3297,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,47.5 ± 1.66% cell viability at 40 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3298,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,26.9 ± 0.5% cell viability at 60 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3299,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,6.5 ± 1.07% cell viability at 80 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
1132,12005420,2001,KWKLFKKIPKFLHLAKK,C-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=38 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1154,12005420,2001,KWKLFKKIPKFLHLAKK,C-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=26 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1176,12005420,2001,KWKLFKKIPKFLHLAKK,C-2,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=23 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
3290,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Bovine lactoferrin (Lf-B),M14,Skin Cancer,MTT/MTS assay,92.2 ± 1.02% cell viability at 10 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3291,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,71.1 ± 2.84% cell viability at 20 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3292,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,50 ± 3.09% cell viability at 40 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3293,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,31.5 ± 1.49% cell viability at 60 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3294,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,13.8 ± 1.44% cell viability at 80 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3295,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,86 ± 0.57% cell viability at 10 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3296,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,63.8 ± 0.8% cell viability at 20 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3297,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,47.5 ± 1.66% cell viability at 40 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3298,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,26.9 ± 0.5% cell viability at 60 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3299,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,6.5 ± 1.07% cell viability at 80 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3290,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Bovine lactoferrin (Lf-B),M14,Skin Cancer,MTT/MTS assay,92.2 ± 1.02% cell viability at 10 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3291,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,71.1 ± 2.84% cell viability at 20 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3292,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,50 ± 3.09% cell viability at 40 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3293,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,31.5 ± 1.49% cell viability at 60 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3294,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,13.8 ± 1.44% cell viability at 80 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3295,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,86 ± 0.57% cell viability at 10 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3296,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,63.8 ± 0.8% cell viability at 20 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3297,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,47.5 ± 1.66% cell viability at 40 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3298,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,26.9 ± 0.5% cell viability at 60 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3299,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,6.5 ± 1.07% cell viability at 80 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
1119,12005420,2001,KWKLFKKIPKFLHSAKKF,CA-MA-P,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=20 µM,48-h,Breast,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1034/j.1399-3011.2001.00934.x
1141,12005420,2001,KWKLFKKIPKFLHSAKKF,CA-MA-P,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=20 µM,48-h,Blood,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1034/j.1399-3011.2001.00934.x
1163,12005420,2001,KWKLFKKIPKFLHSAKKF,CA-MA-P,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=25 µM,48-h,Blood,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1034/j.1399-3011.2001.00934.x
1187,10675500,2000,KWKLFKKIPKFLHSAKKF,CA-MA2,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,K-562,Leukemia Cancer,MTT/MTS assay,IC50=35.1 µM,72-h,Blood,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1191,10675500,2000,KWKLFKKIPKFLHSAKKF,CA-MA2,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,A-549,Lung Cancer,MTT/MTS assay,IC50=25 µM,72-h,Lung,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1195,10675500,2000,KWKLFKKIPKFLHSAKKF,CA-MA2,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,Jurkat,Blood Cancer,MTT/MTS assay,IC50=20 µM,72-h,Blood,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1199,10675500,2000,KWKLFKKIPKFLHSAKKF,CA-MA2,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin-Magainin hybrid peptides,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=28 µM,72-h,Breast,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc2ccccc2)CCCC[NH3])CCCC[NH3])C)CO)Cc2[nH]cnc2)CC(C)C)Cc2ccccc2)CCCC[NH3])CCC1)[C@H](CC)C)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])Cc1c[nH]c2c1cccc2)CCCC[NH3],https://doi.org/10.1016/s0005-2736(99)00210-2
1137,12005420,2001,KWKLFKKIPLAKKF,C-7,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=100. <µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1159,12005420,2001,KWKLFKKIPLAKKF,C-7,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=100.0 <µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1181,12005420,2001,KWKLFKKIPLAKKF,C-7,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=100.0 <µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1133,12005420,2001,KWKLFKKIPLHLAKKF,C-3,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=79 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1155,12005420,2001,KWKLFKKIPLHLAKKF,C-3,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=74 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1177,12005420,2001,KWKLFKKIPLHLAKKF,C-3,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=62 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1139,12005420,2001,KWKLFKKIPLKKF,C-9,13,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=100. <µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1161,12005420,2001,KWKLFKKIPLKKF,C-9,13,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=100.0 <µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1183,12005420,2001,KWKLFKKIPLKKF,C-9,13,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=100.0 <µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1122,12005420,2001,KWKLFKKISKFLHLAKKF,[S9]-P18,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=4 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1144,12005420,2001,KWKLFKKISKFLHLAKKF,[S9]-P18,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=7 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1166,12005420,2001,KWKLFKKISKFLHLAKKF,[S9]-P18,18,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=3 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1819,None,2005,KWKLFKKKTKLFKKFAKKLAKKL,CA (1-7) Shiva10 (1-16),23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1826,None,2005,KWKLFKKKTKLFKKFAKKLAKKL,CA(1-7) Shiva10(1-16)-COOH,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =63 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1971,None,2005,KWKLFKKKTKLFKKFAKKLAKKL,CA(1-7) Shiva10(1-16),23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =70 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1978,None,2005,KWKLFKKKTKLFKKFAKKLAKKL,CA(1-7) Shiva10(1-16)-COOH,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =13 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2123,None,2005,KWKLFKKKTKLFKKFAKKLAKKL,CA(1-7)Shiva10(1-16),23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =360 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2130,None,2005,KWKLFKKKTKLFKKFAKKLAKKL,CA(1-7) Shiva10(1-16)-COOH,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =12 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2275,None,2005,KWKLFKKKTKLFKKFAKKLAKKL,CA(1-7)Shiva10(1-16),23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =360 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2282,None,2005,KWKLFKKKTKLFKKFAKKLAKKL,CA(1-7) Shiva10(1-16)-COOH,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =12 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2427,None,2005,KWKLFKKKTKLFKKFAKKLAKKL,CA(1-7)Shiva10(1-16),23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =115 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2434,None,2005,KWKLFKKKTKLFKKFAKKLAKKL,CA(1-7) Shiva10(1-16),23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =22 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2570,None,2005,KWKLFKKKTKLFKKFAKKLAKKL,CA(1-7)Shiva10(1-16),23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =97 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2577,None,2005,KWKLFKKKTKLFKKFAKKLAKKL,CA(1-7) Shiva10(1-16)-COOH,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =170 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2713,None,2005,KWKLFKKKTKLFKKFAKKLAKKL,CA(1-7) Shiva10(1-16),23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =270 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2720,None,2005,KWKLFKKKTKLFKKFAKKLAKKL,CA(1-7) Shiva10(1-16)-COOH,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =19 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1445,21252288,2011,KWKSFAKTFKSAKKTVAHTALKAISS,L6A/L17A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1455,21252288,2011,KWKSFAKTFKSAKKTVAHTALKAISS,L6A/L17A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1465,21252288,2011,KWKSFAKTFKSAKKTVAHTALKAISS,L6A/L17A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1475,21252288,2011,KWKSFAKTFKSAKKTVAHTALKAISS,L6A/L17A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1485,21252288,2011,KWKSFAKTFKSAKKTVAHTALKAISS,L6A/L17A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1495,21252288,2011,KWKSFAKTFKSAKKTVAHTALKAISS,L6A/L17A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1505,21252288,2011,KWKSFAKTFKSAKKTVAHTALKAISS,L6A/L17A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1515,21252288,2011,KWKSFAKTFKSAKKTVAHTALKAISS,L6A/L17A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1449,21252288,2011,KWKSFAKTFKSAKKTVLHTALKAISS,L6A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=53 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1459,21252288,2011,KWKSFAKTFKSAKKTVLHTALKAISS,L6A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=58.7 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1469,21252288,2011,KWKSFAKTFKSAKKTVLHTALKAISS,L6A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=62.3 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1479,21252288,2011,KWKSFAKTFKSAKKTVLHTALKAISS,L6A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1489,21252288,2011,KWKSFAKTFKSAKKTVLHTALKAISS,L6A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1499,21252288,2011,KWKSFAKTFKSAKKTVLHTALKAISS,L6A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=14 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1509,21252288,2011,KWKSFAKTFKSAKKTVLHTALKAISS,L6A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=62.5 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1519,21252288,2011,KWKSFAKTFKSAKKTVLHTALKAISS,L6A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=58.6 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1446,21252288,2011,KWKSFLKTFKSAKKTVAHTAAKAISS,L17A/L21A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1448,21252288,2011,KWKSFLKTFKSAKKTVAHTAAKAISS,L21A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=71 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1456,21252288,2011,KWKSFLKTFKSAKKTVAHTAAKAISS,L17A/L21A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1458,21252288,2011,KWKSFLKTFKSAKKTVAHTAAKAISS,L21A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=59.8 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1466,21252288,2011,KWKSFLKTFKSAKKTVAHTAAKAISS,L17A/L21A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1468,21252288,2011,KWKSFLKTFKSAKKTVAHTAAKAISS,L21A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=70.8 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1476,21252288,2011,KWKSFLKTFKSAKKTVAHTAAKAISS,L17A/L21A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1478,21252288,2011,KWKSFLKTFKSAKKTVAHTAAKAISS,L21A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1486,21252288,2011,KWKSFLKTFKSAKKTVAHTAAKAISS,L17A/L21A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1488,21252288,2011,KWKSFLKTFKSAKKTVAHTAAKAISS,L21A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1496,21252288,2011,KWKSFLKTFKSAKKTVAHTAAKAISS,L17A/L21A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=37.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1498,21252288,2011,KWKSFLKTFKSAKKTVAHTAAKAISS,L21A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=15.6 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1506,21252288,2011,KWKSFLKTFKSAKKTVAHTAAKAISS,L17A/L21A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1508,21252288,2011,KWKSFLKTFKSAKKTVAHTAAKAISS,L21A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=63.5 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1516,21252288,2011,KWKSFLKTFKSAKKTVAHTAAKAISS,L17A/L21A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1518,21252288,2011,KWKSFLKTFKSAKKTVAHTAAKAISS,L21A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=64.7 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1447,21252288,2011,KWKSFLKTFKSAKKTVAHTALKAISS,L17A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1457,21252288,2011,KWKSFLKTFKSAKKTVAHTALKAISS,L17A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1467,21252288,2011,KWKSFLKTFKSAKKTVAHTALKAISS,L17A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1477,21252288,2011,KWKSFLKTFKSAKKTVAHTALKAISS,L17A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1487,21252288,2011,KWKSFLKTFKSAKKTVAHTALKAISS,L17A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1497,21252288,2011,KWKSFLKTFKSAKKTVAHTALKAISS,L17A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=16.4 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1507,21252288,2011,KWKSFLKTFKSAKKTVAHTALKAISS,L17A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1517,21252288,2011,KWKSFLKTFKSAKKTVAHTALKAISS,L17A,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=>83.6 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1450,21252288,2011,KWKSFLKTFKSAKKTVLHTALKAISS,P,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=33 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O.C(C)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1460,21252288,2011,KWKSFLKTFKSAKKTVLHTALKAISS,P,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=17.8 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O.C(C)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1470,21252288,2011,KWKSFLKTFKSAKKTVLHTALKAISS,P,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=15.8 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O.C(C)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1480,21252288,2011,KWKSFLKTFKSAKKTVLHTALKAISS,P,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=11.1 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O.C(C)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1490,21252288,2011,KWKSFLKTFKSAKKTVLHTALKAISS,P,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=25.2 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O.C(C)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1500,21252288,2011,KWKSFLKTFKSAKKTVLHTALKAISS,P,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=4.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O.C(C)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1510,21252288,2011,KWKSFLKTFKSAKKTVLHTALKAISS,P,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=11.5 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O.C(C)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1520,21252288,2011,KWKSFLKTFKSAKKTVLHTALKAISS,P,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=10.4 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O.C(C)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1452,21252288,2011,KWKSFLKTFKSAKKTVLHTLLKAISS,A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=8.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O.C(C)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1462,21252288,2011,KWKSFLKTFKSAKKTVLHTLLKAISS,A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=6.5 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O.C(C)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1472,21252288,2011,KWKSFLKTFKSAKKTVLHTLLKAISS,A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=5.1 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O.C(C)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1482,21252288,2011,KWKSFLKTFKSAKKTVLHTLLKAISS,A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=5 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O.C(C)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1492,21252288,2011,KWKSFLKTFKSAKKTVLHTLLKAISS,A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=9.8 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O.C(C)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1502,21252288,2011,KWKSFLKTFKSAKKTVLHTLLKAISS,A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=2.9 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O.C(C)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1512,21252288,2011,KWKSFLKTFKSAKKTVLHTLLKAISS,A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=7.8 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O.C(C)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1522,21252288,2011,KWKSFLKTFKSAKKTVLHTLLKAISS,A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=4.3 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O.C(C)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1451,21252288,2011,KWKSFLKTFKSLKKTVLHTALKAISS,A12L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=11.1 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1461,21252288,2011,KWKSFLKTFKSLKKTVLHTALKAISS,A12L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=4.3 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1471,21252288,2011,KWKSFLKTFKSLKKTVLHTALKAISS,A12L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=5 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1481,21252288,2011,KWKSFLKTFKSLKKTVLHTALKAISS,A12L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=6.4 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1491,21252288,2011,KWKSFLKTFKSLKKTVLHTALKAISS,A12L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=7.5 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1501,21252288,2011,KWKSFLKTFKSLKKTVLHTALKAISS,A12L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=4.4 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1511,21252288,2011,KWKSFLKTFKSLKKTVLHTALKAISS,A12L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=5.2 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1521,21252288,2011,KWKSFLKTFKSLKKTVLHTALKAISS,A12L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=3.8 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1453,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=9.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1463,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=8.7 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1473,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=6.2 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1483,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=4.3 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1493,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=6.4 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1503,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=4.1 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1513,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=4.4 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1523,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=2 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
3755,22837667,2012,KWKSFLKTFKSLKKTVLHTLLKAISS,Peptide P,26,Linear,L,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.71±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3756,22837667,2012,KWKSFLkTFKSLKKTVLHTLLKAISS,Peptide K7D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.29±0.03 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3757,22837667,2012,KWKSFLKTFKSLKkTVLHTLLKAISS,Peptide K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.52±0.05 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3758,22837667,2012,KWKSFLKTFKSLKKTVLHTLLkAISS,Peptide K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.39±0.02 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3759,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.06±0.01 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3760,22837667,2012,KWKSFLKTFKSLKkTVLHTLLkAISS,Peptide K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.40±0.09 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3761,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.45±0.19 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3762,22837667,2012,KWKSFLkTFkSLKkTVLHTLLkAISS,Peptide K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.79±0.23 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3763,22837667,2012,KWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 20.41±0.64 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3764,22837667,2012,kWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K1D/K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 18.07±0.48 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3765,22837667,2012,KWKSFlKTFKSLKKTVLHTLLKAISS,Peptide L6D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.23±0.10 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3766,22837667,2012,KWKSFLKTFKSlKKTVLHTLLKAISS,Peptide L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.63±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3767,22837667,2012,KWKSFLKTFKSLKKTVLHTlLKAISS,Peptide L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.33±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3768,22837667,2012,KWKSFlKTFKSlKKTVLHTLLKAISS,Peptide L6D/L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.01±0.08 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3769,22837667,2012,KWKSFLKTFKSlKKTVLHTlLKAISS,Peptide L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.14±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3770,22837667,2012,KWKSFlKTFKSlKKTVLHTlLKAISS,Peptide L6D/L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 7.80±0.26 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3771,22837667,2012,KWKSFlKTFKSlKKTVlHTlLKAISS,Peptide L6D/L12D/L17D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 9.69±0.38 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3772,22837667,2012,KWKSFlKTFKSlKKTVlHTllKAISS,Peptide L6D/L12D/L17D/L20D/L21D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 12.88±0.15 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
1453,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=9.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1463,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=8.7 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1473,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=6.2 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1483,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=4.3 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1493,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=6.4 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1503,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=4.1 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1513,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=4.4 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1523,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=2 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
3755,22837667,2012,KWKSFLKTFKSLKKTVLHTLLKAISS,Peptide P,26,Linear,L,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.71±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3756,22837667,2012,KWKSFLkTFKSLKKTVLHTLLKAISS,Peptide K7D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.29±0.03 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3757,22837667,2012,KWKSFLKTFKSLKkTVLHTLLKAISS,Peptide K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.52±0.05 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3758,22837667,2012,KWKSFLKTFKSLKKTVLHTLLkAISS,Peptide K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.39±0.02 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3759,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.06±0.01 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3760,22837667,2012,KWKSFLKTFKSLKkTVLHTLLkAISS,Peptide K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.40±0.09 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3761,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.45±0.19 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3762,22837667,2012,KWKSFLkTFkSLKkTVLHTLLkAISS,Peptide K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.79±0.23 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3763,22837667,2012,KWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 20.41±0.64 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3764,22837667,2012,kWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K1D/K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 18.07±0.48 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3765,22837667,2012,KWKSFlKTFKSLKKTVLHTLLKAISS,Peptide L6D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.23±0.10 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3766,22837667,2012,KWKSFLKTFKSlKKTVLHTLLKAISS,Peptide L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.63±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3767,22837667,2012,KWKSFLKTFKSLKKTVLHTlLKAISS,Peptide L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.33±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3768,22837667,2012,KWKSFlKTFKSlKKTVLHTLLKAISS,Peptide L6D/L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.01±0.08 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3769,22837667,2012,KWKSFLKTFKSlKKTVLHTlLKAISS,Peptide L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.14±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3770,22837667,2012,KWKSFlKTFKSlKKTVLHTlLKAISS,Peptide L6D/L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 7.80±0.26 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3771,22837667,2012,KWKSFlKTFKSlKKTVlHTlLKAISS,Peptide L6D/L12D/L17D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 9.69±0.38 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3772,22837667,2012,KWKSFlKTFKSlKKTVlHTllKAISS,Peptide L6D/L12D/L17D/L20D/L21D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 12.88±0.15 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
1453,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=9.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1463,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=8.7 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1473,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=6.2 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1483,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=4.3 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1493,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=6.4 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1503,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=4.1 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1513,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=4.4 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1523,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=2 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
3755,22837667,2012,KWKSFLKTFKSLKKTVLHTLLKAISS,Peptide P,26,Linear,L,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.71±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3756,22837667,2012,KWKSFLkTFKSLKKTVLHTLLKAISS,Peptide K7D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.29±0.03 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3757,22837667,2012,KWKSFLKTFKSLKkTVLHTLLKAISS,Peptide K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.52±0.05 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3758,22837667,2012,KWKSFLKTFKSLKKTVLHTLLkAISS,Peptide K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.39±0.02 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3759,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.06±0.01 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3760,22837667,2012,KWKSFLKTFKSLKkTVLHTLLkAISS,Peptide K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.40±0.09 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3761,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.45±0.19 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3762,22837667,2012,KWKSFLkTFkSLKkTVLHTLLkAISS,Peptide K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.79±0.23 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3763,22837667,2012,KWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 20.41±0.64 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3764,22837667,2012,kWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K1D/K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 18.07±0.48 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3765,22837667,2012,KWKSFlKTFKSLKKTVLHTLLKAISS,Peptide L6D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.23±0.10 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3766,22837667,2012,KWKSFLKTFKSlKKTVLHTLLKAISS,Peptide L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.63±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3767,22837667,2012,KWKSFLKTFKSLKKTVLHTlLKAISS,Peptide L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.33±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3768,22837667,2012,KWKSFlKTFKSlKKTVLHTLLKAISS,Peptide L6D/L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.01±0.08 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3769,22837667,2012,KWKSFLKTFKSlKKTVLHTlLKAISS,Peptide L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.14±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3770,22837667,2012,KWKSFlKTFKSlKKTVLHTlLKAISS,Peptide L6D/L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 7.80±0.26 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3771,22837667,2012,KWKSFlKTFKSlKKTVlHTlLKAISS,Peptide L6D/L12D/L17D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 9.69±0.38 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3772,22837667,2012,KWKSFlKTFKSlKKTVlHTllKAISS,Peptide L6D/L12D/L17D/L20D/L21D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 12.88±0.15 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
1453,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=9.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1463,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=8.7 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1473,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=6.2 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1483,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=4.3 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1493,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=6.4 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1503,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=4.1 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1513,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=4.4 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1523,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=2 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
3755,22837667,2012,KWKSFLKTFKSLKKTVLHTLLKAISS,Peptide P,26,Linear,L,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.71±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3756,22837667,2012,KWKSFLkTFKSLKKTVLHTLLKAISS,Peptide K7D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.29±0.03 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3757,22837667,2012,KWKSFLKTFKSLKkTVLHTLLKAISS,Peptide K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.52±0.05 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3758,22837667,2012,KWKSFLKTFKSLKKTVLHTLLkAISS,Peptide K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.39±0.02 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3759,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.06±0.01 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3760,22837667,2012,KWKSFLKTFKSLKkTVLHTLLkAISS,Peptide K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.40±0.09 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3761,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.45±0.19 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3762,22837667,2012,KWKSFLkTFkSLKkTVLHTLLkAISS,Peptide K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.79±0.23 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3763,22837667,2012,KWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 20.41±0.64 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3764,22837667,2012,kWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K1D/K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 18.07±0.48 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3765,22837667,2012,KWKSFlKTFKSLKKTVLHTLLKAISS,Peptide L6D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.23±0.10 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3766,22837667,2012,KWKSFLKTFKSlKKTVLHTLLKAISS,Peptide L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.63±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3767,22837667,2012,KWKSFLKTFKSLKKTVLHTlLKAISS,Peptide L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.33±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3768,22837667,2012,KWKSFlKTFKSlKKTVLHTLLKAISS,Peptide L6D/L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.01±0.08 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3769,22837667,2012,KWKSFLKTFKSlKKTVLHTlLKAISS,Peptide L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.14±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3770,22837667,2012,KWKSFlKTFKSlKKTVLHTlLKAISS,Peptide L6D/L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 7.80±0.26 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3771,22837667,2012,KWKSFlKTFKSlKKTVlHTlLKAISS,Peptide L6D/L12D/L17D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 9.69±0.38 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3772,22837667,2012,KWKSFlKTFKSlKKTVlHTllKAISS,Peptide L6D/L12D/L17D/L20D/L21D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 12.88±0.15 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
1453,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=9.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1463,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=8.7 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1473,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=6.2 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1483,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=4.3 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1493,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=6.4 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1503,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=4.1 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1513,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=4.4 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1523,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=2 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
3755,22837667,2012,KWKSFLKTFKSLKKTVLHTLLKAISS,Peptide P,26,Linear,L,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.71±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3756,22837667,2012,KWKSFLkTFKSLKKTVLHTLLKAISS,Peptide K7D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.29±0.03 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3757,22837667,2012,KWKSFLKTFKSLKkTVLHTLLKAISS,Peptide K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.52±0.05 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3758,22837667,2012,KWKSFLKTFKSLKKTVLHTLLkAISS,Peptide K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.39±0.02 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3759,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.06±0.01 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3760,22837667,2012,KWKSFLKTFKSLKkTVLHTLLkAISS,Peptide K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.40±0.09 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3761,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.45±0.19 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3762,22837667,2012,KWKSFLkTFkSLKkTVLHTLLkAISS,Peptide K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.79±0.23 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3763,22837667,2012,KWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 20.41±0.64 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3764,22837667,2012,kWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K1D/K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 18.07±0.48 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3765,22837667,2012,KWKSFlKTFKSLKKTVLHTLLKAISS,Peptide L6D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.23±0.10 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3766,22837667,2012,KWKSFLKTFKSlKKTVLHTLLKAISS,Peptide L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.63±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3767,22837667,2012,KWKSFLKTFKSLKKTVLHTlLKAISS,Peptide L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.33±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3768,22837667,2012,KWKSFlKTFKSlKKTVLHTLLKAISS,Peptide L6D/L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.01±0.08 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3769,22837667,2012,KWKSFLKTFKSlKKTVLHTlLKAISS,Peptide L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.14±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3770,22837667,2012,KWKSFlKTFKSlKKTVLHTlLKAISS,Peptide L6D/L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 7.80±0.26 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3771,22837667,2012,KWKSFlKTFKSlKKTVlHTlLKAISS,Peptide L6D/L12D/L17D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 9.69±0.38 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3772,22837667,2012,KWKSFlKTFKSlKKTVlHTllKAISS,Peptide L6D/L12D/L17D/L20D/L21D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 12.88±0.15 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
1453,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=9.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1463,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=8.7 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1473,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=6.2 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1483,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=4.3 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1493,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=6.4 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1503,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=4.1 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1513,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=4.4 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1523,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=2 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
3755,22837667,2012,KWKSFLKTFKSLKKTVLHTLLKAISS,Peptide P,26,Linear,L,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.71±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3756,22837667,2012,KWKSFLkTFKSLKKTVLHTLLKAISS,Peptide K7D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.29±0.03 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3757,22837667,2012,KWKSFLKTFKSLKkTVLHTLLKAISS,Peptide K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.52±0.05 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3758,22837667,2012,KWKSFLKTFKSLKKTVLHTLLkAISS,Peptide K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.39±0.02 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3759,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.06±0.01 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3760,22837667,2012,KWKSFLKTFKSLKkTVLHTLLkAISS,Peptide K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.40±0.09 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3761,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.45±0.19 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3762,22837667,2012,KWKSFLkTFkSLKkTVLHTLLkAISS,Peptide K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.79±0.23 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3763,22837667,2012,KWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 20.41±0.64 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3764,22837667,2012,kWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K1D/K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 18.07±0.48 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3765,22837667,2012,KWKSFlKTFKSLKKTVLHTLLKAISS,Peptide L6D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.23±0.10 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3766,22837667,2012,KWKSFLKTFKSlKKTVLHTLLKAISS,Peptide L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.63±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3767,22837667,2012,KWKSFLKTFKSLKKTVLHTlLKAISS,Peptide L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.33±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3768,22837667,2012,KWKSFlKTFKSlKKTVLHTLLKAISS,Peptide L6D/L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.01±0.08 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3769,22837667,2012,KWKSFLKTFKSlKKTVLHTlLKAISS,Peptide L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.14±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3770,22837667,2012,KWKSFlKTFKSlKKTVLHTlLKAISS,Peptide L6D/L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 7.80±0.26 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3771,22837667,2012,KWKSFlKTFKSlKKTVlHTlLKAISS,Peptide L6D/L12D/L17D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 9.69±0.38 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3772,22837667,2012,KWKSFlKTFKSlKKTVlHTllKAISS,Peptide L6D/L12D/L17D/L20D/L21D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 12.88±0.15 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
1453,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=9.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1463,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=8.7 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1473,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=6.2 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1483,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=4.3 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1493,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=6.4 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1503,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=4.1 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1513,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=4.4 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1523,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=2 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
3755,22837667,2012,KWKSFLKTFKSLKKTVLHTLLKAISS,Peptide P,26,Linear,L,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.71±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3756,22837667,2012,KWKSFLkTFKSLKKTVLHTLLKAISS,Peptide K7D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.29±0.03 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3757,22837667,2012,KWKSFLKTFKSLKkTVLHTLLKAISS,Peptide K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.52±0.05 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3758,22837667,2012,KWKSFLKTFKSLKKTVLHTLLkAISS,Peptide K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.39±0.02 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3759,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.06±0.01 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3760,22837667,2012,KWKSFLKTFKSLKkTVLHTLLkAISS,Peptide K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.40±0.09 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3761,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.45±0.19 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3762,22837667,2012,KWKSFLkTFkSLKkTVLHTLLkAISS,Peptide K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.79±0.23 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3763,22837667,2012,KWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 20.41±0.64 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3764,22837667,2012,kWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K1D/K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 18.07±0.48 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3765,22837667,2012,KWKSFlKTFKSLKKTVLHTLLKAISS,Peptide L6D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.23±0.10 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3766,22837667,2012,KWKSFLKTFKSlKKTVLHTLLKAISS,Peptide L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.63±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3767,22837667,2012,KWKSFLKTFKSLKKTVLHTlLKAISS,Peptide L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.33±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3768,22837667,2012,KWKSFlKTFKSlKKTVLHTLLKAISS,Peptide L6D/L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.01±0.08 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3769,22837667,2012,KWKSFLKTFKSlKKTVLHTlLKAISS,Peptide L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.14±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3770,22837667,2012,KWKSFlKTFKSlKKTVLHTlLKAISS,Peptide L6D/L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 7.80±0.26 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3771,22837667,2012,KWKSFlKTFKSlKKTVlHTlLKAISS,Peptide L6D/L12D/L17D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 9.69±0.38 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3772,22837667,2012,KWKSFlKTFKSlKKTVlHTllKAISS,Peptide L6D/L12D/L17D/L20D/L21D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 12.88±0.15 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
1453,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=9.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1463,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=8.7 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1473,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=6.2 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1483,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=4.3 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1493,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=6.4 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1503,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=4.1 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1513,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=4.4 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1523,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=2 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
3755,22837667,2012,KWKSFLKTFKSLKKTVLHTLLKAISS,Peptide P,26,Linear,L,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.71±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3756,22837667,2012,KWKSFLkTFKSLKKTVLHTLLKAISS,Peptide K7D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.29±0.03 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3757,22837667,2012,KWKSFLKTFKSLKkTVLHTLLKAISS,Peptide K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.52±0.05 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3758,22837667,2012,KWKSFLKTFKSLKKTVLHTLLkAISS,Peptide K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.39±0.02 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3759,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.06±0.01 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3760,22837667,2012,KWKSFLKTFKSLKkTVLHTLLkAISS,Peptide K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.40±0.09 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3761,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.45±0.19 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3762,22837667,2012,KWKSFLkTFkSLKkTVLHTLLkAISS,Peptide K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.79±0.23 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3763,22837667,2012,KWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 20.41±0.64 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3764,22837667,2012,kWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K1D/K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 18.07±0.48 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3765,22837667,2012,KWKSFlKTFKSLKKTVLHTLLKAISS,Peptide L6D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.23±0.10 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3766,22837667,2012,KWKSFLKTFKSlKKTVLHTLLKAISS,Peptide L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.63±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3767,22837667,2012,KWKSFLKTFKSLKKTVLHTlLKAISS,Peptide L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.33±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3768,22837667,2012,KWKSFlKTFKSlKKTVLHTLLKAISS,Peptide L6D/L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.01±0.08 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3769,22837667,2012,KWKSFLKTFKSlKKTVLHTlLKAISS,Peptide L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.14±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3770,22837667,2012,KWKSFlKTFKSlKKTVLHTlLKAISS,Peptide L6D/L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 7.80±0.26 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3771,22837667,2012,KWKSFlKTFKSlKKTVlHTlLKAISS,Peptide L6D/L12D/L17D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 9.69±0.38 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3772,22837667,2012,KWKSFlKTFKSlKKTVlHTllKAISS,Peptide L6D/L12D/L17D/L20D/L21D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 12.88±0.15 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
1453,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=9.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1463,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=8.7 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1473,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=6.2 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1483,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=4.3 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1493,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=6.4 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1503,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=4.1 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1513,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=4.4 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1523,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=2 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
3755,22837667,2012,KWKSFLKTFKSLKKTVLHTLLKAISS,Peptide P,26,Linear,L,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.71±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3756,22837667,2012,KWKSFLkTFKSLKKTVLHTLLKAISS,Peptide K7D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.29±0.03 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3757,22837667,2012,KWKSFLKTFKSLKkTVLHTLLKAISS,Peptide K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.52±0.05 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3758,22837667,2012,KWKSFLKTFKSLKKTVLHTLLkAISS,Peptide K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.39±0.02 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3759,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.06±0.01 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3760,22837667,2012,KWKSFLKTFKSLKkTVLHTLLkAISS,Peptide K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.40±0.09 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3761,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.45±0.19 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3762,22837667,2012,KWKSFLkTFkSLKkTVLHTLLkAISS,Peptide K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.79±0.23 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3763,22837667,2012,KWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 20.41±0.64 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3764,22837667,2012,kWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K1D/K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 18.07±0.48 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3765,22837667,2012,KWKSFlKTFKSLKKTVLHTLLKAISS,Peptide L6D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.23±0.10 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3766,22837667,2012,KWKSFLKTFKSlKKTVLHTLLKAISS,Peptide L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.63±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3767,22837667,2012,KWKSFLKTFKSLKKTVLHTlLKAISS,Peptide L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.33±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3768,22837667,2012,KWKSFlKTFKSlKKTVLHTLLKAISS,Peptide L6D/L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.01±0.08 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3769,22837667,2012,KWKSFLKTFKSlKKTVLHTlLKAISS,Peptide L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.14±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3770,22837667,2012,KWKSFlKTFKSlKKTVLHTlLKAISS,Peptide L6D/L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 7.80±0.26 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3771,22837667,2012,KWKSFlKTFKSlKKTVlHTlLKAISS,Peptide L6D/L12D/L17D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 9.69±0.38 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3772,22837667,2012,KWKSFlKTFKSlKKTVlHTllKAISS,Peptide L6D/L12D/L17D/L20D/L21D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 12.88±0.15 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
1453,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=9.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1463,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=8.7 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1473,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=6.2 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1483,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=4.3 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1493,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=6.4 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1503,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=4.1 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1513,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=4.4 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1523,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=2 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
3755,22837667,2012,KWKSFLKTFKSLKKTVLHTLLKAISS,Peptide P,26,Linear,L,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.71±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3756,22837667,2012,KWKSFLkTFKSLKKTVLHTLLKAISS,Peptide K7D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.29±0.03 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3757,22837667,2012,KWKSFLKTFKSLKkTVLHTLLKAISS,Peptide K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.52±0.05 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3758,22837667,2012,KWKSFLKTFKSLKKTVLHTLLkAISS,Peptide K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.39±0.02 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3759,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.06±0.01 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3760,22837667,2012,KWKSFLKTFKSLKkTVLHTLLkAISS,Peptide K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.40±0.09 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3761,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.45±0.19 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3762,22837667,2012,KWKSFLkTFkSLKkTVLHTLLkAISS,Peptide K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.79±0.23 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3763,22837667,2012,KWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 20.41±0.64 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3764,22837667,2012,kWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K1D/K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 18.07±0.48 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3765,22837667,2012,KWKSFlKTFKSLKKTVLHTLLKAISS,Peptide L6D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.23±0.10 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3766,22837667,2012,KWKSFLKTFKSlKKTVLHTLLKAISS,Peptide L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.63±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3767,22837667,2012,KWKSFLKTFKSLKKTVLHTlLKAISS,Peptide L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.33±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3768,22837667,2012,KWKSFlKTFKSlKKTVLHTLLKAISS,Peptide L6D/L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.01±0.08 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3769,22837667,2012,KWKSFLKTFKSlKKTVLHTlLKAISS,Peptide L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.14±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3770,22837667,2012,KWKSFlKTFKSlKKTVLHTlLKAISS,Peptide L6D/L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 7.80±0.26 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3771,22837667,2012,KWKSFlKTFKSlKKTVlHTlLKAISS,Peptide L6D/L12D/L17D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 9.69±0.38 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3772,22837667,2012,KWKSFlKTFKSlKKTVlHTllKAISS,Peptide L6D/L12D/L17D/L20D/L21D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 12.88±0.15 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
1453,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=9.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1463,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=8.7 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1473,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=6.2 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1483,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=4.3 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1493,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=6.4 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1503,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=4.1 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1513,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=4.4 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1523,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=2 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
3755,22837667,2012,KWKSFLKTFKSLKKTVLHTLLKAISS,Peptide P,26,Linear,L,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.71±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3756,22837667,2012,KWKSFLkTFKSLKKTVLHTLLKAISS,Peptide K7D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.29±0.03 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3757,22837667,2012,KWKSFLKTFKSLKkTVLHTLLKAISS,Peptide K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.52±0.05 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3758,22837667,2012,KWKSFLKTFKSLKKTVLHTLLkAISS,Peptide K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.39±0.02 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3759,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.06±0.01 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3760,22837667,2012,KWKSFLKTFKSLKkTVLHTLLkAISS,Peptide K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.40±0.09 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3761,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.45±0.19 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3762,22837667,2012,KWKSFLkTFkSLKkTVLHTLLkAISS,Peptide K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.79±0.23 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3763,22837667,2012,KWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 20.41±0.64 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3764,22837667,2012,kWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K1D/K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 18.07±0.48 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3765,22837667,2012,KWKSFlKTFKSLKKTVLHTLLKAISS,Peptide L6D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.23±0.10 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3766,22837667,2012,KWKSFLKTFKSlKKTVLHTLLKAISS,Peptide L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.63±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3767,22837667,2012,KWKSFLKTFKSLKKTVLHTlLKAISS,Peptide L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.33±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3768,22837667,2012,KWKSFlKTFKSlKKTVLHTLLKAISS,Peptide L6D/L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.01±0.08 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3769,22837667,2012,KWKSFLKTFKSlKKTVLHTlLKAISS,Peptide L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.14±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3770,22837667,2012,KWKSFlKTFKSlKKTVLHTlLKAISS,Peptide L6D/L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 7.80±0.26 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3771,22837667,2012,KWKSFlKTFKSlKKTVlHTlLKAISS,Peptide L6D/L12D/L17D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 9.69±0.38 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3772,22837667,2012,KWKSFlKTFKSlKKTVlHTllKAISS,Peptide L6D/L12D/L17D/L20D/L21D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 12.88±0.15 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
1453,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=9.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1463,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=8.7 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1473,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=6.2 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1483,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=4.3 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1493,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=6.4 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1503,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=4.1 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1513,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=4.4 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1523,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=2 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
3755,22837667,2012,KWKSFLKTFKSLKKTVLHTLLKAISS,Peptide P,26,Linear,L,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.71±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3756,22837667,2012,KWKSFLkTFKSLKKTVLHTLLKAISS,Peptide K7D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.29±0.03 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3757,22837667,2012,KWKSFLKTFKSLKkTVLHTLLKAISS,Peptide K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.52±0.05 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3758,22837667,2012,KWKSFLKTFKSLKKTVLHTLLkAISS,Peptide K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.39±0.02 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3759,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.06±0.01 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3760,22837667,2012,KWKSFLKTFKSLKkTVLHTLLkAISS,Peptide K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.40±0.09 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3761,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.45±0.19 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3762,22837667,2012,KWKSFLkTFkSLKkTVLHTLLkAISS,Peptide K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.79±0.23 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3763,22837667,2012,KWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 20.41±0.64 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3764,22837667,2012,kWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K1D/K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 18.07±0.48 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3765,22837667,2012,KWKSFlKTFKSLKKTVLHTLLKAISS,Peptide L6D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.23±0.10 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3766,22837667,2012,KWKSFLKTFKSlKKTVLHTLLKAISS,Peptide L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.63±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3767,22837667,2012,KWKSFLKTFKSLKKTVLHTlLKAISS,Peptide L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.33±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3768,22837667,2012,KWKSFlKTFKSlKKTVLHTLLKAISS,Peptide L6D/L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.01±0.08 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3769,22837667,2012,KWKSFLKTFKSlKKTVLHTlLKAISS,Peptide L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.14±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3770,22837667,2012,KWKSFlKTFKSlKKTVLHTlLKAISS,Peptide L6D/L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 7.80±0.26 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3771,22837667,2012,KWKSFlKTFKSlKKTVlHTlLKAISS,Peptide L6D/L12D/L17D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 9.69±0.38 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3772,22837667,2012,KWKSFlKTFKSlKKTVlHTllKAISS,Peptide L6D/L12D/L17D/L20D/L21D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 12.88±0.15 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
1453,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=9.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1463,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=8.7 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1473,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=6.2 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1483,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=4.3 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1493,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=6.4 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1503,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=4.1 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1513,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=4.4 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1523,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=2 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
3755,22837667,2012,KWKSFLKTFKSLKKTVLHTLLKAISS,Peptide P,26,Linear,L,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.71±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3756,22837667,2012,KWKSFLkTFKSLKKTVLHTLLKAISS,Peptide K7D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.29±0.03 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3757,22837667,2012,KWKSFLKTFKSLKkTVLHTLLKAISS,Peptide K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.52±0.05 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3758,22837667,2012,KWKSFLKTFKSLKKTVLHTLLkAISS,Peptide K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.39±0.02 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3759,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.06±0.01 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3760,22837667,2012,KWKSFLKTFKSLKkTVLHTLLkAISS,Peptide K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.40±0.09 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3761,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.45±0.19 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3762,22837667,2012,KWKSFLkTFkSLKkTVLHTLLkAISS,Peptide K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.79±0.23 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3763,22837667,2012,KWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 20.41±0.64 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3764,22837667,2012,kWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K1D/K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 18.07±0.48 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3765,22837667,2012,KWKSFlKTFKSLKKTVLHTLLKAISS,Peptide L6D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.23±0.10 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3766,22837667,2012,KWKSFLKTFKSlKKTVLHTLLKAISS,Peptide L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.63±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3767,22837667,2012,KWKSFLKTFKSLKKTVLHTlLKAISS,Peptide L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.33±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3768,22837667,2012,KWKSFlKTFKSlKKTVLHTLLKAISS,Peptide L6D/L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.01±0.08 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3769,22837667,2012,KWKSFLKTFKSlKKTVLHTlLKAISS,Peptide L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.14±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3770,22837667,2012,KWKSFlKTFKSlKKTVLHTlLKAISS,Peptide L6D/L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 7.80±0.26 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3771,22837667,2012,KWKSFlKTFKSlKKTVlHTlLKAISS,Peptide L6D/L12D/L17D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 9.69±0.38 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3772,22837667,2012,KWKSFlKTFKSlKKTVlHTllKAISS,Peptide L6D/L12D/L17D/L20D/L21D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 12.88±0.15 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
1453,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=9.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1463,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=8.7 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1473,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=6.2 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1483,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=4.3 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1493,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=6.4 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1503,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=4.1 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1513,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=4.4 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1523,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=2 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
3755,22837667,2012,KWKSFLKTFKSLKKTVLHTLLKAISS,Peptide P,26,Linear,L,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.71±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3756,22837667,2012,KWKSFLkTFKSLKKTVLHTLLKAISS,Peptide K7D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.29±0.03 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3757,22837667,2012,KWKSFLKTFKSLKkTVLHTLLKAISS,Peptide K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.52±0.05 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3758,22837667,2012,KWKSFLKTFKSLKKTVLHTLLkAISS,Peptide K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.39±0.02 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3759,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.06±0.01 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3760,22837667,2012,KWKSFLKTFKSLKkTVLHTLLkAISS,Peptide K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.40±0.09 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3761,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.45±0.19 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3762,22837667,2012,KWKSFLkTFkSLKkTVLHTLLkAISS,Peptide K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.79±0.23 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3763,22837667,2012,KWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 20.41±0.64 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3764,22837667,2012,kWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K1D/K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 18.07±0.48 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3765,22837667,2012,KWKSFlKTFKSLKKTVLHTLLKAISS,Peptide L6D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.23±0.10 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3766,22837667,2012,KWKSFLKTFKSlKKTVLHTLLKAISS,Peptide L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.63±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3767,22837667,2012,KWKSFLKTFKSLKKTVLHTlLKAISS,Peptide L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.33±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3768,22837667,2012,KWKSFlKTFKSlKKTVLHTLLKAISS,Peptide L6D/L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.01±0.08 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3769,22837667,2012,KWKSFLKTFKSlKKTVLHTlLKAISS,Peptide L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.14±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3770,22837667,2012,KWKSFlKTFKSlKKTVLHTlLKAISS,Peptide L6D/L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 7.80±0.26 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3771,22837667,2012,KWKSFlKTFKSlKKTVlHTlLKAISS,Peptide L6D/L12D/L17D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 9.69±0.38 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3772,22837667,2012,KWKSFlKTFKSlKKTVlHTllKAISS,Peptide L6D/L12D/L17D/L20D/L21D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 12.88±0.15 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
1453,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=9.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1463,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=8.7 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1473,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=6.2 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1483,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=4.3 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1493,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=6.4 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1503,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=4.1 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1513,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=4.4 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1523,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=2 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
3755,22837667,2012,KWKSFLKTFKSLKKTVLHTLLKAISS,Peptide P,26,Linear,L,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.71±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3756,22837667,2012,KWKSFLkTFKSLKKTVLHTLLKAISS,Peptide K7D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.29±0.03 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3757,22837667,2012,KWKSFLKTFKSLKkTVLHTLLKAISS,Peptide K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.52±0.05 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3758,22837667,2012,KWKSFLKTFKSLKKTVLHTLLkAISS,Peptide K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.39±0.02 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3759,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.06±0.01 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3760,22837667,2012,KWKSFLKTFKSLKkTVLHTLLkAISS,Peptide K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.40±0.09 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3761,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.45±0.19 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3762,22837667,2012,KWKSFLkTFkSLKkTVLHTLLkAISS,Peptide K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.79±0.23 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3763,22837667,2012,KWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 20.41±0.64 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3764,22837667,2012,kWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K1D/K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 18.07±0.48 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3765,22837667,2012,KWKSFlKTFKSLKKTVLHTLLKAISS,Peptide L6D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.23±0.10 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3766,22837667,2012,KWKSFLKTFKSlKKTVLHTLLKAISS,Peptide L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.63±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3767,22837667,2012,KWKSFLKTFKSLKKTVLHTlLKAISS,Peptide L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.33±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3768,22837667,2012,KWKSFlKTFKSlKKTVLHTLLKAISS,Peptide L6D/L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.01±0.08 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3769,22837667,2012,KWKSFLKTFKSlKKTVLHTlLKAISS,Peptide L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.14±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3770,22837667,2012,KWKSFlKTFKSlKKTVLHTlLKAISS,Peptide L6D/L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 7.80±0.26 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3771,22837667,2012,KWKSFlKTFKSlKKTVlHTlLKAISS,Peptide L6D/L12D/L17D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 9.69±0.38 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3772,22837667,2012,KWKSFlKTFKSlKKTVlHTllKAISS,Peptide L6D/L12D/L17D/L20D/L21D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 12.88±0.15 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
1453,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=9.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1463,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=8.7 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1473,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=6.2 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1483,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=4.3 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1493,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=6.4 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1503,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=4.1 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1513,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=4.4 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1523,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=2 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
3755,22837667,2012,KWKSFLKTFKSLKKTVLHTLLKAISS,Peptide P,26,Linear,L,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.71±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3756,22837667,2012,KWKSFLkTFKSLKKTVLHTLLKAISS,Peptide K7D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.29±0.03 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3757,22837667,2012,KWKSFLKTFKSLKkTVLHTLLKAISS,Peptide K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.52±0.05 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3758,22837667,2012,KWKSFLKTFKSLKKTVLHTLLkAISS,Peptide K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.39±0.02 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3759,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.06±0.01 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3760,22837667,2012,KWKSFLKTFKSLKkTVLHTLLkAISS,Peptide K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.40±0.09 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3761,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.45±0.19 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3762,22837667,2012,KWKSFLkTFkSLKkTVLHTLLkAISS,Peptide K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.79±0.23 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3763,22837667,2012,KWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 20.41±0.64 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3764,22837667,2012,kWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K1D/K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 18.07±0.48 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3765,22837667,2012,KWKSFlKTFKSLKKTVLHTLLKAISS,Peptide L6D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.23±0.10 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3766,22837667,2012,KWKSFLKTFKSlKKTVLHTLLKAISS,Peptide L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.63±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3767,22837667,2012,KWKSFLKTFKSLKKTVLHTlLKAISS,Peptide L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.33±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3768,22837667,2012,KWKSFlKTFKSlKKTVLHTLLKAISS,Peptide L6D/L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.01±0.08 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3769,22837667,2012,KWKSFLKTFKSlKKTVLHTlLKAISS,Peptide L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.14±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3770,22837667,2012,KWKSFlKTFKSlKKTVLHTlLKAISS,Peptide L6D/L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 7.80±0.26 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3771,22837667,2012,KWKSFlKTFKSlKKTVlHTlLKAISS,Peptide L6D/L12D/L17D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 9.69±0.38 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3772,22837667,2012,KWKSFlKTFKSlKKTVlHTllKAISS,Peptide L6D/L12D/L17D/L20D/L21D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 12.88±0.15 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
1453,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=9.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1463,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=8.7 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1473,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=6.2 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1483,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=4.3 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1493,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=6.4 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1503,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=4.1 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1513,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=4.4 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1523,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKAISS,A12L/A20L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=2 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
3755,22837667,2012,KWKSFLKTFKSLKKTVLHTLLKAISS,Peptide P,26,Linear,L,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.71±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3756,22837667,2012,KWKSFLkTFKSLKKTVLHTLLKAISS,Peptide K7D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.29±0.03 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3757,22837667,2012,KWKSFLKTFKSLKkTVLHTLLKAISS,Peptide K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.52±0.05 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3758,22837667,2012,KWKSFLKTFKSLKKTVLHTLLkAISS,Peptide K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.39±0.02 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3759,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.06±0.01 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3760,22837667,2012,KWKSFLKTFKSLKkTVLHTLLkAISS,Peptide K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 1.40±0.09 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3761,22837667,2012,KWKSFLkTFKSLKkTVLHTLLKAISS,Peptide K7D /K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.45±0.19 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3762,22837667,2012,KWKSFLkTFkSLKkTVLHTLLkAISS,Peptide K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 4.79±0.23 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3763,22837667,2012,KWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 20.41±0.64 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3764,22837667,2012,kWkSFLkTFkSLKkTVLHTLLkAISS,Peptide K1D/K3D/K7D /K10D/K14D/K22D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 18.07±0.48 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3765,22837667,2012,KWKSFlKTFKSLKKTVLHTLLKAISS,Peptide L6D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.23±0.10 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3766,22837667,2012,KWKSFLKTFKSlKKTVLHTLLKAISS,Peptide L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.63±0.07 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3767,22837667,2012,KWKSFLKTFKSLKKTVLHTlLKAISS,Peptide L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 2.33±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3768,22837667,2012,KWKSFlKTFKSlKKTVLHTLLKAISS,Peptide L6D/L12D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.01±0.08 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3769,22837667,2012,KWKSFLKTFKSlKKTVLHTlLKAISS,Peptide L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 3.14±0.06 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3770,22837667,2012,KWKSFlKTFKSlKKTVLHTlLKAISS,Peptide L6D/L12D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 7.80±0.26 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3771,22837667,2012,KWKSFlKTFKSlKKTVlHTlLKAISS,Peptide L6D/L12D/L17D/L20D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 9.69±0.38 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
3772,22837667,2012,KWKSFlKTFKSlKKTVlHTllKAISS,Peptide L6D/L12D/L17D/L20D/L21D,26,Linear,Mix,None,Amidation,Acetylation,Anticancer,A12L/A20L,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 12.88±0.15 µMol/L,1-h,Cervix,None,C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@H]([C@@H](C)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N,https://doi.org/10.3390/ijms13066849
1454,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKLISS,A12L/A20L/A23L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-549,Lung Cancer,MTT/MTS assay,IC50=9.2 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1464,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKLISS,A12L/A20L/A23L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,A-375,Skin Cancer,MTT/MTS assay,IC50=7.2 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1474,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKLISS,A12L/A20L/A23L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,MCF-7,Breast Cancer,MTT/MTS assay,IC50=5.7 µMo/L,36-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1484,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKLISS,A12L/A20L/A23L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,SW-1116,Colorectal Cancer,MTT/MTS assay,IC50=3.5 µMo/L,36-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1494,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKLISS,A12L/A20L/A23L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,RD,Rhabdomyosarcoma Cancer,MTT/MTS assay,IC50=5.5 µMo/L,36-h,Muscle,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1504,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKLISS,A12L/A20L/A23L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,H-1299,Lung Cancer,MTT/MTS assay,IC50=2.7 µMo/L,36-h,Lung,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1514,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKLISS,A12L/A20L/A23L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,B-16,Skin Cancer,MTT/MTS assay,IC50=4.6 µMo/L,36-h,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1524,21252288,2011,KWKSFLKTFKSLKKTVLHTLLKLISS,A12L/A20L/A23L,26,Linear,L,None,Free,Free,Anticancer,PeptideV13K,HeLa,Cervical Cancer,MTT/MTS assay,IC50=2.2 µMo/L,36-h,Cervix,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1158/1535-7163.MCT-10-0811
1231,7849420,1994,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antibacterial,Hyalophora Cecropia(silkmoth),K-562,Leukemia Cancer,MTT assay,IC50=15.5 µM,96-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1232,7849420,1994,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antibacterial,Hyalophora Cecropia(silkmoth),BTS-30,Breast Cancer,MTT assay,IC50=24.8 µM,96-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1233,7849420,1994,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antibacterial,Hyalophora Cecropia(silkmoth),HRT-18,Colon Cancer,MTT assay,IC50=25.5 µM,96-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1234,7849420,1994,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antibacterial,Hyalophora Cecropia(silkmoth),DLD-1,Colon Cancer,MTT assay,IC50=>100 µM,96-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1243,7849420,1994,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antibacterial,Hyalophora Cecropia(silkmoth),WEHI-3B,Leukemia Cancer,MTT assay,IC50=4.4 µM,96-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1244,7849420,1994,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antibacterial,Hyalophora Cecropia(silkmoth),A-2780,Ovarian Cancer,MTT assay,IC50=30.6 µM,96-h,Ovary,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1245,7849420,1994,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antibacterial,Hyalophora Cecropia(silkmoth),HCLO,Colon Cancer,MTT assay,IC50=33.5 µM,96-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1246,7849420,1994,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antibacterial,Hyalophora Cecropia(silkmoth),CHO-KI,Ovarian Cancer,MTT assay,IC50=32 µM,96-h,Ovary,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1247,7849420,1994,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antibacterial,Hyalophora Cecropia(silkmoth),MAC15A,Colon Cancer,MTT assay,IC50=37 µM,96-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1248,7849420,1994,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antibacterial,Hyalophora Cecropia(silkmoth),MCF-7,Breast Cancer,MTT assay,IC50=42.5 µM,96-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1249,7849420,1994,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antibacterial,Hyalophora Cecropia(silkmoth),HT-29,Colon Cancer,MTT assay,IC50=>100 µM,96-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1250,7849420,1994,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antibacterial,Hyalophora Cecropia(silkmoth),A-2780R,Ovarian Cancer,MTT assay,IC50=34.5,96-h,Ovary,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1251,7849420,1994,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL,Cecropin B,35,Linear,L,None,Amidation,Free,Antibacterial,Hyalophora Cecropia(silkmoth),MCF-7R,Breast Cancer,MTT assay,IC50=24.5,96-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
4601,15496597,2004,KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL,CB,36,Linear,L,None,Free,Free,Antibacterial,Synthetic,Ags,Gastric Cancer,Not Available,Not Available,Not Available,Stomach,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1093/jb/mvh114
4618,20964334,2010,KWKWKW,Dex-(KW)3,6,Linear,L,Dextran,Amidation,Dextran,Anticancer,Synthetic,PC-3,Prostate Cancer,MTT/MTS assay,at 10 µM 60% viablity,Not Available,Prostate,None,NA,https://doi.org/10.1021/bc1002899
4619,20964334,2010,KWKWKW,Dex-(KW)3,6,Linear,L,Dextran,Amidation,Dextran,Anticancer,Synthetic,MCF-7,Breast Cancer,MTT/MTS assay,at 10 µM 35-40% viablity,Not Available,Breast,None,NA,https://doi.org/10.1021/bc1002899
3114,23993331,2013,KWLRRVWRWWR,MAP-04-03,11,Linear,L,None,Amidation,Free,Antimicrobial,Analogs of Ixosin-B amide,MCF-7,Breast Cancer,MTT/MTS assay,Cell viability >80% at 25 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.bmcl.2013.07.063
3115,23993331,2013,KWLRRVWRWWR,MAP-04-03,11,Linear,L,None,Amidation,Free,Antimicrobial,Analogs of Ixosin-B amide,MCF-7,Breast Cancer,MTT/MTS assay,Cell viability ~50% at 50 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.bmcl.2013.07.063
3116,23993331,2013,KWLRRVWRWWR,MAP-04-03,11,Linear,L,None,Amidation,Free,Antimicrobial,Analogs of Ixosin-B amide,MCF-7,Breast Cancer,MTT/MTS assay,Cell viability <40% at 75 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.bmcl.2013.07.063
3117,23993331,2013,KWLRRVWRWWR,MAP-04-03,11,Linear,L,None,Amidation,Free,Antimicrobial,Analogs of Ixosin-B amide,MCF-7,Breast Cancer,MTT/MTS assay,Cell viability >20% at 100 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.bmcl.2013.07.063
3118,23993331,2013,KWLRRVWRWWR,MAP-04-03,11,Linear,L,None,Amidation,Free,Antimicrobial,Analogs of Ixosin-B amide,MCF-7,Breast Cancer,MTT/MTS assay,Cell viability ~100% at 25 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.bmcl.2013.07.063
3122,23993331,2013,KWLRRVWRWWR,MAP-04-03,11,Linear,L,None,Amidation,Free,Antimicrobial,Analogs of Ixosin-B amide,MCF-7,Breast Cancer,MTT/MTS assay,IC50=61.5 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.bmcl.2013.07.063
4480,22057278,2011,KWWKKAAKAAKKAAKAAKKWA,Z6,21,Linear,L,None,Free,Free,Anticancer,Synthetic,Meth A,Skin Cancer,MTT/MTS assay,EC50 =17 µM,Not Available,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4490,22057278,2011,KWWKKAAKAAKKAAKAAKKWA,Z6,21,Linear,L,None,Free,Free,Anticancer,Synthetic,MT-1,Breast Cancer,MTT/MTS assay,EC50 =16 µM,Not Available,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
4500,22057278,2011,KWWKKAAKAAKKAAKAAKKWA,Z6,21,Linear,L,None,Free,Free,Anticancer,Synthetic,HT-29,Colon Cancer,MTT/MTS assay,EC50 =31 µM,Not Available,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.M111.279281
No data available in table,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found
3773,22933412,2012,"KKWβ2,2WKK",c1,7,Cyclic,L,"(2,2-di(naphthalen-2-ylmethyl)-3-amino-propionic acid)",Free,Free,Anticancer,"KKWβ2,2WKK",Ramos,Lymphoma Cancer,MTT/MTS assay,IC50= 10±2 µMol/L,NA,Blood,None,NA,https://doi.org/10.1002/psc.2441
3781,22933412,2012,"KKWβ2,2WKK",c1,7,Linear,L,"(2,2-di(naphthalen-2-ylmethyl)-3-amino-propionic acid)",Amidation,Free,Anticancer,"KKWβ2,2WKK",Ramos,Lymphoma Cancer,MTT/MTS assay,IC50= 22±5 µMol/L,NA,Blood,None,NA,https://doi.org/10.1002/psc.2441
1877,None,2005,KYKKALKKLAKLL,FLAK98,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =110 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2029,None,2005,KYKKALKKLAKLL,FLAK98,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =380 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2181,None,2005,KYKKALKKLAKLL,FLAK98,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =185 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2333,None,2005,KYKKALKKLAKLL,FLAK98,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =185 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2486,None,2005,KYKKALKKLAKLL,FLAK98,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =93 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2629,None,2005,KYKKALKKLAKLL,FLAK98,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =440 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2772,None,2005,KYKKALKKLAKLL,FLAK98,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =640 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
3590,22100226,2012,LFGMALKLLKKVL,MAC1/3,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 9±2 µM,48-h,Cervix,None,N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3606,22100226,2012,LFGMALKLLKKVL,MAC1/3,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 11±1 µM,48-h,Colon,None,N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3622,22100226,2012,LFGMALKLLKKVL,MAC1/3,13,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Macropins and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 22 µM,48-h,Blood,None,N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
4165,"12631273, 9266696",2003,LGGIVSAVKKIVDFLG,retro,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Leukemia tumor cellline,Leukemia Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Blood,None,N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4166,"12631273, 9266696",2003,LGGIVSAVKKIVDFLG,retro,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Lung tumor cellline,Lung Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Lung,None,N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4167,"12631273, 9266696",2003,LGGIVSAVKKIVDFLG,retro,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Colon tumor cellline,Colon Cancer,Sulforhodamine B assay,IC50= >10 µM,Not Available,Colon,None,N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4168,"12631273, 9266696",2003,LGGIVSAVKKIVDFLG,retro,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Brain tumor cellline,Brain Tumor,Sulforhodamine B assay,IC50= 5 M,Not Available,Brain,None,N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4169,"12631273, 9266696",2003,LGGIVSAVKKIVDFLG,retro,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Skin tumor cellline,Skin Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Skin,None,N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4170,"12631273, 9266696",2003,LGGIVSAVKKIVDFLG,retro,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Ovary tumor cellline,Ovarian Cancer,Sulforhodamine B assay,IC50= 5 M,Not Available,Ovary,None,N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4171,"12631273, 9266696",2003,LGGIVSAVKKIVDFLG,retro,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Liver tumor celline,Liver Cancer,Sulforhodamine B assay,IC50= >10 µM,Not Available,Liver,None,N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4172,"12631273, 9266696",2003,LGGIVSAVKKIVDFLG,retro,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Prostate tumor cellline,Prostate Cancer,Sulforhodamine B assay,IC50= >10 µM,Not Available,Prostate,None,N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4173,"12631273, 9266696",2003,LGGIVSAVKKIVDFLG,retro,16,Linear,L,None,Amidation,Free,Antimicrobial and Anticancer,Amphibian skin secretions,Breast tumor cellline,Breast Cancer,Sulforhodamine B assay,IC50= >10 µM,Not Available,Breast,None,N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,"['https://doi.org/10.1046/j.1432-1033.2003.03462.x', 'https://doi.org/10.1111/j.1432-1033.1997.00545.x']"
4207,15867360,2005,LGQSAASAHHAYIVLAIENSFMTASKKK,hP8,28,Linear,L,None,Free,Free,Antiangiogenesis,Human endostatin peptides,BxPC-3,Pancreatic Cancer,Matrigel Assay,No inhibition at 7 mg/kg/d,672-h,Pancreatic,None,N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1158/0008-5472.CAN-04-1833
4576,21928125,2012,LIAHNQVRQV,p85,10,Linear,L,None,Free,Free,Antitumor,Synthetic Peptide,Not Available,Tumor,ELISPOT assay,Not Available,Not Available,Not Available,None,N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1007/s00262-011-1113-4
1903,None,2005,LKKLAKLALAF,Flak 96L,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =555 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2055,None,2005,LKKLAKLALAF,Flak 96L,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2207,None,2005,LKKLAKLALAF,Flak 96L,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =920 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2359,None,2005,LKKLAKLALAF,Flak 96L,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =920 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2512,None,2005,LKKLAKLALAF,Flak 96L,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2655,None,2005,LKKLAKLALAF,Flak 96L,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2798,None,2005,LKKLAKLALAF,Flak 96L,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
4263,None,2004,lKKllKKllKKl,DL6K6,12,Linear,Mix,None,Amidation,Free,"Antimicrobial, Antifungal and Anticancer",Synthetic Peptide,22RV1,Prostate Cancer,MTT/MTS assay,LC50>100 µM,Not Available,Prostate,AU_2004_246909_A1,N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N,Not Found
4264,None,2004,lKKllKKllKKl,DL6K6,12,Linear,Mix,None,Amidation,Free,"Antimicrobial, Antifungal and Anticancer",Synthetic Peptide,CL-1,Tumor,MTT/MTS assay,LC50>100 µM,Not Available,Pancreatic,AU_2004_246909_A1,N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N,Not Found
4266,None,2004,lKKllKKllKKl,DDA-DL6K6-22,12,Linear,Mix,None,Amidation,CH3(CH2)10CO,"Antimicrobial, Antifungal and Anticancer",Synthetic Peptide,22RV1,Prostate Cancer,MTT/MTS assay,LC50<3.125 µM,Not Available,Prostate,AU_2004_246909_A1,NA,Not Found
4267,None,2004,lKKllKKllKKl,DDA-DL6K6-22,12,Linear,Mix,None,Amidation,CH3(CH2)10CO,"Antimicrobial, Antifungal and Anticancer",Synthetic Peptide,CL-1,Tumor,MTT/MTS assay,LC50<3.125 µM,Not Available,Pancreatic,AU_2004_246909_A1,NA,Not Found
4269,None,2004,lKKllKKllKKl,MA-DL6K6-23,12,Linear,Mix,None,Amidation,CH3(CH2)12CO,"Antimicrobial, Antifungal and Anticancer",Synthetic Peptide,22RV1,Prostate Cancer,MTT/MTS assay,LC50<3.125 µM,Not Available,Prostate,AU_2004_246909_A1,NA,Not Found
4270,None,2004,lKKllKKllKKl,MA-DL6K6-23,12,Linear,Mix,None,Amidation,CH3(CH2)12CO,"Antimicrobial, Antifungal and Anticancer",Synthetic Peptide,CL-1,Tumor,MTT/MTS assay,LC50<3.125 µM,Not Available,Pancreatic,AU_2004_246909_A1,NA,Not Found
4272,None,2004,lKKllKKllKKl,PA-DL6K6-24,12,Linear,Mix,None,Amidation,CH3(CH2)14CO,"Antimicrobial, Antifungal and Anticancer",Synthetic Peptide,22RV1,Prostate Cancer,MTT/MTS assay,LC50<3.125 µM,Not Available,Prostate,AU_2004_246909_A1,NA,Not Found
4273,None,2004,lKKllKKllKKl,PA-DL6K6-24,12,Linear,Mix,None,Amidation,CH3(CH2)14CO,"Antimicrobial, Antifungal and Anticancer",Synthetic Peptide,CL-1,Tumor,MTT/MTS assay,LC50=3.125 µM,Not Available,Pancreatic,AU_2004_246909_A1,NA,Not Found
4451,"8555423, 18957441",1995,LKLKSIVSWAKKVL,Mastoparan B,14,Not Available,L,None,Free,Free,Antimicrobial,"Hornet,Vespa basalis",Not Available,Colorectal Cancer,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,"['https://doi.org/10.1002/bip.360360611', 'https://doi.org/10.1093/nar/gkn823']"
2869,16707464,2006,LKlLKKLlkKLLkLL,D-K6L9,15,Linear,Mix,None,Amidation,Free,Anticancer,Host Defense lytic Peptide,22RV1,Prostate Cancer,Enzyme Immunoassay (EIA),LC50=6 µMol/L,Not Available,Prostate,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1158/0008-5472.CAN-05-4569
2870,16707464,2006,LKlLKKLlkKLLkLL,D-K6L9,15,Linear,Mix,None,Amidation,Free,Anticancer,Host DefenseÐLike Lytic Peptide,CL-1,Lung Cancer,Enzyme Immunoassay (EIA),LC50=3 µMol/L,Not Available,Lung,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1158/0008-5472.CAN-05-4569
2871,16707464,2006,LKlLKKLlkKLLkLL,D-K6L9,15,Linear,Mix,None,Amidation,Free,Anticancer,Host Defense lytic Peptide,MB-231,Prostate Cancer,Enzyme Immunoassay (EIA),LC50=3 µMol/L,960-h,Prostate,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1158/0008-5472.CAN-05-4569
1001,14499271,2003,FLPLLAGLAANFLPTIICKISYKC,GGN6,24,Cyclic(C18-C24),L,None,Free,Free,Antibacterial,Gaegurin,A-549,Lung Cancer,MTT/MTS assay,IC50=6.49 µg/ml,96-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)[C@@H](C)CC)CO)Cc1ccccc1)CCCCN)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1002,14499271,2003,LLAGLAANFLPTIICKISYKC,PTP1,21,Cyclic(C15-C21),L,None,Free,Free,Antibacterial,Gaegurin,A-549,Lung Cancer,MTT/MTS assay,IC50= >100 µg/ml,96-h,Lung,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)[C@@H](C)CC)CO)Cc1ccccc1)CCCCN)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1009,14499271,2003,FLPLLAGLAANFLPTIICKISYKC,GGN6,24,Cyclic(C18-C24),L,None,Free,Free,Antibacterial,Gaegurin,293,Renal Cancer,MTT/MTS assay,IC50=5.62 µg/ml,96-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)[C@@H](C)CC)CO)Cc1ccccc1)CCCCN)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1010,14499271,2003,LLAGLAANFLPTIICKISYKC,PTP1,21,Cyclic(C15-C21),L,None,Free,Free,Antibacterial,Gaegurin,293,Renal Cancer,MTT/MTS assay,IC50=>100 µg/ml,96-h,Renal,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)[C@@H](C)CC)CO)Cc1ccccc1)CCCCN)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1017,14499271,2003,FLPLLAGLAANFLPTIICKISYKC,GGN6,24,Cyclic(C18-C24),L,None,Free,Free,Antibacterial,Gaegurin,293,Renal Cancer,MTT/MTS assay,IC50=5.75 µg/ml,96-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)[C@@H](C)CC)CO)Cc1ccccc1)CCCCN)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1018,14499271,2003,LLAGLAANFLPTIICKISYKC,PTP1,21,Cyclic(C15-C21),L,None,Free,Free,Antibacterial,Gaegurin,293,Renal Cancer,MTT/MTS assay,IC50=>100 µg/ml,96-h,Renal,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)[C@@H](C)CC)CO)Cc1ccccc1)CCCCN)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1025,14499271,2003,FLPLLAGLAANFLPTIICKISYKC,GGN6,24,Cyclic(C18-C24),L,None,Free,Free,Antibacterial,Gaegurin,Hep3B,Liver Cancer,MTT/MTS assay,IC50=4.91 µg/ml,96-h,Liver,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)[C@@H](C)CC)CO)Cc1ccccc1)CCCCN)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1026,14499271,2003,LLAGLAANFLPTIICKISYKC,PTP1,21,Cyclic(C15-C21),L,None,Free,Free,Antibacterial,Gaegurin,Hep3B,Liver Cancer,MTT/MTS assay,IC50=>100 µg/ml,96-h,Liver,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)[C@@H](C)CC)CO)Cc1ccccc1)CCCCN)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1033,14499271,2003,FLPLLAGLAANFLPTIICKISYKC,GGN6,24,Cyclic(C18-C24),L,None,Free,Free,Antibacterial,Gaegurin,MCF-7,Breast Cancer,MTT/MTS assay,IC50=4.88 µg/ml,96-h,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)[C@@H](C)CC)CO)Cc1ccccc1)CCCCN)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1034,14499271,2003,LLAGLAANFLPTIICKISYKC,PTP1,21,Cyclic(C15-C21),L,None,Free,Free,Antibacterial,Gaegurin,MCF-7,Breast Cancer,MTT/MTS assay,IC50=>100 µg/ml,96-h,Breast,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)[C@@H](C)CC)CO)Cc1ccccc1)CCCCN)C(=O)O,https://doi.org/10.1016/s0196-9781(03)00194-3
1525,16637646,2006,LLGDFFRKSKEK,LL-37(1-12),12,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KBv,Tumor,MTT/MTS assay,Not Available,24-h,Not Available,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1021/ja0584875
1531,16637646,2006,LLGDFFRKSKEK,LL-37(1-12),12,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KB,Oral Cancer,MTT/MTS assay,Not Available,24-h,Not Available,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1021/ja0584875
1537,16637646,2006,LLGDFFRKSKEK,LL-37(1-12),12,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",HBMEC,Prostate Cancer,MTT/MTS assay,Not Available,24-h,Not Available,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1021/ja0584875
5002,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,MCF-7,Breast Cancer,MTT/MTS assay,LC50= 21 at 100 µM,72-h,Breast,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
5004,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,LNCaP,Prostate cancer,MTT/MTS assay,LC50= 27 at 100 µM,72-h,Prostate,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
5006,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,OVRCAR-3,Ovarian Cancer,MTT/MTS assay,LC50= 24 at 100 µM,72-h,Ovary,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
5002,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,MCF-7,Breast Cancer,MTT/MTS assay,LC50= 21 at 100 µM,72-h,Breast,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
5004,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,LNCaP,Prostate cancer,MTT/MTS assay,LC50= 27 at 100 µM,72-h,Prostate,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
5006,24587350,2014,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,LL 37,37,Linear,L,None,Free,Free,Antimicrobial,Also known human cathelicidin,OVRCAR-3,Ovarian Cancer,MTT/MTS assay,LC50= 24 at 100 µM,72-h,Ovary,None,[NH3][C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCNC(=[NH2])N)CCC1)C(C)C)CC(C)C)CC(=O)N)CCCNC(=[NH2])N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCC[NH3])[C@H](CC)C)CCCNC(=[NH2])N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCNC(=[NH2])N)CCCC[NH3])Cc1ccccc1)CCC(=O)O)CCCC[NH3])[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CO)CCCC[NH3])CCCNC(=[NH2])N)Cc1ccccc1)Cc1ccccc1)CC(=O)O)CC(C)C)CC(C)C,https://doi.org/10.1371/journal.pone.0090397
1529,16637646,2006,LLGDFKRIVQRIKDF,"LL-37(1-4,17-27)",15,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KBv,Tumor,MTT/MTS assay,Not Available,24-h,Not Available,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1021/ja0584875
1535,16637646,2006,LLGDFKRIVQRIKDF,"LL-37(1-4,17-27)",15,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",KB,Oral Cancer,MTT/MTS assay,Not Available,24-h,Not Available,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1021/ja0584875
1541,16637646,2006,LLGDFKRIVQRIKDF,"LL-37(1-4,17-27)",15,Linear,L,None,Free,Free,Antibacterial,"LL-37,a series of peptide fragments",HBMEC,Prostate Cancer,MTT/MTS assay,Not Available,24-h,Not Available,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1021/ja0584875
4453,"17561225, 18957441",2007,LLGMIPLAISAISALSKL,Phylloseptin-L1,32,Not Available,L,None,Free,Free,Anticancer,Hylomantis lemur (Hylidae: Phyllomedusinae,Not Available,Colorectal Cancer,Not Available,Not Available,Not Available,Not Available,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,"['https://doi.org/10.1016/j.toxicon.2007.04.017', 'https://doi.org/10.1093/nar/gkn823']"
1670,22641352,2012,LLRHVVKILEKYL,Temporin-La,13,Linear,L,None,Free,Free,Anticancer,Temporins family,SW-1116,Colorectal Cancer,MTT/MTS assay,57.62 Inhibition ratio at 50 µg/ml,24-h,Colon,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1672,22641352,2012,RGDLLRHVVKILEKYL,RGD-La,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,SW-1116,Colorectal Cancer,MTT/MTS assay,72.69 Inhibition ratio at 50 µg/ml,24-h,Colon,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1674,22641352,2012,LLRHVVKILEKYL,Temporin-La,13,Linear,L,None,Free,Free,Anticancer,Temporins family,SMMC-7721,Liver Cancer,MTT/MTS assay,52.77 Inhibition ratio at 50 µg/ml,24-h,Liver,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1676,22641352,2012,RGDLLRHVVKILEKYL,RGD-La,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,SMMC-7721,Liver Cancer,MTT/MTS assay,70.39 Inhibition ratio at 50 µg/ml,24-h,Liver,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1678,22641352,2012,LLRHVVKILEKYL,Temporin-La,13,Linear,L,None,Free,Free,Anticancer,Temporins family,HeLa,Cervical Cancer,MTT/MTS assay,52.32 Inhibition ratio at 50 µg/ml,24-h,Cervix,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1680,22641352,2012,RGDLLRHVVKILEKYL,RGD-La,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,HeLa,Cervical Cancer,MTT/MTS assay,73.09 Inhibition ratio at 50 µg/ml,24-h,Cervix,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1682,22641352,2012,LLRHVVKILEKYL,Temporin-La,13,Linear,L,None,Free,Free,Anticancer,Temporins family,HepG-2,Liver Cancer,MTT/MTS assay,50.90 Inhibition ratio at 50 µg/ml,24-h,Liver,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1684,22641352,2012,RGDLLRHVVKILEKYL,RGD-La,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide aNot Available temporins,HepG-2,Liver Cancer,MTT/MTS assay,60.22 Inhibition ratio at 50 µg/ml,24-h,Liver,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1686,22641352,2012,LLRHVVKILEKYL,Temporin-La,13,Linear,L,None,Free,Free,Anticancer,Temporins family,BGC-823,Gastric Cancer,MTT/MTS assay,48.19 Inhibition ratio at 50 µg/ml,24-h,Stomach,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1688,22641352,2012,RGDLLRHVVKILEKYL,RGD-La,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,BGC-823,Gastric Cancer,MTT/MTS assay,62.49 Inhibition ratio at 50 µg/ml,24-h,Stomach,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1690,22641352,2012,LLRHVVKILEKYL,Temporin-La,13,Linear,L,None,Free,Free,Anticancer,Temporins family,A-549,Lung Cancer,MTT/MTS assay,45.62 Inhibition ratio at 50 µg/ml,24-h,Lung,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1692,22641352,2012,RGDLLRHVVKILEKYL,RGD-La,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,A-549,Lung Cancer,MTT/MTS assay,47.26Inhibition ratio at 50 µg/ml,24-h,Lung,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1694,22641352,2012,LLRHVVKILEKYL,Temporin-La,13,Linear,L,None,Free,Free,Anticancer,Temporins family,HL7702,Liver Cancer,MTT/MTS assay,37.22 Inhibition ratio at 50 µg/ml,24-h,Liver,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1696,22641352,2012,RGDLLRHVVKILEKYL,RGD-La,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,HL7702,Liver Cancer,MTT/MTS assay,36.25 Inhibition ratio at 50 µg/ml,24-h,Liver,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1698,22641352,2012,LLRHVVKILEKYL,Temporin-La,13,Linear,L,None,Free,Free,Anticancer,Temporins family,HEK-293T,Renal Cancer,MTT/MTS assay,30.82 Inhibition ratio at 50 µg/ml,24-h,Renal,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1700,22641352,2012,RGDLLRHVVKILEKYL,RGD-La,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,HEK-293T,Renal Cancer,MTT/MTS assay,27.86 Inhibition ratio at 50 µg/ml,24-h,Renal,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1702,22641352,2012,LLRHVVKILEKYL,Temporin-La,13,Linear,L,None,Free,Free,Anticancer,Temporins family,MEC,Breast Cancer,MTT/MTS assay,24.15Inhibition ratio at 50 µg/ml,24-h,Breast,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1704,22641352,2012,RGDLLRHVVKILEKYL,RGD-La,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,MEC,Breast Cancer,MTT/MTS assay,19.76 Inhibition ratio at 50 µg/ml,24-h,Breast,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1671,22641352,2012,LLRHVVKILSKYL,Temporin-Las,13,Linear,L,None,Free,Free,Anticancer,Temporins family,SW-1116,Colorectal Cancer,MTT/MTS assay,62.73 Inhibition ratio at 50 µg/ml,24-h,Colon,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1673,22641352,2012,RGDLLRHVVKILSKYL,RGD-Las,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,SW-1116,Colorectal Cancer,MTT/MTS assay,81.465 Inhibition ratio at 50 µg/ml,24-h,Colon,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1675,22641352,2012,LLRHVVKILSKYL,Temporin-Las,13,Linear,L,None,Free,Free,Anticancer,Temporins family,SMMC-7721,Liver Cancer,MTT/MTS assay,59.37 Inhibition ratio at 50 µg/ml,24-h,Liver,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1677,22641352,2012,RGDLLRHVVKILSKYL,RGD-Las,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,SMMC-7721,Liver Cancer,MTT/MTS assay,86.175 Inhibition ratio at 50 µg/ml,24-h,Liver,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1679,22641352,2012,LLRHVVKILSKYL,Temporin-Las,13,Linear,L,None,Free,Free,Anticancer,Temporins family,HeLa,Cervical Cancer,MTT/MTS assay,56.81 Inhibition ratio at 50 µg/ml,24-h,Cervix,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1681,22641352,2012,RGDLLRHVVKILSKYL,RGD-Las,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,HeLa,Cervical Cancer,MTT/MTS assay,78.045 Inhibition ratio at 50 µg/ml,24-h,Cervix,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1683,22641352,2012,LLRHVVKILSKYL,Temporin-Las,13,Linear,L,None,Free,Free,Anticancer,Temporins family,HepG-2,Liver Cancer,MTT/MTS assay,55.98 Inhibition ratio at 50 µg/ml,24-h,Liver,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1685,22641352,2012,RGDLLRHVVKILSKYL,RGD-Las,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide aNot Available temporins,HepG-2,Liver Cancer,MTT/MTS assay,73.07 Inhibition ratio at 50 µg/ml,24-h,Liver,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1687,22641352,2012,LLRHVVKILSKYL,Temporin-Las,13,Linear,L,None,Free,Free,Anticancer,Temporins family,BGC-823,Gastric Cancer,MTT/MTS assay,50.85 Inhibition ratio at 50 µg/ml,24-h,Stomach,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1689,22641352,2012,RGDLLRHVVKILSKYL,RGD-Las,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,BGC-823,Gastric Cancer,MTT/MTS assay,73.705 Inhibition ratio at 50 µg/ml,24-h,Stomach,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1691,22641352,2012,LLRHVVKILSKYL,Temporin-Las,13,Linear,L,None,Free,Free,Anticancer,Temporins family,A-549,Lung Cancer,MTT/MTS assay,50.64 Inhibition ratio at 50 µg/ml,24-h,Lung,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1693,22641352,2012,RGDLLRHVVKILSKYL,RGD-Las,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,A-549,Lung Cancer,MTT/MTS assay,52.50 Inhibition ratio at 50 µg/ml,24-h,Lung,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1695,22641352,2012,LLRHVVKILSKYL,Temporin-Las,13,Linear,L,None,Free,Free,Anticancer,Temporins family,HL7702,Liver Cancer,MTT/MTS assay,37.00 Inhibition ratio at 50 µg/ml,24-h,Liver,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1697,22641352,2012,RGDLLRHVVKILSKYL,RGD-Las,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,HL7702,Liver Cancer,MTT/MTS assay,38.13 Inhibition ratio at 50 µg/ml,24-h,Liver,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1699,22641352,2012,LLRHVVKILSKYL,Temporin-Las,13,Linear,L,None,Free,Free,Anticancer,Temporins family,HEK-293T,Renal Cancer,MTT/MTS assay,30.90 Inhibition ratio at 50 µg/ml,24-h,Renal,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1701,22641352,2012,RGDLLRHVVKILSKYL,RGD-Las,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,HEK-293T,Renal Cancer,MTT/MTS assay,32.52 Inhibition ratio at 50 µg/ml,24-h,Renal,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1703,22641352,2012,LLRHVVKILSKYL,Temporin-Las,13,Linear,L,None,Free,Free,Anticancer,Temporins family,MEC,Breast Cancer,MTT/MTS assay,27.99 Inhibition ratio at 50 µg/ml,24-h,Breast,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1705,22641352,2012,RGDLLRHVVKILSKYL,RGD-Las,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,MEC,Breast Cancer,MTT/MTS assay,29.33 Inhibition ratio at 50 µg/ml,24-h,Breast,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1913,None,2005,LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,LSB-37,38,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =50 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,Not Found
2065,None,2005,LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,LSB-37,38,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =240 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,Not Found
2217,None,2005,LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,LSB-37,38,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =170 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,Not Found
2369,None,2005,LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,LSB-37,38,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =170 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,Not Found
2522,None,2005,LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,LSB-37,38,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =120 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,Not Found
2665,None,2005,LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,LSB-37,38,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =370 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,Not Found
2808,None,2005,LPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,LSB-37,38,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =250 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,Not Found
4275,None,2004,lRRllRRllRRl,DL6R6,12,Linear,Mix,None,Free,Free,"Antimicrobial, Antifungal and Anticancer",Synthetic Peptide,22RV1,Prostate Cancer,MTT/MTS assay,LC50=50 µM,Not Available,Prostate,AU_2004_246909_A1,N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H](CC(C)C)C1OO1,Not Found
4276,None,2004,lRRllRRllRRl,DL6R6,12,Linear,Mix,None,Free,Free,"Antimicrobial, Antifungal and Anticancer",Synthetic Peptide,CL-1,Tumor,MTT/MTS assay,LC50>100 µM,Not Available,Pancreatic,AU_2004_246909_A1,N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H](CC(C)C)C1OO1,Not Found
4278,None,2004,DDAlRRllRRllRRl,DDA-DL6R6-25,15,Linear,Mix,None,Free,Free,"Antimicrobial, Antifungal and Anticancer",Synthetic Peptide,22RV1,Prostate Cancer,MTT/MTS assay,LC50=3.125 µM,Not Available,Prostate,AU_2004_246909_A1,N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H](CC(C)C)C1OO1,Not Found
4279,None,2004,DDAlRRllRRllRRl,DDA-DL6R6-25,15,Linear,Mix,None,Free,Free,"Antimicrobial, Antifungal and Anticancer",Synthetic Peptide,CL-1,Tumor,MTT/MTS assay,LC50=3.125 µM,Not Available,Pancreatic,AU_2004_246909_A1,N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H](CC(C)C)C1OO1,Not Found
1665,15796184,2005,LRVRLASHLRKLRKRLLRDADDLQKRLAVY,Apo E,30,Linear,L,None,Free,Free,Antibacterial,Apoprotein E,PANC-1,Pancreatic Cancer,MTT/MTS assay,55 % Cytotoxity at 40 µg/ml,4-h,Pancreatic,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
1666,15796184,2005,LRVRLASHLRKLRKRLLRDADDLQKRLAVY,Apo E,30,Linear,L,None,Free,Free,Antibacterial,Apoprotein E,Paca-2,Pancreatic Cancer,MTT/MTS assay,55 % Cytotoxity at 40 µg/ml,4-h,Pancreatic,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
1667,15796184,2005,LRVRLASHLRKLRKRLLRDADDLQKRLAVY,Apo E,30,Linear,L,None,Free,Free,Antibacterial,Apoprotein E,MKN-1,Gastric Cancer,MTT/MTS assay,60 % Cytotoxity at 40 µg/ml,4-h,Stomach,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
1668,15796184,2005,LRVRLASHLRKLRKRLLRDADDLQKRLAVY,Apo E,30,Linear,L,None,Free,Free,Antibacterial,Apoprotein E,MKN-7,Gastric Cancer,MTT/MTS assay,35 % Cytotoxity at 40 µg/ml,4-h,Stomach,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
1669,15796184,2005,LRVRLASHLRKLRKRLLRDADDLQKRLAVY,Apo E,30,Linear,L,None,Free,Free,Antibacterial,Apoprotein E,COLO-201,Colon Cancer,MTT/MTS assay,65 % Cytotoxity at 40 µg/ml,4-h,Colon,None,N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
4580,21423613,2011,LTAEHYAAQATS,3A,12,Linear,L,None,Free,Free,Antitumor,E3 ubiquitin-protein ligase,HCT-116-p53+/+,Colon Cancer,Immunoprecipitation assay,IC50 >100 µM,Not Available,Colon,None,N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1371/journal.pone.0017898
4590,21423613,2011,LTAEHYAAQATS,3A,12,Linear,L,None,Free,Free,Antitumor,E3 ubiquitin-protein ligase,HCT-116-p53+/+,Colon Cancer,Immunoprecipitation assay,IC50 >100 µM,Not Available,Colon,None,N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1371/journal.pone.0017898
4579,21423613,2011,LTFEHYWAQLTS,DI,12,Linear,L,None,Free,Free,Antitumor,E3 ubiquitin-protein ligase,HCT-116-p53+/+,Colon Cancer,Immunoprecipitation assay,IC50 =0.29 µM,Not Available,Colon,None,N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C=O)CO)[C@H](O)C)CC(C)C)CCC(=O)N)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)Cc1[nH]cnc1)C)Cc1ccccc1)[C@H](O)C)CC(C)C,https://doi.org/10.1371/journal.pone.0017898
4589,21423613,2011,LTFEHYWAQLTS,DI,12,Linear,L,None,Free,Free,Antitumor,E3 ubiquitin-protein ligase,HCT-116-p53+/+,Colon Cancer,Immunoprecipitation assay,IC50 =1.6 µM,Not Available,Colon,None,N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C=O)CO)[C@H](O)C)CC(C)C)CCC(=O)N)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)Cc1[nH]cnc1)C)Cc1ccccc1)[C@H](O)C)CC(C)C,https://doi.org/10.1371/journal.pone.0017898
5059,24830845,2014,LTFSDWWKLLAE,mt_E17L/L22 W/P27A,12,Linear,L,None,Free,Free,Anticancer,MDM3,MCF-7,Breast Cancer,MTT/MTS assay,IC50=15.1 µM,Not Available,Breast,None,N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)O,https://doi.org/10.1007/s00726-014-1750-y
1350,18931881,2008,ETFSDLWKLL,PNC-28,10,Linear,L,None,Free,Free,Anticancer,Antennapedia,MiaPaCa.2,Pancreatic Cancer,MTT/MTS assay,Cytotoxicity=80% µMo/ml,48-h,Pancreatic,None,N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1245/s10434-008-0147-0
1706,9614066,1998,ALWKNMLKGIGKLAGQAALGAVKTLVGA,DRS B3,28,Linear,L,None,Free,Free,Antimicrobial,Dermaseptins B,MCF-7,Breast Cancer,Thymidine Incorporation assay,Cytotoxicity =12 µM,6-h,Breast,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)O,https://doi.org/10.1074/jbc.273.24.14690
1707,9614066,1998,ALWKDILKNVGKAAGKAVLNTVTDMVNQ,DRS B4,28,Linear,L,None,Amidation,Free,Antimicrobial,Dermaseptins B,MCF-7,Breast Cancer,Thymidine Incorporation assay,Cytotoxicity =15 µM,6-h,Breast,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N,https://doi.org/10.1074/jbc.273.24.14690
1708,9614066,1998,ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ,DRS S1,35,Linear,L,None,Free,Free,Antimicrobial,Dermaseptins B,MCF-7,Breast Cancer,Thymidine Incorporation assay,Not Available,6-h,Breast,None,N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O,https://doi.org/10.1074/jbc.273.24.14690
1728,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50 = 13.16 mM,24-h,Skin,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1729,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,A-549,Lung Cancer,MTT/MTS assay,IC50 = 14.8 mM,24-h,Lung,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1730,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50 = 14.58 mM,24-h,Ovary,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1731,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,MKN-45,Gastric Cancer,MTT/MTS assay,IC50 = 13.77 mM,24-h,Stomach,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1732,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,PC-3,Prostate Cancer,MTT/MTS assay,IC50 = 24.32 mM,24-h,Prostate,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1733,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,A-498,Renal Cancer,MTT/MTS assay,Not Available,24-h,Renal,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1737,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,HCTl-16,Colon Cancer,MTT/MTS assay,IC50 = 14.8 mM,24-h,Colon,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1741,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,NCI-H630,Colon Cancer,MTT/MTS assay,IC50 = 57 mM,24-h,Colon,US_008076284_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1765,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,A-498,Renal Cancer,MTT/MTS assay,Not Available,24-h,Renal,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1766,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,A-549,Lung Cancer,MTT/MTS assay,IC50 = 15.88 mM,24-h,Lung,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1767,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,HCTl-16,Colon Cancer,MTT/MTS assay,IC50 = 14.8 mM,24-h,Colon,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1768,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,MKN-45,Gastric Cancer,MTT/MTS assay,IC50 = 13.77 mM,24-h,Stomach,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1769,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,NCI-H630,Colon Cancer,MTT/MTS assay,IC50 = 57 mM,24-h,Colon,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1770,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,PC-3,Prostate Cancer,MTT/MTS assay,IC50 = 24.32 mM,24-h,Prostate,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1771,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50 = 13.16 mM,24-h,Skin,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1772,None,2011,FLWWLFKWAWK,Gaegurin peptides SEQID NO: 4,11,Linear,L,None,Free,Free,Antimicrobial,Korean frog Rana rugosa,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50 = 14.58 mM,24-h,Ovary,WO_2007133033_A1,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
1866,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =54 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1867,None,2005,FAKLWAKLAKKL,FLAK50 Z5,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =500 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2018,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =80 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2019,None,2005,FAKLWAKLAKKL,FLAK50 Z5,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =600 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2170,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =155 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2171,None,2005,FAKLWAKLAKKL,FLAK50 Z5,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =530 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2322,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =155 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2323,None,2005,FAKLWAKLAKKL,FLAK50 Z5,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =530 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2475,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =115 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2476,None,2005,FAKLWAKLAKKL,FLAK50 Z5,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =450 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2618,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =310 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2619,None,2005,FAKLWAKLAKKL,FLAK50 Z5,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =900 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2761,None,2005,FAKLWAKLAFGKGIGKVGKKLL,FLAK50 Z4,22,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =215 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2762,None,2005,FAKLWAKLAKKL,FLAK50 Z5,12,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =400 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2846,23028527,2012,GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV,Adenoregulin,33,Linear,L,None,Free,Free,Antimicrobial,South American frog Phyllomedusa bicolor,PC-3,Prostate Cancer,LDH leakage assay,GI50 =1.24±0.23 µM,24-h,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1371/journal.pone.0044351
2847,23028527,2012,GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV,Adenoregulin,33,Linear,L,None,Free,Free,Antimicrobial,South American frog Phyllomedusa bicolor,LNCaP,Prostate Cancer,LDH leakage assay,GI50 =0.31±0.15 µM,24-h,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1371/journal.pone.0044351
2848,23028527,2012,GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV,Adenoregulin,33,Linear,L,None,Free,Free,Antimicrobial,South American frog Phyllomedusa bicolor,DU-145,Liver Cancer,LDH leakage assay,GI50 =0.91±0.04 µM,24-h,Prostate,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1371/journal.pone.0044351
2849,23028527,2012,GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV,Adenoregulin,33,Linear,L,None,Free,Free,Antimicrobial,South American frog Phyllomedusa bicolor,MDA-MB-231,Breast Cancer,LDH leakage assay,GI50 =8.06±0.50 µM,24-h,Breast,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1371/journal.pone.0044351
2850,23028527,2012,GLWSKIKEVGKEAAKAAAKAAGKAALGAVSEAV,Adenoregulin,33,Linear,L,None,Free,Free,Antimicrobial,South American frog Phyllomedusa bicolor,Raji,Lymphoma Cancer,LDH leakage assay,GI50 =2.57±0.75 µM,24-h,Blood,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1371/journal.pone.0044351
3233,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,A-498,Renal Cancer,MTT/MTS assay,IC50 =22.59 µM,72-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3234,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,A-549,Lung Cancer,MTT/MTS assay,IC50 =15.88 µM,72-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3235,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,HCT-116,Colon Cancer,MTT/MTS assay,IC50 =14.80 µM,72-h,Colon,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3236,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,MKN-45,Gastric Cancer,MTT/MTS assay,IC50 =13.77 µM,72-h,Stomach,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3237,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,PC-3,Prostate Cancer,MTT/MTS assay,IC50 =24.32 µM,72-h,Prostate,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3238,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50 =13.16 µM,72-h,Skin,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3239,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Amidation,Free,Antimicrobial,Undecapeptide analogues derived from Brevinin-1EMa,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50 =14.58 µM,72-h,Ovary,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1007/s12272-012-0505-0
3657,22100226,2012,GKWMSLWKHILK,HAL-2/20,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 30±5 µM,48-h,Cervix,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3685,22100226,2012,GKWMSLWKHILK,HAL-2/20,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Colon,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3713,22100226,2012,GKWMSLWKHILK,HAL-2/20,12,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Halictines and their analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3734,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,A-498,Renal Cancer,MTT/MTS assay,IC50= 22.59 µM,72-h,Renal,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3735,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,A-549,Lung Cancer,MTT/MTS assay,IC50= 15.88 µM,72-h,Lung,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3736,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,HCT-116,Colon Cancer,MTT/MTS assay,IC50= 14.80 µM,72-h,Colon,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3737,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,MKN-45,Gastric Cancer,MTT/MTS assay,IC50= 13.77 µM,72-h,Stomach,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3738,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,PC-3,Prostate Cancer,MTT/MTS assay,IC50= 24.32 µM,72-h,Prostate,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3739,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50= 13.16 µM,72-h,Skin,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3740,22644847,2012,FLWWLFKWAWK,GA-W4,11,Linear,L,None,Free,Free,Anticancer and Antimicrobial,Brevinin-1EMa,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50= 14.58 µM,72-h,Ovary,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1007/s12272-012-0505-0
3816,22963485,2012,"MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG
AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ
NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLAN
NFVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRA
FKQL",wtmda-7/IL-24,206,Linear,L,None,Free,Free,Anticancer,NA,MCF-7,Breast Cancer,MTT/MTS assay,Cell viability(% of control)=0.5 at concentration 7 µg/ml,48-h,Breast,None,,https://doi.org/10.1080/15321819.2012.659782
3817,22963485,2012,"MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG
AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ
NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANN
FVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRA
FKQL",wtmda-7/IL-24,206,Linear,L,None,Free,Free,Anticancer,NA,Ket-3,Tumor,MTT/MTS assay,Cell viability(% of control)= 0.5 at concentration 8 µg/ml,48-h,Not Available,None,,https://doi.org/10.1080/15321819.2012.659782
3818,22963485,2012,"MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG
AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ
NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANN
FVLIVSQLQPSQENEMFSIRGDSAHRRFLLFRRAF
KQLDVEAALTKALGEVDILLTWMQKFYKL",RGD-mda-7,207,Linear,L,None,Free,Free,Anticancer,Derived from wtmda-7/IL-24 by insertion og a glycine residue between Arg(164) and Asp(165).,MCF-7,Breast Cancer,MTT/MTS assay,Cell viability(% of control)=0.5 at concentration 4 µg/ml,48-h,Breast,None,,https://doi.org/10.1080/15321819.2012.659782
3819,22963485,2012,"MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG
AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ
NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANN
FVLIVSQLQPSQENEMFSIRGDSAHRRFLLFRRAF
KQLDVEAALTKALGEVDILLTWMQKFYKL",RGD-mda-7,207,Linear,L,None,Free,Free,Anticancer,Derived from wtmda-7/IL-24 by insertion og a glycine residue between Arg(164) and Asp(165).,Ket-3,Tumor,MTT/MTS assay,Cell viability(% of control)= 0.5 at concentration 8 µg/ml,48-h,Not Available,None,,https://doi.org/10.1080/15321819.2012.659782
3820,22963485,2012,"MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG
AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ
NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANN
FVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRAF
KQL",wtmda-7/IL-24,206,Linear,L,None,Free,Free,Anticancer,NA,MCF-7,Breast Cancer,MTT assay,Apoptotic rate(%)= >50% at concentration of 8 µg/ml,72-h,Breast,None,,https://doi.org/10.1080/15321819.2012.659782
3821,22963485,2012,"MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG
AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ
NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNF
VLIVSQLQPSQENEMFSIRDSAHRRFLLFRRAF
KQL",wtmda-7/IL-24,206,Linear,L,None,Free,Free,Anticancer,NA,Ket-3,Tumor,MTT assay,Apoptotic rate(%)= >30% at concentration of 8 µg/ml,72-h,Not Available,None,,https://doi.org/10.1080/15321819.2012.659782
3823,22963485,2012,"MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG
AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ
NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNF
VLIVSQLQPSQENEMFSIRGDSAHRRFLLFRRAFK
QLDVEAALTKALGEVDILLTWMQKFYKL",RGD-mda-7,207,Linear,L,None,Free,Free,Anticancer,Derived from wtmda-7/IL-24 by insertion og a glycine residue between Arg(164) and Asp(165).,MCF-7,Breast Cancer,MTT assay,Apoptotic rate(%)= >70% at concentration of 8 µg/ml,72-h,Breast,None,,https://doi.org/10.1080/15321819.2012.659782
3824,22963485,2012,"MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG
AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ
NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNF
VLIVSQLQPSQENEMFSIRDSAHRRFLLFRRAFKQL",RGD-mda-7,207,Linear,L,None,Free,Free,Anticancer,Derived from wtmda-7/IL-24 by insertion og a glycine residue between Arg(164) and Asp(165).,Ket-3,Tumor,MTT assay,Apoptotic rate(%)= >50% at concentration of 8 µg/ml,72-h,Not Available,None,,https://doi.org/10.1080/15321819.2012.659782
4199,15835725,2004,lw,Psychrophilin D (1),Not Available,Cyclic,D,Anthranilic acid,Free,Free,Anticancer and Antiplasmodial,Penicillium algidum,P-388,Leukemia Cancer,Cell Viability assay,ID50=10.1 µg/ml,Not Available,Blood,None,NA,https://doi.org/10.1038/ja.2005.16
4227,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,SK-N-AS,Brain Tumor,MTT/MTS assay,0% apoptosis at 10 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4228,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,SK-N-AS,Brain Tumor,MTT/MTS assay,10% apoptosis at 20 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4229,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,SK-N-AS,Brain Tumor,MTT/MTS assay,30% apoptosis at 50 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4230,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NB69,Brain Tumor,MTT/MTS assay,30% apoptosis at 10 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4231,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NB69,Brain Tumor,MTT/MTS assay,80% apoptosis at 20 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4232,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NB69,Brain Tumor,MTT/MTS assay,80% apoptosis at 50 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4233,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NGP,Tumor,MTT/MTS assay,20% apoptosis at 10 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4234,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NGP,Tumor,MTT/MTS assay,>50% apoptosis at 20 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4235,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NGP,Tumor,MTT/MTS assay,30% apoptosis at 50 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4236,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,IMR5,Tumor,MTT/MTS assay,15% apoptosis at 10 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4237,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,IMR5,Tumor,MTT/MTS assay,20% apoptosis at 20 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4238,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,IMR5,Tumor,MTT/MTS assay,50% apoptosis at 50 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4430,"4056036, 18957441",1985,ACYCRIPACIAGERRYGTCIYQGRLWAFCC,HNP-1,30,Not Available,L,None,Free,Free,Anticancer,Homo sapiens,Not Available,Fibrosarcoma,Not Available,Not Available,Not Available,Fibrous connective tissue ,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CS)CS)Cc2ccccc2)C)Cc2c[nH]c3c2cccc3)CC(C)C)CCCNC(=[NH2])N)CCC(=O)N)Cc2ccc(cc2)O)[C@H](CC)C)CS)[C@H](O)C)Cc2ccc(cc2)O)CCCNC(=[NH2])N)CCCNC(=[NH2])N)CCC(=O)O)C)[C@H](CC)C)CS)C)CCC1)[C@H](CC)C)CCCNC(=[NH2])N)CS)Cc1ccc(cc1)O)CS)C,"['https://doi.org/10.1172/JCI112121', 'https://doi.org/10.1093/nar/gkn823']"
4431,"4056036, 18957441",1985,CYCRIPACIAGERRYGTCIYQGRLWAFCC,HNP-2,29,Not Available,L,None,Free,Free,Anticancer,Homo sapiens,Not Available,Fibrosarcoma,Not Available,Not Available,Not Available,Fibrous connective tissue ,None,N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)O,"['https://doi.org/10.1172/JCI112121', 'https://doi.org/10.1093/nar/gkn823']"
4432,"4056036, 18957441",1985,DCYCRIPACIAGERRYGTCIYQGRLWAFCC,HNP-3,30,Not Available,L,None,Free,Free,Anticancer,Homo sapiens,Not Available,Fibrosarcoma,Not Available,Not Available,Not Available,Fibrous connective tissue ,None,N[C@H](C(=O)N[C@@H]1C(=O)N[C@H](C(=O)N[C@@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@@H]4C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CSSC1)CSSC4)Cc1ccccc1)C)Cc1c[nH]c4c1cccc4)CC(C)C)CCCNC(=N)N)CCC(=O)N)Cc1ccc(cc1)O)[C@H](CC)C)CSSC2)[C@H](O)C)Cc1ccc(cc1)O)CCCNC(=N)N)C)CCC(=O)O)C)[C@H](CC)C)C)CCC3)[C@H](CC)C)CCCNC(=N)N)Cc1ccc(cc1)O)CC(=O)O,"['https://doi.org/10.1172/JCI112121', 'https://doi.org/10.1093/nar/gkn823']"
4452,"17561225, 18957441",2007,GLWSKIKEAAKAAGKAALNAVTGLVNQGDQPS,Phylloseptin,32,Not Available,L,None,Free,Free,Anticancer,Hylomantis lemur (Hylidae: Phyllomedusinae,Not Available,Colorectal Cancer,Not Available,Not Available,Not Available,Not Available,None,NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O,"['https://doi.org/10.1016/j.toxicon.2007.04.017', 'https://doi.org/10.1093/nar/gkn823']"
4581,21423613,2011,QETFSDLWKLLP,P5317-28,12,Linear,L,None,Free,Free,Antitumor,E3 ubiquitin-protein ligase,HCT-116-p53+/+,Colon Cancer,Immunoprecipitation assay,IC50 =4.7 µM,Not Available,Colon,None,N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C=O)CCC1)CC(C)C)CC(C)C)CC)Cc1c[nH]c2c1cccc2)CC(C)C)CC(=O)O)CO)Cc1ccccc1)[C@H](O)C)CCC(=O)O)CCC(=O)N,https://doi.org/10.1371/journal.pone.0017898
4591,21423613,2011,QETFSDLWKLLP,P5317-28,12,Linear,L,None,Free,Free,Antitumor,E3 ubiquitin-protein ligase,HCT-116-p53+/+,Colon Cancer,Immunoprecipitation assay,IC50 =30 µM,Not Available,Colon,None,N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C=O)CCC1)CC(C)C)CC(C)C)CC)Cc1c[nH]c2c1cccc2)CC(C)C)CC(=O)O)CO)Cc1ccccc1)[C@H](O)C)CCC(=O)O)CCC(=O)N,https://doi.org/10.1371/journal.pone.0017898
3826,23034893,2012,"MDSNKDERAYAQWVIIILHNVGSSPFKIANLGLSWGKLYADGNKDKEVY
PSDYNGKTVGPDEKIQINSCGRENASSGTEGSFDIVDPNDGNKTIRHFYW
ECPWGSKRNTWTPSGSNTKWMVEWSGQNLDSGALGTITVDVLRKGN",AAD (or Aa-Pri1),145,Linear,L,None,Free,Free,Antitumor,Purified from Agrocybe aegerita,HepG-2,Liver Cancer,MTT/MTS assay,"At 2.5 µM concentration,decrease in cell vibility= 35%",48-h,Liver,None,,https://doi.org/10.1002/mnfr.201200316
2886,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,91.8% Cell viability at 12.5 µM,24-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2887,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,84.1% Cell viability at 25 µM,24-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2888,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,76.3% Cell viability at 50 µM,24-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2889,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,71.5 % Cell viability at 75 µM,24-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2890,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,54.2 % Cell viability at 100 µM,24-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2891,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,87.3 % Cell viability at 25 µM,48-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2892,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,75.6 % Cell viability at 50 µM,48-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2893,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,62.8 % Cell viability at 75 µM,48-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2894,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,54.3 % Cell viability at 100 µM,48-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2895,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,48.6 % Cell viability at 100 µM,48-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2896,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,72.1 % Cell viability at 12.5 µM,72-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2897,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,63.3 % Cell viability at 25 µM,72-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2898,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,49.7 % Cell viability at 50 µM,72-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2899,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,41.1 % Cell viability at 75 µM,72-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
2900,20383464,2010,MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG,Ceropin,63,Linear,L,None,Free,Free,Antimicrobial,Musca domestica,BEL-7402,Liver Cancer,Trypan blue assay,35.2 % Cell viability at 100 µM,72-h,Liver,None,N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc1c2c([nH]c1)cccc2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H]([C@H](CC)C)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O,https://doi.org/10.1093/abbs/gmq021
3817,22963485,2012,"MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG
AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ
NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANN
FVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRA
FKQL",wtmda-7/IL-24,206,Linear,L,None,Free,Free,Anticancer,NA,Ket-3,Tumor,MTT/MTS assay,Cell viability(% of control)= 0.5 at concentration 8 µg/ml,48-h,Not Available,None,,https://doi.org/10.1080/15321819.2012.659782
3816,22963485,2012,"MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSG
AQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQ
NVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLAN
NFVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRA
FKQL",wtmda-7/IL-24,206,Linear,L,None,Free,Free,Anticancer,NA,MCF-7,Breast Cancer,MTT/MTS assay,Cell viability(% of control)=0.5 at concentration 7 µg/ml,48-h,Breast,None,,https://doi.org/10.1080/15321819.2012.659782
1840,None,2005,MPKEKVFLKIEKMGRNIRN,VISHNU3,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N,Not Found
1992,None,2005,MPKEKVFLKIEKMGRNIRN,VISHNU3,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N,Not Found
2144,None,2005,MPKEKVFLKIEKMGRNIRN,VISHNU3,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N,Not Found
2296,None,2005,MPKEKVFLKIEKMGRNIRN,VISHNU3,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N,Not Found
2449,None,2005,MPKEKVFLKIEKMGRNIRN,VISHNU3,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N,Not Found
2592,None,2005,MPKEKVFLKIEKMGRNIRN,VISHNU3,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N,Not Found
2735,None,2005,MPKEKVFLKIEKMGRNIRN,VISHNU3,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N,Not Found
1775,None,2005,MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,SB-37 AC,38,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =175 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O,Not Found
1776,None,2005,MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,SB-37 AM,38,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =540 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,Not Found
1927,None,2005,MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,SB-37 AC,38,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =82 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O,Not Found
1928,None,2005,MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,SB-37 AM,38,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,Not Found
2079,None,2005,MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,SB-37 AC,38,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =120 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O,Not Found
2080,None,2005,MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,SB-37 AM,38,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,Not Found
2231,None,2005,MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,SB-37 AC,38,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =120 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O,Not Found
2232,None,2005,MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,SB-37 AM,38,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,Not Found
2383,None,2005,MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,SB-37 AC,38,Linear,L,None,Free,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =220 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O,Not Found
2384,None,2005,MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,SB-37 AM,38,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =720 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,Not Found
2526,None,2005,MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,SB-37 AC,38,Linear,L,None,Free,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,Not Available,24-h,Prostate,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O,Not Found
2527,None,2005,MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,SB-37 AM,38,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =630 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,Not Found
2669,None,2005,MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,SB-37 AC,38,Linear,L,None,Free,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =150 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O,Not Found
2670,None,2005,MPKWKVFKKIEKVGRNIRNGIVKAGPAIAVLGEAKALG,SB-37 AM,38,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N,Not Found
1239,7849420,1994,MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG,Shiva-1,38,Linear,L,None,Free,Free,Antibacterial,Magainin,K-562,Leukemia Cancer,MTT assay,IC50=28.7 µM,96-h,Blood,None,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)O,Not Found
1240,7849420,1994,MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG,Shiva-1,38,Linear,L,None,Free,Free,Antibacterial,Magainin,BTS-30,Breast Cancer,MTT assay,IC50=56 µM,96-h,Breast,None,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)O,Not Found
1241,7849420,1994,MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG,Shiva-1,38,Linear,L,None,Free,Free,Antibacterial,Magainin,HRT-18,Colon Cancer,MTT assay,IC50=49.3 µM,96-h,Colon,None,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)O,Not Found
1242,7849420,1994,MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG,Shiva-1,38,Linear,L,None,Free,Free,Antibacterial,Magainin,DLD-1,Colon Cancer,MTT assay,IC50=>100 µM,96-h,Colon,None,N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)O,Not Found
4201,15867360,2005,MRGIRGADFQAFQQARAVGLAGTFR,hP2,25,Linear,L,None,Free,Free,Antiangiogenesis,Human endostatin peptides,BxPC-3,Pancreatic Cancer,Matrigel Assay,19% inhibition at 7 mg/kg/d,672-h,Pancreatic,None,N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1158/0008-5472.CAN-04-1833
3072,16004618,2005,MRKEFHNVLSSGQLLADKRPARDYNRK,Pep27,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,AML-2,Leukemia Cancer,MTT/MTS assay,Not Available,14.54-Min,Blood,None,N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H]1CC(=O)OOC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccccc1)CC(=O)N)CCCN=C)CCCCN,https://doi.org/10.1186/1475-2867-5-21
3078,16004618,2005,MRKEFHNVLSSGQLLADKRPARDYNRK,Pep27,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,HL-60,Leukemia Cancer,MTT/MTS assay,IC50= >70 µM,14.54-Min,Blood,None,N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H]1CC(=O)OOC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccccc1)CC(=O)N)CCCN=C)CCCCN,https://doi.org/10.1186/1475-2867-5-21
3084,16004618,2005,MRKEFHNVLSSGQLLADKRPARDYNRK,Pep27,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,Jurkat,Blood Cancer,MTT/MTS assay,IC50=>70 µM,14.54-Min,Blood,None,N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H]1CC(=O)OOC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccccc1)CC(=O)N)CCCN=C)CCCCN,https://doi.org/10.1186/1475-2867-5-21
3090,16004618,2005,MRKEFHNVLSSGQLLADKRPARDYNRK,Pep27,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,SNU-601,Gastric Cancer,MTT/MTS assay,IC50= >70 µM,14.54-Min,Stomach,None,N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H]1CC(=O)OOC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccccc1)CC(=O)N)CCCN=C)CCCCN,https://doi.org/10.1186/1475-2867-5-21
3096,16004618,2005,MRKEFHNVLSSGQLLADKRPARDYNRK,Pep27,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,MCF-7,Breast Cancer,MTT/MTS assay,IC50= >70 µM,14.54-Min,Breast,None,N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@H]1CC(=O)OOC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccccc1)CC(=O)N)CCCN=C)CCCCN,https://doi.org/10.1186/1475-2867-5-21
3075,16004618,2005,MRKWFHNVLSSGQLLADKWPAWDYNRK,Pep27anal3,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,AML-2,Leukemia Cancer,MTT/MTS assay,IC50= 67 µM,20.08-Min,Blood,None,N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3081,16004618,2005,MRKWFHNVLSSGQLLADKWPAWDYNRK,Pep27anal3,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,HL-60,Leukemia Cancer,MTT/MTS assay,IC50= 52 µM,20.08-Min,Blood,None,N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3087,16004618,2005,MRKWFHNVLSSGQLLADKWPAWDYNRK,Pep27anal3,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,Jurkat,Blood Cancer,MTT/MTS assay,IC50= 50 µM,20.08-Min,Blood,None,N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3093,16004618,2005,MRKWFHNVLSSGQLLADKWPAWDYNRK,Pep27anal3,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,SNU-601,Gastric Cancer,MTT/MTS assay,IC50= 50 µM,20.08-Min,Stomach,None,N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3099,16004618,2005,MRKWFHNVLSSGQLLADKWPAWDYNRK,Pep27anal3,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,MCF-7,Breast Cancer,MTT/MTS assay,IC50= 38 µM,20.08-Min,Breast,None,N[C@@H](CCSC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3198,22184121,2011,MTLTG,BPP-II,5,Linear,L,None,Free,Free,Antitumor,Immunomodulatory bursal-derived Pentapeptide-II,CEF,Tumor,MTT/MTS assay,NA,48-h,Not Available,None,N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O,https://doi.org/10.1074/jbc.M111.273854
3200,22184121,2011,MTLTG,BPP-II,5,Linear,L,None,Free,Free,Antitumor,Immunomodulatory bursal-derived Pentapeptide-II,Vero,Renal Cancer,MTT/MTS assay,NA,48-h,Renal,None,N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O,https://doi.org/10.1074/jbc.M111.273854
3201,22184121,2011,MTLTG,BPP-II,5,Linear,L,None,Free,Free,Antitumor,Immunomodulatory bursal-derived Pentapeptide-II,MDBK,Renal Cancer,MTT/MTS assay,NA,48-h,Renal,None,N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O,https://doi.org/10.1074/jbc.M111.273854
3202,22184121,2011,MTLTG,BPP-II,5,Linear,L,None,Free,Free,Antitumor,Immunomodulatory bursal-derived Pentapeptide-II,MDBK,Renal Cancer,MTT/MTS assay,NA,48-h,Renal,None,N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O,https://doi.org/10.1074/jbc.M111.273854
3203,22184121,2011,MTLTG,BPP-II,5,Linear,L,None,Free,Free,Antitumor,Immunomodulatory bursal-derived Pentapeptide-II,MDBK,Renal Cancer,MTT/MTS assay,NA,48-h,Renal,None,N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O,https://doi.org/10.1074/jbc.M111.273854
3204,22184121,2011,MTLTG,BPP-II,5,Linear,L,None,Free,Free,Antitumor,Immunomodulatory bursal-derived Pentapeptide-II,MDBK,Renal Cancer,MTT/MTS assay,NA,48-h,Renal,None,N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O,https://doi.org/10.1074/jbc.M111.273854
3205,22184121,2011,MTLTG,BPP-II,5,Linear,L,None,Free,Free,Antitumor,Immunomodulatory bursal-derived Pentapeptide-II,MDBK,Renal Cancer,MTT/MTS assay,NA,48-h,Renal,None,N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O,https://doi.org/10.1074/jbc.M111.273854
3208,22184121,2011,MTLTG,BPP-II,5,Linear,L,None,Free,Free,Antitumor,Immunomodulatory bursal-derived Pentapeptide-II,CEF,Tumor,MTT/MTS assay,NA,48-h,Not Available,None,N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O,https://doi.org/10.1074/jbc.M111.273854
3210,22184121,2011,MTLTG,BPP-II,5,Linear,L,None,Free,Free,Antitumor,Immunomodulatory bursal-derived Pentapeptide-II,Vero,Renal Cancer,MTT/MTS assay,NA,48-h,Renal,None,N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O,https://doi.org/10.1074/jbc.M111.273854
3211,22184121,2011,MTLTG,BPP-II,5,Linear,L,None,Free,Free,Antitumor,Immunomodulatory bursal-derived Pentapeptide-II,MDBK,Renal Cancer,MTT/MTS assay,NA,48-h,Renal,None,N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O,https://doi.org/10.1074/jbc.M111.273854
3212,22184121,2011,MTLTG,BPP-II,5,Linear,L,None,Free,Free,Antitumor,Immunomodulatory bursal-derived Pentapeptide-II,MDBK,Renal Cancer,MTT/MTS assay,NA,48-h,Renal,None,N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O,https://doi.org/10.1074/jbc.M111.273854
3213,22184121,2011,MTLTG,BPP-II,5,Linear,L,None,Free,Free,Antitumor,Immunomodulatory bursal-derived Pentapeptide-II,MDBK,Renal Cancer,MTT/MTS assay,NA,48-h,Renal,None,N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O,https://doi.org/10.1074/jbc.M111.273854
3214,22184121,2011,MTLTG,BPP-II,5,Linear,L,None,Free,Free,Antitumor,Immunomodulatory bursal-derived Pentapeptide-II,MDBK,Renal Cancer,MTT/MTS assay,NA,48-h,Renal,None,N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O,https://doi.org/10.1074/jbc.M111.273854
3215,22184121,2011,MTLTG,BPP-II,5,Linear,L,None,Free,Free,Antitumor,Immunomodulatory bursal-derived Pentapeptide-II,MDBK,Renal Cancer,MTT/MTS assay,NA,48-h,Renal,None,N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O,https://doi.org/10.1074/jbc.M111.273854
3076,16004618,2005,MWKEFHNVLSSGQLLADKRWARWYNRW,Pep27anal4,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,AML-2,Leukemia Cancer,MTT/MTS assay,IC50= 50 µM,19.15-Min,Blood,None,N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3082,16004618,2005,MWKEFHNVLSSGQLLADKRWARWYNRW,Pep27anal4,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,HL-60,Leukemia Cancer,MTT/MTS assay,IC50=51 µM,19.15-Min,Blood,None,N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3088,16004618,2005,MWKEFHNVLSSGQLLADKRWARWYNRW,Pep27anal4,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,Jurkat,Blood Cancer,MTT/MTS assay,IC50= 46 µM,19.15-Min,Blood,None,N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3094,16004618,2005,MWKEFHNVLSSGQLLADKRWARWYNRW,Pep27anal4,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,SNU-601,Gastric Cancer,MTT/MTS assay,IC50= 37 µM,19.15-Min,Stomach,None,N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3100,16004618,2005,MWKEFHNVLSSGQLLADKRWARWYNRW,Pep27anal4,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,MCF-7,Breast Cancer,MTT/MTS assay,IC50= 29 µM,19.15-Min,Breast,None,N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3077,16004618,2005,MWKWFHNVLSSGQLLADKWWAWWYNWW,Pep27anal5,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,AML-2,Leukemia Cancer,MTT/MTS assay,IC50= >70 µM,19.17-Min,Blood,None,N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3083,16004618,2005,MWKWFHNVLSSGQLLADKWWAWWYNWW,Pep27anal5,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,HL-60,Leukemia Cancer,MTT/MTS assay,IC50= >70 µM,19.17-Min,Blood,None,N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3089,16004618,2005,MWKWFHNVLSSGQLLADKWWAWWYNWW,Pep27anal5,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,Jurkat,Blood Cancer,MTT/MTS assay,IC50=>70 µM,19.17-Min,Blood,None,N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3095,16004618,2005,MWKWFHNVLSSGQLLADKWWAWWYNWW,Pep27anal5,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,SNU-601,Gastric Cancer,MTT/MTS assay,IC50=>70 µM,19.17-Min,Stomach,None,N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3101,16004618,2005,MWKWFHNVLSSGQLLADKWWAWWYNWW,Pep27anal5,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,MCF-7,Breast Cancer,MTT/MTS assay,IC50=>70 µM,19.17-Min,Breast,None,N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3073,16004618,2005,MWKWFHNVLSSWQLLADKRPARDYNRK,Pep27anal1,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,AML-2,Leukemia Cancer,MTT/MTS assay,IC50= 50 µM,18.67-Min,Blood,None,N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3079,16004618,2005,MWKWFHNVLSSWQLLADKRPARDYNRK,Pep27anal1,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,HL-60,Leukemia Cancer,MTT/MTS assay,IC50= 53 µM,18.67-Min,Blood,None,N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3085,16004618,2005,MWKWFHNVLSSWQLLADKRPARDYNRK,Pep27anal1,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,Jurkat,Blood Cancer,MTT/MTS assay,IC50= 47 µM,18.67-Min,Blood,None,N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3091,16004618,2005,MWKWFHNVLSSWQLLADKRPARDYNRK,Pep27anal1,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,SNU-601,Gastric Cancer,MTT/MTS assay,IC50= 37 µM,18.67-Min,Stomach,None,N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3097,16004618,2005,MWKWFHNVLSSWQLLADKRPARDYNRK,Pep27anal1,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,MCF-7,Breast Cancer,MTT/MTS assay,IC50= 55 µM,18.67-Min,Breast,None,N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3074,16004618,2005,MWKWFHNVLSWWWLLADKRPARDYNRK,Pep27anal2,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,AML-2,Leukemia Cancer,MTT/MTS assay,IC50= 29 µM,22.5-Min,Blood,None,N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3080,16004618,2005,MWKWFHNVLSWWWLLADKRPARDYNRK,Pep27anal2,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,HL-60,Leukemia Cancer,MTT/MTS assay,IC50= 20 µM,22.5-Min,Blood,None,N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3086,16004618,2005,MWKWFHNVLSWWWLLADKRPARDYNRK,Pep27anal2,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,Jurkat,Blood Cancer,MTT/MTS assay,IC50= 23 µM,22.5-Min,Blood,None,N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3092,16004618,2005,MWKWFHNVLSWWWLLADKRPARDYNRK,Pep27anal2,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,SNU-601,Gastric Cancer,MTT/MTS assay,IC50= 25 µM,22.5-Min,Stomach,None,N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3098,16004618,2005,MWKWFHNVLSWWWLLADKRPARDYNRK,Pep27anal2,27,Linear,L,None,Free,Free,Anticancer,S. pneumoniae,MCF-7,Breast Cancer,MTT/MTS assay,IC50= <10 µM,22.5-Min,Breast,None,N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1475-2867-5-21
3362,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,COLO-205,Colon Cancer,MTT/MTS assay,<5% cytotoxicity at 1 µM,24-h,Colon,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3363,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,COLO-205,Colon Cancer,MTT/MTS assay,<20% cytotoxicity at 10 µM,24-h,Colon,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3364,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,COLO-205,Colon Cancer,MTT/MTS assay,~15% cytotoxicity at 1 µM,48-h,Colon,WO2012042540A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3365,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,COLO-205,Colon Cancer,MTT/MTS assay,>20% cytotoxicity at 10 µM,48-h,Colon,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3366,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,COLO-205,Colon Cancer,MTT/MTS assay,<5% cytotoxicity at 1 µM,72-h,Colon,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3367,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,COLO-205,Colon Cancer,MTT/MTS assay,<5% cytotoxicity at 10 µM,72-h,Colon,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3380,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,UM-UC-3,Bladder Cancer,MTT/MTS assay,10% cytotoxicity at 1 µM,24-h,Bladder,WO2012042540A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3381,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,UM-UC-3,Bladder Cancer,MTT/MTS assay,<10% cytotoxicity at 10 µM,24-h,Bladder,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3382,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,UM-UC-3,Bladder Cancer,MTT/MTS assay,~25% cytotoxicity at 1 µM,48-h,Bladder,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3383,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,UM-UC-3,Bladder Cancer,MTT/MTS assay,<25% cytotoxicity at 10 µM,48-h,Bladder,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3384,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,UM-UC-3,Bladder Cancer,MTT/MTS assay,~45% cytotoxicity at 1 µM,72-h,Bladder,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3385,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,UM-UC-3,Bladder Cancer,MTT/MTS assay,<45% cytotoxicity at 10 µM,72-h,Bladder,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3398,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HCT-116,Colon Cancer,MTT/MTS assay,20% cytotoxicity at 1 µM,24-h,Colon,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3399,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HCT-116,Colon Cancer,MTT/MTS assay,10% cytotoxicity at 10 µM,24-h,Colon,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3400,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HCT-116,Colon Cancer,MTT/MTS assay,<5% cytotoxicity at 1 µM,48-h,Colon,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3401,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HCT-116,Colon Cancer,MTT/MTS assay,<3% cytotoxicity at 10 µM,48-h,Colon,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3402,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HCT-116,Colon Cancer,MTT/MTS assay,<20% cytotoxicity at 1 µM,72-h,Colon,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3403,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HCT-116,Colon Cancer,MTT/MTS assay,15% cytotoxicity at 10 µM,72-h,Colon,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3416,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,SiHa,Cervical Cancer,MTT/MTS assay,~15% cytotoxicity at 1 µM,24-h,Cervix,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3417,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,SiHa,Cervical Cancer,MTT/MTS assay,5% cytotoxicity at 10 µM,24-h,Cervix,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3418,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,SiHa,Cervical Cancer,MTT/MTS assay,10% cytotoxicity at 1 µM,48-h,Cervix,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3419,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,SiHa,Cervical Cancer,MTT/MTS assay,<10% cytotoxicity at 10 µM,48-h,Cervix,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3420,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,SiHa,Cervical Cancer,MTT/MTS assay,<20% cytotoxicity at 1 µM,72-h,Cervix,WO2012042540A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3421,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,SiHa,Cervical Cancer,MTT/MTS assay,20% cytotoxicity at 10 µM,72-h,Cervix,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3434,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,CaSki,Cervical Cancer,MTT/MTS assay,~15% cytotoxicity at 1 µM,24-h,Cervix,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3435,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,CaSki,Cervical Cancer,MTT/MTS assay,~5% cytotoxicity at 10 µM,24-h,Cervix,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3436,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,CaSki,Cervical Cancer,MTT/MTS assay,~10% cytotoxicity at 1 µM,48-h,Cervix,WO2012042540A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3437,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,CaSki,Cervical Cancer,MTT/MTS assay,<10% cytotoxicity at 10 µM,48-h,Cervix,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3438,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,CaSki,Cervical Cancer,MTT/MTS assay,<20% cytotoxicity at 1 µM,72-h,Cervix,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3439,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,CaSki,Cervical Cancer,MTT/MTS assay,20% cytotoxicity at 10 µM,72-h,Cervix,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3452,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HTB-9,Bladder Cancer,MTT/MTS assay,20% cytotoxicity at 1 µM,24-h,Bladder,WO2012042540A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3453,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HTB-9,Bladder Cancer,MTT/MTS assay,~10% cytotoxicity at 10 µM,24-h,Bladder,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3454,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HTB-9,Bladder Cancer,MTT/MTS assay,<5% cytotoxicity at 1 µM,48-h,Bladder,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3455,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HTB-9,Bladder Cancer,MTT/MTS assay,<3% cytotoxicity at 10 µM,48-h,Bladder,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3456,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HTB-9,Bladder Cancer,MTT/MTS assay,<20% cytotoxicity at 1 µM,72-h,Bladder,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3457,None,2012,NHFTLKCPKTALTEPPTLAY,TG20,20,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HTB-9,Bladder Cancer,MTT/MTS assay,~15% cytotoxicity at 10 µM,72-h,Bladder,WO_2012042540_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,Not Found
3517,22100226,2012,NKWKKILGKIIKVVK,LL-III/34,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 5±2 µM,48-h,Cervix,None,N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3542,22100226,2012,NKWKKILGKIIKVVK,LL-III/34,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 37 µM,48-h,Colon,None,N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3567,22100226,2012,NKWKKILGKIIKVVK,LL-III/34,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 5±3 µM,48-h,Blood,None,N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
No data available in table,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found,Not Found
3497,22100226,2012,NVWKKILGKIIKVVK,LL-III/2,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,Not tested,48-h,Cervix,None,N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3522,22100226,2012,NVWKKILGKIIKVVK,LL-III/2,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 11 µM,48-h,Colon,None,N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3547,22100226,2012,NVWKKILGKIIKVVK,LL-III/2,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 7±2 µM,48-h,Blood,None,N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
4347,None,2009,NYQWVPYQGRVPYPRGGLLkLLKklLKKLlKL,Sema3A(aa363-377) -nLytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,BxPC-3,Pancreatic Cancer,WST-1 assay,IC50= 12.5 µM,48-h,Pancreatic,WO_2010_064207_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
4348,None,2009,NYQWVPYQGRVPYPRGGLLkLLKklLKKLlKL,Sema3A(aa363-377) -nLytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,CFPAC-I,Pancreatic Cancer,WST-1 assay,IC50= 10.6 µM,48-h,Pancreatic,WO_2010_064207_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
4349,None,2009,NYQWVPYQGRVPYPRGGLLkLLKklLKKLlKL,Sema3A(aa363-377) -nLytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,Pane- 1,Breast Cancer,WST-1 assay,IC50= 13.1 µM,48-h,Breast,WO_2010_064207_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
4350,None,2009,NYQWVPYQGRVPYPRGGLLkLLKklLKKLlKL,Sema3A(aa363-377) -nLytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,SU.86.86,Pancreatic Cancer,WST-1 assay,IC50= 7.9 µM,48-h,Pancreatic,WO_2010_064207_A2,N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
3311,21453492,2011,OOW-Dip-OOWWO,LTX-318,9,Linear,L,"Dip = diphenylalanine, O=ornithine",Amidation,Free,Antimicrobial,Synthetic peptide,HT-29,Colon Cancer,MTT/MTS assay,IC50 =248 ± 5 µM,30-Min,Colon,None,NA,https://doi.org/10.1186/1471-2407-11-116
3312,21453492,2011,OOW-Dip-OOWWO,LTX-318,9,Linear,L,"Dip = diphenylalanine, O=ornithine",Amidation,Free,Antimicrobial,Synthetic peptide,MT-1,Breast Cancer,MTT/MTS assay,IC50 =216 ± 36 µM,30-Min,Breast,None,NA,https://doi.org/10.1186/1471-2407-11-116
3313,21453492,2011,OOW-Dip-OOWWO,LTX-318,9,Linear,L,"Dip = diphenylalanine, O=ornithine",Amidation,Free,Antimicrobial,Synthetic peptide,Kelly,Brain Tumor,MTT/MTS assay,IC50 =78 ± 7 µM,30-Min,Brain,None,NA,https://doi.org/10.1186/1471-2407-11-116
1614,12366526,2002,PAARKAARWAWRMLKKGA,L11,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,Meth A,Skin Cancer,MTT/MTS assay,IC50=116 µM,4-h,Skin,None,N(CCC)C.C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC.C(=O)O,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1629,12366526,2002,PAARKAARWAWRMLKKGA,L11,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,MT-1,Breast Cancer,MTT/MTS assay,IC50=75 µM,4-h,Breast,None,N(CCC)C.C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC.C(=O)O,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1644,12366526,2002,PAARKAARWAWRMLKKGA,L11,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,HT-29,Colon Cancer,MTT/MTS assay,IC50=248 µM,4-h,Colon,None,N(CCC)C.C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC.C(=O)O,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1613,12366526,2002,PAARKAFRWAWRMLKKAA,L10,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,Meth A,Skin Cancer,MTT/MTS assay,IC50=24 µM,4-h,Skin,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1628,12366526,2002,PAARKAFRWAWRMLKKAA,L10,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,MT-1,Breast Cancer,MTT/MTS assay,IC50=20 µM,4-h,Breast,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1643,12366526,2002,PAARKAFRWAWRMLKKAA,L10,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,HT-29,Colon Cancer,MTT/MTS assay,IC50=35 µM,4-h,Colon,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1611,12366526,2002,PAWAKAFRAAARMKLKAA,L8,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,Meth A,Skin Cancer,MTT/MTS assay,IC50=110 µM,4-h,Skin,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1626,12366526,2002,PAWAKAFRAAARMKLKAA,L8,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,MT-1,Breast Cancer,MTT/MTS assay,IC50=87 µM,4-h,Breast,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1641,12366526,2002,PAWAKAFRAAARMKLKAA,L8,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,HT-29,Colon Cancer,MTT/MTS assay,IC50=180 µM,4-h,Colon,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1605,12366526,2002,PAWFKARRWAWRMKKLAA,L2,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,Meth A,Skin Cancer,MTT/MTS assay,IC50=144 µM,4-h,Skin,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1620,12366526,2002,PAWFKARRWAWRMKKLAA,L2,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,MT-1,Breast Cancer,MTT/MTS assay,IC50=>254 µM,4-h,Breast,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1635,12366526,2002,PAWFKARRWAWRMKKLAA,L2,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,HT-29,Colon Cancer,MTT/MTS assay,IC50=>440 µM,4-h,Colon,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1607,12366526,2002,PAWFKARRWAWRMLKKAA,L4,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,Meth A,Skin Cancer,MTT/MTS assay,IC50=31 µM,4-h,Skin,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1622,12366526,2002,PAWFKARRWAWRMLKKAA,L4,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,MT-1,Breast Cancer,MTT/MTS assay,IC50=16 µM,4-h,Breast,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1637,12366526,2002,PAWFKARRWAWRMLKKAA,L4,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,HT-29,Colon Cancer,MTT/MTS assay,IC50=57 µM,4-h,Colon,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1612,12366526,2002,PAWRKAARWAWRMLKKAA,L9,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,Meth A,Skin Cancer,MTT/MTS assay,IC50=35 µM,4-h,Skin,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1627,12366526,2002,PAWRKAARWAWRMLKKAA,L9,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,MT-1,Breast Cancer,MTT/MTS assay,IC50=32 µM,4-h,Breast,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1642,12366526,2002,PAWRKAARWAWRMLKKAA,L9,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,HT-29,Colon Cancer,MTT/MTS assay,IC50=52 µM,4-h,Colon,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1610,12366526,2002,PAWRKAFRAAWRMLKKAA,L7,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,Meth A,Skin Cancer,MTT/MTS assay,IC50=16 µM,4-h,Skin,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1625,12366526,2002,PAWRKAFRAAWRMLKKAA,L7,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,MT-1,Breast Cancer,MTT/MTS assay,IC50=11 µM,4-h,Breast,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1640,12366526,2002,PAWRKAFRAAWRMLKKAA,L7,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,HT-29,Colon Cancer,MTT/MTS assay,IC50=16 µM,4-h,Colon,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1616,12366526,2002,PAWRKAFRKAWRMLKKAA,L13,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,Meth A,Skin Cancer,MTT/MTS assay,IC50=14 µM,4-h,Skin,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1631,12366526,2002,PAWRKAFRKAWRMLKKAA,L13,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,MT-1,Breast Cancer,MTT/MTS assay,IC50=12 µM,4-h,Breast,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1646,12366526,2002,PAWRKAFRKAWRMLKKAA,L13,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,HT-29,Colon Cancer,MTT/MTS assay,IC50=29 µM,4-h,Colon,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1609,12366526,2002,PAWRKAFRWAARMLKKAA,L6,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,Meth A,Skin Cancer,MTT/MTS assay,IC50=11 µM,4-h,Skin,None,N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC.C(=O)O,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1624,12366526,2002,PAWRKAFRWAARMLKKAA,L6,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,MT-1,Breast Cancer,MTT/MTS assay,IC50=12 µM,4-h,Breast,None,N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC.C(=O)O,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1639,12366526,2002,PAWRKAFRWAARMLKKAA,L6,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,HT-29,Colon Cancer,MTT/MTS assay,IC50=15 µM,4-h,Colon,None,N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC.C(=O)O,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1615,12366526,2002,PAWRKAFRWAKRMLKKAA,L12,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,Meth A,Skin Cancer,MTT/MTS assay,IC50=7.9 µM,4-h,Skin,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1630,12366526,2002,PAWRKAFRWAKRMLKKAA,L12,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,MT-1,Breast Cancer,MTT/MTS assay,IC50=10 µM,4-h,Breast,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1645,12366526,2002,PAWRKAFRWAKRMLKKAA,L12,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,HT-29,Colon Cancer,MTT/MTS assay,IC50=25 µM,4-h,Colon,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1606,12366526,2002,PAWRKAFRWAWRMKKLAA,L3,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,Meth A,Skin Cancer,MTT/MTS assay,IC50=32 µM,4-h,Skin,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1621,12366526,2002,PAWRKAFRWAWRMKKLAA,L3,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,MT-1,Breast Cancer,MTT/MTS assay,IC50=18 µM,4-h,Breast,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1636,12366526,2002,PAWRKAFRWAWRMKKLAA,L3,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,HT-29,Colon Cancer,MTT/MTS assay,IC50=141 µM,4-h,Colon,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1608,12366526,2002,PAWRKAFRWAWRMLKKAA,L5,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,Meth A,Skin Cancer,MTT/MTS assay,IC50=6.6 µM,4-h,Skin,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1623,12366526,2002,PAWRKAFRWAWRMLKKAA,L5,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,MT-1,Breast Cancer,MTT/MTS assay,IC50=8 µM,4-h,Breast,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1638,12366526,2002,PAWRKAFRWAWRMLKKAA,L5,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,HT-29,Colon Cancer,MTT/MTS assay,IC50=14 µM,4-h,Colon,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1618,12366526,2002,PAWRKARRWARRMKKLAA,L15,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,Meth A,Skin Cancer,MTT/MTS assay,IC50=87 µM,4-h,Skin,None,N(C)[C@@H](CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC.C(=O)O,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1633,12366526,2002,PAWRKARRWARRMKKLAA,L15,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,MT-1,Breast Cancer,MTT/MTS assay,IC50=92 µM,4-h,Breast,None,N(C)[C@@H](CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC.C(=O)O,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1648,12366526,2002,PAWRKARRWARRMKKLAA,L15,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,HT-29,Colon Cancer,MTT/MTS assay,IC50=178 µM,4-h,Colon,None,N(C)[C@@H](CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC.C(=O)O,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1617,12366526,2002,PAWRKARRWAWRMKKLAA,L14,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,Meth A,Skin Cancer,MTT/MTS assay,IC50=125 µM,4-h,Skin,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1632,12366526,2002,PAWRKARRWAWRMKKLAA,L14,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,MT-1,Breast Cancer,MTT/MTS assay,IC50=141 µM,4-h,Breast,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1647,12366526,2002,PAWRKARRWAWRMKKLAA,L14,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,HT-29,Colon Cancer,MTT/MTS assay,IC50=423 µM,4-h,Colon,None,N12CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
3108,22783018,2012,PDEDAINDALNKVCSTGRRQRSICKQLLKK,N29D,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,SW-480,Colon Cancer,Cell Viability assay,>100% cell viability at 5 µM,24-h,Colon,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3109,22783018,2012,PDEDAINDALNKVCSTGRRQRSICKQLLKK,N29D,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,SW-480,Colon Cancer,Cell Viability assay,60% cell viability at 50 µM,24-h,Colon,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3110,22783018,2012,PDEDAINDALNKVCSTGRRQRSICKQLLKK,N29D,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,U-937,Lymphoma Cancer,Cell Viability assay,100% cell viability at 5 µM,24-h,Blood,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3111,22783018,2012,PDEDAINDALNKVCSTGRRQRSICKQLLKK,N29D,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,U-937,Lymphoma Cancer,Cell Viability assay,<60% cell viability at 50 µM,24-h,Blood,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3112,22783018,2012,PDEDAINDALNKVCSTGRRQRSICKQLLKK,N29D,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,SNU-1,Gastric Cancer,Cell Viability assay,<100% cell viability at 5 µM,24-h,Stomach,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3113,22783018,2012,PDEDAINDALNKVCSTGRRQRSICKQLLKK,N29D,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,SNU-1,Gastric Cancer,Cell Viability assay,<40% cell viability at 50 µM,24-h,Stomach,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3260,22783018,2012,PDEDAINDALNKVCSTGRRQRSICKQLLKK,N29D,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,SW-480,Colon Cancer,Cell Viability assay,>100% cell viability at 5 µM,NA,Colon,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3261,22783018,2012,PDEDAINDALNKVCSTGRRQRSICKQLLKK,N29D,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,SW-480,Colon Cancer,Cell Viability assay,60% cell viability at 50 µM,NA,Colon,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3262,22783018,2012,PDEDAINDALNKVCSTGRRQRSICKQLLKK,N29D,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,U-937,Lymphoma Cancer,Cell Viability assay,100% cell viability at 5 µM,NA,Blood,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3263,22783018,2012,PDEDAINDALNKVCSTGRRQRSICKQLLKK,N29D,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,U-937,Lymphoma Cancer,Cell Viability assay,<60% cell viability at 50 µM,NA,Blood,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3264,22783018,2012,PDEDAINDALNKVCSTGRRQRSICKQLLKK,N29D,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,SNU-1,Gastric Cancer,Cell Viability assay,100% cell viability at 5 µM,NA,Stomach,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3265,22783018,2012,PDEDAINDALNKVCSTGRRQRSICKQLLKK,N29D,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,SNU-1,Gastric Cancer,Cell Viability assay,<40% cell viability at 50 µM,NA,Stomach,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3102,22783018,2012,PDEDAINNALNKVCSTGRRQRSICKQLLKK,N29N,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,SW-480,Colon Cancer,Cell Viability assay,100% cell viability at 5 µM,24-h,Colon,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC=NC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3103,22783018,2012,PDEDAINNALNKVCSTGRRQRSICKQLLKK,N29N,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,SW-480,Colon Cancer,Cell Viability assay,40% cell viability at 50 µM,24-h,Colon,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC=NC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3104,22783018,2012,PDEDAINNALNKVCSTGRRQRSICKQLLKK,N29N,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,U-937,Lymphoma Cancer,Cell Viability assay,100% cell viability at 5 µM,24-h,Blood,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC=NC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3105,22783018,2012,PDEDAINNALNKVCSTGRRQRSICKQLLKK,N29N,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,U-937,Lymphoma Cancer,Cell Viability assay,<40% cell viability at 50 µM,24-h,Blood,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC=NC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3106,22783018,2012,PDEDAINNALNKVCSTGRRQRSICKQLLKK,N29N,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,SNU-1,Gastric Cancer,Cell Viability assay,<100% cell viability at 5 µM,24-h,Stomach,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC=NC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3107,22783018,2012,PDEDAINNALNKVCSTGRRQRSICKQLLKK,N29N,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,SNU-1,Gastric Cancer,Cell Viability assay,<20% cell viability at 50 µM,24-h,Stomach,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC=NC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3254,22783018,2012,PDEDAINNALNKVCSTGRRQRSICKQLLKK,N29N,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,SW-480,Colon Cancer,Cell Viability assay,100% cell viability at 5 µM,NA,Colon,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC=NC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3255,22783018,2012,PDEDAINNALNKVCSTGRRQRSICKQLLKK,N29N,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,SW-480,Colon Cancer,Cell Viability assay,40% cell viability at 50 µM,NA,Colon,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC=NC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3256,22783018,2012,PDEDAINNALNKVCSTGRRQRSICKQLLKK,N29N,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,U-937,Lymphoma Cancer,Cell Viability assay,100% cell viability at 5 µM,NA,Blood,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC=NC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3257,22783018,2012,PDEDAINNALNKVCSTGRRQRSICKQLLKK,N29N,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,U-937,Lymphoma Cancer,Cell Viability assay,<40% cell viability at 50 µM,NA,Blood,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC=NC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3258,22783018,2012,PDEDAINNALNKVCSTGRRQRSICKQLLKK,N29N,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,SNU-1,Gastric Cancer,Cell Viability assay,<100% cell viability at 5 µM,NA,Stomach,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC=NC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
3259,22783018,2012,PDEDAINNALNKVCSTGRRQRSICKQLLKK,N29N,30,Linear,L,None,Free,Free,Antibacterial and Anticancer,Synthetic peptide,SNU-1,Gastric Cancer,Cell Viability assay,<20% cell viability at 50 µM,NA,Stomach,None,N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC=NC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1073/pnas.1209161109
1604,12366526,2002,PEWFKCRRWQWRMKKLGA,L1,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,Meth A,Skin Cancer,MTT/MTS assay,IC50=>404 µM,4-h,Skin,None,N12CCC[C@@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1619,12366526,2002,PEWFKCRRWQWRMKKLGA,L1,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,MT-1,Breast Cancer,MTT/MTS assay,IC50=>404 µM,4-h,Breast,None,N12CCC[C@@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
1634,12366526,2002,PEWFKCRRWQWRMKKLGA,L1,18,Cyclic,L,None,Free,Free,Antimicrobial,Lactoferrin,HT-29,Colon Cancer,MTT/MTS assay,IC50=>404 µM,4-h,Colon,None,N12CCC[C@@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@H](C)C12OO1,https://doi.org/10.1034/j.1399-3011.2002.21008.x
3726,22481251,2012,PLLQATLGGGS,P7,11,Linear,L,None,Free,Free,Antiproliferative and Antiangiogenic,NA,B16-F10,Skin Cancer,WST-1 assay,IC50= 1 µM,48-h,Skin,None,N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1007/s00432-012-1201-7
3344,23533710,2013,PPPEE,Caseinphosphopeptides,5,Linear,L,None,Amidation,Free,"Immunomodulant, Antihypertensive, Antimicrobial,Antiviral, and Antioxidant",Bovine milk,AZ-97,Colon Cancer,MTT/MTS assay,Inhibition at 24-28g/l,NA,Colon,None,N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N,https://doi.org/10.1155/2013/939804
4582,21423613,2011,PRAWEYWLRLME,MIP(F3A),12,Linear,L,None,Free,Free,Antitumor,E3 ubiquitin-protein ligase,HCT-116-p53+/+,Colon Cancer,Immunoprecipitation assay,IC50 =0.57 µM,Not Available,Colon,None,N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)O,https://doi.org/10.1371/journal.pone.0017898
4583,21423613,2011,PRFWEAWLRLME,MIP(Y6A),12,Linear,L,None,Free,Free,Antitumor,E3 ubiquitin-protein ligase,HCT-116-p53+/+,Colon Cancer,Immunoprecipitation assay,IC50 >100 µM,Not Available,Colon,None,N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)O,https://doi.org/10.1371/journal.pone.0017898
4584,21423613,2011,PRFWEYALRLME,MIP(W7A),12,Linear,L,None,Free,Free,Antitumor,E3 ubiquitin-protein ligase,HCT-116-p53+/+,Colon Cancer,Immunoprecipitation assay,IC50 >100 µM,Not Available,Colon,None,N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)O,https://doi.org/10.1371/journal.pone.0017898
4585,21423613,2011,PRFWEYWLALME,MIP(R9A),12,Linear,L,None,Free,Free,Antitumor,E3 ubiquitin-protein ligase,HCT-116-p53+/+,Colon Cancer,Immunoprecipitation assay,IC50 =0.02 µM,Not Available,Colon,None,N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)O,https://doi.org/10.1371/journal.pone.0017898
4586,21423613,2011,PRFWEYWLRAME,MIP(L10A),12,Linear,L,None,Free,Free,Antitumor,E3 ubiquitin-protein ligase,HCT-116-p53+/+,Colon Cancer,Immunoprecipitation assay,IC50 =1.14 µM,Not Available,Colon,None,N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)O,https://doi.org/10.1371/journal.pone.0017898
4587,21423613,2011,PRFWEYWLRLAE,MIP(M11A),12,Linear,L,None,Free,Free,Antitumor,E3 ubiquitin-protein ligase,HCT-116-p53+/+,Colon Cancer,Immunoprecipitation assay,IC50 =0.4 µM,Not Available,Colon,None,N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)O,https://doi.org/10.1371/journal.pone.0017898
4578,21423613,2011,PRFWEYWLRLME,MIP,12,Linear,L,None,Free,Free,Antitumor,E3 ubiquitin-protein ligase,HCT-116-p53+/+,Colon Cancer,Immunoprecipitation assay,IC50 =0.01 µM,Not Available,Colon,None,N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)O,https://doi.org/10.1371/journal.pone.0017898
4588,21423613,2011,PRFWEYWLRLME,MIP,12,Linear,L,None,Free,Free,Antitumor,E3 ubiquitin-protein ligase,HCT-116-p53+/+,Colon Cancer,Immunoprecipitation assay,IC50 =0.12 µM,Not Available,Colon,None,N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)O,https://doi.org/10.1371/journal.pone.0017898
4581,21423613,2011,QETFSDLWKLLP,P5317-28,12,Linear,L,None,Free,Free,Antitumor,E3 ubiquitin-protein ligase,HCT-116-p53+/+,Colon Cancer,Immunoprecipitation assay,IC50 =4.7 µM,Not Available,Colon,None,N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C=O)CCC1)CC(C)C)CC(C)C)CC)Cc1c[nH]c2c1cccc2)CC(C)C)CC(=O)O)CO)Cc1ccccc1)[C@H](O)C)CCC(=O)O)CCC(=O)N,https://doi.org/10.1371/journal.pone.0017898
4591,21423613,2011,QETFSDLWKLLP,P5317-28,12,Linear,L,None,Free,Free,Antitumor,E3 ubiquitin-protein ligase,HCT-116-p53+/+,Colon Cancer,Immunoprecipitation assay,IC50 =30 µM,Not Available,Colon,None,N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C=O)CCC1)CC(C)C)CC(C)C)CC)Cc1c[nH]c2c1cccc2)CC(C)C)CC(=O)O)CO)Cc1ccccc1)[C@H](O)C)CCC(=O)O)CCC(=O)N,https://doi.org/10.1371/journal.pone.0017898
1053,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50=14.7 µg/ml,48-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1054,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,HL-60,Leukemia Cancer,MTT/MTS assay,IC50=11.3 µg/ml,48-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1055,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=8.2 µg/ml,48-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1056,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,MOLT-4,Leukemia Cancer,MTT/MTS assay,IC50=17 µg/ml,48-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1057,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,RPMI-8226,Leukemia Cancer,MTT/MTS assay,IC50=10.5 µg/ml,48-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1058,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,SR,Leukemia Cancer,MTT/MTS assay,IC50=20.2 µg/ml,48-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1059,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,MCF-7,Breast Cancer,MTT/MTS assay,IC50=15.1 µg/ml,48-h,Breast,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1060,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,NCI/ADR-RES,Breast Cancer,MTT/MTS assay,IC50=11.5 µg/ml,48-h,Breast,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1061,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,MDA-MB-231,Breast Cancer,MTT/MTS assay,IC50=11.3 µg/ml,48-h,Breast,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1062,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,HS578T,Breast Cancer,MTT/MTS assay,IC50=11.7 µg/ml,48-h,Breast,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1063,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,MDA-MB-435,Breast Cancer,MTT/MTS assay,IC50=11.3 µg/ml,48-h,Breast,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1064,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,MDA-N,Breast Cancer,MTT/MTS assay,IC50=10.6 µg/ml,48-h,Breast,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1065,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,BT-549,Breast Cancer,MTT/MTS assay,IC50=12.9 µg/ml,48-h,Breast,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1066,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,T-47D,Breast Cancer,MTT/MTS assay,IC50=23.9 µg/ml,48-h,Breast,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1067,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,A-549,Lung Cancer,MTT/MTS assay,IC50=11.7 µg/ml,48-h,Lung,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1068,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,EKVX,Lung Cancer,MTT/MTS assay,IC50=12.1 µg/ml,48-h,Lung,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1069,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,HOP-62,Lung Cancer,MTT/MTS assay,IC50=12.6 µg/ml,48-h,Lung,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1070,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,HOP-92,Lung Cancer,MTT/MTS assay,IC50=7.2 µg/ml,48-h,Lung,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1071,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,NCI-H226,Lung Cancer,MTT/MTS assay,IC50=13.3 µg/ml,48-h,Lung,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1072,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,NCI-H23,Lung Cancer,MTT/MTS assay,IC50=10.8 µg/ml,48-h,Lung,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1073,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,NCI-H322M,Lung Cancer,MTT/MTS assay,IC50=10.7 µg/ml,48-h,Lung,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1074,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,NCI-H460,Lung Cancer,MTT/MTS assay,IC50=12.1 µg/ml,48-h,Lung,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1075,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,NCI-H522,Lung Cancer,MTT/MTS assay,IC50=11.2 µg/ml,48-h,Lung,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1076,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,SF-268,Brain Tumor,MTT/MTS assay,IC50=12.4 µg/ml,48-h,Brain,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1077,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,SF-295,Brain Tumor,MTT/MTS assay,IC50=12.9 µg/ml,48-h,Brain,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1078,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,SF-539,Brain Tumor,MTT/MTS assay,IC50=9.5 µg/ml,48-h,Brain,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1079,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,SNB-19,Brain Tumor,MTT/MTS assay,IC50=13.8 µg/ml,48-h,Brain,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1080,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,SNB-75,Brain Tumor,MTT/MTS assay,IC50=15.5 µg/ml,48-h,Brain,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1081,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,U-251,Brain Tumor,MTT/MTS assay,IC50=10.6 µg/ml,48-h,Brain,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1082,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,LOXIMVI,Skin Cancer,MTT/MTS assay,IC50=9.5 µg/ml,48-h,Skin,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1083,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,MALME-3M,Skin Cancer,MTT/MTS assay,IC50=10.9 µg/ml,48-h,Skin,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1084,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,M14,Skin Cancer,MTT/MTS assay,IC50=15.1 µg/ml,48-h,Skin,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1085,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,SK-MEL-2,Skin Cancer,MTT/MTS assay,IC50=11.1 µg/ml,48-h,Skin,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1086,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,SK-MEL-5,Skin Cancer,MTT/MTS assay,IC50=8.9 µg/ml,48-h,Skin,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1087,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,UACC-257,Skin Cancer,MTT/MTS assay,IC50=12.5 µg/ml,48-h,Skin,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1088,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,UACC-62,Skin Cancer,MTT/MTS assay,IC50=10.6 µg/ml,48-h,Skin,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1089,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,786-0,Renal Cancer,MTT/MTS assay,IC50=12.2 µg/ml,48-h,Renal,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1090,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,A-498,Renal Cancer,MTT/MTS assay,IC50=10 µg/ml,48-h,Renal,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1091,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,ACHN,Renal Cancer,MTT/MTS assay,IC50=12 µg/ml,48-h,Renal,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1092,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,CAKI-1,Renal Cancer,MTT/MTS assay,IC50=14.1 µg/ml,48-h,Renal,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1093,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,RFX393,Renal Cancer,MTT/MTS assay,IC50=11 µg/ml,48-h,Renal,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1094,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,SN-12C,Renal Cancer,MTT/MTS assay,IC50=11.4 µg/ml,48-h,Renal,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1095,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,TK-10,Renal Cancer,MTT/MTS assay,IC50=13.1 µg/ml,48-h,Renal,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1096,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,UO-31,Renal Cancer,MTT/MTS assay,IC50=10.6 µg/ml,48-h,Renal,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1097,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,IGROV1,Ovarian Cancer,MTT/MTS assay,IC50=9 µg/ml,48-h,Ovary,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1098,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,OVRCAR-3,Ovarian Cancer,MTT/MTS assay,IC50=15.2 µg/ml,48-h,Ovary,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1099,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,OVRCAR-4,Ovarian Cancer,MTT/MTS assay,IC50=17.6 µg/ml,48-h,Ovary,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1100,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,OVRCAR-5,Ovarian Cancer,MTT/MTS assay,IC50=13.8 µg/ml,48-h,Ovary,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1101,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,OVRCAR-8,Ovarian Cancer,MTT/MTS assay,IC50=13 µg/ml,48-h,Ovary,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1102,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,Histone H2A,SK-OV-3,Ovarian Cancer,MTT/MTS assay,IC50=12.6 µg/ml,48-h,Ovary,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1103,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,COLO-205,Colon Cancer,MTT/MTS assay,IC50=11.2 µg/ml,48-h,Colon,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1104,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,HCT-116,Colon Cancer,MTT/MTS assay,IC50=14.6 µg/ml,48-h,Colon,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1105,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,HCT-15,Colon Cancer,MTT/MTS assay,IC50=13.2 µg/ml,48-h,Colon,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1106,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,HT-29,Colon Cancer,MTT/MTS assay,IC50=17.6 µg/ml,48-h,Colon,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1107,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,KM12,Colon Cancer,MTT/MTS assay,IC50=12 µg/ml,48-h,Colon,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1108,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,SW-620,Colon Cancer,MTT/MTS assay,IC50=12.7 µg/ml,48-h,Colon,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1109,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,PC-3,Prostate Cancer,MTT/MTS assay,IC50=12 µg/ml,48-h,Prostate,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1110,18617323,2008,RAGLQFPVGRLLRRLLRRLLR,Buforin IIb,21,Linear,L,None,Free,Free,Antibacterial,histone H2A,DU-145,Prostate Cancer,MTT/MTS assay,IC50=15.3 µg/ml,48-h,Prostate,None,N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.canlet.2008.05.041
1672,22641352,2012,RGDLLRHVVKILEKYL,RGD-La,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,SW-1116,Colorectal Cancer,MTT/MTS assay,72.69 Inhibition ratio at 50 µg/ml,24-h,Colon,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1676,22641352,2012,RGDLLRHVVKILEKYL,RGD-La,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,SMMC-7721,Liver Cancer,MTT/MTS assay,70.39 Inhibition ratio at 50 µg/ml,24-h,Liver,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1680,22641352,2012,RGDLLRHVVKILEKYL,RGD-La,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,HeLa,Cervical Cancer,MTT/MTS assay,73.09 Inhibition ratio at 50 µg/ml,24-h,Cervix,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1684,22641352,2012,RGDLLRHVVKILEKYL,RGD-La,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide aNot Available temporins,HepG-2,Liver Cancer,MTT/MTS assay,60.22 Inhibition ratio at 50 µg/ml,24-h,Liver,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1688,22641352,2012,RGDLLRHVVKILEKYL,RGD-La,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,BGC-823,Gastric Cancer,MTT/MTS assay,62.49 Inhibition ratio at 50 µg/ml,24-h,Stomach,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1692,22641352,2012,RGDLLRHVVKILEKYL,RGD-La,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,A-549,Lung Cancer,MTT/MTS assay,47.26Inhibition ratio at 50 µg/ml,24-h,Lung,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1696,22641352,2012,RGDLLRHVVKILEKYL,RGD-La,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,HL7702,Liver Cancer,MTT/MTS assay,36.25 Inhibition ratio at 50 µg/ml,24-h,Liver,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1700,22641352,2012,RGDLLRHVVKILEKYL,RGD-La,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,HEK-293T,Renal Cancer,MTT/MTS assay,27.86 Inhibition ratio at 50 µg/ml,24-h,Renal,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1704,22641352,2012,RGDLLRHVVKILEKYL,RGD-La,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,MEC,Breast Cancer,MTT/MTS assay,19.76 Inhibition ratio at 50 µg/ml,24-h,Breast,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1673,22641352,2012,RGDLLRHVVKILSKYL,RGD-Las,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,SW-1116,Colorectal Cancer,MTT/MTS assay,81.465 Inhibition ratio at 50 µg/ml,24-h,Colon,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1677,22641352,2012,RGDLLRHVVKILSKYL,RGD-Las,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,SMMC-7721,Liver Cancer,MTT/MTS assay,86.175 Inhibition ratio at 50 µg/ml,24-h,Liver,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1681,22641352,2012,RGDLLRHVVKILSKYL,RGD-Las,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,HeLa,Cervical Cancer,MTT/MTS assay,78.045 Inhibition ratio at 50 µg/ml,24-h,Cervix,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1685,22641352,2012,RGDLLRHVVKILSKYL,RGD-Las,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide aNot Available temporins,HepG-2,Liver Cancer,MTT/MTS assay,73.07 Inhibition ratio at 50 µg/ml,24-h,Liver,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1689,22641352,2012,RGDLLRHVVKILSKYL,RGD-Las,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,BGC-823,Gastric Cancer,MTT/MTS assay,73.705 Inhibition ratio at 50 µg/ml,24-h,Stomach,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1693,22641352,2012,RGDLLRHVVKILSKYL,RGD-Las,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,A-549,Lung Cancer,MTT/MTS assay,52.50 Inhibition ratio at 50 µg/ml,24-h,Lung,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1697,22641352,2012,RGDLLRHVVKILSKYL,RGD-Las,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,HL7702,Liver Cancer,MTT/MTS assay,38.13 Inhibition ratio at 50 µg/ml,24-h,Liver,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1701,22641352,2012,RGDLLRHVVKILSKYL,RGD-Las,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,HEK-293T,Renal Cancer,MTT/MTS assay,32.52 Inhibition ratio at 50 µg/ml,24-h,Renal,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1705,22641352,2012,RGDLLRHVVKILSKYL,RGD-Las,16,Linear,L,None,Free,Free,Anticancer,Arg-Gly-Asp(RGD) tripeptide ana temporins,MEC,Breast Cancer,MTT/MTS assay,29.33 Inhibition ratio at 50 µg/ml,24-h,Breast,None,N[C@@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1002/psc.2420
1426,"8335113, 21403917",1993,RGGRLCYCRRRFCVCVGR,Protegrin 1,18,Linear,L,None,Amidation,Free,Antimicrobial,Alpha helical peptide without cysteines,U-937,Lymphoma Cancer,MTT/MTS assay,61% Cytotoxicity at 0.5 µg/ml,6-h,Blood,None,[NH3][C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]1C(=O)N[C@H](C(=O)N[C@@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)C(C)C)CSSC1)C(C)C)CSSC2)Cc1ccccc1)CCCNC(=[NH2])N)CCCNC(=[NH2])N)CCCNC(=[NH2])N)Cc1ccc(cc1)O)CC(C)C)CCCNC(=[NH2])N)CCCNC(=[NH2])N,"['https://doi.org/10.1016/0014-5793(93)80175-t', 'Not Found']"
4597,21403917,2011,RGGRLCYCRRRFCVCVGR,Protegrin 1,18,Linear,L,None,Amidation,Free,Antimicrobial,alpha helical peptide without cysteines,U-942,Lymphoma Cancer,MTT/MTS assay,IC50 =30-40 µg/ml,Not Available,Blood,None,[NH3][C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]1C(=O)N[C@H](C(=O)N[C@@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N)CCCNC(=[NH2])N)C(C)C)CSSC1)C(C)C)CSSC2)Cc1ccccc1)CCCNC(=[NH2])N)CCCNC(=[NH2])N)CCCNC(=[NH2])N)Cc1ccc(cc1)O)CC(C)C)CCCNC(=[NH2])N)CCCNC(=[NH2])N,Not Found
1353,18425992,2008,RKAFRWAWRMLKKAAPSITCVR,mPep1,22,Linear,L,None,Free,Free,Antimicrobial,Bovine lactoferrin (Lf-B),HL-60,Skin Cancer,MTT/MTS assay,IC50=8 µM,24-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1002/psc.1039
1548,18656352,2008,RKKRRQRRR,Tat,9,Linear,L,None,Free,Free,Anticancer,HIV-Tat (49-57),HCT-116,Colon Cancer,MTT/MTS assay,~10% Cytotoxicity at 100 µM,24-h,Colon,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.bmcl.2008.07.017
1549,18656352,2008,KAQIRAMECNILGRKKRRQRRR,Tat-a5,22,Linear,L,None,Free,Free,Anticancer,HIV-Tat (49-57),HCT-116,Colon Cancer,MTT/MTS assay,~80% Cytotoxicity at 100 µM,24-h,Colon,None,N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1016/j.bmcl.2008.07.017
3718,24176852,2013,YGRKKRRQRRRREADFFWSLCTADMS,KilerFLIP,26,linear,L,None,Free,Free,NA,NA,Jurkat,Blood Cancer,Not Available,NA,NA,Blood,None,N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1038/cddis.2013.401
4191,15467750,2004,GRKKRRQRRR,HIV-TAT48-57,10,Linear,L,None,Free,Free,Anticancer,Not Available,HeLa,Cervical Cancer,LDH leakage assay,7% apoptosis at 10 µM,16 to 24-h,Cervix,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1207999
4192,15467750,2004,GRKKRRQRRR,HIV-TAT48-57,10,Linear,L,None,Free,Free,Anticancer,Not Available,HeLa,Cervical Cancer,LDH leakage assay,15% apoptosis at 20 µM,16 to 24-h,Cervix,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1207999
4193,15467750,2004,GRKKRRQRRR,HIV-TAT48-57,10,Linear,L,None,Free,Free,Anticancer,Not Available,HeLa,Cervical Cancer,LDH leakage assay,35% apoptosis at 30 µM,16 to 24-h,Cervix,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1207999
4194,15467750,2004,GRKKRRQRRR,HIV-TAT48-57,10,Linear,L,None,Free,Free,Anticancer,Not Available,HeLa,Cervical Cancer,LDH leakage assay,65% apoptosis at 50 µM,16 to 24-h,Cervix,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1207999
4195,15467750,2004,GRKKRRQRRRGGWMWVTNLRTD,TAT-Ras-GAP317-326,22,Linear,L,None,Free,Free,Anticancer,Not Available,HeLa,Cervical Cancer,LDH leakage assay,15% apoptosis at 10 µM,16 to 24-h,Cervix,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O,https://doi.org/10.1038/sj.onc.1207999
4196,15467750,2004,GRKKRRQRRRGGWMWVTNLRTD,TAT-Ras-GAP317-326,22,Linear,L,None,Free,Free,Anticancer,Not Available,HeLa,Cervical Cancer,LDH leakage assay,47% apoptosis at 20 µM,16 to 24-h,Cervix,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O,https://doi.org/10.1038/sj.onc.1207999
4197,15467750,2004,GRKKRRQRRRGGWMWVTNLRTD,TAT-Ras-GAP317-326,22,Linear,L,None,Free,Free,Anticancer,Not Available,HeLa,Cervical Cancer,LDH leakage assay,72% apoptosis at 30 µM,16 to 24-h,Cervix,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O,https://doi.org/10.1038/sj.onc.1207999
4198,15467750,2004,GRKKRRQRRRGGWMWVTNLRTD,TAT-Ras-GAP317-326,22,Linear,L,None,Free,Free,Anticancer,Not Available,HeLa,Cervical Cancer,LDH leakage assay,79% apoptosis at 50 µM,16 to 24-h,Cervix,None,NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O,https://doi.org/10.1038/sj.onc.1207999
4604,12417587,2003,YGRKKRRQRRR,Tat (47-57),11,Linear,L,None,Free,Free,Antimicrobial,Synthetic,HeLa,Cervical Cancer,MTT/MTS assay,at 1 µM 90-100% viablity,6-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1074/jbc.M208762200
4606,12417587,2003,YGRKKRRQRRR,Tat (47-57),11,Linear,L,None,Free,Free,Antimicrobial,Synthetic,HeLa,Cervical Cancer,MTT/MTS assay,at 10 µM 80% viablity,6-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1074/jbc.M208762200
4608,12417587,2003,YGRKKRRQRRR,Tat (47-57),11,Linear,L,None,Free,Free,Antimicrobial,Synthetic,HeLa,Cervical Cancer,MTT/MTS assay,at 100 µM 60% viablity,6-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1074/jbc.M208762200
2810,23000474,2012,RRRRRNWMWC,9R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,LNCaP,Prostate Cancer,MTT/MTS assay,IC50=44 µM,2-h,Prostate,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2812,23000474,2012,RRRRRNWMWC,9R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,LNCaP,Prostate Cancer,MTT/MTS assay,IC50=23 µM,24-h,Prostate,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2814,23000474,2012,RRRRRNWMWC,9R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,LNCaP,Prostate Cancer,MTT/MTS assay,IC50=28 µM,48-h,Prostate,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2816,23000474,2012,RRRRRNWMWC,9R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,MDA-MB-231,Breast Cancer,MTT/MTS assay,IC50=39 µM,2-h,Breast,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2818,23000474,2012,RRRRRNWMWC,9R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,MDA-MB-231,Breast Cancer,MTT/MTS assay,IC50=29 µM,24-h,Breast,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2820,23000474,2012,RRRRRNWMWC,9R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,MDA-MB-231,Breast Cancer,MTT/MTS assay,IC50=16 µM,48-h,Breast,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2822,23000474,2012,RRRRRNWMWC,9R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,HUT-102,Lymphoma Cancer,MTT/MTS assay,IC50=93 µM,2-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2824,23000474,2012,RRRRRNWMWC,9R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,HUT-102,Lymphoma Cancer,MTT/MTS assay,IC50=39 µM,24-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2826,23000474,2012,RRRRRNWMWC,9R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,HUT-102,Lymphoma Cancer,MTT/MTS assay,IC50=37 µM,48-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2828,23000474,2012,RRRRRNWMWC,9R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,HUT-102,Lymphoma Cancer,MTT/MTS assay,IC50=36 µM,72-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2830,23000474,2012,RRRRRNWMWC,9R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,HUT-102,Lymphoma Cancer,MTT/MTS assay,IC50=25 µM,96-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2832,23000474,2012,RRRRRNWMWC,9R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,J774A.1,Tumor,MTT/MTS assay,IC50=47 µM,24-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2834,23000474,2012,RRRRRNWMWC,9R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,J774A.1,Tumor,MTT/MTS assay,IC50=12 µM,96-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
4251,16568093,2006,rrrrrrrrGEDIIRNIARHAAQVGASMDR,r8-BidBH3Alt,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,SK-N-AS,Brain Tumor,MTT/MTS assay,1% apoptosis at 10 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4252,16568093,2006,rrrrrrrrGEDIIRNIARHAAQVGASMDR,r8-BidBH3Alt,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,SK-N-AS,Brain Tumor,MTT/MTS assay,2% apoptosis at 20 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4253,16568093,2006,rrrrrrrrGEDIIRNIARHAAQVGASMDR,r8-BidBH3Alt,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,SK-N-AS,Brain Tumor,MTT/MTS assay,3% apoptosis at 50 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4254,16568093,2006,rrrrrrrrGEDIIRNIARHAAQVGASMDR,r8-BidBH3Alt,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NB69,Brain Tumor,MTT/MTS assay,2% apoptosis at 10 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4255,16568093,2006,rrrrrrrrGEDIIRNIARHAAQVGASMDR,r8-BidBH3Alt,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NB69,Brain Tumor,MTT/MTS assay,1% apoptosis at 20 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4256,16568093,2006,rrrrrrrrGEDIIRNIARHAAQVGASMDR,r8-BidBH3Alt,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NB69,Brain Tumor,MTT/MTS assay,5% apoptosis at 50 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4257,16568093,2006,rrrrrrrrGEDIIRNIARHAAQVGASMDR,r8-BidBH3Alt,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NGP,Tumor,MTT/MTS assay,1% apoptosis at 10 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4258,16568093,2006,rrrrrrrrGEDIIRNIARHAAQVGASMDR,r8-BidBH3Alt,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NGP,Tumor,MTT/MTS assay,2% apoptosis at 20 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4259,16568093,2006,rrrrrrrrGEDIIRNIARHAAQVGASMDR,r8-BidBH3Alt,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NGP,Tumor,MTT/MTS assay,3% apoptosis at 50 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4260,16568093,2006,rrrrrrrrGEDIIRNIARHAAQVGASMDR,r8-BidBH3Alt,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,IMR5,Tumor,MTT/MTS assay,0% apoptosis at 10 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4261,16568093,2006,rrrrrrrrGEDIIRNIARHAAQVGASMDR,r8-BidBH3Alt,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,IMR5,Tumor,MTT/MTS assay,1% apoptosis at 20 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4262,16568093,2006,rrrrrrrrGEDIIRNIARHAAQVGASMDR,r8-BidBH3Alt,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,IMR5,Tumor,MTT/MTS assay,2% apoptosis at 50 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4239,16568093,2006,rrrrrrrrGEDIIRNIARHLAQVGDSMDR,r8-BidBH3,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,SK-N-AS,Brain Tumor,MTT/MTS assay,8% apoptosis at 10 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4240,16568093,2006,rrrrrrrrGEDIIRNIARHLAQVGDSMDR,r8-BidBH3,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,SK-N-AS,Brain Tumor,MTT/MTS assay,45% apoptosis at 20 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4241,16568093,2006,rrrrrrrrGEDIIRNIARHLAQVGDSMDR,r8-BidBH3,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,SK-N-AS,Brain Tumor,MTT/MTS assay,65% apoptosis at 50 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4242,16568093,2006,rrrrrrrrGEDIIRNIARHLAQVGDSMDR,r8-BidBH3,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NB69,Brain Tumor,MTT/MTS assay,25% apoptosis at 10 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4243,16568093,2006,rrrrrrrrGEDIIRNIARHLAQVGDSMDR,r8-BidBH3,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NB69,Brain Tumor,MTT/MTS assay,66% apoptosis at 20 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4244,16568093,2006,rrrrrrrrGEDIIRNIARHLAQVGDSMDR,r8-BidBH3,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NB69,Brain Tumor,MTT/MTS assay,68% apoptosis at 50 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4245,16568093,2006,rrrrrrrrGEDIIRNIARHLAQVGDSMDR,r8-BidBH3,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NGP,Tumor,MTT/MTS assay,43% apoptosis at 10 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4246,16568093,2006,rrrrrrrrGEDIIRNIARHLAQVGDSMDR,r8-BidBH3,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NGP,Tumor,MTT/MTS assay,46% apoptosis at 20 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4247,16568093,2006,rrrrrrrrGEDIIRNIARHLAQVGDSMDR,r8-BidBH3,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NGP,Tumor,MTT/MTS assay,79% apoptosis at 50 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4248,16568093,2006,rrrrrrrrGEDIIRNIARHLAQVGDSMDR,r8-BidBH3,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,IMR5,Tumor,MTT/MTS assay,23% apoptosis at 10 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4249,16568093,2006,rrrrrrrrGEDIIRNIARHLAQVGDSMDR,r8-BidBH3,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,IMR5,Tumor,MTT/MTS assay,35% apoptosis at 20 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4250,16568093,2006,rrrrrrrrGEDIIRNIARHLAQVGDSMDR,r8-BidBH3,29,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,IMR5,Tumor,MTT/MTS assay,55% apoptosis at 50 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4471,22076954,2011,RRRRRRRRGGC-Pem,Peptide-3,11,Linear,L,Pem= Pemetrexed,Amidation,Free,Anticancer,Synthetic,HL-60,Leukemia Cancer,MTT/MTS assay,IC50 = 6.24 µM,3-h,Blood,None,NA,https://doi.org/10.1002/psc.1407
4474,22076954,2011,RRRRRRRRGGC-Pem,Peptide-3,11,Linear,L,Pem= Pemetrexed,Amidation,Free,Anticancer,Synthetic,NCI-H358,Lung Cancer,MTT/MTS assay,IC50 = 8.41 µM,3-h,Lung,None,NA,https://doi.org/10.1002/psc.1407
4227,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,SK-N-AS,Brain Tumor,MTT/MTS assay,0% apoptosis at 10 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4228,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,SK-N-AS,Brain Tumor,MTT/MTS assay,10% apoptosis at 20 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4229,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,SK-N-AS,Brain Tumor,MTT/MTS assay,30% apoptosis at 50 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4230,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NB69,Brain Tumor,MTT/MTS assay,30% apoptosis at 10 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4231,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NB69,Brain Tumor,MTT/MTS assay,80% apoptosis at 20 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4232,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NB69,Brain Tumor,MTT/MTS assay,80% apoptosis at 50 µM,8-h,Brain,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4233,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NGP,Tumor,MTT/MTS assay,20% apoptosis at 10 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4234,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NGP,Tumor,MTT/MTS assay,>50% apoptosis at 20 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4235,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,NGP,Tumor,MTT/MTS assay,30% apoptosis at 50 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4236,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,IMR5,Tumor,MTT/MTS assay,15% apoptosis at 10 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4237,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,IMR5,Tumor,MTT/MTS assay,20% apoptosis at 20 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
4238,16568093,2006,rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK,r8-BadBH3,35,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,IMR5,Tumor,MTT/MTS assay,50% apoptosis at 50 µM,8-h,Not Available,None,N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)N[C@H](CCCN=C)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1038/sj.onc.1209489
2811,23000474,2012,RRRRRWCMNW,9S1R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,LNCaP,Prostate Cancer,MTT/MTS assay,IC50=26 µM,2-h,Prostate,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2813,23000474,2012,RRRRRWCMNW,9S1R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,LNCaP,Prostate Cancer,MTT/MTS assay,IC50=9 µM,24-h,Prostate,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2815,23000474,2012,RRRRRWCMNW,9S1R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,LNCaP,Prostate Cancer,MTT/MTS assay,IC50=8 µM,48-h,Prostate,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2817,23000474,2012,RRRRRWCMNW,9S1R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,MDA-MB-231,Breast Cancer,MTT/MTS assay,IC50=18 µM,2-h,Breast,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2819,23000474,2012,RRRRRWCMNW,9S1R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,MDA-MB-231,Breast Cancer,MTT/MTS assay,IC50=12 µM,24-h,Breast,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2821,23000474,2012,RRRRRWCMNW,9S1R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,MDA-MB-231,Breast Cancer,MTT/MTS assay,IC50=10 µM,48-h,Breast,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2823,23000474,2012,RRRRRWCMNW,9S1R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,HUT-102,Lymphoma Cancer,MTT/MTS assay,IC50=38 µM,2-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2825,23000474,2012,RRRRRWCMNW,9S1R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,HUT-102,Lymphoma Cancer,MTT/MTS assay,IC50=43 µM,24-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2827,23000474,2012,RRRRRWCMNW,9S1R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,HUT-102,Lymphoma Cancer,MTT/MTS assay,IC50=43 µM,48-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2829,23000474,2012,RRRRRWCMNW,9S1R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,HUT-102,Lymphoma Cancer,MTT/MTS assay,IC50=45 µM,72-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2831,23000474,2012,RRRRRWCMNW,9S1R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,HUT-102,Lymphoma Cancer,MTT/MTS assay,IC50=36 µM,96-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2833,23000474,2012,RRRRRWCMNW,9S1R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,J774A.1,Tumor,MTT/MTS assay,IC50=26 µM,24-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
2835,23000474,2012,RRRRRWCMNW,9S1R,10,Linear,L,None,Free,Free,Anticancer,Nullomer derived anticancer peptides (NulloPs):,J774A.1,Tumor,MTT/MTS assay,IC50=17 µM,96-h,Blood,None,N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)O,https://doi.org/10.1016/j.peptides.2012.09.015
4532,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-231,Breast Cancer,MTT/MTS assay,5% cytotoxic at 10 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4533,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-231,Breast Cancer,MTT/MTS assay,20-30% cytotoxic at 25 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4534,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-231,Breast Cancer,MTT/MTS assay,40-50% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4535,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,T-47D,Breast Cancer,MTT/MTS assay,~0% cytotoxic at 5 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4536,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,T-47D,Breast Cancer,MTT/MTS assay,10% cytotoxic at 10 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4537,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,T-47D,Breast Cancer,MTT/MTS assay,20% cytotoxic at 25 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4538,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,T-47D,Breast Cancer,MTT/MTS assay,40-50% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4539,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,SKBR-3,Breast Cancer,MTT/MTS assay,~0% cytotoxic at 5 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4540,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,SKBR-3,Breast Cancer,MTT/MTS assay,20% cytotoxic at 10 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4541,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,SKBR-3,Breast Cancer,MTT/MTS assay,70-80% cytotoxic at 25 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4542,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,SKBR-3,Breast Cancer,MTT/MTS assay,80-85% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4543,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-468,Breast Cancer,MTT/MTS assay,10% cytotoxic at 5 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4544,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-468,Breast Cancer,MTT/MTS assay,50% cytotoxic at 10 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4545,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-468,Breast Cancer,MTT/MTS assay,80% cytotoxic at 25 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4546,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MDA-MB-468,Breast Cancer,MTT/MTS assay,80-90% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4547,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,4T1,Breast Cancer,MTT/MTS assay,30-40% cytotoxic at 5 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4548,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,4T1,Breast Cancer,MTT/MTS assay,60-70% cytotoxic at 10 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4549,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,4T1,Breast Cancer,MTT/MTS assay,80-90% cytotoxic at 25 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4550,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,4T1,Breast Cancer,MTT/MTS assay,85-90% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4571,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MCF-7,Breast Cancer,MTT/MTS assay,70% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
4574,22023734,2011,RWGKWFKKATHVGKHVGKAALTAYL,NRC-07,25,Linear,L,None,Amidation,Biotinylated,Antimicrobial,Pleurocidin-family,MCF-7-TX400,Breast Cancer,MTT/MTS assay,60-70% cytotoxic at 50 µM,24-h,Breast,None,NA,https://doi.org/10.1186/bcr3043
3157,23301519,2013,WRWRWRWRW,Cyclic [W(RW)4 ]-Dox,9,Cyclic,L,Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ],Free,Free,Anticancer,Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,62-73% inhibition of cell proliferation at 1 µM,72 to 120-h,Blood,None,NA,https://doi.org/10.1021/mp3004034
3158,23301519,2013,WRWRWRWRW,Cyclic [W(RW)4 ]-Dox,9,Cyclic,L,Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ],Free,Free,Anticancer,Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP,SK-OV-3,Ovarian Cancer,MTT/MTS assay,51-74% inhibition of cell proliferation at 1 µM,72 to 120-h,Ovary,None,NA,https://doi.org/10.1021/mp3004034
3159,23301519,2013,WRWRWRWRW,Cyclic [W(RW)4 ]-Dox,9,Cyclic,L,Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ],Free,Free,Anticancer,Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP,HCT-116,Colon Cancer,MTT/MTS assay,50-67% inhibition of cell proliferation at 1 µM,72 to 120-h,Colon,None,NA,https://doi.org/10.1021/mp3004034
3160,23301519,2013,WRWRWRWRW,Cyclic [W(RW)4 ]-Dox,9,Cyclic,L,Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ],Free,Free,Anticancer,Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP,MDA-MB-468,Breast Cancer,MTT/MTS assay,60-79% inhibition of cell proliferation at 1 µM,72 to 120-h,Breast,None,NA,https://doi.org/10.1021/mp3004034
3161,23301519,2013,RWRWRWRW,linear (RW)4-Dox,8,Linear,L,Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ],Free,Free,Anticancer,Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,46-69% antiproliferative activity at 1 µM,72 to 120-h,Blood,None,NA,https://doi.org/10.1021/mp3004034
3162,23301519,2013,RWRWRWRW,linear (RW)4-Dox,8,Linear,L,Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ],Free,Free,Anticancer,Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP,SK-OV-3,Ovarian Cancer,MTT/MTS assay,28-34% antiproliferative activity at 1 µM,72 to 120-h,Ovary,None,NA,https://doi.org/10.1021/mp3004034
3163,23301519,2013,RWRWRWRW,linear (RW)4-Dox,8,Linear,L,Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ],Free,Free,Anticancer,Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP,HCT-116,Colon Cancer,MTT/MTS assay,21-61% antiproliferative activity at 1 µM,72 to 120-h,Colon,None,NA,https://doi.org/10.1021/mp3004034
3164,23301519,2013,RWRWRWRW,linear (RW)4-Dox,8,Linear,L,Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ],Free,Free,Anticancer,Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP,MDA-MB-468,Breast Cancer,MTT/MTS assay,60-74% antiproliferative activity at 1 µM,72 to 120-h,Breast,None,NA,https://doi.org/10.1021/mp3004034
3343,23533710,2013,RYLGYL,αs1-casein f(90_95),6,Linear,L,None,Amidation,Free,"Immunomodulant, Antihypertensive, Antimicrobial,Antiviral, and Antioxidant",Bovine milk,AZ-97,Colon Cancer,MTT/MTS assay,Inhibition at 12-15g/l,NA,Colon,None,N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N,https://doi.org/10.1155/2013/939804
1652,11835991,2001,SIGAKILGGVKTFFKGALKELASTYLQ,maximin5,27,Linear,L,None,Free,Free,Antimicrobial,Bombina maxima,C8166,Leukemia Cancer,MTT/MTS assay,IC50=34.4 µg/ml,48-h,Blood,None,N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)O,https://doi.org/10.1016/s0196-9781(01)00641-6
1656,11835991,2001,SIGAKILGGVKTFFKGALKELASTYLQ,maximin5,27,Linear,L,None,Free,Free,Antimicrobial,Bombina maxima,MOLT-4,Leukemia Cancer,MTT/MTS assay,IC50 >50 µg/ml,48-h,Blood,None,N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)O,https://doi.org/10.1016/s0196-9781(01)00641-6
1660,11835991,2001,SIGAKILGGVKTFFKGALKELASTYLQ,maximin5,27,Linear,L,None,Free,Free,Antimicrobial,Bombina maxima,BIU-87,Bladder Cancer,MTT/MTS assay,IC50 =>50 µg/ml,48-h,Bladder,None,N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)O,https://doi.org/10.1016/s0196-9781(01)00641-6
1664,11835991,2001,SIGAKILGGVKTFFKGALKELASTYLQ,maximin5,27,Linear,L,None,Free,Free,Antimicrobial,Bombina maxima,T-24,Bladder Cancer,MTT/MTS assay,IC50=>50 µg/ml,48-h,Bladder,None,N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)O,https://doi.org/10.1016/s0196-9781(01)00641-6
3345,22820149,2012,Structure Given,BAA-1,Not Available,Linear,L,None,Amidation,Free,Antimicrobial,Bovine lactoferrin (Lf-B),Ramos,Lymphoma Cancer,MTT/MTS assay,IC50 = 8.1 µg/ml,1-h,Blood,None,NA,https://doi.org/10.1016/j.bbamem.2012.07.005
3346,22820149,2012,Structure Given,BAA-2,Not Available,Linear,L,None,Amidation,Free,Antimicrobial,Bovine lactoferrin (Lf-B),Ramos,Lymphoma Cancer,MTT/MTS assay,IC50 = 3.8 µg/ml,8-h,Blood,None,NA,https://doi.org/10.1016/j.bbamem.2012.07.005
1235,7849420,1994,SWLSKTAKKLENSAKKRISEGIAIAIQGGPR,Cecropin P1,31,Linear,L,None,Free,Free,Antibacterial,Small Intestine of Pig,K-562,Leukemia Cancer,MTT assay,IC50=93 µM,96-h,Blood,None,N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)O,Not Found
1236,7849420,1994,SWLSKTAKKLENSAKKRISEGIAIAIQGGPR,Cecropin P1,31,Linear,L,None,Free,Free,Antibacterial,Small Intestine of Pig,BTS-30,Breast Cancer,MTT assay,IC50=>100 µM,96-h,Breast,None,N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)O,Not Found
1237,7849420,1994,SWLSKTAKKLENSAKKRISEGIAIAIQGGPR,Cecropin P1,31,Linear,L,None,Free,Free,Antibacterial,Small Intestine of Pig,HRT-18,Colon Cancer,MTT assay,IC50=>100 µM,96-h,Colon,None,N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)O,Not Found
1238,7849420,1994,SWLSKTAKKLENSAKKRISEGIAIAIQGGPR,Cecropin P1,31,Linear,L,None,Free,Free,Antibacterial,Small Intestine of Pig,DLD-1,Colon Cancer,MTT assay,IC50=>100 µM,96-h,Colon,None,N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)O,Not Found
3368,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,COLO-205,Colon Cancer,MTT/MTS assay,<5% cytotoxicity at 1 µM,24-h,Colon,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3369,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,COLO-205,Colon Cancer,MTT/MTS assay,~10% cytotoxicity at 10 µM,24-h,Colon,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3370,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,COLO-205,Colon Cancer,MTT/MTS assay,10% cytotoxicity at 1 µM,48-h,Colon,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3371,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,COLO-205,Colon Cancer,MTT/MTS assay,>10% cytotoxicity at 10 µM,48-h,Colon,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3372,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,COLO-205,Colon Cancer,MTT/MTS assay,>10% cytotoxicity at 1 µM,72-h,Colon,WO2012042540A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3373,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,COLO-205,Colon Cancer,MTT/MTS assay,<5% cytotoxicity at 10 µM,72-h,Colon,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3386,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,UM-UC-3,Bladder Cancer,MTT/MTS assay,~25% cytotoxicity at 1 µM,24-h,Bladder,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3387,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,UM-UC-3,Bladder Cancer,MTT/MTS assay,~25% cytotoxicity at 10 µM,24-h,Bladder,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3388,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,UM-UC-3,Bladder Cancer,MTT/MTS assay,~25% cytotoxicity at 1 µM,48-h,Bladder,WO2012042540A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3389,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,UM-UC-3,Bladder Cancer,MTT/MTS assay,>25% cytotoxicity at 10 µM,48-h,Bladder,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3390,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,UM-UC-3,Bladder Cancer,MTT/MTS assay,~45% cytotoxicity at 1 µM,72-h,Bladder,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3391,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,UM-UC-3,Bladder Cancer,MTT/MTS assay,<45% cytotoxicity at 10 µM,72-h,Bladder,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3404,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HCT-116,Colon Cancer,MTT/MTS assay,<15% cytotoxicity at 1 µM,24-h,Colon,WO2012042540A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3405,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HCT-116,Colon Cancer,MTT/MTS assay,15% cytotoxicity at 10 µM,24-h,Colon,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3406,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HCT-116,Colon Cancer,MTT/MTS assay,~5% cytotoxicity at 1 µM,48-h,Colon,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3407,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HCT-116,Colon Cancer,MTT/MTS assay,<5% cytotoxicity at 10 µM,48-h,Colon,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3408,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HCT-116,Colon Cancer,MTT/MTS assay,<5% cytotoxicity at 1 µM,72-h,Colon,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3409,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HCT-116,Colon Cancer,MTT/MTS assay,<5% cytotoxicity at 10 µM,72-h,Colon,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3422,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,SiHa,Cervical Cancer,MTT/MTS assay,5% cytotoxicity at 1 µM,24-h,Cervix,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3423,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,SiHa,Cervical Cancer,MTT/MTS assay,>10% cytotoxicity at 10 µM,24-h,Cervix,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3424,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,SiHa,Cervical Cancer,MTT/MTS assay,<3% cytotoxicity at 1 µM,48-h,Cervix,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3425,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,SiHa,Cervical Cancer,MTT/MTS assay,>20% cytotoxicity at 10 µM,48-h,Cervix,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3426,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,SiHa,Cervical Cancer,MTT/MTS assay,~20% cytotoxicity at 1 µM,72-h,Cervix,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3427,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,SiHa,Cervical Cancer,MTT/MTS assay,~40% cytotoxicity at 10 µM,72-h,Cervix,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3440,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,CaSki,Cervical Cancer,MTT/MTS assay,~5% cytotoxicity at 1 µM,24-h,Cervix,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3441,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,CaSki,Cervical Cancer,MTT/MTS assay,~15% cytotoxicity at 10 µM,24-h,Cervix,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3442,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,CaSki,Cervical Cancer,MTT/MTS assay,<3% cytotoxicity at 1 µM,48-h,Cervix,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3443,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,CaSki,Cervical Cancer,MTT/MTS assay,>20% cytotoxicity at 10 µM,48-h,Cervix,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3444,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,CaSki,Cervical Cancer,MTT/MTS assay,~15% cytotoxicity at 1 µM,72-h,Cervix,WO2012042540A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3445,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,CaSki,Cervical Cancer,MTT/MTS assay,>20% cytotoxicity at 10 µM,72-h,Cervix,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3458,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HTB-9,Bladder Cancer,MTT/MTS assay,<15% cytotoxicity at 1 µM,24-h,Bladder,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3459,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HTB-9,Bladder Cancer,MTT/MTS assay,~15% cytotoxicity at 10 µM,24-h,Bladder,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3460,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HTB-9,Bladder Cancer,MTT/MTS assay,<5% cytotoxicity at 1 µM,48-h,Bladder,WO2012042540A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3461,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HTB-9,Bladder Cancer,MTT/MTS assay,<3% cytotoxicity at 10 µM,48-h,Bladder,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3462,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HTB-9,Bladder Cancer,MTT/MTS assay,<5% cytotoxicity at 1 µM,72-h,Bladder,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
3463,None,2012,TAGIKLTVPIEKFPVTTQTFWG,TG23,22,Linear,L,None,Free,Free,Anticancer,Derived from the SAG1 surface protein from the parasite Toxoplasma gondii,HTB-9,Bladder Cancer,MTT/MTS assay,<5% cytotoxicity at 10 µM,72-h,Bladder,WO_2012042540_A2,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)NCC(=O)O,Not Found
4202,15867360,2005,TFRAFLSSRLQDLYSIVRRADRAAV,hP3,25,Linear,L,None,Free,Free,Antiangiogenesis,Human endostatin peptides,BxPC-3,Pancreatic Cancer,Matrigel Assay,No inhibition at 7 mg/kg/d,672-h,Pancreatic,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O,https://doi.org/10.1158/0008-5472.CAN-04-1833
2913,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),BT-474,Breast Cancer,WST-1 assay,IC50= 8.8 µM,72-h,Breast,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2914,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),T-47D,Breast Cancer,WST-1 assay,IC50= 4.0 µM,72-h,Breast,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2915,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),SK-BR-3,Breast Cancer,WST-1 assay,IC50= 6.5 µM,72-h,Breast,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2916,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),MDA-MB-231,Breast Cancer,WST-1 assay,IC50= 7.8 µM,72-h,Breast,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2917,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),BT-20,Breast Cancer,WST-1 assay,IC50= 4.8 µM,72-h,Breast,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2918,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),ZR75-1,Breast Cancer,WST-1 assay,IC50= 9.3 µM,72-h,Breast,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2919,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),SF-295,Brain Tumor,WST-1 assay,IC50= 6.3 µM,72-h,Brain,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2920,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),SN-19,Brain Tumor,WST-1 assay,IC50= 7.8 µM,72-h,Brain,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2921,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),U-251,Brain Tumor,WST-1 assay,IC50=7.0 µM,72-h,Brain,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2922,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),HuCCT-1,Human epithelial Cancer,WST-1 assay,IC50= 8.3 µM,72-h,Bileduct,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2923,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),LNCaP,Prostate Cancer,WST-1 assay,IC50= 6.2 µM,72-h,Prostate,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
2924,21849092,2011,THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK,Transferrin receptor (TfR)-lytic hybrid peptide,32,Linear,Mix,None,Free,Free,Anticancer,Transferrin receptor (TfR),COLO-587,Human epithelial Cancer,WST-1 assay,IC50=6.4 µM,72-h,Pancreatic,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1186/1471-2407-11-359
5055,24714081,2014,TKPRKTKPRKTKPRKTKPR,T Peptide,19,Linear,L,None,Free,Free,Anticancer,Tuftsin derivative,HepG-2,Liver Cancer,MTT/MTS assay,69.6% maximum inhibitory rate at 8 mg/kg,48-h,Liver,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1097/CAD.0000000000000111
5056,24714081,2014,TKPRKTKPRKTKPRKTKPR,T Peptide,19,Linear,L,None,Free,Free,Anticancer,Tuftsin derivative,HT-29,Colon Cancer,MTT/MTS assay,70% maximum inhibitory rate at 8 mg/kg,48-h,Colon,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1097/CAD.0000000000000111
5057,24714081,2014,TKPRKTKPRKTKPRKTKPR,T Peptide,19,Linear,L,None,Free,Free,Anticancer,Tuftsin derivative,BGC-823,Gastric Cancer,MTT/MTS assay,67.2% maximum inhibitory rate at 8 mg/kg,48-h,Stomach,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1097/CAD.0000000000000111
1420,"8573171, 21403917",1996,TRSSRAGLQFPVGRVHRLLRK,Buforin2,21,Linear,L,None,Amidation,Free,Antimicrobial,Bufo Bufo Gargarizans,U-937,Lymphoma Cancer,MTT/MTS assay,5% Cytotoxicity at 0.5 µg/ml,6-h,Blood,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N,"['https://doi.org/10.1006/bbrc.1996.0071', 'Not Found']"
4592,21403917,2011,TRSSRAGLQFPVGRVHRLLRK,Buforin 2,21,Linear,L,None,Free,Free,Antimicrobial,Bufo Bufo Gargarizans,U-937,Lymphoma Cancer,MTT/MTS assay,IC50 =90-95 µg/ml,Not Available,Blood,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4603,12417587,2003,TRSSRAGLQWPVGRVHRLLRKGGC,BF2d,24,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic,HeLa,Cervical Cancer,MTT/MTS assay,at 1 µM 90-100% viablity,6-h,Cervix,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)N,https://doi.org/10.1074/jbc.M208762200
4605,12417587,2003,TRSSRAGLQWPVGRVHRLLRKGGC,BF2d,24,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic,HeLa,Cervical Cancer,MTT/MTS assay,at 10 µM 90-95% viablity,6-h,Cervix,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)N,https://doi.org/10.1074/jbc.M208762200
4607,12417587,2003,TRSSRAGLQWPVGRVHRLLRKGGC,BF2d,24,Linear,L,None,Amidation,Free,Antimicrobial,Synthetic,HeLa,Cervical Cancer,MTT/MTS assay,at 100 µM 90-100% viablity,6-h,Cervix,None,N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)N,https://doi.org/10.1074/jbc.M208762200
2371,None,2005,VAKALAKALLKALKAL,FLAK 17 CV,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2219,None,2005,VAKALKALLKALKAL,FLAK 17 CV,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1916,None,2005,VAKFLAKFLKKAL,FLAK50 Q1V,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =92 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2068,None,2005,VAKFLAKFLKKAL,FLAK50 Q1V,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2220,None,2005,VAKFLAKFLKKAL,FLAK50 Q1V,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2372,None,2005,VAKFLAKFLKKAL,FLAK50 Q1V,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1917,None,2005,VAKKFAKKFKKFAKKFAKFAFAF,D2A21V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =210 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2069,None,2005,VAKKFAKKFKKFAKKFAKFAFAF,D2A21V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2221,None,2005,VAKKFAKKFKKFAKKFAKFAFAF,D2A21V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
2373,None,2005,VAKKFAKKFKKFAKKFAKFAFAF,D2A21V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,Not Found
1802,None,2005,VAKKLAKLAKKLAKLAL,FLAK26V AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =32 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1918,None,2005,VAKKLAKLAKKLAKLALAL,FLAK 25 AM V,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =130 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1954,None,2005,VAKKLAKLAKKLAKLAL,FLAK26V AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =46 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2106,None,2005,VAKKLAKLAKKLAKLAL,FLAK26V AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =40 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2222,None,2005,VAKKLAKLAKKLAKLALAL,FLAK 25 AM V,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2258,None,2005,VAKKLAKLAKKLAKLAL,FLAK26V AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =40 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2374,None,2005,VAKKLAKLAKKLAKLALAL,FLAK 25 AM V,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2410,None,2005,VAKKLAKLAKKLAKLAL,FLAK26V AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =7 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2553,None,2005,VAKKLAKLAKKLAKLAL,FLAK26V AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =54 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2696,None,2005,VAKKLAKLAKKLAKLAL,FLAK26V AM,17,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =33 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1918,None,2005,VAKKLAKLAKKLAKLALAL,FLAK 25 AM V,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =130 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2222,None,2005,VAKKLAKLAKKLAKLALAL,FLAK 25 AM V,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2374,None,2005,VAKKLAKLAKKLAKLALAL,FLAK 25 AM V,19,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1919,None,2005,VAKKLAKLAKKLLAL,FLAK43 AM V,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =86 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2223,None,2005,VAKKLAKLAKKLLAL,FLAK43 AM V,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2375,None,2005,VAKKLAKLAKKLLAL,FLAK43 AM V,15,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1920,None,2005,VAKLLAKALKKLL,FLAK50D V,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =45 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2072,None,2005,VAKLLAKALKKLL,FLAK50D V,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2224,None,2005,VAKLLAKALKKLL,FLAK50D V,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2376,None,2005,VAKLLAKALKKLL,FLAK50D V,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1800,None,2005,VAKLLAKLAKKLL,FLAK50V,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =23 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1952,None,2005,VAKLLAKLAKKLL,FLAK50V,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =47 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2104,None,2005,VAKLLAKLAKKLL,FLAK50V,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =43 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2256,None,2005,VAKLLAKLAKKLL,FLAK50V,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =43 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2408,None,2005,VAKLLAKLAKKLL,FLAK50V,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =17 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2551,None,2005,VAKLLAKLAKKLL,FLAK50V,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =32 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2694,None,2005,VAKLLAKLAKKLL,FLAK50V,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =44 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1885,None,2005,VAKLLAKLAKKVL,FLAK50T8,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =315 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2037,None,2005,VAKLLAKLAKKVL,FLAK50T8,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =750 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2189,None,2005,VAKLLAKLAKKVL,FLAK50T8,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =330 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2341,None,2005,VAKLLAKLAKKVL,FLAK50T8,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =330 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2494,None,2005,VAKLLAKLAKKVL,FLAK50T8,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =400 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2637,None,2005,VAKLLAKLAKKVL,FLAK50T8,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =640 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2780,None,2005,VAKLLAKLAKKVL,FLAK50T8,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1785,None,2005,VALALKALKKALKKLKKALKKAL,KAL V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =72 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1921,None,2005,VALALKALKKALKKLKKALKKAL,Hecate AM V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =340 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1922,None,2005,VALALKALKKALKKLKKALKKAL,Hecate AC V,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =160 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
1937,None,2005,VALALKALKKALKKLKKALKKAL,KAL V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =62 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2073,None,2005,VALALKALKKALKKLKKALKKAL,Hecate AM V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2074,None,2005,VALALKALKKALKKLKKALKKAL,Hecate AC V,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,Not Available,24-h,Colon,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2089,None,2005,VALALKALKKALKKLKKALKKAL,KAL V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2225,None,2005,VALALKALKKALKKLKKALKKAL,Hecate AM V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2226,None,2005,VALALKALKKALKKLKKALKKAL,Hecate AC V,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2241,None,2005,VALALKALKKALKKLKKALKKAL,KAL V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =140 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2377,None,2005,VALALKALKKALKKLKKALKKAL,Hecate AM V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2378,None,2005,VALALKALKKALKKLKKALKKAL,Hecate AC V,23,Linear,L,None,Free,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O,Not Found
2393,None,2005,VALALKALKKALKKLKKALKKAL,KAL V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =125 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2536,None,2005,VALALKALKKALKKLKKALKKAL,KAL V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =65 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2679,None,2005,VALALKALKKALKKLKKALKKAL,KAL V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =190 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1904,None,2005,VALALKALKKL,FLAK-120G,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =950 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1923,None,2005,VALALKALKKLAKKLKKLAKKAL,FLAK04 AM V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =84 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2056,None,2005,VALALKALKKL,FLAK-120G,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =600 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2208,None,2005,VALALKALKKL,FLAK-120G,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =770 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2360,None,2005,VALALKALKKL,FLAK-120G,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =770 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2379,None,2005,VALALKALKKLAKKLKKLAKKAL,FLAK04 AM V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2513,None,2005,VALALKALKKL,FLAK-120G,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2656,None,2005,VALALKALKKL,FLAK-120G,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2799,None,2005,VALALKALKKL,FLAK-120G,11,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =760 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1923,None,2005,VALALKALKKLAKKLKKLAKKAL,FLAK04 AM V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =84 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2379,None,2005,VALALKALKKLAKKLKKLAKKAL,FLAK04 AM V,23,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,Not Available,24-h,Skin,US_06875744_B2,N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
3507,22100226,2012,VN-Nal-KKLLGKLLKVVK,LL-III/16,15,Linear,L,Nal = 3-(1-naphthyl)alanine,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 6±1 µM,48-h,Cervix,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c(c(ccc1)C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3532,22100226,2012,VN-Nal-KKLLGKLLKVVK,LL-III/16,15,Linear,L,Nal = 3-(1-naphthyl)alanine,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,Not tested,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c(c(ccc1)C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3557,22100226,2012,VN-Nal-KKLLGKLLKVVK,LL-III/16,15,Linear,L,Nal = 3-(1-naphthyl)alanine,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c(c(ccc1)C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3506,22100226,2012,VNFKKLLGKLLKVVK,LL-III/15,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 7±1 µM,48-h,Cervix,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3531,22100226,2012,VNFKKLLGKLLKVVK,LL-III/15,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 42 µM,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3556,22100226,2012,VNFKKLLGKLLKVVK,LL-III/15,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 9±3 µM,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3510,22100226,2012,VNWKK-Aib-LGK-Aib-IK-Aib-VK,LL-III/19,15,Linear,L,Aib = 1-amino-isobutyric acid,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 3±1 µM,48-h,Cervix,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3535,22100226,2012,VNWKK-Aib-LGK-Aib-IK-Aib-VK,LL-III/19,15,Linear,L,Aib = 1-amino-isobutyric acid,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 28 µM,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3560,22100226,2012,VNWKK-Aib-LGK-Aib-IK-Aib-VK,LL-III/19,15,Linear,L,Aib = 1-amino-isobutyric acid,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 8±2 µM,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)NC(C)(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3504,22100226,2012,VNWKKIILGKIIKVVK,LL-III/11,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 8±1 µM,48-h,Cervix,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3529,22100226,2012,VNWKKIILGKIIKVVK,LL-III/11,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 48 µM,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3554,22100226,2012,VNWKKIILGKIIKVVK,LL-III/11,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 4±1 µM,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3496,22100226,2012,VNWKKILAKIIKVVK,LL-III/1,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 3±1 µM,48-h,Cervix,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3518,22100226,2012,VNWKKILAKIIKVVK,LL-III/36,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 8 µM,48-h,Cervix,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3521,22100226,2012,VNWKKILAKIIKVVK,LL-III/1,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 12± 3 µM,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3543,22100226,2012,VNWKKILAKIIKVVK,LL-III/36,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,Not tested,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3546,22100226,2012,VNWKKILAKIIKVVK,LL-III/1,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 3±1 µM,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3568,22100226,2012,VNWKKILAKIIKVVK,LL-III/36,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3495,22100226,2012,VNWKKILGKIIKVVK,LL-III,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 4±1 µM,48-h,Cervix,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3501,22100226,2012,VNWKKILGKIIKVVK,LL-III/8,15,Linear,L,None,Free,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 12±1 µM,48-h,Cervix,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1016/j.peptides.2011.11.002
3502,22100226,2012,VNWKKILGKIIKVVK,LL-III/9,15,Linear,L,None,Methoxylation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 3±1 µM,48-h,Cervix,None,NA,https://doi.org/10.1016/j.peptides.2011.11.002
3505,22100226,2012,vnwkkilgkiikvvk,LL-III/12,15,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 6±2 µM,48-h,Cervix,None,N[C@H](C(C)C)C(=O)N[C@H](CC(=O)N)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3519,22100226,2012,VNWKKILGKIIKVVK,LL-III/37,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 5±1 µM,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3520,22100226,2012,VNWKKILGKIIKVVK,LL-III,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 18±4 µM,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3526,22100226,2012,VNWKKILGKIIKVVK,LL-III/8,15,Linear,L,None,Free,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,Not tested,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1016/j.peptides.2011.11.002
3527,22100226,2012,VNWKKILGKIIKVVK,LL-III/9,15,Linear,L,None,Methoxylation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 25± 5 µM,48-h,Colon,None,NA,https://doi.org/10.1016/j.peptides.2011.11.002
3530,22100226,2012,vnwkkilgkiikvvk,LL-III/12,15,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 20 µM,48-h,Colon,None,N[C@H](C(C)C)C(=O)N[C@H](CC(=O)N)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3544,22100226,2012,VNWKKILGKIIKVVK,LL-III/37,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 13 µM,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3545,22100226,2012,VNWKKILGKIIKVVK,LL-III,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 5±3 µM,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3551,22100226,2012,VNWKKILGKIIKVVK,LL-III/8,15,Linear,L,None,Free,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 9 µM,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1016/j.peptides.2011.11.002
3552,22100226,2012,VNWKKILGKIIKVVK,LL-III/9,15,Linear,L,None,Methoxylation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NA,https://doi.org/10.1016/j.peptides.2011.11.002
3555,22100226,2012,vnwkkilgkiikvvk,LL-III/12,15,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 5±2 µM,48-h,Blood,None,N[C@H](C(C)C)C(=O)N[C@H](CC(=O)N)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3569,22100226,2012,VNWKKILGKIIKVVK,LL-III/37,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50= 4±1 µM,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3495,22100226,2012,VNWKKILGKIIKVVK,LL-III,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 4±1 µM,48-h,Cervix,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3501,22100226,2012,VNWKKILGKIIKVVK,LL-III/8,15,Linear,L,None,Free,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 12±1 µM,48-h,Cervix,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1016/j.peptides.2011.11.002
3502,22100226,2012,VNWKKILGKIIKVVK,LL-III/9,15,Linear,L,None,Methoxylation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 3±1 µM,48-h,Cervix,None,NA,https://doi.org/10.1016/j.peptides.2011.11.002
3505,22100226,2012,vnwkkilgkiikvvk,LL-III/12,15,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 6±2 µM,48-h,Cervix,None,N[C@H](C(C)C)C(=O)N[C@H](CC(=O)N)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3519,22100226,2012,VNWKKILGKIIKVVK,LL-III/37,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 5±1 µM,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3520,22100226,2012,VNWKKILGKIIKVVK,LL-III,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 18±4 µM,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3526,22100226,2012,VNWKKILGKIIKVVK,LL-III/8,15,Linear,L,None,Free,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,Not tested,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1016/j.peptides.2011.11.002
3527,22100226,2012,VNWKKILGKIIKVVK,LL-III/9,15,Linear,L,None,Methoxylation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 25± 5 µM,48-h,Colon,None,NA,https://doi.org/10.1016/j.peptides.2011.11.002
3530,22100226,2012,vnwkkilgkiikvvk,LL-III/12,15,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 20 µM,48-h,Colon,None,N[C@H](C(C)C)C(=O)N[C@H](CC(=O)N)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3544,22100226,2012,VNWKKILGKIIKVVK,LL-III/37,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 13 µM,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3545,22100226,2012,VNWKKILGKIIKVVK,LL-III,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 5±3 µM,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3551,22100226,2012,VNWKKILGKIIKVVK,LL-III/8,15,Linear,L,None,Free,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 9 µM,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1016/j.peptides.2011.11.002
3552,22100226,2012,VNWKKILGKIIKVVK,LL-III/9,15,Linear,L,None,Methoxylation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,NA,https://doi.org/10.1016/j.peptides.2011.11.002
3555,22100226,2012,vnwkkilgkiikvvk,LL-III/12,15,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 5±2 µM,48-h,Blood,None,N[C@H](C(C)C)C(=O)N[C@H](CC(=O)N)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3569,22100226,2012,VNWKKILGKIIKVVK,LL-III/37,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50= 4±1 µM,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3499,22100226,2012,VNWKKILGKIKKVVK,LL-III/4,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 7±1 µM,48-h,Cervix,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3524,22100226,2012,VNWKKILGKIKKVVK,LL-III/4,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3549,22100226,2012,VNWKKILGKIKKVVK,LL-III/4,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 18 µM,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3498,22100226,2012,VNWKKILKKIIKVVK,LL-III/3,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,Not tested,48-h,Cervix,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3523,22100226,2012,VNWKKILKKIIKVVK,LL-III/3,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3548,22100226,2012,VNWKKILKKIIKVVK,LL-III/3,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3500,22100226,2012,VNWKKILPKIIKVVK,LL-III/6,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 > 40 µM,48-h,Cervix,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3525,22100226,2012,VNWKKILPKIIKVVK,LL-III/6,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,Not tested,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3550,22100226,2012,VNWKKILPKIIKVVK,LL-III/6,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 6±3 µM,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3512,22100226,2012,VNWKKLLGKLLKVVK,LL-III/23,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 4 µM,48-h,Cervix,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3514,22100226,2012,vnwkkllgkllkvvk,LL-III/25,15,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 4±2 µM,48-h,Cervix,None,N[C@H](C(C)C)C(=O)N[C@H](CC(=O)N)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3537,22100226,2012,VNWKKLLGKLLKVVK,LL-III/23,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 15 µM,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3539,22100226,2012,vnwkkllgkllkvvk,LL-III/25,15,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 20 µM,48-h,Colon,None,N[C@H](C(C)C)C(=O)N[C@H](CC(=O)N)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3562,22100226,2012,VNWKKLLGKLLKVVK,LL-III/23,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 6 µM,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3564,22100226,2012,vnwkkllgkllkvvk,LL-III/25,15,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 4 µM,48-h,Blood,None,N[C@H](C(C)C)C(=O)N[C@H](CC(=O)N)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3512,22100226,2012,VNWKKLLGKLLKVVK,LL-III/23,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 4 µM,48-h,Cervix,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3514,22100226,2012,vnwkkllgkllkvvk,LL-III/25,15,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 4±2 µM,48-h,Cervix,None,N[C@H](C(C)C)C(=O)N[C@H](CC(=O)N)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3537,22100226,2012,VNWKKLLGKLLKVVK,LL-III/23,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 15 µM,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3539,22100226,2012,vnwkkllgkllkvvk,LL-III/25,15,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 20 µM,48-h,Colon,None,N[C@H](C(C)C)C(=O)N[C@H](CC(=O)N)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3562,22100226,2012,VNWKKLLGKLLKVVK,LL-III/23,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 6 µM,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3564,22100226,2012,vnwkkllgkllkvvk,LL-III/25,15,Linear,D,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 4 µM,48-h,Blood,None,N[C@H](C(C)C)C(=O)N[C@H](CC(=O)N)C(=O)N[C@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3516,22100226,2012,VNWKKVLGKVVKVVK,LL-III/27,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 13±2 µM,48-h,Cervix,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3541,22100226,2012,VNWKKVLGKVVKVVK,LL-III/27,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 > 100 µM,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3566,22100226,2012,VNWKKVLGKVVKVVK,LL-III/27,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 18 µM,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3513,22100226,2012,VNWOOILGOIIOVVO,LL-III/24,15,Linear,L,O = Ornithine,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 3±1 µM,48-h,Cervix,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3538,22100226,2012,VNWOOILGOIIOVVO,LL-III/24,15,Linear,L,O = Ornithine,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 20 µM,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3563,22100226,2012,VNWOOILGOIIOVVO,LL-III/24,15,Linear,L,O = Ornithine,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 5±2 µM,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3508,22100226,2012,VNWRRILGRIIRVVR,LL-III/17,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50= 9 µM,48-h,Cervix,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3533,22100226,2012,VNWRRILGRIIRVVR,LL-III/17,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,Not tested,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3558,22100226,2012,VNWRRILGRIIRVVR,LL-III/17,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,Not tested,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3268,18815734,2008,VRRFPWWWPFLRR,Tritrpticin,13,Linear,L,None,Amidation,Free,Antimicrobial,Derivative of tritrpticin,A-549,Lung Cancer,MTT/MTS assay,IC50 >200 µg/ml,NA,Lung,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCNC(=[NH2])N)CCCNC(=[NH2])N)CC(C)C)Cc3ccccc3)CCC2)Cc2c[nH]c3c2cccc3)Cc2c[nH]c3c2cccc3)Cc2c[nH]c3c2cccc3)CCC1)Cc1ccccc1)CCCNC(=[NH2])N)CCCNC(=[NH2])N)C(C)C,https://doi.org/10.1007/s10529-008-9848-5
3269,18815734,2008,VRRFPWWWPFLRR,Tritrpticin,13,Linear,L,None,Amidation,Free,Antimicrobial,Derivative of tritrpticin,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50 =142 µg/ml,NA,Breast,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCNC(=[NH2])N)CCCNC(=[NH2])N)CC(C)C)Cc3ccccc3)CCC2)Cc2c[nH]c3c2cccc3)Cc2c[nH]c3c2cccc3)Cc2c[nH]c3c2cccc3)CCC1)Cc1ccccc1)CCCNC(=[NH2])N)CCCNC(=[NH2])N)C(C)C,https://doi.org/10.1007/s10529-008-9848-5
4640,8445676,1993,"VV-Nme-VPP-2-hydroxyisovaleryl-2-
oxo-4-methoxy-5-benzyl-3-pyrroline",Dolastatin 15,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,Antineoplastic,Dolabella auricularia,DB,Lymphoma Cancer,Cell Viability assay,IC50=.00013-.0013 nM,Not Available,Blood,None,NA,https://doi.org/10.1093/jnci/85.6.483
4641,8445676,1993,"VV-Nme-VPP-2-hydroxyisovaleryl-2-
oxo-4-methoxy-5-benzyl-3-pyrroline",Dolastatin 15,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,Antineoplastic,Dolabella auricularia,HT,Lymphoma Cancer,Cell Viability assay,IC50=.00013-.0013 nM,Not Available,Blood,None,NA,https://doi.org/10.1093/jnci/85.6.483
4642,8445676,1993,"VV-Nme-VPP-2-hydroxyisovaleryl-2-
oxo-4-methoxy-5-benzyl-3-pyrroline",Dolastatin 15,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,Antineoplastic,Dolabella auricularia,RL,Lymphoma Cancer,Cell Viability assay,IC50=.00013-.0013 nM,Not Available,Blood,None,NA,https://doi.org/10.1093/jnci/85.6.483
4643,8445676,1993,"VV-Nme-VPP-2-hydroxyisovaleryl-2-
oxo-4-methoxy-5-benzyl-3-pyrroline",Dolastatin 15,Not Available,Not Available,Not Available,Not Available,Not Available,Not Available,Antineoplastic,Dolabella auricularia,SR,Leukemia Cancer,Cell Viability assay,IC50=.00013-.0013 nM,Not Available,Blood,None,NA,https://doi.org/10.1093/jnci/85.6.483
3515,22100226,2012,VYWKKILGKIIKVVK,LL-III/26,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,HeLa,Cervical Cancer,MTT/MTS assay,IC50 = 5±1 µM,48-h,Cervix,None,N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3540,22100226,2012,VYWKKILGKIIKVVK,LL-III/26,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,SW,Colon Cancer,MTT/MTS assay,IC50 = 30 µM,48-h,Colon,None,N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
3565,22100226,2012,VYWKKILGKIIKVVK,LL-III/26,15,Linear,L,None,Amidation,Free,Antimicrobial and Antifungal,Lasioglossin III and its analogs,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,IC50 = 6 µM,48-h,Blood,None,N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N,https://doi.org/10.1016/j.peptides.2011.11.002
1908,None,2005,WALAL,FLAK-120F,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =260 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2060,None,2005,WALAL,FLAK-120F,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =440 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2212,None,2005,WALAL,FLAK-120F,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =600 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2364,None,2005,WALAL,FLAK-120F,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =600 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2517,None,2005,WALAL,FLAK-120F,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =370 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2660,None,2005,WALAL,FLAK-120F,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,LD50 =570 µg/ml,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2803,None,2005,WALAL,FLAK-120F,5,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 =302 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
1125,12005420,2001,KWFKKIPKFLHLAKKF,N-3,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=17 µM,48-h,Breast,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1126,12005420,2001,WFKKIPKFLHLAKKF,N-4,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=32 µM,48-h,Breast,None,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1147,12005420,2001,KWFKKIPKFLHLAKKF,N-3,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=17 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1148,12005420,2001,WFKKIPKFLHLAKKF,N-4,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=23 µM,48-h,Blood,None,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1169,12005420,2001,KWFKKIPKFLHLAKKF,N-3,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=11 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1170,12005420,2001,WFKKIPKFLHLAKKF,N-4,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=24 µM,48-h,Blood,None,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1128,12005420,2001,WFKKIPKFLHLLKKF,N-3L,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=5 µM,48-h,Breast,None,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1150,12005420,2001,KWFKKIPKFLHLLKKF,N-3L,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=4 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCCC1.C(O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1151,12005420,2001,WFKKIPKFLHLLKKF,N-4L,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=6 µM,48-h,Blood,None,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1172,12005420,2001,KWFKKIPKFLHLLKKF,N-3L,16,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=4.2 µM,48-h,Blood,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCCC1.C(O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1173,12005420,2001,WFKKIPKFLHLLKKF,N-4L,15,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=3 µM,48-h,Blood,None,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1127,12005420,2001,WKKIPKFLHLAKKF,N-5,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=100. <µM,48-h,Breast,None,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1149,12005420,2001,WKKIPKFLHLAKKF,N-5,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=100.0 <µM,48-h,Blood,None,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1171,12005420,2001,WKKIPKFLHLAKKF,N-5,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=100.0 <µM,48-h,Blood,None,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1129,12005420,2001,WKKIPKFLHLLKKF,N-4L,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=5 µM,48-h,Breast,None,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1130,12005420,2001,WKKIPKFLHLLKKF,N-5L,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=17 µM,48-h,Breast,None,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1152,12005420,2001,WKKIPKFLHLLKKF,N-5L,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=14 µM,48-h,Blood,None,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1174,12005420,2001,WKKIPKFLHLLKKF,N-5L,14,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=10 µM,48-h,Blood,None,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
3305,21453492,2011,WKKW-Dip-KKWK,LTX-302,9,Linear,L,Dip = diphenylalanine,Amidation,Free,Antimicrobial,Synthetic peptide,HT-29,Colon Cancer,MTT/MTS assay,IC50 =75 ± 5 µM,30-Min,Colon,None,NA,https://doi.org/10.1186/1471-2407-11-116
3306,21453492,2011,WKKW-Dip-KKWK,LTX-302,9,Linear,L,Dip = diphenylalanine,Amidation,Free,Antimicrobial,Synthetic peptide,MT-1,Breast Cancer,MTT/MTS assay,IC50 =73 ± 2 µM,30-Min,Breast,None,NA,https://doi.org/10.1186/1471-2407-11-116
3307,21453492,2011,WKKW-Dip-KKWK,LTX-302,9,Linear,L,Dip = diphenylalanine,Amidation,Free,Antimicrobial,Synthetic peptide,Kelly,Brain Tumor,MTT/MTS assay,IC50 =28 ± 0 µM,30-Min,Brain,None,NA,https://doi.org/10.1186/1471-2407-11-116
1123,12005420,2001,WKLFKKIPKFLHLAKKF,N-1,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,MDA-MB-361,Breast Cancer,MTT/MTS assay,IC50=9.5 µM,48-h,Breast,None,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1145,12005420,2001,WKLFKKIPKFLHLAKKF,N-1,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,Jurkat,Blood Cancer,MTT/MTS assay,IC50=12 µM,48-h,Blood,None,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
1167,12005420,2001,WKLFKKIPKFLHLAKKF,N-1,17,Linear,L,None,Amidation,Free,Antibacterial,Ceropin A,K-562,Leukemia Cancer,MTT/MTS assay,IC50=6 µM,48-h,Blood,None,N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N,https://doi.org/10.1034/j.1399-3011.2001.00934.x
3290,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Bovine lactoferrin (Lf-B),M14,Skin Cancer,MTT/MTS assay,92.2 ± 1.02% cell viability at 10 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3291,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,71.1 ± 2.84% cell viability at 20 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3292,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,50 ± 3.09% cell viability at 40 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3293,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,31.5 ± 1.49% cell viability at 60 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3294,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,M14,Skin Cancer,MTT/MTS assay,13.8 ± 1.44% cell viability at 80 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3295,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,86 ± 0.57% cell viability at 10 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3296,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,63.8 ± 0.8% cell viability at 20 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3297,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,47.5 ± 1.66% cell viability at 40 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3298,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,26.9 ± 0.5% cell viability at 60 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3299,19957017,2010,KWKLFKKIPKFLHLAKKF,P18,18,Linear,L,None,Free,Free,Antibacterial,Synthetic peptide,A-375,Skin Cancer,MTT/MTS assay,6.5 ± 1.07% cell viability at 80 µM,NA,Skin,None,N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O,https://doi.org/10.1007/s10529-009-0175-2
3157,23301519,2013,WRWRWRWRW,Cyclic [W(RW)4 ]-Dox,9,Cyclic,L,Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ],Free,Free,Anticancer,Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP,CCRF-CEM,Leukemia Cancer,MTT/MTS assay,62-73% inhibition of cell proliferation at 1 µM,72 to 120-h,Blood,None,NA,https://doi.org/10.1021/mp3004034
3158,23301519,2013,WRWRWRWRW,Cyclic [W(RW)4 ]-Dox,9,Cyclic,L,Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ],Free,Free,Anticancer,Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP,SK-OV-3,Ovarian Cancer,MTT/MTS assay,51-74% inhibition of cell proliferation at 1 µM,72 to 120-h,Ovary,None,NA,https://doi.org/10.1021/mp3004034
3159,23301519,2013,WRWRWRWRW,Cyclic [W(RW)4 ]-Dox,9,Cyclic,L,Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ],Free,Free,Anticancer,Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP,HCT-116,Colon Cancer,MTT/MTS assay,50-67% inhibition of cell proliferation at 1 µM,72 to 120-h,Colon,None,NA,https://doi.org/10.1021/mp3004034
3160,23301519,2013,WRWRWRWRW,Cyclic [W(RW)4 ]-Dox,9,Cyclic,L,Doxorubicin (Dox) which is anthracycline attached with linker to CPP [W(RW)4 ],Free,Free,Anticancer,Doxorubicin (Dox) is a well-known anthracycline which has been conjugated to a CPP,MDA-MB-468,Breast Cancer,MTT/MTS assay,60-79% inhibition of cell proliferation at 1 µM,72 to 120-h,Breast,None,NA,https://doi.org/10.1021/mp3004034
3847,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,14.2% inhibition at 10-6,12.81-Min,Not Available,None,NA,https://doi.org/10.1021/jm051026+
3848,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,19.7% inhibition at 10-5,12.81-Min,Not Available,None,NA,https://doi.org/10.1021/jm051026+
3849,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,24.9% inhibition at 10-4,12.81-Min,Not Available,None,NA,https://doi.org/10.1021/jm051026+
3850,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,30.4% inhibition at 10-3,12.81-Min,Not Available,None,NA,https://doi.org/10.1021/jm051026+
3851,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,10% inhibition at 10-5,12.81-Min,Not Available,None,NA,https://doi.org/10.1021/jm051026+
3852,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,8.2% inhibition at 10-4,12.81-Min,Not Available,None,NA,https://doi.org/10.1021/jm051026+
3853,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,36.1% inhibition at 10-3,12.81-Min,Not Available,None,NA,https://doi.org/10.1021/jm051026+
3854,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,6.5% inhibition at 10-6,12.81-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3855,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,14% inhibition at 10-5,12.81-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3856,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,7.5% inhibition at 10-4,12.81-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3857,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,14% inhibition at 10-3,12.81-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3858,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,9.8% inhibition at 10-6,12.81-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3859,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,1.6% inhibition at 10-5,12.81-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3860,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,5.4% inhibition at 10-4,12.81-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3861,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,26.5% inhibition at 10-3,12.81-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3862,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,12.9% inhibition at 10-6,12.81-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3863,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,16.5% inhibition at 10-5,12.81-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3864,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,28.1% inhibition at 10-4,12.81-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3865,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,58.2% inhibition at 10-3,12.81-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3866,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,3.5% inhibition at 10-6,12.81-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3867,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,22.7% inhibition at 10-5,12.81-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3868,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,18.9% inhibition at 10-4,12.81-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3869,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,26.4% inhibition at 10-3,12.81-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3870,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,MCF-7,Breast Cancer,MTT/MTS assay,2.4% inhibition at 10-5,12.81-Min,Breast,None,NA,https://doi.org/10.1021/jm051026+
3871,16722632,2006,YA*,8,2,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,MCF-7,Breast Cancer,MTT/MTS assay,7.5% inhibition at 10-4,12.81-Min,Breast,None,NA,https://doi.org/10.1021/jm051026+
3966,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,1.0% inhibition at 10-6M,26.70-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3967,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,10.1% inhibition at 10-5M,26.70-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3968,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,16.8% inhibition at 10-4M,26.70-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3969,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,36.1% inhibition at 10-3M,26.70-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3970,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,4.9% inhibition at 10-6M,26.70-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3971,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,10.2% inhibition at 10-5M,26.70-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3972,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,13.3% inhibition at 10-4M,26.70-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3973,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,28.0% inhibition at 10-3M,26.70-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3974,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,0.8% inhibition at 10-6M,26.70-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3975,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,1.4% inhibition at 10-5M,26.70-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3976,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,2.4% inhibition at 10-4M,26.70-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3977,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,18.3% inhibition at 10-3M,26.70-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3978,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,3.3% inhibition at 10-6M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3979,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,11.0% inhibition at 10-5M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3980,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,7.9% inhibition at 10-4M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3981,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,23.7% inhibition at 10-3M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3982,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,12.2% inhibition at 10-6M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3983,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,15.5% inhibition at 10-5M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3984,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,24.7% inhibition at 10-4M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3985,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,29.0% inhibition at 10-3M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3986,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,3.0% inhibition at 10-6M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3987,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,8.4% inhibition at 10-5M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3988,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,18.5% inhibition at 10-4M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3989,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,10.6% inhibition at 10-3M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3990,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,MCF-7,Breast Cancer,MTT/MTS assay,22.8% inhibition at 10-3M,26.70-Min,Breast,None,NA,https://doi.org/10.1021/jm051026+
3991,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,13.7% inhibition at 10-6M,23.03-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3992,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,25.8% inhibition at 10-5M,23.03-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3993,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,34.7% inhibition at 10-4M,23.03-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3994,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,44.5% inhibition at 10-3M,23.03-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3995,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,8.5% inhibition at 10-6M,23.03-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3996,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,9.5% inhibition at 10-5M,23.03-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3997,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,15.4% inhibition at 10-4M,23.03-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3998,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,24.1% inhibition at 10-3M,23.03-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3999,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,2.4% inhibition at 10-6M,23.03-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
4000,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,4.5% inhibition at 10-5M,23.03-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
4001,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,11.4% inhibition at 10-4M,23.03-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
4002,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,23.2% inhibition at 10-3M,23.03-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
4003,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,16.2% inhibition at 10-6M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4004,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,6.6% inhibition at 10-5M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4005,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,5.1% inhibition at 10-4M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4006,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,14.5% inhibition at 10-3M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4007,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,26.4% inhibition at 10-6M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4008,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,13.1% inhibition at 10-5M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4009,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,14.6% inhibition at 10-4M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4010,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,38.4% inhibition at 10-3M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4011,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,17.7% inhibition at 10-6M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4012,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,10.9% inhibition at 10-5M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4013,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,12.1% inhibition at 10-4M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4014,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,8.1% inhibition at 10-3M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4015,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,MCF-7,Breast Cancer,MTT/MTS assay,9.6% inhibition at 10-4M,23.03-Min,Breast,None,NA,https://doi.org/10.1021/jm051026+
4016,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,MCF-7,Breast Cancer,MTT/MTS assay,29.9% inhibition at 10-3M,23.03-Min,Breast,None,NA,https://doi.org/10.1021/jm051026+
3966,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,1.0% inhibition at 10-6M,26.70-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3967,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,10.1% inhibition at 10-5M,26.70-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3968,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,16.8% inhibition at 10-4M,26.70-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3969,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,36.1% inhibition at 10-3M,26.70-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3970,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,4.9% inhibition at 10-6M,26.70-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3971,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,10.2% inhibition at 10-5M,26.70-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3972,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,13.3% inhibition at 10-4M,26.70-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3973,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,28.0% inhibition at 10-3M,26.70-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3974,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,0.8% inhibition at 10-6M,26.70-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3975,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,1.4% inhibition at 10-5M,26.70-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3976,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,2.4% inhibition at 10-4M,26.70-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3977,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,18.3% inhibition at 10-3M,26.70-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3978,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,3.3% inhibition at 10-6M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3979,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,11.0% inhibition at 10-5M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3980,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,7.9% inhibition at 10-4M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3981,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,23.7% inhibition at 10-3M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3982,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,12.2% inhibition at 10-6M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3983,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,15.5% inhibition at 10-5M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3984,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,24.7% inhibition at 10-4M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3985,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,29.0% inhibition at 10-3M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3986,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,3.0% inhibition at 10-6M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3987,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,8.4% inhibition at 10-5M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3988,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,18.5% inhibition at 10-4M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3989,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,10.6% inhibition at 10-3M,26.70-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3990,16722632,2006,YA*GFM,17,5,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,MCF-7,Breast Cancer,MTT/MTS assay,22.8% inhibition at 10-3M,26.70-Min,Breast,None,NA,https://doi.org/10.1021/jm051026+
3991,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,13.7% inhibition at 10-6M,23.03-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3992,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,25.8% inhibition at 10-5M,23.03-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3993,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,34.7% inhibition at 10-4M,23.03-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3994,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,44.5% inhibition at 10-3M,23.03-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3995,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,8.5% inhibition at 10-6M,23.03-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3996,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,9.5% inhibition at 10-5M,23.03-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3997,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,15.4% inhibition at 10-4M,23.03-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3998,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,24.1% inhibition at 10-3M,23.03-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3999,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,2.4% inhibition at 10-6M,23.03-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
4000,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,4.5% inhibition at 10-5M,23.03-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
4001,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,11.4% inhibition at 10-4M,23.03-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
4002,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,23.2% inhibition at 10-3M,23.03-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
4003,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,16.2% inhibition at 10-6M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4004,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,6.6% inhibition at 10-5M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4005,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,5.1% inhibition at 10-4M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4006,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,14.5% inhibition at 10-3M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4007,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,26.4% inhibition at 10-6M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4008,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,13.1% inhibition at 10-5M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4009,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,14.6% inhibition at 10-4M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4010,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,38.4% inhibition at 10-3M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4011,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,17.7% inhibition at 10-6M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4012,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,10.9% inhibition at 10-5M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4013,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,12.1% inhibition at 10-4M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4014,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,8.1% inhibition at 10-3M,23.03-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4015,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,MCF-7,Breast Cancer,MTT/MTS assay,9.6% inhibition at 10-4M,23.03-Min,Breast,None,NA,https://doi.org/10.1021/jm051026+
4016,16722632,2006,YA*GFM,18,5,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,MCF-7,Breast Cancer,MTT/MTS assay,29.9% inhibition at 10-3M,23.03-Min,Breast,None,NA,https://doi.org/10.1021/jm051026+
1886,None,2005,YAKLLAKLAKKAL,FLAK50T9,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,MCF-7,Breast Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Breast,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2038,None,2005,YAKLLAKLAKKAL,FLAK50T9,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,SW-480,Colon Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Colon,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2190,None,2005,YAKLLAKLAKKAL,FLAK50T9,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2342,None,2005,YAKLLAKLAKKAL,FLAK50T9,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,BMKC,Skin Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Skin,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2495,None,2005,YAKLLAKLAKKAL,FLAK50T9,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,H-1299,Lung Cancer,MTT/MTS assay,LD50 =>1000 µg/ml,24-h,Lung,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2638,None,2005,YAKLLAKLAKKAL,FLAK50T9,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,PC-3,Prostate Cancer,MTT/MTS assay,Not Available,24-h,Prostate,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
2781,None,2005,YAKLLAKLAKKAL,FLAK50T9,13,Linear,L,None,Amidation,Free,Anticancer,FLAK peptides,HeLa,Cervical Cancer,MTT/MTS assay,LD50 = >1000 µg/ml,24-h,Cervix,US_06875744_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N,Not Found
4017,16722632,2006,YGGFMA*,23,6,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,3.9% inhibition at 10-5M,31.92-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
4018,16722632,2006,YGGFMA*,23,6,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,45% inhibition at 10-3M,31.92-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
4019,16722632,2006,YGGFMA*,23,6,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,9.3% inhibition at 10-3M,31.92-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
4020,16722632,2006,YGGFMA*,23,6,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,4.1% inhibition at 10-6M,31.92-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
4021,16722632,2006,YGGFMA*,23,6,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,70.7% inhibition at 10-5M,31.92-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
4022,16722632,2006,YGGFMA*,23,6,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,34.4% inhibition at 10-3M,31.92-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
4023,16722632,2006,YGGFMA*,23,6,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,9.2% inhibition at 10-3M,31.92-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4024,16722632,2006,YGGFMA*,23,6,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,11.08% inhibition at 10-5M,31.92-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4025,16722632,2006,YGGFMA*,23,6,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,47.0% inhibition at 10-3M,31.92-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
4026,16722632,2006,YGGFMA*,23,6,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,MCF-7,Breast Cancer,MTT/MTS assay,2.2% inhibition at 10-6M,31.92-Min,Breast,None,NA,https://doi.org/10.1021/jm051026+
4027,16722632,2006,YGGFMA*,23,6,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,MCF-7,Breast Cancer,MTT/MTS assay,7.1% inhibition at 10-5M,31.92-Min,Breast,None,NA,https://doi.org/10.1021/jm051026+
4028,16722632,2006,YGGFMA*,23,6,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,MCF-7,Breast Cancer,MTT/MTS assay,6.9% inhibition at 10-4M,31.92-Min,Breast,None,NA,https://doi.org/10.1021/jm051026+
4029,16722632,2006,YGGFMA*,23,6,Linear,L,"A* = Cαα -dialkylated glycine (Aaa1,1 )",Free,Free,Antitumor,Synthetic Peptide,MCF-7,Breast Cancer,MTT/MTS assay,25.9% inhibition at 10-3M,31.92-Min,Breast,None,NA,https://doi.org/10.1021/jm051026+
3718,24176852,2013,YGRKKRRQRRRREADFFWSLCTADMS,KilerFLIP,26,linear,L,None,Free,Free,NA,NA,Jurkat,Blood Cancer,Not Available,NA,NA,Blood,None,N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1038/cddis.2013.401
4604,12417587,2003,YGRKKRRQRRR,Tat (47-57),11,Linear,L,None,Free,Free,Antimicrobial,Synthetic,HeLa,Cervical Cancer,MTT/MTS assay,at 1 µM 90-100% viablity,6-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1074/jbc.M208762200
4606,12417587,2003,YGRKKRRQRRR,Tat (47-57),11,Linear,L,None,Free,Free,Antimicrobial,Synthetic,HeLa,Cervical Cancer,MTT/MTS assay,at 10 µM 80% viablity,6-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1074/jbc.M208762200
4608,12417587,2003,YGRKKRRQRRR,Tat (47-57),11,Linear,L,None,Free,Free,Antimicrobial,Synthetic,HeLa,Cervical Cancer,MTT/MTS assay,at 100 µM 60% viablity,6-h,Cervix,None,N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O,https://doi.org/10.1074/jbc.M208762200
3718,24176852,2013,YGRKKRRQRRRREADFFWSLCTADMS,KilerFLIP,26,linear,L,None,Free,Free,NA,NA,Jurkat,Blood Cancer,Not Available,NA,NA,Blood,None,N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)O,https://doi.org/10.1038/cddis.2013.401
4335,None,2009,YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB-Lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,H-322,Lung Cancer,WST-1 assay,IC50= 6.8 µM,Not Available,Lung,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4336,None,2009,YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB-Lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,BT-20,Breast Cancer,WST-1 assay,IC50= 6.5 µM,Not Available,Breast,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4337,None,2009,YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB-Lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,U-251,Brain Tumor,WST-1 assay,IC50= 12 µM,Not Available,Brain,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4338,None,2009,YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB-Lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,BxPC-3,Pancreatic Cancer,WST-1 assay,IC50= 12 µM,Not Available,Pancreatic,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4339,None,2009,YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB-Lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,SU.86.86,Pancreatic Cancer,WST-1 assay,IC50= 12 µM,Not Available,Pancreatic,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4340,None,2009,YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB-Lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,LNCaP,Prostate Cancer,WST-1 assay,IC50= 10 µM,Not Available,Prostate,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4599,21351323,2011,YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EGFR-lytic,32,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,MDA-MB-231,Breast Cancer,ELISA,IC50 =0.12 µM,60-Min,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1002/psc.1349
4600,21351323,2011,YHWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EGFR-lytic,32,Linear,Mix,None,Free,Free,Antitumor,Synthetic Peptide,MDA-MB-231,Breast Cancer,ELISA,IC50 =0.46 µM,15-Min,Breast,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,https://doi.org/10.1002/psc.1349
4461,"10531277, 18957441",1999,"YKQCHKKGGHCFPKEKICLPPSSDFGKMDCRWRWK
CCKKGSG",Crotamine,42,Not Available,L,None,Free,Free,Antibacterial,"Rattlesnake venom, Crotalus durissus terrificus",Not Available,Breast Cancer,Not Available,Not Available,Not Available,Not Available,None,[NH3][C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H]2C(=O)N[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]4C(=O)N[C@H](C(=O)N5[C@H](C(=O)N6[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)O)CO)CCCC[NH3])CCCC[NH3])CSSC4)CSSC1)CCCC[NH3])Cc1c[nH]c4c1cccc4)CCCNC(=[NH2])N)Cc1c[nH]c4c1cccc4)CCCNC(=[NH2])N)CSSC2)CC(=O)O)CCSC)CCCC[NH3])Cc1ccccc1)CC(=O)O)CO)CO)CCC6)CCC5)CC(C)C)[C@H](CC)C)CCCC[NH3])CCC(=O)O)CCCC[NH3])CCC3)Cc1ccccc1)CC1=CNCN1)CCCC[NH3])CCCC[NH3])CC1=CNCN1)CCC(=O)N)CCCC[NH3])Cc1ccc(cc1)O,"['https://doi.org/10.1128/IAI.67.11.6139-6144.1999', 'https://doi.org/10.1093/nar/gkn823']"
3342,23533710,2013,YPFPG,β-Casomorphins 5 f(60_64),4,Linear,L,None,Amidation,Free,"Immunomodulant, Antihypertensive, Antimicrobial,Antiviral, and Antioxidant",Bovine milk,AZ-97,Colon Cancer,MTT/MTS assay,Inhibition at 9-11g/l,NA,Colon,None,N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N,https://doi.org/10.1155/2013/939804
3942,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,4.6% inhibition at 10-6M,10.79-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3943,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,4.9% inhibition at 10-5M,10.79-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3944,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,12.6% inhibition at 10-4M,10.79-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3945,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,26.4% inhibition at 10-3M,10.79-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3946,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,11.0% inhibition at 10-6M,10.79-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3947,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,11.7% inhibition at 10-5M,10.79-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3948,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,11.6% inhibition at 10-4M,10.79-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3949,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,28.2% inhibition at 10-3M,10.79-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3950,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,1.2% inhibition at 10-5M,10.79-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3951,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,3.3% inhibition at 10-4M,10.79-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3952,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,19.4% inhibition at 10-3M,10.79-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3953,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,7.6% inhibition at 10-6M,10.79-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3954,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,3.8% inhibition at 10-5M,10.79-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3955,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,12.4% inhibition at 10-4M,10.79-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3956,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,22.4% inhibition at 10-3M,10.79-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3957,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,17.0% inhibition at 10-6M,10.79-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3958,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,13.5% inhibition at 10-5M,10.79-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3959,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,13.5% inhibition at 10-4M,10.79-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3960,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,25.3% inhibition at 10-3M,10.79-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3961,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,8.1% inhibition at 10-6M,10.79-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3962,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,6.9% inhibition at 10-5M,10.79-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3963,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,8.1% inhibition at 10-4M,10.79-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3964,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,8.6% inhibition at 10-3M,10.79-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3965,16722632,2006,YRA*G,16,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,MCF-7,Breast Cancer,MTT/MTS assay,15.6% inhibition at 10-3M,10.79-Min,Breast,None,NA,https://doi.org/10.1021/jm051026+
4341,None,2009,YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB(H2R)-lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,H-322,Lung Cancer,WST-1 assay,IC50= 3.2 µM,Not Available,Lung,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4342,None,2009,YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB(H2R)-lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,BT-20,Breast Cancer,WST-1 assay,IC50= 1.9 µM,Not Available,Breast,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4343,None,2009,YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB(H2R)-lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,U-251,Brain Tumor,WST-1 assay,IC50= 8.4 µM,Not Available,Brain,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4344,None,2009,YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB(H2R)-lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,BxPC-3,Pancreatic Cancer,WST-1 assay,IC50= 6.6 µM,Not Available,Pancreatic,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4345,None,2009,YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB(H2R)-lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,SU.86.86,Pancreatic Cancer,WST-1 assay,IC50= 7.4 µM,Not Available,Pancreatic,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
4346,None,2009,YRWYGYTPQNVIGGGKLlLKlLkkLLKlLKKK,EB(H2R)-lytic,32,Linear,Mix,None,Free,Free,Anticancer,Synthetic Peptide,LNCaP,Prostate Cancer,WST-1 assay,IC50= 4.8 µM,Not Available,Prostate,US_8436137_B2,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O,Not Found
3872,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,6.2% inhibition at 10-6,12.46-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3873,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,6.4% inhibition at 10-5,12.46-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3874,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,8.2% inhibition at 10-4,12.46-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3875,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,21.2% inhibition at 10-3,12.46-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3876,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,7.5% inhibition at 10-6,12.46-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3877,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,6.1% inhibition at 10-5,12.46-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3878,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,3.1% inhibition at 10-4,12.46-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3879,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,14.8% inhibition at 10-3,12.46-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3880,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,3.9% inhibition at 10-5,12.46-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3881,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,7.3% inhibition at 10-3,12.46-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3882,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,4.9% inhibition at 10-6,12.46-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3883,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,8.9% inhibition at 10-5,12.46-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3884,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,3.4% inhibition at 10-4,12.46-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3885,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,20.8% inhibition at 10-3,12.46-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3886,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,10.5% inhibition at 10-6,12.46-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3887,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,21.9% inhibition at 10-5,12.46-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3888,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,11.8% inhibition at 10-4,12.46-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3889,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,17.9% inhibition at 10-3,12.46-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3890,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,3.7% inhibition at 10-6,12.46-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3891,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,16.5% inhibition at 10-5,12.46-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3892,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,8.4% inhibition at 10-4,12.46-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3893,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,14.5% inhibition at 10-3,12.46-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3894,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,MCF-7,Breast Cancer,MTT/MTS assay,1.1% inhibition at 10-5,12.46-Min,Breast,None,NA,https://doi.org/10.1021/jm051026+
3895,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,MCF-7,Breast Cancer,MTT/MTS assay,1.2% inhibition at 10-4,12.46-Min,Breast,None,NA,https://doi.org/10.1021/jm051026+
3896,16722632,2006,YSA*,9,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,MCF-7,Breast Cancer,MTT/MTS assay,17.8% inhibition at 10-3,12.46-Min,Breast,None,NA,https://doi.org/10.1021/jm051026+
3897,16722632,2006,YSA*,10,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,8.5% inhibition at 10-6,14.05-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3898,16722632,2006,YSA*,10,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,4.9% inhibition at 10-5,14.05-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3899,16722632,2006,YSA*,10,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,1.9% inhibition at 10-4,14.05-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3900,16722632,2006,YSA*,10,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,16.2% inhibition at 10-3,14.05-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3901,16722632,2006,YSA*,10,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,7.2% inhibition at 10-6,14.05-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3902,16722632,2006,YSA*,10,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,17.1% inhibition at 10-5,14.05-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3903,16722632,2006,YSA*,10,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,11.0% inhibition at 10-4,14.05-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3904,16722632,2006,YSA*,10,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,20.5% inhibition at 10-3,14.05-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3905,16722632,2006,YSA*,10,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,3.0% inhibition at 10-6,14.05-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3906,16722632,2006,YSA*,10,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,4.7% inhibition at 10-5,14.05-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3907,16722632,2006,YSA*,10,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,2.7% inhibition at 10-4,14.05-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3908,16722632,2006,YSA*,10,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,7.3% inhibition at 10-3,14.05-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3909,16722632,2006,YSA*,10,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,0.7% inhibition at 10-6,14.05-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3910,16722632,2006,YSA*,10,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,8.3% inhibition at 10-5,14.05-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3911,16722632,2006,YSA*,10,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,10.5% inhibition at 10-4,14.05-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3912,16722632,2006,YSA*,10,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,21.8% inhibition at 10-3,14.05-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3913,16722632,2006,YSA*,10,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,10.7% inhibition at 10-6,14.05-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3914,16722632,2006,YSA*,10,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,10.0% inhibition at 10-5,14.05-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3915,16722632,2006,YSA*,10,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,MCF-7,Breast Cancer,MTT/MTS assay,7.7% inhibition at 10-4M,14.05-Min,Breast,None,NA,https://doi.org/10.1021/jm051026+
3916,16722632,2006,YSA*,10,3,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,MCF-7,Breast Cancer,MTT/MTS assay,18.7% inhibition at 10-3M,14.05-Min,Breast,None,NA,https://doi.org/10.1021/jm051026+
3917,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,2.7% inhibition at 10-6M,9.53-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3918,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,2.0% inhibition at 10-5M,9.53-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3919,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,18.8% inhibition at 10-4M,9.53-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3920,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,26.7% inhibition at 10-3M,9.53-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3921,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,9.8% inhibition at 10-6M,9.53-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3922,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,7.3% inhibition at 10-5M,9.53-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3923,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,9.9% inhibition at 10-4M,9.53-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3924,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,28.2% inhibition at 10-3M,9.53-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3925,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,1.6% inhibition at 10-6M,9.53-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3926,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,2.9% inhibition at 10-5M,9.53-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3927,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,5.9% inhibition at 10-4M,9.53-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3928,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,17.9% inhibition at 10-3M,9.53-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3929,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,5.4% inhibition at 10-6M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3930,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,7.4% inhibition at 10-5M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3931,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,9.5% inhibition at 10-4M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3932,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,15.7% inhibition at 10-3M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3933,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,13.6% inhibition at 10-6M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3934,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,20.4% inhibition at 10-5M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3935,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,14.4% inhibition at 10-4M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3936,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,23.4% inhibition at 10-3M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3937,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,2.2% inhibition at 10-6M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3938,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,4.2% inhibition at 10-5M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3939,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,6.4% inhibition at 10-4M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3940,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,6.2% inhibition at 10-3M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3941,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,MCF-7,Breast Cancer,MTT/MTS assay,21.2% inhibition at 10-3M,9.53-Min,Breast,None,NA,https://doi.org/10.1021/jm051026+
3917,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,2.7% inhibition at 10-6M,9.53-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3918,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,2.0% inhibition at 10-5M,9.53-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3919,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,18.8% inhibition at 10-4M,9.53-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3920,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HEp-2,Larynx Cancer,MTT/MTS assay,26.7% inhibition at 10-3M,9.53-Min,Larynx,None,NA,https://doi.org/10.1021/jm051026+
3921,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,9.8% inhibition at 10-6M,9.53-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3922,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,7.3% inhibition at 10-5M,9.53-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3923,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,9.9% inhibition at 10-4M,9.53-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3924,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HeLa,Cervical Cancer,MTT/MTS assay,28.2% inhibition at 10-3M,9.53-Min,Cervix,None,NA,https://doi.org/10.1021/jm051026+
3925,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,1.6% inhibition at 10-6M,9.53-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3926,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,2.9% inhibition at 10-5M,9.53-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3927,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,5.9% inhibition at 10-4M,9.53-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3928,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HBL,Skin Cancer,MTT/MTS assay,17.9% inhibition at 10-3M,9.53-Min,Skin,None,NA,https://doi.org/10.1021/jm051026+
3929,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,5.4% inhibition at 10-6M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3930,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,7.4% inhibition at 10-5M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3931,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,9.5% inhibition at 10-4M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3932,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,HT-29,Colon Cancer,MTT/MTS assay,15.7% inhibition at 10-3M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3933,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,13.6% inhibition at 10-6M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3934,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,20.4% inhibition at 10-5M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3935,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,14.4% inhibition at 10-4M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3936,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,SW-620,Colon Cancer,MTT/MTS assay,23.4% inhibition at 10-3M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3937,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,2.2% inhibition at 10-6M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3938,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,4.2% inhibition at 10-5M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3939,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,6.4% inhibition at 10-4M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3940,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,CaCo-2,Colon Cancer,MTT/MTS assay,6.2% inhibition at 10-3M,9.53-Min,Colon,None,NA,https://doi.org/10.1021/jm051026+
3941,16722632,2006,YSA*G,15,4,Linear,L,"A* = Cα -dialkylated glycine (Aaa2,2 )",Free,Free,Antitumor,Synthetic Peptide,MCF-7,Breast Cancer,MTT/MTS assay,21.2% inhibition at 10-3M,9.53-Min,Breast,None,NA,https://doi.org/10.1021/jm051026+
4219,16091933,2005,YSL,Tyroserleutide,3,Linear,L,None,Free,Free,Antitumor,Synthetic Peptide,B16-F10,Skin Cancer,MTT/MTS assay,49.4% cytotoxic at 0.1 µg/ml,96-h,Skin,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1007/s00262-005-0024-7
4220,16091933,2005,YSL,Tyroserleutide,3,Linear,L,None,Free,Free,Antitumor,Synthetic Peptide,B16-F10,Skin Cancer,MTT/MTS assay,51.2% cytotoxic at 1 µg/ml,96-h,Skin,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1007/s00262-005-0024-7
4221,16091933,2005,YSL,Tyroserleutide,3,Linear,L,None,Free,Free,Antitumor,Synthetic Peptide,B16-F10,Skin Cancer,MTT/MTS assay,53.0% cytotoxic at 10 µg/ml,96-h,Skin,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1007/s00262-005-0024-7
4222,16091933,2005,YSL,Tyroserleutide,3,Linear,L,None,Free,Free,Antitumor,Synthetic Peptide,B16-F10,Skin Cancer,MTT/MTS assay,61.2% cytotoxic at 100 µg/ml,96-h,Skin,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1007/s00262-005-0024-7
4223,16091933,2005,YSL,Tyroserleutide,3,Linear,L,None,Free,Free,Antitumor,Synthetic Peptide,BEL-7402,Liver Cancer,MTT/MTS assay,39.0% cytotoxic at 0.1 µg/ml,96-h,Liver,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1007/s00262-005-0024-7
4224,16091933,2005,YSL,Tyroserleutide,3,Linear,L,None,Free,Free,Antitumor,Synthetic Peptide,BEL-7402,Liver Cancer,MTT/MTS assay,20.8% cytotoxic at 1 µg/ml,96-h,Liver,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1007/s00262-005-0024-7
4225,16091933,2005,YSL,Tyroserleutide,3,Linear,L,None,Free,Free,Antitumor,Synthetic Peptide,BEL-7402,Liver Cancer,MTT/MTS assay,33.8% cytotoxic at 10 µg/ml,96-h,Liver,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1007/s00262-005-0024-7
4226,16091933,2005,YSL,Tyroserleutide,3,Linear,L,None,Free,Free,Antitumor,Synthetic Peptide,BEL-7402,Liver Cancer,MTT/MTS assay,35.6% cytotoxic at 100 µg/ml,96-h,Liver,None,N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O,https://doi.org/10.1007/s00262-005-0024-7
4448,"8245827, 18957441",1993,KSSAYSLQMGATAIKQVKKLFKKWGW,Plantaricin A,26,Not Available,L,None,Free,Free,Antibacterial,"Lactobacillus plantarumC11, WCFS1, V90",Not Available,Colorectal Cancer,Not Available,Not Available,Not Available,Not Available,None,N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C=O)Cc1c[nH]c2c1cccc2)Cc1c[nH]c2c1cccc2)CCCC[NH3])CCCC[NH3])Cc1ccccc1)CC(C)C)CCCC[NH3])CCCC[NH3])C(C)C)CCC(=O)N)CCCC[NH3])[C@H](CC)C)C)[C@H](O)C)C)CCSC)CCC(=O)N)CC(C)C)CO)Cc1ccc(cc1)O)C)CO)CO)CCCC[NH3],"['https://doi.org/10.1099/00221287-139-9-1973', 'https://doi.org/10.1093/nar/gkn823']"
